Publications 2018

1. Aanhane, E, Schulkens, IA, Heusschen, R, Castricum, K, Leffler, H, Griffioen, AW & Thijssen, VL 2018, 'Different angioregulatory activity of monovalent galectin-9 isoforms', Angiogenesis;21(3): 545-555. (AmsterdamUMC) 2. Abdul, KU, Houweling, M, Svensson, F, Narayan, RS, Cornelissen, FMG, Küçükosmanoglu, A, Metzakopian, E, Watts, C, Bailey, D, Wurdinger, T & Westerman, BA 2018, 'WINDOW consortium: A path towards increased therapy efficacy against glioblastoma', Drug resistance updates;40: 17-24. (AmsterdamUMC) 3. Aben N, Westerhuis JA, Song Y, Kiers HAL, Michaut M, Smilde AK, Wessels LFA,` iTOP: inferring the topology of omics data`, Bioinformatics 2018; 34:i988-i996 (NKI) 4. Abou-Alfa, GK, Meyer, T, Cheng, A-L, el-Khoueiry, AB, Rimassa, L, Ryoo, B-Y, Cicin, I, Merle, P, Chen, Y, Park, J-W, Blanc, J-F, Bolondi, L, Klümpen, H-J, Chan, SL, Zagonel, V, Pressiani, T, Ryu, M-H, Venook, AP, Hessel, C, Borgman-Hagey, AE, Schwab, G & Kelley, RK 2018, 'Cabozantinib in patients with advanced and progressing hepatocellular carcinoma', New England journal of medicine;379(1): 54-63. (AmsterdamUMC) 5. Abrahams, HJG, Gielissen, MFM, Verhagen, CAHHVM & Knoop, H 2018, 'The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: A systematic review', Clinical psychology review;63: 1-11. (AmsterdamUMC) 6. Abu Hilal, M, Aldrighetti, L, Dagher, I, Edwin, B, Troisi, RI, Alikhanov, R, Aroori, S, Belli, G, Besselink, M, Briceno, J, Gayet, B, D'Hondt, M, Lesurtel, M, Menon, K, Lodge, P, Rotellar, F, Santoyo, J, Scatton, O, Soubrane, O, Sutcliffe, R, van Dam, R, White, S, Halls, MC, Cipriani, F, van der Poel, M, Ciria, R, Barkhatov, L, Gomez-Luque, Y, Ocana-Garcia, S, Cook, A, Buell, J, Clavien, P-A, Dervenis, C, Fusai, G, Geller, D, Lang, H, Primrose, J, Taylor, M, van Gulik, T, Wakabayashi, G, Asbun, H & Cherqui, D 2018, 'The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation', Annals of surgery;268(1): 11-18. (AmsterdamUMC) 7. Abubakar M, Chang-Claude J, Ali HR, Chatterjee N, Coulson P, Daley F, Blows F, Benitez J, Milne RL, Brenner H, Stegmaier C, Mannermaa A, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RA, Seynaeve C, Figueroa J, Lissowska J, Hewitt S, Hooning MJ, Hollestelle A, Foekens R, Koppert LB, Investigators K, Bolla MK, Wang Q, Jones ME, Schoemaker MJ, Keeman R, Easton DF, Swerdlow AJ, Sherman ME, Schmidt MK, Pharoah PD, Garcia-Closas M,` Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation`, Int J Cancer 2018; 143:746-57 (NKI) 8. Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat AM, Kanzaki R, Zlotta AR, Shariat SF,` The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review`, Eur Urol 2018; 73:543-57 (NKI) 9. Adam, JA, Arkies, H, Hinnen, K, Stalpers, LJ, van Waesberghe, JH, Stoker, J, van Os, R, Laan, JJ, Mom, CH & van Eck-Smit, BL 2018, '18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer', quarterly journal of nuclear medicine and molecular imaging, ;62(4): 420-428. (AmsterdamUMC) 10. Adami HO, Berns A, Celis JE, de VE, Eggermont A, Harris A, Zur Hausen H, Pelicci PG, Ringborg U,` European Academy of Cancer Sciences - position paper`, Mol Oncol 2018; 12:1829-37 (NKI) 11. Adan F, Crijns MB, Zandstra WSE, Bekkenk MW, Bleeker FE, Dekker E, van Leerdam ME,` Cumulative risk of skin tumours in patients with Lynch syndrome`, Br J Dermatol 2018; 179:522-3 [Letter] (NKI) 12. Aderetti, DA, Hira, VVV, Molenaar, RJ & van Noorden, CJF 2018, 'The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma', BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, ;1869(2): 346-354. (AmsterdamUMC) 13. Adriaensen W, Dorlo TPC, Vanham G, Kestens L, Kaye PM, van Griensven J,` Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients`, Front Immunol 2018; 8:1943 (16 pp) (NKI) 14. Advanced Radiation Technology Committee of the International Association for the Study of Lung Cancer 2018, 'Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay', Journal of Thoracic Oncology, ;13(6): 855-862. (AmsterdamUMC) 15. Aflakparast, M, de Gunst, M & van Wieringen, WN 2018, 'Reconstruction of molecular network evolution from cross-sectional omics data', Biometrical Journal, ;60(2): 547. (AmsterdamUMC) 16. Agahozo MC, Hammerl D, Debets R, Kok M, van Deurzen CHM,` Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes? Mod Pathol 2018; 31:1012-25 `, (NKI) 17. Agarwal, S, Milazzo, G, Rajapakshe, K, Bernardi, R, Chen, Z, Barberi, E, Koster, J, Perini, G, Coarfa, C & Shohet, JM 2018, 'MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma', Oncotarget, ;9(29): 20323-20338. (AmsterdamUMC) 18. Ahmed Ali, U, ten Hove, JR, Reiber, BM, van der Sluis, PC & Besselink, MG 2018, 'Sample size of surgical randomized controlled trials: a lack of improvement over time', Journal of surgical research, ;228: 1-7. (AmsterdamUMC) 19. Akkermans, A, Henkemans, FS, Labrie, N, Henselmans, I & van Laarhoven, H 2018, 'The stereotypicality of symptomatic and pragmatic argumentation in consultations about palliative systemic treatment for advanced cancer', Journal of Argumentation in Context, ;7(2): 181-203. (AmsterdamUMC) 20. Alieva M, van Rheenen J, Broekman MLD,` Potential impact of invasive surgical procedures on primary tumor growth and metastasis`, Clin Exp Metastasis 2018; 35:319-31 (NKI) 21. Allahyar A, Vermeulen C, Bouwman BAM, Krijger PHL, Verstegen MJAM, Geeven G, van Kranenburg M, Pieterse M, Straver R, Haarhuis JHI, Jalink K, Teunissen H, Renkens IJ, Kloosterman WP, Rowland BD, de Wit E, de Ridder J, de Laat W,` Enhancer hubs and loop collisions identified from single-allele topologies`, Nat Genet 2018; 50:1151-60 (NKI) 22. Allard B, Aspeslagh S, Garaud S, Dupont FA, Solinas C, Kok M, Routy B, Sotiriou C, Stagg J, Buisseret L,` Immuno-oncology-101: overview of major concepts and translational perspectives`, Semin Cancer Biol 2018; 52:1-11 (NKI) 23. Amant, F, Mirza, MR, Koskas, M & Creutzberg, CL 2018, 'Cancer of the corpus uteri', International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, ;143: 37-50. (AmsterdamUMC) 24. Amant, F, Nooij, L, Annibali, D, van Rompuy, A-S, Han, S, van den Bulck, H & Goffin, F 2018, 'Brief Report on 3-Weekly Paclitaxel Carboplatin Efficacy in Locally Advanced or Metastatic Squamous Vulvar Cancer', Gynecologic and obstetric investigation, ;83(6): 620-626. (AmsterdamUMC/NKI) 25. Amelung, FJ, Burghgraef, TA, Tanis, PJ, van Hooft, JE, ter Borg, F, Siersema, PD, Bemelman, WA & Consten, ECJ 2018, 'Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer;(): (AmsterdamUMC) 26. Amir, Z, Popa, A, Tamminga, S, Yagil, D, Munir, F & de Boer, A 2018, 'Employer's management of employees affected by cancer', Supportive care in cancer, ;26(3): 681-684. (AmsterdamUMC) 27. Amsen, D, van Gisbergen, KPJM, Hombrink, P & van Lier, RAW 2018, 'Tissue-resident memory T cells at the center of immunity to solid tumors', Nature immunology, ;19(6): 538-546. (AmsterdamUMC) 28. Amstutz U, Henricks LM, Offer SM, Barbarino J, Schellens JHM, Swen JJ, Klein TE, McLeod HL, Caudle KE, Diasio RB, Schwab M,` Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update`, Clin Pharmacol Ther 2018; 103:210-6 (NKI) 29. Andry, G, Hamoir, M & Leemans, CR 2018, 'Quality assurance in head and neck surgery: special considerations to catch up', European Archives of Oto-Rhino-Laryngology, ;275(8): 2145-2149. (AmsterdamUMC) 30. Annamdevula NS, Sweat R, Griswold J, Trinh K, Hoffman C, West S, Deal J, Britain AL, Jalink K, Rich T, Leavesley SJ,` Spectral imaging of FRET-based sensors reveals sustained cAMP gradients in three spatial dimensions`, Cytometry A 2018; 93:1029-38 (NKI) 31. Anupama J, Francescatto M, Rahman F, Fatima N, DeBlasio D, Shanmugam AK, Satagopam V, Santos A, Kolekar P, Michaut M, Guney E,` The ISCB Student Council Internship Program: Expanding computational biology capacity worldwide`, PLoS Comput Biol 2018; 14:e1005802 [12 pp] (NKI) 32. Argenzio E, Klarenbeek J, Kedziora KM, Nahidiazar L, Isogai T, Perrakis A, Jalink K, Moolenaar WH, Innocenti M,` Profilin 1 binding couples chloride intracellular channel protein CLIC4 to RhoA-mDia2 signaling and filopodium formation`, J Biol Chem 2018; 293:19161-76 (NKI) 33. Argillander, TE, Koornstra, JJ, van Kouwen, M, Langers, AMJ, Nagengast, FM, Vecht, J, de Vos tot Nederveen Cappel, WH, Dekker, E, van Duijvendijk, P & Vasen, HFA 2018, 'Features of incident colorectal cancer in Lynch syndrome', United European gastroenterology journal, ;6(8): 1215-1222. (AmsterdamUMC) 34. Aristotle Consortium 2018, 'Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis', The Lancet Haematology, ;5(8): e359-e367. (AmsterdamUMC) 35. Armand P, Engert A, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman JM, Collins GP, Ramchandren R, Cohen JB, de Boer JP, Kuruvilla J, Savage KJ, Trneny M, Shipp MA, Kato K, Sumbul A, Farsaci B, Ansell SM,` Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial`, J Clin Oncol 2018; 36:1428-39 (NKI) 36. Armenian, SH, Armstrong, GT, Aune, G, Chow, EJ, Ehrhardt, MJ, Ky, B, Moslehi, J, Mulrooney, DA, Nathan, PC, Ryan, TD, van der Pal, HJ, van Dalen, EC & Kremer, LCM 2018, 'Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention', Journal of clinical oncology, ;36(21): 2135-2144. (AmsterdamUMC) 37. Azimi A, Caramuta S, Seashore-Ludlow B, Bostrom J, Robinson JL, Edfors F, Tuominen R, Kemper K, Krijgsman O, Peeper DS, Nielsen J, Hansson J, Egyhazi Brage S, Altun M, Uhlen M, Maddalo G,` Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors`, Mol Syst Biol 2018; 14:e7858 (NKI) 38. Azizi, AA & Schouten-van Meeteren, AYN 2018, 'Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey', Journal of neuro-oncology, ;136(1): 127-134. (AmsterdamUMC) 39. Baas P, Burgers S,` Malignant pleural effusions: will PROMISE make its name true? Lancet Oncol 2018; 19:853-5 [Comment] `, (NKI) 40. Baas P, Disselhorst M,` Immuno-oncology in malignant pleural mesothelioma`, Lancet Respir Med 2018; 6:408-10 [Comment] (NKI) 41. Baas, J, Krens, L, Bohringer, S, Mol, L, Punt, C, Guchelaar, H-J & Gelderblom, H 2018, 'Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab', PLoS ONE, ;13(12): e0208080. (AmsterdamUMC) 42. Babaei M, Jansen L, Balavarca Y, Sjovall A, Bos A, van de Velde T, Moreau M, Liberale G, Goncalves AF, Bento MJ, Ulrich CM, Schrotz-King P, Lemmens V, Glimelius B, Brenner H,` Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes`, Clin Colorectal Cancer 2018; 17:e129-e142 (NKI) 43. Babała, N, Bovens, A, de Vries, E, Iglesias-Guimarais, V, Ahrends, T, Krummel, MF, Borst, J & Bins, AD 2018, 'Subcellular localization of antigen in keratinocytes dictates delivery of CD4þ T-cell Help for the CTL response upon therapeutic DNA vaccination into the Skin', Cancer immunology research, ;6(7): 835-847. (AmsterdamUMC/NKI) 44. Babion, I, Snoek, BC, Novianti, PW, Jaspers, A, van Trommel, N, Heideman, DAM, Meijer, CJLM, Snijders, PJF, Steenbergen, RDM & Wilting, SM 2018, 'Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes;(): (AmsterdamUMC/NKI) 45. Babjuk M, Burger M, Comperat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Roupret M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernandez V, Peyronnet B, Seisen T, Soukup V,` Indication for a Single Postoperative Instillation of Chemotherapy in Non- muscle-invasive Bladder Cancer: What Factors Should Be Considered? Eur Urol Focus 2018; 4:525-8 `, (NKI) 46. Bach T, Behrendt M, Tanidir Y, Cornford P, Sun Y, van Poppel H,` Harnessing New Media Tools in Patient Information`, Eur Urol 2018; 74:685-7 [Editorial] (NKI) 47. Bachas, C, Hodzic, J, van der Mijn, JC, Stoepker, C, Verheul, HMW, Wolthuis, RMF, Felley-Bosco, E, van Wieringen, WN, van Beusechem, VW, Brakenhoff, RH & de Menezes, RX 2018, 'Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection', BMC Bioinformatics, ;19(1): 301. (AmsterdamUMC/NKI) 48. Bady, P, Kurscheid, S, Delorenzi, M, Gorlia, T, van den Bent, MJ, Hoang-Xuan, K, Vauléon, É, Gijtenbeek, A, Enting, R, Thiessen, B, Chinot, O, Dhermain, F, Brandes, AA, Reijneveld, JC, Marosi, C, Taphoorn, MJB, Wick, W, von Deimling, A, French, P, Stupp, R, Baumert, BG & Hegi, ME 2018, 'The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033', Acta Neuropathologica, ;135(4): 601-615. (AmsterdamUMC) 49. Bager, N, Juul-Dam, KL, Sandahl, JD, Abrahamsson, J, Beverloo, B, de Bont, ESJM, Ha, S-Y, Jahnukainen, K, Jónsson, ÓG, Kaspers, GL, Kovalova, Z, Lausen, B, de Moerloose, B, Noren-Nyström, U, Palle, J, Saks, K, Zeller, B, Kjeldsen, E & Hasle, H 2018, 'Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study', British Journal of Haematology, ;183(4): 618-628. (AmsterdamUMC) 50. Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD,` Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a- 2b/Bayesian phase II trial`, Clin Transl Radiat Oncol 2018; 13:19-23 (NKI) 51. Bailey, DL, Pichler, BJ, Gückel, B, Antoch, G, Barthel, H, Bhujwalla, ZM, Biskup, S, Biswal, S, Bitzer, M, Boellaard, R, Braren, RF, Brendle, C, Brindle, K, Chiti, A, la Fougère, C, Gillies, R, Goh, V, Goyen, M, Hacker, M, Heukamp, L, Knudsen, GM, Krackhardt, AM, Law, I, Morris, JC, Nikolaou, K, Nuyts, J, Ordonez, AA, Pantel, K, Quick, HH, Riklund, K, Sabri, O, Sattler, B, Troost, EGC, Zaiss, M, Zender, L & Beyer, T 2018, 'Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany', Molecular Imaging and Biology, ;20(1): 4-20. (AmsterdamUMC) 52. Baird, JR, Bryan Bell, R, Troesch, V, Friedman, D, Bambina, S, Kramer, G, Blair, TC, Medler, T, Wu, Y, Sun, Z, de Gruijl, TD, van de Ven, R, Leidner, RS, Crittenden, MR & Gough, MJ 2018, 'Evaluation of explant responses to STING ligands: Personalized immunosurgical therapy for head and neck squamous cell carcinoma', Cancer Research, ;78(21): 6308-6319. (AmsterdamUMC) 53. Bajrami I, Marlow R, van de Ven M, Brough R, Pemberton HN, Frankum J, Song F, Rafiq R, Konde A, Krastev DB, Menon M, Campbell J, Gulati A, Kumar R, Pettitt SJ, Gurden MD, Cardenosa ML, Chong I, Gazinska P, Wallberg F, Sawyer EJ, Martin LA, Dowsett M, Linardopoulos S, Natrajan R, Ryan CJ, Derksen PWB, Jonkers J, Tutt ANJ, Ashworth A, Lord CJ,` E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer`, Cancer Discov 2018; 8:498-515 (NKI) 54. Bakker, A, Holman, R, Rodrigues, DB, Dobšíček Trefná, H, Stauffer, PR, van Tienhoven, G, Rasch, CRN & Crezee, H 2018, 'Analysis of clinical data to determine the minimum number of sensors required for adequate skin temperature monitoring of superficial hyperthermia treatments', International journal of hyperthermia, ;34(7): 910-917. (AmsterdamUMC) 55. Banerjee S, Dafni U, Allen T, Arnold D, Curigliano GMD, Garralda E, Garassino MC, Haanen J, Hofstadter-Thalmann E, Robert C, Sessa C, Tsourti Z, Zygoura P, Peters S,` Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey`, ESMO Open 2018; 3:e000422 (NKI) 56. Banerji U, Dean E, Perez-Fidalgo JA, Batist G, Bedard PL, You B, Westin SN, Kabos P, Garrett MD, Tall M, Ambrose HJ, Barrett JC, Carr TH, Cheung SA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Elvin P, Foxley A, Lawrence P, Lindemann JPO, Maudsley R, Pass M, Rowlands V, Rugman P, Schiavon G, Yates JW, Schellens JHM,` A Phase 1 open-label study to identify a dosing regimen of the pan-AKT inhibitor AZD5363 for evaluation in solid tumors and in PIK3CA-mutated breast and gynecologic cancers`, Clin Cancer Res 2018; 24:2050-9 (NKI) 57. Barazas M, Annunziato S, Pettitt SJ, de Krijger I, Ghezraoui H, Roobol SJ, Lutz C, Frankum J, Song FF, Brough R, Evers B, Gogola E, Bhin J, van de Ven M, van Gent DC, Jacobs JJL, Chapman R, Lord CJ, Jonkers J, Rottenberg S,` The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells`, Cell Rep 2018; 23:2107-18 (NKI) 58. Barendse, RM, Musters, GD, de Graaf, EJR, van den Broek, FJC, Consten, ECJ, Doornebosch, PG, Hardwick, JC, de Hingh, IHJT, Hoff, C, Jansen, JM, van Milligen de Wit, AWM, van der Schelling, GP, Schoon, EJ, Schwartz, MP, Weusten, BLAM, Dijkgraaf, MG, Fockens, P, Bemelman, WA & Dekker, E 2018, 'Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study)', Gut, ;67(5): 837-846. (AmsterdamUMC) 59. Baron, F, Labopin, M, Ruggeri, A, Cornelissen, JJ, Meijer, E, Sengeloev, H, Niederwieser, D, de Groot, MR, Schouten, HC, Milpied, N, Blaise, D, Savani, BN, Gluckman, E, Mohty, M & Nagler, A 2018, 'Impact of donor type in patients with AML given allogeneic hematopoietic cell transplantation after low-dose TBI-based regimen', Clinical Cancer Research, ;24(12): 2794-2803. (AmsterdamUMC) 60. Barten, D, Hoffmans, D, Palacios, MA, Heukelom, S & van Battum, L 2018, 'Suitability of EBT3 GafChromic film for quality assurance in MR-guided radiotherapy at 0.35T with and without real-time imaging', Physics in Medicine and Biology, ;63(16):63 (AmsterdamUMC) 61. Barthel, FP, Johnson, KC, Wesseling, P & Verhaak, RGW 2018, 'Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults', Neurologic Clinics, ;36(3): 421-437. (AmsterdamUMC) 62. Barthel, FP, Wesseling, P & Verhaak, RGW 2018, 'Reconstructing the molecular life history of gliomas', Acta Neuropathologica, ;135(5): 649-670. (AmsterdamUMC) 63. Basiri, A, de La Rosette, JJMCH, Tabatabaei, S, Woo, HH, Laguna, MP & Shemshaki, H 2018, 'Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner?', World journal of urology, ;36(4): 609-621. (AmsterdamUMC) 64. Bastida C, Ruiz-Esquide V, Pascal M, de Vries Schultink AHM, Yague J, Sanmarti R, Huitema ADR, Soy D,` Fixed dosing of intravenous tocilizumab in rheumatoid arthritis`, Br J Clin Pharmacol 2018; 84:716- 25 (NKI) 65. Baumgarten A, Chipollini J, Yan S, Ottenhof SR, Tang DH, Draeger D, Protzel C, Zhu Y, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE,` Penile Sparing Surgery for Penile Cancer: A Multicenter International Retrospective Cohort`, J Urol 2018; 199:1233-7 (NKI) 66. Bebelman, MP, Smit, MJ, Pegtel, DM & Baglio, SR 2018, 'Biogenesis and function of extracellular vesicles in cancer', Pharmacology and Therapeutics, ;188: 1-11. (AmsterdamUMC) 67. Beck ACC, Lohuis PJFM, Al Mamgani A, Smit LA, Klop WMC ,` Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute`, Eur Arch Otorhinolaryngol 2018; 275:1885-92 (NKI) 68. Beck N, Hoeijmakers F, Wiegman EM, Smit HJM, Schramel FM, Steup WH, Verhagen AFTM, Schreurs WH, Wouters MWJM,` Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment`, J Thorac Dis 2018; 10:S3472-S3485 (NKI) 69. Beck, N, Busweiler, LAD, Schouwenburg, MG, Fiocco, M, Cats, A, Voncken, FEM, Wijnhoven, BPL, van Berge Henegouwen, MI, Wouters, MWJM, van Sandick, JW & AUTHOR GROUP 2018, 'Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study', European journal of surgical oncology, ;44(2): 260-267. (AmsterdamUMC/NKI) 70. Beck, N, Hoeijmakers, F, van der Willik, EM, Heineman, DJ, Braun, J, Tollenaar, RAEM, Schreurs, WH & Wouters, MWJM 2018, 'National Comparison of Hospital Performances in Lung Cancer Surgery: The Role of Case Mix Adjustment', Annals of Thoracic Surgery, ;106(2): 412-420. (AmsterdamUMC/NKI) 71. Becker JR, Cuella-Martin R, Barazas M, Liu R, Oliveira C, Oliver AW, Bilham K, Holt AB, Blackford AN, Heierhorst J, Jonkers J, Rottenberg S, Chapman JR,` The ASCIZ-DYNLL1 axis promotes 53BP1- dependent non-homologous end joining and PARP inhibitor sensitivity`, Nat Commun 2018; 9:5406 (NKI) 72. Beckers RCJ, Lambregts DMJ, Lahaye MJ, Rao SX, Kleinen K, Grootscholten C, Beets GL, Beets-Tan RGH, Maas M,` Advanced imaging to predict response to chemotherapy in colorectal liver metastases - a systematic review`, HPB (Oxford) 2018; 20:120-7 (NKI) 73. Beckers RCJ, Trebeschi S, Maas M, Schnerr RS, Sijmons JML, Beets GL, Houwers JB, Beets-Tan RGH, Lambregts DMJ,` CT texture analysis in colorectal liver metastases and the surrounding liver parenchyma and its potential as an imaging biomarker of disease aggressiveness, response and survival`, Eur J Radiol 2018; 102:15-21 (NKI) 74. Beekman C, van Triest B, van Beek S, Jan-Jakob S, Remeijer P,` Margin and PTV volume reduction using a population based library of plans strategy for rectal cancer radiotherapy`, Med Phys 2018; 45:4345- 54 (NKI) 75. Beelen K, Opdam M, Severson T, Koornstra R, Vincent A, Wesseling J, Sanders J, Vermorken J, van Diest P, Linn S,` Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot`, BMC Cancer 2018; 18:761 (NKI) 76. Beets-Tan, RGH, Lambregts, DMJ, Maas, M, Bipat, S, Barbaro, B, Curvo-Semedo, L, Fenlon, HM, Gollub, MJ, Gourtsoyianni, S, Halligan, S, Hoeffel, C, Kim, SH, Laghi, A, Maier, A, Rafaelsen, SR, Stoker, J, Taylor, SA, Torkzad, MR & Blomqvist, L 2018, 'Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting', European radiology, ;28(4): 1465–1475. (AmsterdamUMC/NKI) 77. Beier, D, Proescholdt, M, Reinert, C, Pietsch, T, Jones, DTW, Pfister, SM, Hattingen, E, Seidel, C, Dirven, L, Luerding, R, Reijneveld, J, Warmuth-Metz, M, Bonsanto, M, Bremer, M, Combs, SE, Rieken, S, Herrlinger, U, Kuntze, H, Mayer-Steinacker, R, Moskopp, D, Schneider, T, Beringer, A, Schlegel, U, Stummer, W, Welker, H, Weyerbrock, A, Paulsen, F, Rutkowski, S, Weller, M, Wick, W, Kortmann, R-D, Bogdahn, U & Hau, P 2018, 'Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)', Neuro-Oncology, ;20(3): 400-410. (AmsterdamUMC) 78. Beilenhoff, U, Biering, H, Blum, R, Brljak, J, Cimbro, M, Dumonceau, J-M, Hassan, C, Jung, M, Kampf, B, Neumann, C, Pietsch, M, Pineau, L, Ponchon, T, Rejchrt, S, Rey, J-F, Schmidt, V, Tillett, J & van Hooft, JE 2018, 'Reprocessing of flexible endoscopes and endoscopic accessories used in gastrointestinal endoscopy: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA) - Update 2018', Endoscopy, ;50(12): 1205-1234. (AmsterdamUMC) 79. Belghazi, K, Pouw, RE & Bergman, JJ 2018, 'In the expanding arena of endoscopic management for Barrett's neoplasia, how should we fit in endoscopic submucosal dissection?', Gastrointestinal endoscopy, ;87(6): 1394-1395. (AmsterdamUMC) 80. Belghazi, K, Pouw, RE, Sondermeijer, CMT, Meijer, SL, Schoon, EJ, Koch, AD, Weusten, BLAM & Bergman, JJGHM 2018, 'A single-step sizing and radiofrequency ablation catheter for circumferential ablation of Barrett's esophagus: Results of a pilot study', United European gastroenterology journal, ;6(7): 990-999. (AmsterdamUMC) 81. Belghazi, K, van Vilsteren, FGI, Weusten, BLAM, Meijer, SL, Bergman, JJGHM & Pouw, RE 2018, 'Long- term follow-up results of stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia', Gastrointestinal endoscopy, ;87(1): 77-84. (AmsterdamUMC) 82. Benedict, B, van Harn, T, Dekker, M, Hermsen, S, Kucukosmanoglu, A, Pieters, W, Delzenne-Goette, E, Dorsman, JC, Petermann, E, Foijer, F & te Riele, H 2018, 'Loss of p53 suppresses replication-stress- induced DNA breakage in G1/S checkpoint deficient cells', eLife, (AmsterdamUMC/NKI) 83. Bensch, F, Smeenk, MM, van Es, SC, de Jong, JR, Schröder, CP, Oosting, SF, Lub-de Hooge, MN, Menke- van der Houven van Oordt, CW, Brouwers, AH, Boellaard, R & de Vries, EGE 2018, 'Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers-The first step towards an imaging warehouse', Theranostics, ;8(16): 4295-4304. (AmsterdamUMC) 84. Bensch, F, van der Veen, EL, Lub-de Hooge, MN, Jorritsma-Smit, A, Boellaard, R, Kok, IC, Oosting, SF, Schröder, CP, Hiltermann, TJN, van der Wekken, AJ, Groen, HJM, Kwee, TC, Elias, SG, Gietema, JA, Bohorquez, SS, de Crespigny, A, Williams, S-P, Mancao, C, Brouwers, AH, Fine, BM & de Vries, EGE 2018, '89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer', Nature Medicine, ;24(12): 1852-1858. (AmsterdamUMC) 85. Berenguer J, Lagerweij T, Zhao XW, Dusoswa S, van der Stoop P, Westerman B, de Gooijer MC, Zoetemelk M, Zomer A, Crommentuijn MHW, Wedekind LE, Lopez-Lopez A, Giovanazzi A, Bruch-Oms M, van der Meulen-Muileman IH, Reijmers RM, van Kuppevelt TH, Garcia-Vallejo JJ, van Kooyk Y, Tannous BA, Wesseling P, Koppers-Lalic D, Vandertop WP, Noske DP, van Beusechem VW, van Rheenen J, Pegtel DM, van Tellingen O, Wurdinger T,` Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8`, J Extracell Vesicles 2018; 7:1446660-(21 pp) (NKI) 86. Berge MT, Beck N, Heineman DJ, Damhuis R, Steup WH, van Huijstee PJ, Eerenberg JP, Veen E, Maat A, Versteegh M, van Brakel T, Schreurs WH, Wouters MW,` Dutch Lung Surgery Audit: A National Audit Comprising Lung and Thoracic Surgery Patients`, Ann Thorac Surg 2018; 106:390-7 (AmsterdamUMC/NKI) 87. Bergman, JJ & Yachimski, PS 2018, 'Advances in Endoscopic Therapy', Gastroenterology, ;154(7): 1859-1860. (AmsterdamUMC) 88. Berlow, NE, Svalina, MN, Quist, MJ, Settelmeyer, TP, Zherebitskiy, V, Kogiso, M, Qi, L, du, Y, Hawkins, CE, Hulleman, E, Li, X-N, Gultekin, SH & Keller, C 2018, 'IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma', PLoS ONE, ;13(4): e0193565. (AmsterdamUMC) 89. Berns K, Caumanns JJ, Hijmans EM, Gennissen AMC, Severson TM, Evers B, Wisman GBA, Jan Meersma G, Lieftink C, Beijersbergen RL, Itamochi H, van der Zee AGJ, de Jong S, Bernards R,` ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors`, Oncogene 2018; 37:4611-25 (NKI) 90. Berto M, Jean V, Zwart W, Picard D,` ERalpha activity depends on interaction and target site corecruitment with phosphorylated CREB1`, Life Sci Alliance 2018; 1:e201800055 (14 pp) (NKI) 91. Best, MG, Wesseling, P & Wurdinger, T 2018, 'Tumor-educated platelets as a noninvasive biomarker source for cancer detection and progression monitoring', Cancer Research, ;78(13): 3407-3412. (AmsterdamUMC) 92. Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles R, Hofmann F, Hora M, Kuczyk M, Lam T, Marconi L, Merseburger A, Fernandez-Pello S, Tahbaz R, Abu-Ghanem Y, Staehler M, Volpe A, Powles T,` Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma`, Eur Urol 2018; 74:805-9 (NKI) 93. Bex A, Albiges L, Staehler M, Bensalah K, Giles RH, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernandez-Pello S, Tahbaz R, bu-Ghanem Y, Volpe A, Ljungberg B, Escudier B, Powles T ,` A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations`, Eur Urol 2018; 74:849-51 (NKI) 94. Bex A, Haanen J,` Cytoreductive nephrectomy in metastatic renal cancer - less is more`, Nat Rev Clin Oncol 2018; 15:595-6 (NKI) 95. Bex A, Powles T, Haanen J,` Sunitinib Alone or after Nephrectomy in Renal Cancer`, N Engl J Med 2018; 379:1877-8 [Comment] (NKI) 96. Bibault JE, Franco P, Borst GR, Van Elmpt W, Thorwhart D, Schmid MP, Rouschop KMA, Spalek M, Mullaney L, Redalen KR, Dubois L, Verfaillie C, Eriksen JG,` Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey`, Clin Transl Radiat Oncol 2018; 9:61-7 (NKI) 97. Bigenzahn JW, Collu GM, Kartnig F, Pieraks M, Vladimer GI, Heinz LX, Sedlyarov V, Schischlik F, Fauster A, Rebsamen M, Parapatics K, Blomen VA, Muller AC, Winter GE, Kralovics R, Brummelkamp TR, Mlodzik M, Superti-Furga G,` LZTR1 is a regulator of RAS ubiquitination and signaling`, Science 2018; 362:1171-7 (NKI) 98. Bijen, HM, Hassan, C, Kester, MGD, Janssen, GMC, Hombrink, P, de Ru, AH, Drijfhout, JW, Meiring, HD, de Jong, AP, Falkenburg, JHF, Jimenez, CR, Heemskerk, MHM & van Veelen, PA 2018, 'Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface', Proteomics, ;18(12): 1700250. (AmsterdamUMC) 99. Bijker R, Duijts SFA, Smith SN, Wildt-Liesveld R, Anema JR, Regeer BJ,` Functional Impairments and Work-Related Outcomes in Breast Cancer Survivors: A Systematic Review`, J Occup Rehabil 2018; 28:429-51 (AmsterdamUMCNKI) 100. Bijlsma RM, Wessels H, Wouters RHP, May AM, Ausems MGEM, Voest EE, Bredenoord AL,` Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing`, Fam Cancer 2018; 17:309-16 (NKI) 101. Bijlsma RM, Wouters RHP, Wessels H, May AM, Ausems MGEM, Voest EE, Bredenoord AL,` Managing unsolicited findings in genomics: a qualitative interview study with cancer patients`, Psychooncology 2018; 27:1327-33 (NKI) 102. Billiet, T, Emsell, L, Vandenbulcke, M, Peeters, R, Christiaens, D, Leemans, A, van Hecke, W, Smeets, A, Amant, F, Sunaert, S & Deprez, S 2018, 'Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?', Brain imaging and behavior, ;12(1): 64-77. (AmsterdamUMC) 103. Bismeijer T, Canisius S, Wessels LFA,` Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis`, PLoS Comput Biol 2018; 14:e1006520 (28 pp) (NKI) 104. Blaauwgeers, H, Russell, PA, Jones, KD, Radonic, T & Thunnissen, E 2018, 'Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review', Lung Cancer, ;123: 107-111. (AmsterdamUMC) 105. Blanas, A, Sahasrabudhe, NM, Rodríguez, E, van Kooyk, Y & van Vliet, SJ 2018, 'Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy', Frontiers in Oncology, ;8: 39. (AmsterdamUMC) 106. Blank CU, Rozeman EA, Fanchi LF, Sikorska K, van de WB, Kvistborg P, Krijgsman O, van den Braber M, Philips D, Broeks A, van Thienen JV, Mallo HA, Adriaansz S, Ter MS, Pronk LM, Grijpink-Ongering LG, Bruining A, Gittelman RM, Warren S, Van Tinteren H, Peeper DS, Haanen JBAG, van Akkooi ACJ, Schumacher TN,` Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma`, Nat Med 2018; 24:1655-61 (NKI) 107. Bleijenberg, A & Dekker, E 2018, 'Reverse-engineering the serrated neoplasia pathway using CRISPR– Cas9', Nature reviews. Gastroenterology & hepatology, ;15(9): 522-524. (AmsterdamUMC) 108. Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, Liefers GJ, Nortier JWR, Rutgers EJT, Seynaeve CM, van de Velde CJH,` Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer`, Breast Cancer Res Treat 2018; 168:413-20 (NKI) 109. Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, Liefers GJ, Nortier JWR, Rutgers EJT, Seynaeve CM, van de Velde CJH,` Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer`, Eur J Cancer 2018; 95:59-67 (NKI) 110. Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, van den Bosch J, Maartense E, Leeuwen-Stok AE, Liefers GJ, Nortier JWR, Rutgers EJT, van de Velde CJH,` Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)`, J Natl Cancer Inst 2018; 110:40-8 (NKI) 111. Blok RD, Musters GD, Borstlap WAA, Buskens CJ, Bemelman WA, Tanis PJ, Collaborators (183), Aalbers A, Wouters MW,` Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer`, Ann Surg Oncol 2018; 25:729-36 (AmsterdamUMCNKI) 112. Blok, RD & Tanis, PJ 2018, 'ASO Author Reflections: Omentoplasty to Improve Perineal Wound Healing After Abdominoperineal Resection', Annals of surgical oncology, ;25(3): 836-837. (AmsterdamUMC) 113. Blok, RD, Stam, R, Westerduin, E, Borstlap, WAA, Hompes, R, Bemelman, WA & Tanis, PJ 2018, 'Impact of an institutional change from routine to highly selective diversion of a low anastomosis after TME for rectal cancer', European journal of surgical oncology, ;44(8): 1220-1225. (AmsterdamUMC) 114. Blomberg OS, Spagnuolo L, de Visser KE,` Immune regulation of metastasis: mechanistic insights and therapeutic opportunities`, Dis Model Mech 2018; 11:dmm036236 (NKI) 115. Blommestein, H, Groot CA, U, Sonneveld, P, de Groot, S, Zweegman, S, Franken, MG, van Beurden- Tan, C & Blijlevens, N 2018, 'MO1 - COMBINING INTERNALLY VALID TRIAL EVIDENCE WITH GENERALIZABLE REAL-WORLD DATA: INSIGHTS INTO EFFECTS, COSTS, AND COST-EFFECTIVENESS OF NOVEL TREATMENT SEQUENCES IN PATIENTS WITH MULTIPLE MYELOMA', Value in Health, ;21: S10- S11. (AmsterdamUMC) 116. Bodalal Z, Trebeschi S, Beets-Tan R,` Radiomics: a critical step towards integrated healthcare`, Insights Imaging 2018; 9:911-4 (NKI) 117. Boekel NB, Jacobse JN, Schaapveld M, Hooning MJ, Gietema JA, Duane FK, Taylor CW, Darby SC, Hauptmann M, Seynaeve CM, Baaijens MHA, Sonke GS, Rutgers EJT, Russell NS, Aleman BMP, van Leeuwen FE,` Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer`, Br J Cancer 2018; 119:408-18 (NKI) 118. Boele, FW, Klein, M, Verdonck-de Leeuw, IM, Cuijpers, P, Heimans, JJ, Snijders, TJ, Vos, M, Bosma, I, Tijssen, CC, Reijneveld, JC & On behalf of the Dutch Society for Neuro-Oncology (LWNO) 2018, 'Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial', Journal of Neuro-Oncology, ;137(1): 191-203. (AmsterdamUMC) 119. Boellaard, R, Kobe, C, Zijlstra, JM, Mikhaeel, NG, Johnson, PWM, Müller, S, Dührsen, U, Hoekstra, OS & Barrington, S 2018, 'Does PET reconstruction method affect deauville scoring in lymphoma patients?', Journal of Nuclear Medicine, ;59(7): 1167-1169. (AmsterdamUMC) 120. Boevé, LMS, Hulshof, MCCM, Vis, AN, Zwinderman, AH, Twisk, JWR, Witjes, WPJ, Delaere, KPJ, Moorselaar, RJAV, Verhagen, PCMS & van Andel, G 2018, 'Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial', European Urology, ;75(3): 410-418. (AmsterdamUMC) 121. Bohoudi, O, Bruynzeel, AM, Senan, S, Cuijpers, JP, Slotman, BJ, Lagerwaard, FJ & Palacios, MA 2018, 'SBRT for pancreatic cancer: In regard of Bohoudi et al.', Radiotherapy and Oncology, ;127(3): 511- 512. (AmsterdamUMC) 122. Bohte, AE, Nelissen, JL, Runge, JH, Holub, O, Lambert, SA, de Graaf, L, Kolkman, S, van der Meij, S, Stoker, J, Strijkers, GJ, Nederveen, AJ & Sinkus, R 2018, 'Breast magnetic resonance elastography: a review of clinical work and future perspectives', NMR in biomedicine, ;31(10): e3932. (AmsterdamUMC) 123. Bol N, Smets EMA, Burgers JA, Samii SM, De Haes HCJM, Van Weert JCM,` Older Patients' Recall of Online Cancer Information: Do Ability and Motivation Matter More than Chronological Age? J Health Commun 2018; 23:9-19 `, (NKI) 124. Bonde, J, Ejegod, DM, Cuschieri, K, Dillner, J, Heideman, DAM, Quint, W, Pavon Ribas, MA, Padalko, E, Christiansen, IK, Xu, L & Arbyn, M 2018, 'The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium', Journal of Clinical Virology, ;108: 64-71. (AmsterdamUMC) 125. Bonomi, PD, Gandara, D, Hirsch, FR, Kerr, KM, Obasaju, C, Paz-Ares, L, Bellomo, C, Bradley, JD, Bunn, PA, Culligan, M, Jett, JR, Kim, ES, Langer, CJ, Natale, RB, Novello, S, Pérol, M, Ramalingam, SS, Reck, M, Reynolds, CH, Smit, EF, Socinski, MA, Spigel, DR, Vansteenkiste, JF, Wakelee, H & Thatcher, N 2018, 'Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer', Annals of Oncology, ;29(8): 1701-1709. (AmsterdamUMC) 126. Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF, Jonker MA, Flucke UE, van Herpen CML,` A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands`, Int J Cancer 2018; 143:758-66 (NKI) 127. Boon E, Valstar MH, van der Graaf WTA, Bloemena E, Willems SM, Meeuwis CA, Slootweg PJ, Smit LA, Merkx MAW, Takes RP, Kaanders JHAM, Groenen PJTA, Flucke UE, van Herpen CML,` Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands`, Oral Oncol 2018; 82:29-33 (AmsterdamUMCNKI) 128. Boon E, van Boxtel W, Buter J, Baatenburg de Jong RJ, van Es RJJ, Bel M, Fiets E, Oosting SF, Slingerland M, Hoeben A, Tesselaar MET, Jonker MA, Flucke UE, van der Graaf WTA, van Herpen CML,` Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands`, Head Neck 2018; 40:605-13 (AmsterdamUMC/NKI) 129. Boons, CCLM, Harbers, L, Timmers, L, de Jong, J, Swart, EL, Hendrikse, NH, Janssen, JJWM & Hugtenburg, JG 2018, 'Needs for information and reasons for (non-)adherence in chronic myeloid leukaemia: be aware of social activities disturbing daily routines', European Journal of Haematology, ;101(5): 643-653. (AmsterdamUMC) 130. Boons, CCLM, Timmers, L, van Schoor, NM, Swart, EL, Hendrikse, NH, Janssen, JJWM & Hugtenburg, JG 2018, 'Patient satisfaction with information on oral anticancer agent use', Cancer Medicine, ;7( 1. ): (AmsterdamUMC) 131. Boonstra PA, Ter Elst A, Tibbesma M, Bosman LJ, Mathijssen R, Atrafi F, van Coevorden F, Steeghs N, Farag S, Gelderblom H, van der Graaf WTA, Desar IME, Maier J, Overbosch J, Suurmeijer AJH, Gietema J, Schuuring E, Reyners AKL,` A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors`, Oncotarget 2018; 9:13870-83 (NKI) 132. Boormans, JL, Mayor de Castro, J, Marconi, L, Yuan, Y, Laguna Pes, MP, Bokemeyer, C, Nicolai, N, Algaba, F, Oldenburg, J & Albers, P 2018, 'Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel', European urology, ;73(3): 394-405. (AmsterdamUMC) 133. Boosman R, Burgers JSA,` Optimisation of chemotherapy in the era of immunotherapy`, Eur Respir J 2018; 52:1801698 (3 pp) (NKI) 134. Boot, MV, van Belzen, MJ, Overbeek, LI, Hijmering, N, Mendeville, M, Waisfisz, Q, Wesseling, P, Hennekam, RC & de Jong, D 2018, 'Benign and malignant tumors in Rubinstein-Taybi syndrome', American Journal of Medical Genetics Part A, ;176(3): 597-608. (AmsterdamUMC) 135. Bootsma, BT, Huisman, DE, Plat, VD, Schoonmade, LJ, Stens, J, Hubens, G, van der Peet, DL & Daams, F 2018, 'Towards optimal intraoperative conditions in esophageal surgery: A review of literature for the prevention of esophageal anastomotic leakage', International Journal of Surgery, ;54: 113-123. (AmsterdamUMC) 136. Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHM, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ,` Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study`, BMC Cancer 2018; 18:1006 (AmsterdamUMC/NKI) 137. Borst J, Ahrends T, Babala N, Melief CJM, Kastenmuller W,` CD4(+) T cell help in cancer immunology and immunotherapy`, Nat Rev Immunol 2018; 18:635-47 (NKI) 138. Borstlap, WAA, Musters, GD, Stassen, LPS, van Westreenen, HL, Hess, D, van Dieren, S, Festen, S, van der Zaag, EJ, Tanis, PJ & Bemelman, WA 2018, 'Vacuum-assisted early transanal closure of leaking low colorectal anastomoses: the CLEAN study', Surgical endoscopy, ;32(1): 315-327. (AmsterdamUMC) 139. Borstlap, WAA, van Oostendorp, SE, Klaver, CEL, Hahnloser, D, Cunningham, C, Rullier, E, Bemelman, WA, Tuynman, JB & Tanis, PJ 2018, 'Organ preservation in rectal cancer: a synopsis of current guidelines', Colorectal disease, ;20(3): 201-210. (AmsterdamUMC) 140. Bos, ACRK, Matthijsen, RA, van Erning, FN, van Oijen, MGH, Rutten, HJT & Lemmens, VEPP 2018, 'Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study', Annals of surgical oncology, ;25(2): 414-421. (AmsterdamUMC) 141. Bosdriesz E, Prahallad A, Klinger B, Sieber A, Bosma A, Bernards R, Bluthgen N, Wessels LFA,` Comparative Network Reconstruction using mixed integer programming`, Bioinformatics 2018; 34:i997-i1004 (NKI) 142. Boshuizen J, Koopman LA, Krijgsman O, Shahrabi A, van den Heuvel EG, Ligtenberg MA, Vredevoogd DW, Kemper K, Kuilman T, Song JY, Pencheva N, Mortensen JT, Foppen MG, Rozeman EA, Blank CU, Janmaat ML, Satijn D, Breij ECW, Peeper DS, Parren PWHI,` Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors`, Nat Med 2018; 24:203- 12 (NKI) 143. Bosschieter J, Hentschel A, Savci-Heijink CD, Patrick van der Voorn J, Rozendaal L, Vis AN, van Rhijn BWG, Lissenberg-Witte BI, Fransen van de Putte EE, van Moorselaar RJA, Nieuwenhuijzen JA,` Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors`, Clin Genitourin Cancer 2018; 16:e985-e992 (AmsterdamUMC/NKI) 144. Bosschieter J, Lutz C, Segerink LI, Vis AN, Zwarthoff EC, Moorselaar RJ Av, van Rhijn BW, Heymans MW, Jansma EP, Steenbergen RD, Nieuwenhuijzen JA,` The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review`, Epigenomics 2018; 10:673-87 (AmsterdamUMC/NKI) 145. Bosschieter J, Vis AN, van der Poel HG, Moonen LM, Horenblas S, van Rhijn BWG, Pieters BR, Nieuwenhuijzen JA, Hendricksen K,` Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer`, Eur Urol 2018; 74:369-75 (AmsterdamUMC/NKI) 146. Bosschieter, J, Bach, S, Bijnsdorp, IV, Segerink, LI, Rurup, WF, van Splunter, AP, Bahce, I, Novianti, PW, Kazemier, G, van Moorselaar, RJA, Steenbergen, RDM & Nieuwenhuijzen, JA 2018, 'A protocol for urine collection and storage prior to DNA methylation analysis', PLoS ONE, ;13(8): e0200906. (AmsterdamUMC) 147. Bosschieter, J, Nieuwenhuijzen, JA, Hentschel, AE, Vis, AN, Lissenberg-Witte, BI, den Otter, W & van Moorselaar, RJA 2018, 'Value of a Marker Lesion in Non-Muscle-Invasive Bladder Cancer Patients Treated with Interleukin-2 Instillations: A Randomized Controlled Multicentre Trial.', Urologia Internationalis. (AmsterdamUMC) 148. Bosschieter, J, Nieuwenhuijzen, JA, van Ginkel, T, Vis, AN, Witte, B, Newling, D, Beckers, GMA & Moorselaar, RJAV 2018, 'Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients', European Urology. (AmsterdamUMC) 149. Bosschieter, J, van Moorselaar, RJA, Vis, AN, van Ginkel, T, Lissenberg-Witte, BI, Beckers, GMA & Nieuwenhuijzen, JA 2018, 'The effect of timing of an immediate instillation of mitomycin C after transurethral resection in 941 patients with non-muscle-invasive bladder cancer', BJU International, ;122(4): 571-575. (AmsterdamUMC) 150. Bottomley, A, Pe, M, Sloan, J, Basch, E, Bonnetain, F, Calvert, M, Campbell, A, Cleeland, C, Cocks, K, Collette, L, Dueck, AC, Devlin, N, Flechtner, H-H, Gotay, C, Greimel, E, Griebsch, I, Groenvold, M, Hamel, J-F, King, M, Kluetz, PG, Koller, M, Malone, DC, Martinelli, F, Mitchell, SA, Moinpour, CM, Musoro, JZ, O’Connor, D, Oliver, K, Piault-Louis, E, Piccart, M, Pimentel, FL, Quinten, C, Reijneveld, JC, Schürmann, C, Smith, AW, Soltys, KM, Sridhara, R, Taphoorn, MJB, Velikova, G & Coens, C 2018, 'Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials', Clinical trials, ;15(6): 624-630. (AmsterdamUMC) 151. Boucek, J, de Haan, J, Halaska, MJ, Plzak, J, van Calsteren, K, de Groot, CJM, Dahl Steffensen, K, Fruscio, R, Massolt, ET, Klaritsch, P, Zola, P & Amant, F 2018, 'Maternal and obstetrical outcome in 35 cases of well-differentiated thyroid carcinoma during pregnancy', Laryngoscope, ;128(6): 1493-1500. (AmsterdamUMC) 152. Bouman A, van Koningsbruggen S, Karakullukcu MB, Schreuder WH, Lakeman P,` Bloom syndrome does not always present with sun-sensitive facial erythema`, Eur J Med Genet 2018; 61:94-7 (NKI) 153. Bouman-Wammes EW, van den Berg HP, de Munck L, Beeker A, Smorenburg CH, Vervenne WL, Coenen JLLM, Verheul HMW, Gerritsen WR, van den Eertwegh AJM,` A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial`, Eur J Cancer 2018; 90:1-9 (AmsterdamUMC/NKI) 154. Bourke, MJ, Neuhaus, H & Bergman, JJ 2018, ' (AmsterdamUMC) 155. Bousema, JE, Dijkgraaf, MGW, Papen-Botterhuis, NE, Schreurs, HW, Maessen, JG, van der Heijden, EH, Steup, WH, Braun, J, Noyez, VJJM, Hoeijmakers, F, Beck, N, van Dorp, M, Claessens, NJM, Hiddinga, BI, Daniels, JMA, Heineman, DJ, Zandbergen, HR, Verhagen, AFTM, van Schil, PE, Annema, JT, van den Broek, FJC, Youssef-el Soud, M, van Boven, WJ, Horn, T, Brocken, P, Ramai, RRS, Barlo, NP, Dingemans, A-MC, Lardenoije, J-W, van der Wekken, AJ, van de Wauwer, C, Kortekaas, RTJ, Hanselaar, WE, Rijna, H, Bard, MP, van Vollenhoven, FHM, Murrmann, GB, Bootsma, GP, Vissers, Y, Veen, EJ, van der Leest, CH, Citgez, E, van Duyn, EB, Marres, GMH, van Thiel, ER, Zhang, XH, Barendregt, WB, Janssen, JP, Smakman, N, van der Meer, F & Saboerali, MD 2018, 'MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): Study protocol of a multicenter randomised controlled trial', BMC surgery, ;18(1): 27. (AmsterdamUMC) 156. Braam, KI, van Dijk-Lokkart, EM, Kaspers, GJL, Takken, T, Huisman, J, Buffart, LM, Bierings, MB, Merks, JHM, van den Heuvel-Eibrink, MM, Veening, MA & van Dulmen-den Broeder, E 2018, 'Effects of a combined physical and psychosocial training for children with cancer: A randomized controlled trial', BMC cancer, ;18(1): 1289. (AmsterdamUMC) 157. Braat, AJAT, Kwekkeboom, DJ, Kam, BLR, Teunissen, JJM, de Herder, WW, Dreijerink, KMA, van Rooij, R, Krijger, GC, de Jong, HWAM, van den Bosch, MAAJ & Lam, MGEH 2018, 'Additional hepatic 166Ho- radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE;(): (AmsterdamUMC) 158. Brabetz, S, Leary, SES, Gröbner, SN, Nakamoto, MW, Şeker-Cin, H, Girard, EJ, Cole, B, Strand, AD, Bloom, KL, Hovestadt, V, Mack, NL, Pakiam, F, Schwalm, B, Korshunov, A, Balasubramanian, GP, Northcott, PA, Pedro, KD, Dey, J, Hansen, S, Ditzler, S, Lichter, P, Chavez, L, Jones, DTW, Koster, J, Pfister, SM, Kool, M & Olson, JM 2018, 'A biobank of patient-derived pediatric brain tumor models', Nature medicine, ;24(11): 1752-1761. (AmsterdamUMC) 159. Brachtlova, T & van Beusechem, VW 2018, 'Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens', Cells, ;7(12): 228. (AmsterdamUMC) 160. Braekeveldt, N, von Stedingk, K, Fransson, S, Martinez-Monleon, A, Lindgren, D, Axelson, HK, Levander, F, Willforss, J, Hansson, K, Øra, I, Backman, T, Börjesson, A, Beckman, S, Esfandyari, J, Berbegall, AP, Noguera, R, Karlsson, J, Koster, J, Martinsson, T, Gisselsson, D, Påhlman, S & Bexell, D 2018, 'Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma', Cancer research, ;78(20): 5958-5969. (AmsterdamUMC) 161. Brahm, CG, den Hollander, MW, Enting, RH, de Groot, JC, Solouki, AM, den Dunnen, WFA, Heesters, MAAM, Wagemakers, M, Verheul, HMW, de Vries, EGE, Pruim, J & Walenkamp, AME 2018, 'Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study', European Journal of Nuclear Medicine and Molecular Imaging, ;45(13): 2404-2412. (AmsterdamUMC) 162. Brandsma D, Bromberg JEC,` Primary CNS lymphoma in HIV infection`, Handb Clin Neurol 2018; 152:177-86 (NKI) 163. Braunschmid, T, Kührer, I, Mittlböck, M, Westerhoff, M, Kappel-Latif, S, Brammen, L, Krishnadath, KK, Phillips, WA, Gnant, M & Kandioler, D 2018, 'TP53 is not a prognostic marker—clinical consequences of a generally disregarded fact', Annals of the New York Academy of Sciences, ;1434(1): 46-53. (AmsterdamUMC) 164. Bredart A, Anota A, Young T, Tomaszewski KA, Arraras JI, Moura De Albuquerque Melo H, Schmidt H, Friend E, Bergenmar M, Costantini A, Vassiliou V, Hureaux J, Marchal F, Tomaszewska IM, Chie WC, Ramage J, Beaudeau A, Conroy T, Bleiker E, Kulis D, Bonnetain F, Aaronson NK,` Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT- PATSAT7)`, Eur J Cancer Care (Engl) 2018; 27:e12786-(11 pp) (NKI) 165. Brenkman HJF, Gertsen EC, Vegt E, van Hillegersberg R, Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Sandick JW, van Grieken NCT, Heisterkamp J, van Etten B, Haveman JW, Pierie JP, Jonker F, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wessels FJ, Haj Mohammad N, van Stel HF, Frederix GWJ, Siersema PD, Ruurda JP,` Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)`, BMC Cancer 2018; 18:450 (NKI) 166. Brenkman, HJF, Tegels, JJW, Ruurda, JP, Luyer, MDP, Kouwenhoven, EA, Draaisma, WA, van der Peet, DL, Wijnhoven, BPL, Stoot, JHMB, van Hillegersberg, R & on behalf of the LOGICA Study Group 2018, 'Factors influencing health-related quality of life after gastrectomy for cancer', Gastric Cancer, ;21(3): 524-532. (AmsterdamUMC) 167. Breugom AJ, Bastiaannet E, Dekker JWT, Wouters MWJM, van de Velde CJH, Liefers GJ,` Decrease in 30-day and one-year mortality over time in patients aged >/=75 years with stage I-III colon cancer: A population-based study`, Eur J Surg Oncol 2018; 44:1889-93 (NKI) 168. Breznik, B, Limback, C, Porcnik, A, Blejec, A, Krajnc, MK, Bosnjak, R, Kos, J, van Noorden, CJF & Lah, TT 2018, 'Localization patterns of cathepsins K and X and their predictive value in glioblastoma', Radiology and Oncology, ;52(4): 433-442. (AmsterdamUMC) 169. Breznik, B, Limbaeck Stokin, C, Kos, J, Khurshed, M, Hira, VVV, Bošnjak, R, Lah, TT & van Noorden, CJF 2018, 'Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches', Journal of molecular histology, ;49(5): 481-497. (AmsterdamUMC) 170. Bright, CJ, Hawkins, MM, Winter, DL, Alessi, D, Allodji, RS, Bagnasco, F, Bárdi, E, Bautz, A, Byrne, J, Feijen, EAM, Fidler, MM, Garwicz, S, Grabow, D, Gudmundsdottir, T, Guha, J, Haddy, N, Jankovic, M, Kaatsch, P, Kaiser, M, Kuehni, CE, Linge, H, Øfstaas, H, Ronckers, CM, Skinner, R, Teepen, JC, Terenziani, M, Vu-Bezin, G, Wesenberg, F, Wiebe, T, Sacerdote, C, Jakab, Z, Haupt, R, Lähteenmäki, P, Zaletel, LZ, Kuonen, R, Winther, JF, de Vathaire, F, Kremer, LC, Hjorth, L & Reulen, RC 2018, 'Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe', Journal of the National Cancer Institute, ;110(6): 649-660. (AmsterdamUMC) 171. Brinkman EK, Chen T, de Haas M, Holland HA, Akhtar W, van Steensel B,` Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks`, Mol Cell 2018; 70:801-13 (NKI) 172. Brinkman EK, Kousholt AN, Harmsen T, Leemans C, Chen T, Jonkers J, van Steensel B,` Easy quantification of template-directed CRISPR/Cas9 editing`, Nucleic Acids Res 2018; 46:e58 [9 pp] (NKI) 173. Brinkman, TM, Recklitis, CJ, Michel, G, Grootenhuis, MA & Klosky, JL 2018, 'Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: Current state of the literature', Journal of clinical oncology, ;36(21): 2190-2197. (AmsterdamUMC) 174. Brok J, Lopez-Yurda M, Van Tinteren H, Treger TD, Furtwangler R, Graf N, Bergeron C, van den Heuvel- Eibrink MM, Pritchard-Jones K, Olsen OE, de Camargo B, Verschuur A, Spreafico F,` Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group- International Society of Paediatric Oncology Wilms' tumour protocol database`, Lancet Oncol 2018; 19:1072-81 (NKI) 175. Bronsveld HK, De Bruin ML, Wesseling J, Sanders J, Hofland I, Jensen V, Bazelier MT, Ter Braak B, de Boer A, Vestergaard P, Schmidt MK ,` The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors`, BMC Cancer 2018; 18:224 (NKI) 176. Bronzwaer MES, Koens L, Bemelman WA, Dekker E, Fockens P, Coppe JP, COPOS study group C2, Aalbers AGJ, van Leerdam ME,` Volume of surgery for benign colorectal polyps in the last 11 years`, Gastrointest Endosc 2018; 87:552-61 (NKI) 177. Bronzwaer, MES, Dekker, E, Weingart, V, Groth, S, Pioche, M, Rivory, J, Beyna, T, Neuhaus, H, Ponchon, T, Allescher, H, Fockens, P & Rösch, T 2018, 'Feasibility, safety, and diagnostic yield of the Extra Wide Angle View (EWAVE) colonoscope for the detection of colorectal lesions', Endoscopy, ;50(1): 63-68. (AmsterdamUMC) 178. Bronzwaer, MES, Greuter, MJE, Bleijenberg, AGC, IJspeert, JEG, Dekker, E & Coupé, VMH 2018, 'Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening', BMC cancer, ;18(1): 465. (AmsterdamUMC) 179. Brouwer de Koning SG, Baltussen EJM, Karakullukcu MB, Dashtbozorg B, Smit LA, Dirven R, Hendriks BHW, Sterenborg HJCM, Ruers TJM,` Toward complete oral cavity cancer resection using a handheld diffuse reflectance spectroscopy probe`, J Biomed Opt 2018; 23:1-8 (AmsterdamUMC/NKI) 180. Brouwer de Koning SG, Vrancken Peeters MTFD, Jozwiak K, Bhairosing PA, Ruers TJM,` Tumor Resection Margin Definitions in Breast-Conserving Surgery: Systematic Review and Meta-analysis of the Current Literature`, Clin Breast Cancer 2018; 18:e595-e600 (NKI) 181. Brouwer NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, Beets-Tan RGH, Futterer JJ, Tanis PJ, Verhoeven RHA, de Wilt JHW,` Clinical lymph node staging in colorectal cancer; a flip of the coin? `, (AmsterdamUMC/NKI) 182. Brouwer, NPM, Bos, ACRK, Lemmens, VEPP, Tanis, PJ, Hugen, N, Nagtegaal, ID, de Wilt, JHW & Verhoeven, RHA 2018, 'An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients', International journal of cancer. Journal international du cancer, ;143(11): 2758-2766. (AmsterdamUMC) 183. Brouwers PJAM, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJEE, Schinagl DAX, Westenberg AH, Poortmans P, Boersma LJ,` Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial`, Radiother Oncol 2018; 128:434-41 (NKI) 184. Brown, JR, Hamadani, M, Hayslip, J, Janssens, A, Wagner-Johnston, N, Ottmann, O, Arnason, J, Tilly, H, Millenson, M, Offner, F, Gabrail, NY, Ganguly, S, Ailawadh, S, Kasar, S, Kater, AP, Doorduijn, JK, Gao, L, Lager, JJ, Wu, B, Egile, C & Kersten, MJ 2018, 'Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial', Lancet. Haematology, ;5(4): e170-e180. (AmsterdamUMC) 185. Bruggeman, JW, Koster, J, Lodder, P, Repping, S & Hamer, G 2018, 'Massive expression of germ cell- specific genes is a hallmark of cancer and a potential target for novel treatment development', Oncogene, ;37(42): 5694-5700. (AmsterdamUMC) 186. Bruijnen, STG, Verweij, NJF, van Duivenvoorde, LM, Bravenboer, N, Baeten, DLP, van Denderen, CJ, van der Horst-Bruinsma, IE, Voskuyl, AE, Custers, M, van de Ven, PM, Bot, JCJ, Boden, BJH, Lammertsma, AA, Hoekstra, OSH, Raijmakers, PGHM & van der Laken, CJ 2018, 'Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography', Rheumatology (United Kingdom), ;57(4): 631-638. (AmsterdamUMC) 187. Brundage M, Blackford A, Tolbert E, Smith K, Bantug E, Snyder C, PRO Data Presentation Stakeholder Advisory Board, Collaborators (9), Aaronson NK,` Presenting comparative study PRO results to clinicians and researchers: beyond the eye of the beholder`, Qual Life Res 2018; 27:75-90 (NKI) 188. Brunen D, de Vries RC, Lieftink C, Beijersbergen RL, Bernards R,` PIM kinases are a potential prognostic biomarker and therapeutic target in neuroblastoma`, Mol Cancer Ther 2018; 17:849-57 (NKI) 189. Bruns, ERJ, Argillander, TE, van den Heuvel, B, Buskens, CJ, van Duijvendijk, P, Winkels, RM, Kalf, A, van der Zaag, ES, Wassenaar, EB, Bemelman, WA & van Munster, BC 2018, 'Oral Nutrition as a Form of Pre- Operative Enhancement in Patients Undergoing Surgery for Colorectal Cancer: A Systematic Review', Surgical infections, ;19(1): 1-10. (AmsterdamUMC) 190. Buckle T, van Willigen DM, Spa SJ, Hensbergen AW, van der Wal S, de Korne CM, Welling MM, van der Poel HG, Hardwick JCH, van Leeuwen FWB,` Tracers for fluorescence-guided surgery: how elongation of the polymethine chain in cyanine dyes alters the pharmacokinetics of a (bimodal) c[RGDyK] tracer`, J Nucl Med 2018; 59:986-92 (NKI) 191. Buczacki, SJA, Popova, S, Biggs, E, Koukorava, C, Buzzelli, J, Vermeulen, L, Hazelwood, L, Francies, H, Garnett, MJ & Winton, DJ 2018, 'Itraconazole targets cell cycle heterogeneity in colorectal cancer', Journal of experimental medicine, ;215(7): 1891-1912. (AmsterdamUMC) 192. Buffart LM, De Bree R, Altena M, van der Werff S, Drossaert CHC, Speksnijder CM, van den Brekel MW, Jager-Wittenaar H, Aaronson NK, Stuiver MM,` Demographic, clinical, lifestyle-related, and social- cognitive correlates of physical activity in head and neck cancer survivors`, Support Care Cancer 2018; 26:1447-56 (AmsterdamUMC/NKI) 193. Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, Galvao DA, Aaronson NK, Stuiver MM, Jacobsen PB, Verdonck-de L, I, Steindorf K, Irwin ML, Hayes S, Griffith KA, Lucia A, Herrero-Roman F, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL, Plotnikoff RC, Arbane G, Schmidt ME, Potthoff K, van Beurden M, Oldenburg HS, Sonke GS, van Harten WH, Garrod R, Schmitz KH, Winters-Stone KM, Velthuis MJ, Taaffe DR, van Mechelen W, Jose KM, Nollet F, Wenzel J, Wiskemann J, Brug J, Courneya KS,` Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis`, J Natl Cancer Inst 2018; 110:1190-200 (AmsterdamUMC/NKI) 194. Buijs, M, Wagstaff, PGK, de Bruin, DM, Zondervan, PJ, Savci-Heijink, CD, van Delden, OM, van Leeuwen, TG, van Moorselaar, RJA, de La Rosette, JJMCH & Laguna Pes, MP 2018, 'An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis', European urology focus, ;4(6): 978-985. (AmsterdamUMC) 195. Buitenwerf, E, Korteweg, T, Visser, A, Haag, C, Feelders, RA, Timmers, HJ, Canu, L, Haak, HR, Bisschop, PH, Eekhoff, EMW, van der Kleij-Corssmit, EPM, Krak, NC, Rasenberg, E, van den Bergh, J, Stoker, J, Greuter, MJW, Dullaart, RPF, Links, TP & Kerstens, MN 2018, 'Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study', European journal of endocrinology / European Federation of Endocrine Societies, ;178(5): 431-437. (AmsterdamUMC) 196. Buiting HM, de Graas T,` Possible Underestimation of the Provision of Palliative Care`, JAMA Oncol 2018; 4:885-6 [Comment] (NKI) 197. Buoninfante OA, Pilzecker B, Aslam MA, Zavrakidis I, van der Wiel R, van de Ven M, van den Berk PCM, Jacobs H,` Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system`, Oncotarget 2018; 9:18832-43 (NKI) 198. Burgers JA, Damhuis RA,` 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator? ERJ Open Res 2018; 4:00030-2018 (6 pp) `,Eur J Surg Oncol 2018; 44:1241-6 (NKI) 199. Burggraaff, CN, Cornelisse, AC, Hoekstra, OS, Lugtenburg, PJ, de Keizer, B, Arens, AIJ, Celik, F, Huijbregts, JE, de Vet, HCW & Zijlstra, JM 2018, 'Interobserver agreement of interim and end-of- treatment F-FDG PET/CT in diffuse large B-cell lymphoma (DLBCL): impact on clinical practice and trials', Journal of Nuclear Medicine, ;59(12): 1831-1836. (AmsterdamUMC) 200. Bus, MTJ, Cernohorsky, P, de Bruin, DM, Meijer, SL, Streekstra, GJ, Faber, DJ, Kamphuis, GM, Zondervan, PJ, van Herk, M, Laguna Pes, MP, Grundeken, MJ, Brandt, MJ, de Reijke, TM, de La Rosette, JJMCH & van Leeuwen, TG 2018, 'Ex-vivo (AmsterdamUMC) 201. Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, Calaminus G, Kremer L, Langer T, van den Heuvel-Eibrink MM, van Dulmen-den BE, Baust K, Bautz A, Beck JD, Berger C, Binder H, Borgmann-Staudt A, Broer L, Cario H, Casagranda L, Clemens E, Deuster D, de VA, Dirksen U, Falck WJ, Fossa S, Font-Gonzalez A, Grandage V, Haupt R, Hecker-Nolting S, Hjorth L, Kaiser M, Kenborg L, Kepak T, Kepakova K, Knudsen LE, Krawczuk-Rybak M, Kruseova J, Kuehni CE, Kunstreich M, Kuonen R, Lackner H, Leiper A, Loeffen EAH, Luks A, Modan-Moses D, Mulder R, Parfitt R, Paul NW, Ranft A, Ruud E, Schilling R, Spix C, Stefanowicz J, Straubeta G, Uitterlinden AG, van den Berg M, van der Kooi AL, van Dijk M, van Leeuwen F, Zolk O, Zoller D, Kaatsch P,` PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents`, Eur J Cancer 2018; 103:227-37 (AmsterdamUMC/NKI) 202. Byrne, J, Alessi, D, Allodji, RS, Bagnasco, F, Bárdi, E, Bautz, A, Bright, CJ, Brown, M, Diallo, I, Feijen, EAML, Fidler, MM, Frey, E, Garwicz, S, Grabow, D, Gudmundsdottir, T, Hagberg, O, Harila-Saari, A, Hau, EM, Haupt, R, Hawkins, MM, Jakab, Z, Jankovic, M, Kaatsch, P, Kaiser, M, Kremer, LCM, Kuehni, CE, Kuonen, R, Ladenstein, R, Lähteenmäki, PIM, Levitt, G, Linge, H, LLanas, D, Michel, G, Morsellino, V, Mulder, RL, Reulen, RC, Ronckers, CCM, Sacerdote, C, Skinner, R, Steliarova-Foucher, E, van der Pal, HJ, de Vathaire, F, Vũ Bezin, G, Wesenberg, F, Wiebe, T, Winter, DL, Falck Winther, J, Witthoff, E, Zadravec Zaletel, L & Hjorth, L 2018, 'The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer', European journal of cancer (Oxford, England, ;103: 238-248. (AmsterdamUMC) 203. Caers, J, Garderet, L, Kortüm, KM, O'Dwyer, ME, van de Donk, NWCJ, Binder, M, Dold, SM, Gay, F, Corre, J, Beguin, Y, Ludwig, H, Larocca, A, Driessen, C, Dimopoulos, MA, Boccadoro, M, Gramatzki, M, Zweegman, S, Einsele, H, Cavo, M, Goldschmidt, H, Sonneveld, P, Delforge, M, Auner, HW, Terpos, E & Engelhardt, M 2018, 'European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when', Haematologica, ;103(11): 1772-1784. (AmsterdamUMC) 204. Cagnan, I, Gunel-Ozcan, A, Aerts-Kaya, F, Ameziane, N, Kuskonmaz, B, Dorsman, J, Gumruk, F & Uckan, D 2018, 'Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production', Stem Cell Reviews and Reports, ;14(3): 425-437. (AmsterdamUMC) 205. Calvo F, Apolone G, Baumann M, Caldas C, Celis JE, de LF, Ernberg I, Ringborg U, Rowell J, Tabernero J, Voest E, Eggermont A,` Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century`, Eur J Cancer 2018; 103:155-9 (NKI) 206. Campa, D, Pastore, M, Capurso, G, Hackert, T, Di Leo, M, Izbicki, JR, Khaw, K-T, Gioffreda, D, Kupcinskas, J, Pasquali, C, Macinga, P, Kaaks, R, Stigliano, S, Peeters, PH, Key, TJ, Talar-Wojnarowska, R, Vodicka, P, Valente, R, Vashist, YK, Salvia, R, Papaconstantinou, I, Shimizu, Y, Valsuani, C, Zambon, CF, Gazouli, M, Valantiene, I, Niesen, W, Mohelnikova-Duchonova, B, Hara, K, Soucek, P, Malecka- Panas, E, Bueno-de-Mesquita, HBA, Johnson, T, Brenner, H, Tavano, F, Fogar, P, Ito, H, Sperti, C, Butterbach, K, Latiano, A, Andriulli, A, Cavestro, GM, Busch, ORC, Dijk, F, Greenhalf, W, Matsuo, K, Lombardo, C, Strobel, O, König, A-K, Cuk, K, Strothmann, H, Katzke, V, Cantore, M, Mambrini, A, Oliverius, M, Pezzilli, R, Landi, S & Canzian, F 2018, 'Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation', International journal of cancer. Journal international du cancer, ;142(2): 290-296. (AmsterdamUMC) 207. Canadian Cancer Trials Group and the European Organization for Research and Treatment of Cancer 2018, 'Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials', Cancer, ;124(16): 3409-3416. (AmsterdamUMC) 208. Cao, J, Brouwer, NJ, Jordanova, ES, Marinkovic, M, Van Duinen, SG, De Waard, NE, Ksander, BR, Mulder, A, Claas, FHJ, Heemskerk, MHM & Jager, MJ 2018, 'HLA class I antigen expression in conjunctival melanoma is not associated with PD-L1/PD-1 status', Investigative Ophthalmology and Visual Science, ;59(2): 1005-1015. (AmsterdamUMC) 209. Cao, J, Pontes, KC, Heijkants, RC, Brouwer, NJ, Groenewoud, A, Jordanova, ES, Marinkovic, M, van Duinen, S, Teunisse, AF, Verdijk, RM, Snaar-Jagalska, E, Jochemsen, AG & Jager, MJ 2018, 'Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target', Journal of Pathology, ;245(4): 433-444. (AmsterdamUMC) 210. Capper, D, Jones, DTW, Sill, M, Hovestadt, V, Schrimpf, D, Sturm, D, Koelsche, C, Sahm, F, Chavez, L, Reuss, DE, Kratz, A, Wefers, AK, Huang, K, Pajtler, KW, Schweizer, L, Stichel, D, Olar, A, Engel, NW, Lindenberg, K, Harter, PN, Braczynski, AK, Plate, KH, Dohmen, H, Garvalov, BK, Coras, R, Hölsken, A, Hewer, E, Bewerunge-Hudler, M, Schick, M, Fischer, R, Beschorner, R, Schittenhelm, J, Staszewski, O, Wani, K, Varlet, P, Pages, M, Temming, P, Lohmann, D, Selt, F, Witt, H, Milde, T, Witt, O, Aronica, E, Giangaspero, F, Rushing, E, Scheurlen, W, Geisenberger, C, Rodriguez, FJ, Becker, A, Preusser, M, Haberler, C, Bjerkvig, R, Cryan, J, Farrell, M, Deckert, M, Hench, JR, Frank, S, Serrano, J, Kannan, K, Tsirigos, A, Brück, W, Hofer, S, Brehmer, S, Seiz-Rosenhagen, M, Hänggi, D, Hans, V, Rozsnoki, S, Hansford, JR, Kohlhof, P, Kristensen, BW, Lechner, M, Lopes, B, Mawrin, C, Ketter, R, Kulozik, A, Khatib, Z, Heppner, F, Koch, A, Jouvet, A, Keohane, C, Mühleisen, H, Mueller, W, Pohl, U, Prinz, M, Benner, A, Zapatka, M, Gottardo, NG, Driever, PH, Kramm, CM, Müller, HL, Rutkowski, S, von Hoff, K, Frühwald, MC, Gnekow, A, Fleischhack, G, Tippelt, S, Calaminus, G, Monoranu, C-M, Perry, A, Jones, C, Jacques, TS, Radlwimmer, B, Gessi, M, Pietsch, T, Schramm, J, Schackert, G, Westphal, M, Reifenberger, G, Wesseling, P, Weller, M, Collins, VP, Blümcke, I, Bendszus, M, Debus, JR, Huang, A, Jabado, N, Northcott, PA, Paulus, W, Gajjar, A, Robinson, GW, Taylor, MD, Jaunmuktane, Z, Ryzhova, M, Platten, M, Unterberg, A, Wick, W, Karajannis, MA, Mittelbronn, M, Acker, T, Hartmann, C, Aldape, K, Schüller, U, Buslei, R, Lichter, P, Kool, M, Herold-Mende, C, Ellison, DW, Hasselblatt, M, Snuderl, M, Brandner, S, Korshunov, A, von Deimling, A & Pfister, SM 2018, 'DNA methylation-based classification of central nervous system tumours', Nature, ;555(7697): 469-474. (AmsterdamUMC) 211. Carlino MS, Long GV, Schadendorf D, Robert C, Ribas A, Richtig E, Nyakas M, Caglevic C, Tarhini A, Blank C, Hoeller C, Bar-Sela G, Barrow C, Wolter P, Zhou H, Emancipator K, Jensen EH, Ebbinghaus S, Ibrahim N, Daud A,` Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial`, Eur J Cancer 2018; 101:236-43 (NKI) 212. Carvalho B, Diosdado B, Terhaar Sive Droste JS, Bolijn AS, Komor MA, de Wit M, Bosch LJW, van Burink M, Dekker E, Kuipers EJ, Coupe VMH, van Grieken NCT, Fijneman RJA, Meijer GA,` Evaluation of cancer associated DNA copy number events in colorectal (advanced) adenomas`, Cancer Prev Res (Phila) 2018; 11:403-12 (AmsterdamUMC/NKI) 213. Carvello, M, de Groof, EJ, de Buck van Overstraeten, A, Sacchi, M, Wolthuis, AM, Buskens, CJ, D'Hoore, A, Bemelman, WA & Spinelli, A 2018, 'Single port laparoscopic ileocaecal resection for Crohn's disease: a multicentre comparison with multi-port laparoscopy', Colorectal disease, ;20(1): 53-58. (AmsterdamUMC) 214. Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Alava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krakorova DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkovski P, Safwat AA, Schoffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, van Coevorden F, van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY,` Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up`, Ann Oncol 2018; 29(Suppl_4):iv68-iv78 (AmsterdamUMC/NKI) 215. Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugieres L, Buonadonna A, De AE, Dei Tos AP, Del M, X, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krakorova DA, Ladenstein R, Le CA, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schoffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby HK, Unk M, van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY,` Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up`, Ann Oncol 2018; 29:iv79-iv95[Guideline] (NKI) 216. Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutierrez-Enriquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzman M, Rodriguez O, Grueso J, Bonache S, Moles-Fernandez A, Villacampa G, Viaplana C, Gomez P, Vidal M, Peg V, Serres-Creixams X, Dellaire G, Simard J, Nuciforo P, Rubio IT, Dientsmann R, Barrett JC, Caldas C, Baselga J, Saura C, Cortes J, Deas O, Jonkers J, Masson JY, Cairo S, Judde JG, O'Connor MJ, Diez O, Balmana J, Serra V,` A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation`, EMBO Mol Med 2018; 10:e9172 (16 pp) (NKI) 217. Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, Meershoek-Klein Kranenbarg E, Boot H, Trip AK, Swellengrebel HAM, van Laarhoven HWM, Putter H, van Sandick JW, Berge Henegouwen MI, Hartgrink HH, Van Tinteren H, van de Velde CJH, Verheij M,` Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial`, Lancet Oncol 2018; 19:616-28 (NKI) 218. Cats A, Sikorska K, Verheij M,` Adjuvant therapy in resectable gastric cancer-the CRITICS trial - Authors' reply`, Lancet Oncol 2018; 19:e331 [Letter] (NKI) 219. Caumanns JJ, Berns K, Wisman GBA, Fehrmann RSN, Tomar T, Klip H, Meersma GJ, Hijmans EM, Gennissen A, Duiker EW, Weening D, Itamochi H, Kluin RJ, Reyners AKL, Birrer MJ, Salvesen HB, Vergote I, Van Nieuwenhuysen E, Brenton JD, Braicu EI, Kupryjanczyk J, Spiewankiewicz B, Mittempergher L, Bernards R, van der Zee AGJ, de Jong S,` Integrative kinome profiling identifies mTORC1/2 inhibition as treatment strategy in ovarian clear cell carcinoma`, Clin Cancer Res 2018; 24:3928-40 (NKI) 220. Caumanns JJ, Wisman GBA, Berns K, van der Zee AGJ, de Jong S,` ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies`, Biochim Biophys Acta - Rev Cancer 2018; 1870:176-84 (NKI) 221. Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun MA, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Sao JG, Perez R, Renehan AG,` Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis`, Lancet Gastroenterol Hepatol 2018; 3:825-36 (NKI) 222. Chalfin, HJ, Kates, M, van der Toom, EE, Glavaris, S, Verdone, JE, Hahn, NM, Pienta, KJ, Bivalacqua, TJ & Gorin, MA 2018, 'Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection- Free Method', Urology, ;115: 82-86. (AmsterdamUMC) 223. Chao, ST, de Salles, A, Hayashi, M, Levivier, M, Ma, L, Martinez, R, Paddick, I, Régis, J, Ryu, S, Slotman, BJ & Sahgal, A 2018, 'Stereotactic radiosurgery in the management of limited (1-4) brain metasteses: Systematic review and International Stereotactic Radiosurgery Society practice guideline', Neurosurgery, ;83(3): 345-353. (AmsterdamUMC) 224. Chapman, SJ & AUTHOR GROUP 2018, 'Ileus Management International (IMAGINE): protocol for a multicentre, observational study of ileus after colorectal surgery', Colorectal disease, ;20(1): O17-O25. (AmsterdamUMC) 225. Chen Y, Zhang Y, Wang Y, Zhang L, Brinkman EK, Adam SA, Goldman R, van Steensel B, Ma J, Belmont AS,` Mapping 3D genome organization relative to nuclear compartments using TSA-Seq as a cytological ruler`, J Cell Biol 2018; 217:4025-48 (NKI) 226. Chiaradia M, Izamis ML, Radaelli A, Prevoo W, Maleux G, Schlachter T, Mayer J, Luciani A, Kobeiter H, Tacher V,` Sensitivity and Reproducibility of Automated Feeding Artery Detection Software during Transarterial Chemoembolization of Hepatocellular Carcinoma`, J Vasc Interv Radiol 2018; 29:425-31 (NKI) 227. Chipollini J, Yan S, Ottenhof SR, Zhu Y, Draeger D, Baumgarten AS, Tang DH, Protzel C, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE,` Surgical Management of Penile Carcinoma in Situ: Results from an International Collaborative Study and Review of the Literature`, BJU Int 2018; 121:393-8 (NKI) 228. Choi, EK, Eisenhut, M, van der Vliet, HJ, Lee, KH & Shin, JI 2018, 'Reply to the letter to the editor 'Body mass index and 20-specific cancers-re-analyses of dose-response meta-analyses of observational studies' by Markozannes et al', Annals of Oncology, ;29(11): 2265-2266. (AmsterdamUMC) 229. Choi, EK, Park, HB, Lee, KH, Park, JH, Eisenhut, M, van der Vliet, HJ, Kim, G & Shin, JI 2018, 'Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies', Annals of Oncology, ;29(3): 749-757. (AmsterdamUMC) 230. Choi, J, Beaino, W, Fecek, RJ, Fabian, KPL, Laymon, CM, Kurland, BF, Storkus, WJ & Anderson, CJ 2018, 'Combined VLA-4–targeted radionuclide therapy and immunotherapy in a mouse model of melanoma', Journal of Nuclear Medicine, ;59(12): 1843-1849. (AmsterdamUMC) 231. Chondronasiou D, Eisden TTHD, Stam AGM, Matthews QL, Icyuz M, Hooijberg E, Dmitriev I, Curiel DT, de Gruijl TD, van de Ven R,` Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs`, Vaccines (Basel) 2018; 6:pii: E42 (17 pp) (AmsterdamUMC/NKI) 232. Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Border WL, Green DM, Meacham LR, Mulrooney DA, Ness KK, Oeffinger KC, Ronckers CM, Sklar CA, Stovall M, van der Pal HJ, van Dijk IWEM, van Leeuwen FE, Weathers RE, Robison LL, Armstrong GT, Yasui Y,` Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer`, J Clin Oncol 2018; 36:44-52 (AmsterdamUMC/NKI) 233. Choy, ATF, Carnevale, I, Coppola, S, Meijer, LL, Kazemier, G, Zaura, E, Deng, D & Giovannetti, E 2018, 'The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine', Expert review of molecular diagnostics, ;18(12): 1005-1009. (AmsterdamUMC) 234. Cil, M, Vermue, E, Zweegman, S, Smit, M, Schuurhuis, GJ, Klootwijk, LLDV, Menezes, RX, Tsui, M-L, Smit, L, Rutten, A, Gils, NV, Brocco, F, Roemer, MG, Ossenkoppele, GJ, Verhagen, HJ, Rhenen, AV, Janssen, JJ, Denkers, F & Heukelom, S 2018, 'Abstract 1114: IGFBP7 reduces acute myeloid leukemia stem cell survival without affecting normal hematopoiesis', Cancer Research, ;78( 13 Supplement): 1114-1114. (AmsterdamUMC) 235. Cimmino, F, Avitabile, M, Diskin, SJ, Vaksman, Z, Pignataro, P, Formicola, D, Cardinale, A, Testori, A, Koster, J, de Torres, C, Devoto, M, Maris, JM, Iolascon, A & Capasso, M 2018, 'Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor', International journal of cancer. Journal international du cancer, ;143(11): 2828-2837. (AmsterdamUMC) 236. Cioni B, Nevedomskaya E, Melis MHM, van Burgsteden J, Stelloo S, Hodel E, Spinozzi D, de Jong J, van der Poel H, de Boer JP, Wessels LFA, Zwart W, Bergman AM,` Loss of Androgen Receptor Signaling in Prostate Cancer-Associated Fibroblasts (CAFs) Promotes CCL2 and CXCL8 Mediated Cancer Cell Migration`, Mol Oncol 2018; 12:1308-23 (NKI) 237. Cioni B, Zwart W, Bergman AM,` Androgen receptor moonlighting in the prostate cancer microenvironment`, Endocr Relat Cancer 2018; 25:R331-R349 (NKI) 238. Civantos FJ, Karakullukcu B, Biel M, Silver CE, Rinaldo A, Saba NF, Takes RP, Vander Poorten V, Ferlito A,` A Review of Photodynamic Therapy for Neoplasms of the Head and Neck`, Adv Ther 2018; 35:324- 40 (NKI) 239. Claassen YHM, de Steur WO, Hartgrink HH, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, Berge Henegouwen MI, Verheij M, van de Velde CJH,` Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial`, Ann Surg 2018; 268:1008-13 (AmsterdamUMC/NKI) 240. Claassen YHM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, Berge Henegouwen MI, Verheij M, van de Velde CJH,` Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial`, Eur J Surg Oncol 2018; 44:613-9 (AmsterdamUMC/NKI) 241. Claassen YHM, van Sandick JW, Hartgrink HH, Dikken JL, de Steur WO, van Grieken NCT, Boot H, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, Berge Henegouwen MI, Verheij M, van de Velde CJH,` Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial`, Br J Surg 2018; 105:728-35 (AmsterdamUMC/NKI) 242. Claessens AKM, Bos MEMM, Lopez-Yurda M, Bouma JM, Rademaker-Lakhai JM, Honkoop AH, De Graaf H, van Druten E, van Warmerdam LJC, van der Sangen MJC, Tjan-Heijnen VCG, Erdkamp FLG, Dutch Breast Cancer Research Group (BOOG),` Intermittent versus continuous first-line treatment for HER2- negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)`, Breast Cancer Res Treat 2018; 172:413-23 (NKI) 243. Clayton, A, Buschmann, D, Byrd, JB, Carter, DRF, Cheng, L, Compton, C, Daaboul, G, Devitt, A, Falcon- Perez, JM, Gardiner, C, Gustafson, D, Harrison, P, Helmbrecht, C, Hendrix, A, Hill, A, Hoffman, A, Jones, JC, Kalluri, R, Kang, JY, Kirchner, B, Lässer, C, Lawson, C, Lenassi, M, Levin, C, Llorente, A, Martens- Uzunova, ES, Möller, A, Musante, L, Ochiya, T, Pink, RC, Tahara, H, Wauben, MHM, Webber, JP, Welsh, JA, Witwer, KW, Yin, H & Nieuwland, R 2018, 'Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017', Journal of extracellular vesicles, ;7(1): 1473707. (AmsterdamUMC) 244. Clemens, E, van der Kooi, ALF, Broer, L, van Dulmen-den Broeder, E, Visscher, H, Kremer, L, Tissing, W, Loonen, J, Ronckers, CM, Pluijm, SMF, Neggers, SJCMM, Zolk, O, Langer, T, Zehnhoff-Dinnesen, AA, Wilson, CL, Hudson, MM, Carleton, B, Laven, JSE, Uitterlinden, AG & van den Heuvel-Eibrink, MM 2018, 'The influence of genetic variation on late toxicities in childhood cancer survivors: A review', Critical reviews in oncology/hematology, ;126: 154-167. (AmsterdamUMC) 245. Clement, SC, Kremer, LCM, Verburg, FA, Simmons, JH, Goldfarb, M, Peeters, RP, Alexander, EK, Bardi, E, Brignardello, E, Constine, LS, Dinauer, CA, Drozd, VM, Felicetti, F, Frey, E, Heinzel, A, van den Heuvel-Eibrink, MM, Huang, SA, Links, TP, Lorenz, K, Mulder, RL, Neggers, SJ, Nieveen van Dijkum, EJM, Oeffinger, KC, van Rijn, RR, Rivkees, SA, Ronckers, CM, Schneider, AB, Skinner, R, Wasserman, JD, Wynn, T, Hudson, MM, Nathan, PC & van Santen, HM 2018, 'Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium', Cancer treatment reviews, ;63: 28-39. (AmsterdamUMC) 246. Cloos, J, Harris, JR, Janssen, JJWM, Kelder, A, Huang, F, Sijm, G, Vonk, M, Snel, AN, Scheick, JR, Scholten, WJ, Carbaat-Ham, J, Veldhuizen, D, Hanekamp, D, Oussoren-Brockhoff, YJM, Kaspers, GJL, Schuurhuis, GJ, Sasser, AK & Ossenkoppele, G 2018, 'Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia', Journal of Visualized Experiments, no. 133. (AmsterdamUMC) 247. Coebergh van den Braak, RRJ, van Rijssen, LB, van Kleef, JJ, Vink, GR, Berbee, M, van Berge Henegouwen, MI, Bloemendal, HJ, Bruno, MJ, Burgmans, MC, Busch, ORC, Coene, PPLO, Coupé, VMH, Dekker, JWT, van Eijck, CHJ, Elferink, MAG, Erdkamp, FLG, van Grevenstein, WMU, de Groot, JWB, van Grieken, NCT, de Hingh, IHJT, Hulshof, MCCM, Ijzermans, JNM, Kwakkenbos, L, Lemmens, VEPP, Los, M, Meijer, GA, Molenaar, IQ, Nieuwenhuijzen, GAP, de Noo, ME, van de Poll-Franse, LV, Punt, CJA, Rietbroek, RC, Roeloffzen, WWH, Rozema, T, Ruurda, JP, van Sandick, JW, Schiphorst, AHW, Schipper, H, Siersema, PD, Slingerland, M, Sommeijer, DW, Spaander, MCW, Sprangers, MAG, Stockmann, HBAC, Strijker, M, van Tienhoven, G, Timmermans, LM, Tjin-A-Ton, MLR, van der Velden, AMT, Verhaar, MJ, Verkooijen, HM, Vles, WJ, de Vos-Geelen, JMPGM, Wilmink, JW, Zimmerman, DDE, van Oijen, MGH, Koopman, M, Besselink, MGH & van Laarhoven, HWM 2018, 'Nationwide comprehensive gastro- intestinal cancer cohorts: the 3P initiative', Acta oncologica (Stockholm, Sweden), ;57(2): 195-202. (AmsterdamUMC) 248. Coelen, RJS, Roos, E, Wiggers, JK, Besselink, MG, Buis, CI, Busch, ORC, Dejong, CHC, van Delden, OM, van Eijck, CHJ, Fockens, P, Gouma, DJ, Koerkamp, BG, de Haan, MW, van Hooft, JE, IJzermans, JNM, Kater, GM, Koornstra, JJ, van Lienden, KP, Moelker, A, Damink, SWMO, Poley, J-W, Porte, RJ, de Ridder, RJ, Verheij, J, van Woerden, V, Rauws, EAJ, Dijkgraaf, MGW & van Gulik, TM 2018, 'Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial', lancet. Gastroenterology & hepatology, ;3(10): 681-690. (AmsterdamUMC) 249. Coghill, AE, Pfeiffer, RM, Proietti, C, Hsu, W-L, Chien, Y-C, Lekieffre, L, Krause, L, Teng, A, Pablo, J, Yu, KJ, Lou, P-J, Wang, C-P, Liu, Z, Chen, C-J, Middeldorp, J, Mulvenna, J, Bethony, J, Hildesheim, A & Doolan, DL 2018, 'Identification of a Novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan', Clinical Cancer Research, ;24(6): 1305-1314. (AmsterdamUMC) 250. Coghill, AE, Wang, C-P, Verkuijilen, SAWM, Yu, KJ, Hsu, W-L, Middeldorp, JM & Hildesheim, A 2018, 'Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma', Journal of Medical Virology, ;90(1): 191-195. (AmsterdamUMC) 251. Collaborators of The Difficulty of Laparoscopic Liver Surgery Survey 2018, 'Are the current difficulty scores for laparoscopic liver surgery telling the whole story? An international survey and recommendations for the future', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(3): 216-221. (AmsterdamUMC) 252. COLLISION Trial Group 2018, 'Colorectal liver metastases: Surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial', BMC cancer, ;18(1): 821. (AmsterdamUMC) 253. Colombo M, Lopez-Perolio I, Meeks HD, Caleca L, Parsons M, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, Schmidt AY, Varesco L, Wappenschmidt B, Bolla MK, Dennis J, Michailidou K, Wang Q, Aittomaki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadel A, Benitez J, Boeckx B, Bogdanova NV, Bojesen SE, Bonanni B, Brauch H, Brenner H, Burwinkel B, Chang-Claude J, Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Dork T, Eriksson M, Fasching PA, Figueroa J, Fletcher O, Flyger H, Gabrielson M, Garcia-Closas M, Giles GG, Gonzalez-Neira A, Guenel P, Haiman CA, Hall P, Hamann U, Hartman M, Hauke J, Hollestelle A, Hopper JL, Jakubowska A, Jung A, Kosma VM, Lambrechts D, Marchand LL, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Miao H, Milne RL, Neuhausen SL, Nevanlinna H, Olson JE, Peterlongo P, Peto J, Pylkas K, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, See MH, Southey MC, Swerdlow A, Teo SH, Toland AE, Tomlinson I, Truong T, van Asperen CJ, van den Ouweland AMW, van der Kolk L, Winqvist R, Yannoukakos D, Zheng W, Dunning AM, Easton DF, Henderson A, Hogervorst F, Izatt L, Offitt K, Side LE, van Rensburg EJ, Embrace S, Hebon S, McGuffog L, Antoniou AC, Chenevix-Trench G, Spurdle AB, Goldgar DE, de la Hoya M, Radice P,` The BRCA2 c68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity`, Hum Mutat 2018; 39:729-41 (NKI) 254. Compter A, Schilling S, Vaineau CJ, Goeggel-Simonetti B, Metso TM, Southerland A, Pezzini A, Kloss M, Touze E, Worrall BB, Thijs V, Bejot Y, Reiner P, Grond-Ginsbach C, Bersano A, Brandt T, Caso V, Lyrer PA, Traenka C, Lichy C, Martin JJ, Leys D, Sarikaya H, Baumgartner RW, Jung S, Fischer U, Engelter ST, Dallongeville J, Chabriat H, Tatlisumak T, Bousser MG, Arnold M, Debette S, CADISP-plus Consortium,`, Collaborators (51) Determinants and outcome of multiple and early recurrent cervical artery dissections`, Neurology 2018; 91:e769-e780 (NKI) 255. Conemans, EB, Lodewijk, L, Moelans, CB, Offerhaus, GJA, Pieterman, CRC, Morsink, FH, Dekkers, OM, De Herder, WW, Hermus, AR, Van Der Horst-Schrivers, AN, Drent, ML, Bisschop, PH, Havekes, B, Brosens, LAA, Dreijerink, KMA, Rinkes, IHMB, Timmers, HTM, Valk, GD & Vriens, MR 2018, 'DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment', European Journal of Endocrinology, ;179(3): 153-160. (AmsterdamUMC) 256. Conemans, EB, Raicu-Ionita, GM, Pieterman, CRC, Dreijerink, KMA, Dekkers, OM, Hermus, AR, de Herder, WW, Drent, ML, van der Horst-Schrivers, ANA, Havekes, B, Bisschop, PH, Offerhaus, GJ, Borel Rinkes, IHM, Valk, GD, Timmers, HTM & Vriens, MR 2018, 'Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors', Journal of Endocrinological Investigation, pp. 1-7. (AmsterdamUMC) 257. Cook, G, Zweegman, S, Mateos, M-V, Suzan, F & Moreau, P 2018, 'A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma', Critical Reviews in Oncology/Hematology, ;121: 74-89. (AmsterdamUMC) 258. Corcoran RB, Andre T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Middleton G, Muro K, Gordon MS, Tabernero J, Yaeger R, O'Dwyer PJ, Humblet Y, De Vos F, Jung AS, Brase JC, Jaeger S, Bettinger S, Mookerjee B, Rangwala F, Van Cutsem E,` Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer`, Cancer Discov 2018; 8:428-43 (NKI) 259. Correia, S, Bridges, R, Wegner, F, Venturini, C, Palser, A, Middeldorp, JM, Cohen, JI, Lorenzetti, MA, Bassano, I, White, RE, Kellam, P, Breuer, J & Farrell, PJ 2018, 'Sequence variation of Epstein-Barr virus: Viral types, geography, codon usage, and diseases', Journal of Virology, ;92(22): e01132-18. (AmsterdamUMC) 260. Creemers, A, Ebbing, EA, Hooijer, GKJ, Stap, L, Jibodh-Mulder, RA, Gisbertz, SS, Henegouwen, MIVB, van Montfoort, ML, Hulshof, MCCM, Krishnadath, KK, van Oijen, MGH, Bijlsma, MF, Meijer, SL & van Laarhoven, HWM 2018, 'The dynamics of HER2 status in esophageal adenocarcinoma', Oncotarget, ;9(42): 26787-26799. (AmsterdamUMC) 261. Creemers, A, Ebbing, EA, Pelgrim, TC, Lagarde, SM, van Etten-Jamaludin, FS, van Berge Henegouwen, MI, Hulshof, MCCM, Krishnadath, KK, Meijer, SL, Bijlsma, MF, van Oijen, MGH & van Laarhoven, HWM 2018, 'A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas', Scientific reports, ;8(1): 13281. (AmsterdamUMC) 262. Crijnen, J & de Reijke, TM 2018, 'Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer', Expert opinion on emerging drugs, ;23(2): 135-147. (AmsterdamUMC) 263. CRITICS investigators, van Laarhoven, HWM, van Berge Henegouwen, MI & Hulshof, MCCM 2018, 'Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial', lancet oncology, ;19(5): 616-628. (AmsterdamUMC) 264. Croce, S, Ducoulombier, A, Ribeiro, A, Lesluyes, T, Noel, J-C, Amant, F, Guillou, L, Stoeckle, E, Devouassoux-Shisheboran, M, Penel, N, Floquet, A, Arnould, L, Guyon, F, Mishellany, F, Chakiba, C, Cuppens, T, Zikan, M, Leroux, A, Frouin, E, Farre, I, Genestie, C, Valo, I, MacGrogan, G & Chibon, F 2018, 'Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors', Modern pathology, ;31: 816-828. (AmsterdamUMC) 265. Crombag MBS, van Doremalen JGC, Janssen JM, Rosing H, Schellens JHM, Beijnen JH, Steeghs N, Huitema ADR,` Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Oncology in a Real- world Cohort Study: Does Age Matter? Br J Clin Pharmacol 2018; 84:2770-8 `, (NKI) 266. Crombag, LMMJ & Annema, JT 2018, 'Do we understage SABR candidates?', Lung cancer (Amsterdam, Netherlands), ;117: 60-61. (AmsterdamUMC) 267. Cruz C, Castroviejo-Bermejo M, Gutierrez-Enriquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN, Kristel P, de Bustos L, Guzman M, Rodriguez O, Grueso J, Montalban G, Caratu G, Mancuso F, Fasani R, Jimenez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Creixams X, Rubio IT, Oaknin A, Cadogan E, Barrett JC, Caldas C, Baselga J, Saura C, Cortes J, Arribas J, Jonkers J, Diez O, O'Connor MJ, Balmana J, Serra V,` RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA mutated breast cancer`, Ann Oncol 2018; 29:1203-10 (NKI) 268. Cuadrado E, van den Biggelaar M, de Kivit S, Chen YY, Slot M, Doubal I, Meijer A, van Lier RAW, Borst J, Amsen D,` Proteomic Analyses of Human Regulatory T Cells Reveal Adaptations in Signaling Pathways that Protect Cellular Identity`, Immunity 2018; 48:1046-59 (NKI) 269. Cuppens, T, Moisse, M, Depreeuw, J, Annibali, D, Colas, E, Gil-Moreno, A, Huvila, J, Carpén, O, Zikán, M, Matias-Guiu, X, Moerman, P, Croce, S, Lambrechts, D & Amant, F 2018, 'Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways', International journal of cancer. Journal international du cancer, ;142(6): 1230-1243. (AmsterdamUMC) 270. Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart- Gebhart M, Senn HJ, Thurlimann B, Andre F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B,` Reply to "The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology" by Kirova et al`, Ann Oncol 2018; 29:281-2 [Letter] (NKI) 271. Cuschieri, K, Ronco, G, Lorincz, A, Smith, L, Ogilvie, G, Mirabello, L, Carozzi, F, Cubie, H, Wentzensen, N, Snijders, P, Arbyn, M, Monsonego, J & Franceschi, S 2018, 'Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs', International Journal of Cancer, ;143(4): 735-745. (AmsterdamUMC) 272. Cysouw, M, Bouman-Wammes, E, Hoekstra, O, van den Eertwegh, A, Piet, M, van Moorselaar, J, Boellaard, R, Dahele, M & Oprea-Lager, D 2018, 'Prognostic Value of [18F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer', International Journal of Radiation Oncology Biology Physics, ;101(2): 406-410. (AmsterdamUMC) 273. Dabestani S, Marconi L, Kuusk T, Bex A,` Follow-up after curative treatment of localised renal cell carcinoma`, World J Urol 2018; 36:1953-9 (NKI) 274. Dackus GMHE, Jozwiak K, Sonke GS, van der Wall E, van Diest PJ, Hauptmann M, Siesling S, Linn SC,` Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study`, Eur J Cancer 2018; 90:92-101 (NKI) 275. Dall'Igna, P, Brugieres, L, Christin, AS, Maibach, R, Casanova, M, Alaggio, R, de Goyet, JDV, Zsiros, J, Morland, B, Czauderna, P, Childs, M, Aronson, DC, Branchereau, S, Brock, P & Perilongo, G 2018, 'Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group', Pediatric blood & cancer, ;65(1): e26791. (AmsterdamUMC) 276. Damhuis RAM, Senan S, Belderbos JS,` Usage of Prophylactic Cranial Irradiation in Elderly Patients With Small-cell Lung Cancer`, Clin Lung Cancer 2018; 19:e263-e267 (NKI) 277. Dankers FJWM, Wijsman R, Troost EGC, Tissing-Tan CJA, Kwint MH, Belderbos J, de RD, Hendriks LE, de Geus-Oei LF, Rodwell L, Dekker A, Monshouwer R, Hoffmann AL, Bussink J,` External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity- modulated (chemo-)radiotherapy`, Radiother Oncol 2018; 129:249-56 (NKI) 278. Davila Fajardo R, Oldenburger E, Rube C, Lopez-Yurda M, Pritchard-Jones K, Bergeron C, Graf N, van Grotel M, Van Tinteren H, Saunders D, van den Heuvel-Eibrink MM, Janssens GO, Oldenburger F,` Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry`, Pediatr Blood Cancer 2018; 65 (AmsterdamUMC/NKI) 279. de Back, TR, Kater, AP & Tonino, SH 2018, 'Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations', Expert review of hematology, ;11(8): 613-624. (AmsterdamUMC) 280. de Boer LL, Bydlon TM, van Duijnhoven F, Vranken Peeters MTFD, Loo CE, Winter-Warnars GAO, Sanders J, Sterenborg HJCM, Hendriks BHW, Ruers TJM,` Towards the use of diffuse reflectance spectroscopy for real-time in vivo detection of breast cancer during surgery`, J Transl Med 2018; 16:367 (34 p) (NKI) 281. de Boer M, Hauptmann M, de Jong D, van Leeuwen FE, Rakhorst HA, van der Hulst RRWJ,` Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants`, Plast Reconstr Surg 2018; 142:590e-1e [Letter] (NKI) 282. de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D,` Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast`, JAMA Oncol 2018; 4:335-41 (AmsterdamUMC/NKI) 283. de Boer P, van de Schoot AJAJ, Westerveld H, Smit M, Buist MR, Bel A, Rasch CRN, Stalpers LJA,` Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits`, (AmsterdamUMC/NKI) 284. de Boer, LL, Bydlon, TM, van Duijnhoven, F, Vranken Peeters, M-J, Loo, CE, Winter-Warnars, GAO, Sanders, J, Sterenborg, HJCM, Hendriks, BHW & Ruers, TJM 2018, 'Towards the use of diffuse reflectance spectroscopy for real-time in vivo detection of breast cancer during surgery', Journal of translational medicine, ;16: 367. (AmsterdamUMC) 285. de Brabander J, Eskens FALM, Korsse SE, Dekker E, Dewint P, van Leerdam ME, van Eeden S, Klumpen HJ,` Chemoprevention in Patients with Peutz-Jeghers Syndrome: Lessons Learned`, Oncologist 2018; 23:399-e33 (AmsterdamUMC/NKI) 286. de Bree, K, Westermann, AM, Klümpen, H-J, Verheij, J, Phoa, SSKS, Oomen, M & van Gulik, TM 2018, 'Two Cases of Hepatoblastoma in Young Adults', Journal of adolescent and young adult oncology, ;7(3): 404-408. (AmsterdamUMC) 287. de Bree, R, Senft, A, Coca-Pelaz, A, Kowalski, L, Lopez, F, Mendenhall, W, Quer, M, Rinaldo, A, Shaha, AR, Strojan, P, Takes, RP, Silver, CE, Leemans, CR & Ferlito, A 2018, 'Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape', Advances in therapy, ;35(2): 161-172. (AmsterdamUMC) 288. de Geus, KF, Maggen, C, de Haan, J & Amant, F 2018, 'Implementation of cancer treatment during pregnancy in daily practice: The important role of perinatologists', Oncotarget, ;9(61): 31795-31796. (AmsterdamUMC) 289. De Gooijer CJ, Baas P,` Treat it or Leave it: Immuno-Oncology in Mesothelioma Observed by the Eyes of Argus`, J Thorac Oncol 2018; 13:1619-22 [Editorial] (NKI) 290. de Gooijer MC, Buil LCM, Beijnen JH, van Tellingen O,` ATP-binding cassette transporters limit the brain penetration of Wee1 inhibitors`, Invest New Drugs 2018; 36:380-7 (NKI) 291. de Gooijer MC, Buil LCM, Citirikkaya CH, Hermans J, Beijnen JH, van Tellingen O,` ABCB1 Attenuates the Brain Penetration of the PARP Inhibitor AZD2461`, Mol Pharm 2018; 15:5236-43 (NKI) 292. de Gooijer MC, de Vries NA, Buckle T, Buil LCM, Beijnen JH, Boogerd W, van Tellingen O,` Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2`, Neoplasia 2018; 20:710-20 (NKI) 293. de Gooijer MC, Guillen Navarro M, Bernards R, Wurdinger T, van Tellingen O,` An Experimenter's Guide to Glioblastoma Invasion Pathways`, Trends Mol Med 2018; 24:763-80 (NKI) 294. de Gooijer MC, Zhang P, Buil LCM, Citirikkaya CH, Thota N, Beijnen JH, van Tellingen O,` Buparlisib is a brain penetrable pan-PI3K inhibitor`, Sci Rep 2018; 8:10784 (8 pp) (NKI) 295. de Gooijer MC, Zhang P, Weijer R, Buil LCM, Beijnen JH, van Tellingen O,` The impact of P-glycoprotein and Breast Cancer Resistance Protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors`, Int J Cancer 2018; 142:381-91 (NKI) 296. de Gooijer, MC, Guillén Navarro, M, Bernards, R, Wurdinger, T & van Tellingen, O 2018, 'An Experimenter's Guide to Glioblastoma Invasion Pathways', Trends in Molecular Medicine, ;24(9): 763- 780. (AmsterdamUMC) 297. de Groot JS, Ratze MAK, van Amersfoort M, Eisemann T, Vlug EJ, Niklaas MT, Chin SF, Caldas C, van Diest PJ, Jonkers J, de Rooij J, Derksen PWB,` alphaE-catenin is a candidate tumor suppressor for the development of E-cadherin expressing lobular-type breast cancer`, J Pathol 2018; 245:456-67 (NKI) 298. de Haan J, van Thienen JV, Casaer M, Hannivoort RA, Van Calsteren K, van Tuyl M, van Gerwen MM, Debeer A, Amant F, Painter RC,` Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma`, Case Rep Oncol 2018; 11:119-24 (NKI) 299. de Haan J, Verheecke M, Van Calsteren K, Van Calster B, Shmakov RG, Mhallem Gziri M, Halaska MJ, Fruscio R, Lok CAR, Boere IA, Zola P, Ottevanger PB, de Groot CJM, Peccatori FA, Dahl Steffensen K, Cardonick EH, Polushkina E, Rob L, Ceppi L, Sukhikh GT, Han SN, Amant F,` Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients`, Lancet Oncol 2018; 19:337-46 (NKI) 300. de Haan R, Pluim D, van Triest B, van den Heuvel M, Peulen H, van Berlo D, George J, Verheij M, Schellens JHM, Vens C,` Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials`, Radiother Oncol 2018; 126:443-9 (NKI) 301. de Haan, J, van Thienen, JV, Casaer, M, Hannivoort, RA, van Calsteren, K, van Tuyl, M, van Gerwen, MM, Debeer, A, Amant, F & Painter, RC 2018, 'Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma', Case reports in oncology, ;11(1): 119-124. (AmsterdamUMC) 302. de Haan, J, Verheecke, M, van Calsteren, K, van Calster, B, Shmakov, RG, Mhallem Gziri, M, Halaska, MJ, Fruscio, R, Lok, CAR, Boere, IA, Zola, P, Ottevanger, PB, de Groot, CJM, Peccatori, FA, Dahl Steffensen, K, Cardonick, EH, Polushkina, E, Rob, L, Ceppi, L, Sukhikh, GT, Han, SN & Amant, F 2018, 'Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients', lancet oncology, ;19(3): 337- 346. (AmsterdamUMC) 303. de Haan, R, Pluim, D, van Triest, B, van den Heuvel, M, Peulen, H, van Berlo, D, George, J, Verheij, M, Schellens, JHM & Vens, C 2018, 'Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials', Radiotherapy and Oncology, ;126(3): 443-449. (AmsterdamUMC) 304. de Heer, EC, Brouwers, AH, Boellaard, R, Sluiter, WJ, Diercks, GFH, Hospers, GAP, de Vries, EGE & Jalving, M 2018, 'Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis', EJNMMI Research, ;8(1): 101. (AmsterdamUMC) 305. de Jong D, de Boer M, van Leeuwen FE,` Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reply`, JAMA Oncol 2018; 4:1435 [Comment] (NKI) 306. de Jong JJ, Hendricksen K, Rosier M, Mostafid H, Boormans JL,` Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients`, Bladder Cancer 2018; 4:395-401 (NKI) 307. de Jong, F, Frings-Dresen, MH, Dijk, NV, van Etten-Jamaludin, FS, van Asselt, KM & de Boer, AGEM 2018, 'The role of the general practitioner in return to work after cancer-a systematic review', Family practice, ;35(5): 531-541. (AmsterdamUMC) 308. de Jong, M, Tamminga, SJ, van Es, RJJ, Frings-Dresen, MHW & de Boer, AGEM 2018, 'The quality of working life questionnaire for cancer survivors (QWLQ-CS): factorial structure, internal consistency, construct validity and reproducibility', BMC cancer, ;18(1): 66. (AmsterdamUMC) 309. de Jong, MC, de Graaf, P, Pouwels, PJW, Beenakker, JW, Jansen, RW, Geurts, JJG, Moll, AC, Castelijns, JA, van der Valk, P & van der Weerd, L 2018, '9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology', Journal of Magnetic Resonance Imaging, pp. 1487-1497. (AmsterdamUMC) 310. de Klerk, CM, Gupta, S, Dekker, E & Essink-Bot, ML 2018, 'Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide', Gut, ;67(4): 679-687. (AmsterdamUMC) 311. de Klerk, CM, van der Vlugt, M, Bossuyt, PM & Dekker, E 2018, 'A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic', United European gastroenterology journal, ;6(3): 471-479. (AmsterdamUMC) 312. de Klerk, CM, Vendrig, LM, Bossuyt, PM & Dekker, E 2018, 'Participant-Related Risk Factors for False- Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis', American journal of gastroenterology, ;113(12): 1778-1787. (AmsterdamUMC) 313. de Kruijff, RM, van der Meer, AJGM, Windmeijer, CAA, Kouwenberg, JJM, Morgenstern, A, Bruchertseifer, F, Sminia, P & Denkova, AG 2018, 'The therapeutic potential of polymersomes loaded with Ac evaluated in 2D and 3D in vitro glioma models', European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, ;127: 85-91. (AmsterdamUMC) 314. de Lange SV, Bakker MF, Monninkhof EM, Peeters PHM, Koekkoek-Doll PK, Mann RM, Rutten MJCM, Bisschops RHC, Veltman J, Duvivier KM, Lobbes MBI, de Koning HJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, Van Gils CH,` Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts`, Clin Radiol 2018; 73:759 (NKI) 315. de Lange, MJ, Nell, RJ, Lalai, RN, Versluis, M, Jordanova, ES, Luyten, GPM, Jager, MJ, van der Burg, SH, Zoutman, WH, van Hall, T & van der Velden, PA 2018, 'Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma', Molecular Cancer Research, ;16(12): 1902-1911. (AmsterdamUMC) 316. de Lange, SV, Bakker, MF, Monninkhof, EM, Peeters, PHM, de Koekkoek-Doll, PK, Mann, RM, Rutten, MJCM, Bisschops, RHC, Veltman, J, Duvivier, KM, Lobbes, MBI, de Koning, HJ, Karssemeijer, N, Pijnappel, RM, Veldhuis, WB & van Gils, CH 2018, 'Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts', Clinical Radiology, ;73(8): 759.e1-759.e9. (AmsterdamUMC) 317. de Langen AJ, Jebbink M, Hashemi SMS, Kuiper JL, Bruin-Visser J, Monkhorst K, Thunnissen E, Smit EF,` Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment`, Br J Cancer 2018; 119:558-64 (AmsterdamUMC/NKI) 318. de Ligt KM, Spronk PER, van Bommel ACM, Vrancken Peeters MTFD, Siesling S, Smorenburg CH,` Patients' experiences with decisions on timing of chemotherapy for breast cancer`, Breast 2018; 37:99-106 (NKI) 319. de Ligt KM, van Bommel ACM, Schreuder K, Maduro JH, Vrancken Peeters MTFD, Mureau MAM, Siesling S,` The effect of being informed on receiving immediate breast reconstruction in breast cancer patients`, Eur J Surg Oncol 2018; 44:717-24 (NKI) 320. de Marinis F, Ciardiello F, Baas P, Crino L, Giaccone G, Grossi F, Hellmann MD, Mok TSK, Lena H, Paz- Ares L, Rodriguez-Abreu D, Von Pavel J, Gridelli C,` 30 Immunotherapy in advanced NSCLC-from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)`, ESMO Open 2018; 3:e000298 (NKI) 321. De Mello, RA, Castelo-Branco, L, Castelo-Branco, P, Pozza, DH, Vermeulen, L, Palacio, S, Salzberg, M & Lockhart, AC 2018, 'What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?', American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, no. 38, pp. 249-261. (AmsterdamUMC) 322. de Munck, L, Fracheboud, J, de Bock, GH, den Heeten, GJ, Siesling, S & Broeders, MJM 2018, 'Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?', International journal of cancer. Journal international du cancer, ;143(4): 842- 850. (AmsterdamUMC) 323. de Neree Tot Babberich MPM, Detering R, Dekker JWT, Elferink MA, Tollenaar RAEM, Wouters MWJM, Tanis PJ, Dutch ColoRectal Audit Group, (Collaborators 18), Beets-Tan RGH,` Achievements in colorectal cancer care during 8 years of auditing in The Netherlands`, Eur J Surg Oncol 2018; 44:1361- 70 (NKI) 324. de Neree Tot Babberich MPM, van Groningen JT, Dekker E, Wiggers T, Wouters MWJM, Bemelman WA, Tanis PJ,` Laparoscopic conversion in colorectal cancer surgery; is there any improvement over time at a population level? `,Surg Endosc 2018; 32:3234-46 (AmsterdamUMC/NKI) 325. de Neree Tot Babberich MPM, Vermeer NCA, Wouters MWJM, van Grevenstein WMU, Peeters KCMJ, Dekker E, Tanis PJ,` Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands`, JAMA Surg 2018; 153:e183567 (11 pp) (AmsterdamUMC/NKI) 326. de Pastena, M, Nijkamp, MW, van Gulik, TG, Busch, OR, Hermanides, HS & Besselink, MG 2018, 'Laparoscopic hemi-splenectomy', Surgery today, ;48(7): 735-738. (AmsterdamUMC) 327. de Pastena, M, van Hilst, J, de Rooij, T, Busch, OR, Gerhards, MF, Festen, S & Besselink, MG 2018, 'Laparoscopic pancreatoduodenectomy with modified Blumgart pancreaticojejunostomy', Journal of visualized experiments, ;2018(136): e56819. (AmsterdamUMC) 328. de Raaij, EJ, Ostelo, RW, Maissan, F, Mollema, J & Wittink, H 2018, 'The association of illness perception and prognosis for pain and physical function in patients with noncancer musculoskeletal pain: A systematic literature review', Journal of Orthopaedic and Sports Physical Therapy, ;48(10): 789-800. (AmsterdamUMC) 329. de Rond, L, Coumans, FAW, Nieuwland, R, van Leeuwen, TG & van der Pol, E 2018, 'Deriving Extracellular Vesicle Size From Scatter Intensities Measured by Flow Cytometry', Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.], ;86(1): e43. (AmsterdamUMC) 330. de Rond, L, van der Pol, E, Hau, CM, Varga, Z, Sturk, A, van Leeuwen, TG, Nieuwland, R & Coumans, FAW 2018, 'Comparison of Generic Fluorescent Markers for Detection of Extracellular Vesicles by Flow Cytometry', Clinical chemistry, ;64(4): 680-689. (AmsterdamUMC) 331. de Rooij, T, van Hilst, J, Bosscha, K, Dijkgraaf, MG, Gerhards, MF, Groot Koerkamp, B, Hagendoorn, J, de Hingh, IH, Karsten, TM, Lips, DJ, Luyer, MD, Molenaar, IQ, van Santvoort, HC, Tran, TCK, Busch, OR, Festen, S & Besselink, MG 2018, 'Minimally invasive versus open pancreatoduodenectomy (LEOPARD- 2): study protocol for a randomized controlled trial', Trials, ;19(1): 1. (AmsterdamUMC) 332. de Ruiter JR, Wessels LFA, Jonkers J,` Mouse models in the era of large human tumour sequencing studies`, Open Biol 2018; 8:180080 (16 pp) (NKI) 333. De Ruysscher D, Dingemans AC, Praag J, Belderbos J, Tissing-Tan C, Herder J, Haitjema T, Ubbels F, Lagerwaard F, El Sharouni SY, Stigt JA, Smit E, Van Tinteren H, van der Noort V, Groen HJM,` Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study`, J Clin Oncol 2018; 36:2366-77 (AmsterdamUMC/NKI) 334. de Souza DK, Dorlo TPC,` Safe mass drug administration for neglected tropical diseases`, Lancet Glob Health 2018; 6:e1054-e1055 (NKI) 335. De Strooper, LMA, Berkhof, J, Steenbergen, RDM, Lissenberg-Witte, BI, Snijders, PJF, Meijer, CJLM & Heideman, DAM 2018, 'Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124- 2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up', International Journal of Cancer, ;143(6): 1541-1548. (AmsterdamUMC) 336. de van der Schueren, MAE, Laviano, A, Blanchard, H, Jourdan, M, Arends, J & Baracos, VE 2018, 'Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: Current evidence and guidance for design of future trials', Annals of Oncology, ;29(5): 1141-1153. (AmsterdamUMC) 337. de Veij Mestdagh PD, Jonker MCJ, Vogel WV, Schreuder WH, Donswijk ML, Klop WMC, Al Mamgani A,` SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma`, Eur Arch Otorhinolaryngol 2018; 275:2135-44 (NKI) 338. de Vos, B, Rijken, JA, Adank, MA, Hoksbergen, AWJ, Bayley, JP, Leemans, CR & Hensen, EF 2018, 'A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study', Clinical Otolaryngology, ;43(3): 841-845. (AmsterdamUMC) 339. de Vries S, Schaapveld M, Kardaun JW, de Bruin KH, Krol AD, Lugtenburg PJ, Jacobse JN, Aleman BMP, van Leeuwen FE,` Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics`, Clin Epidemiol 2018; 10:1523-31 (NKI) 340. de Vries S, Schaapveld M, van Nimwegen FA, Jozwiak K, Lugtenburg PJ, Daniels LA, Roesink JM, van der Maazen RWM, Kok WEM, Aleman BMP, van Leeuwen FE,` High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors`, Br J Cancer 2018; 118:887-95 (NKI) 341. de Vries Schultink AHM, Boekhout AH, Gietema JA, Burylo AM, Dorlo TPC, van Hasselt JGC, Schellens JHM, Huitema ADR,` Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens`, J Pharmacokinet Pharmacodyn 2018; 45:431- 42 (NKI) 342. de Vries Schultink AHM, Doornbos RP, Bakker ABH, Bol K, Throsby M, Geuijen C, Maussang D, Schellens JHM, Beijnen JH, Huitema ADR,` Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose`, Invest New Drugs 2018; 36:1006-15 (NKI) 343. de Vries Schultink AHM, Huitema ADR, Beijnen JH,` Therapeutic Drug Monitoring of endoxifen as an alternative for CYP2D6 genotyping in individualizing tamoxifen therapy`, Breast 2018; 42:38-40 (NKI) 344. De Vries, AMM, Gholamrezaee, MM, Verdonck-de Leeuw, IM, de Roten, Y, Despland, JN, Stiefel, F & Passchier, J 2018, 'Physicians' emotion regulation during communication with advanced cancer patients', Psycho-Oncology, ;27(3): 929-936. (AmsterdamUMC) 345. de Vries, HJC & Steenbergen, RDM 2018, 'The effect of ART on cervical cancer precursor lesions', The Lancet HIV, ;5(1): e6-e8. (AmsterdamUMC) 346. de Vries, LH, Lodewijk, L, Willems, SM, Dreijerink, KMA, de Keizer, B, van Diest, PJ, Schepers, A, Bonenkamp, HJ, van Engen-van Grunsven, IACH, Kruijff, S, van Hemel, BM, Links, TP, Nieveen van Dijkum, EJM, van Eeden, S, Valk, GD, Borel Rinkes, IHM & Vriens, MR 2018, 'SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival', Endocrine, ;62(3): 639-647. (AmsterdamUMC) 347. de Vries, M, de Ruiter, MA, Oostrom, KJ, Schouten-van Meeteren, AYN, Maurice-Stam, H, Oosterlaan, J & Grootenhuis, MA 2018, 'The association between the behavior rating inventory of executive functioning and cognitive testing in children diagnosed with a brain tumor', Child neuropsychology, ;24(6): 844-858. (AmsterdamUMC) 348. de Vries, VA, Müller, MCA, Sesmu Arbous, M, Biemond, BJ, Blijlevens, NMA, Kusadasi, N, Choi, GCW, Vlaar, APJ, van Westerloo, DJ, Kluin-Nelemans, HC, van den Bergh, WM & AUTHOR GROUP 2018, 'Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units', British journal of haematology, ;181(1): 68-76. (AmsterdamUMC) 349. de Vries, YC, Boesveldt, S, Kelfkens, CS, Posthuma, EE, van den Berg, MMGA, de Kruif, JTCM, Haringhuizen, A, Sommeijer, DW, Buist, N, Grosfeld, S, de Graaf, C, van Laarhoven, HWM, Kampman, E & Winkels, RM 2018, 'Taste and smell perception and quality of life during and after systemic therapy for breast cancer', Breast cancer research and treatment, ;170(1): 27-34. (AmsterdamUMC) 350. de Vries, YC, Winkels, RM, van den Berg, MMGA, de Graaf, C, Kelfkens, CS, de Kruif, JTCM, Göker, E, Grosfeld, S, Sommeijer, DW, van Laarhoven, HWM, Kampman, E & Boesveldt, S 2018, 'Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls', FOOD QUALITY AND PREFERENCE, ;63: 135-143. (AmsterdamUMC) 351. de Weerdt, I, Hofland, T, Lameris, R, Endstra, S, Jongejan, A, Moerland, PD, de Bruin, RCG, Remmerswaal, EBM, ten Berge, IJM, Liu, N, van der Stelt, M, Faber, LM, Levin, M-D, Eldering, E, Tonino, SH, de Gruijl, TD, van der Vliet, HJ & Kater, AP 2018, 'Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib', Blood, ;132(21): 2260-2272. (AmsterdamUMC) 352. de Weger VA, Goel S, von Moos R, Schellens JHM, Mach N, Tan E, Anand S, Scott JW, Lassen U,` A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors`, Cancer Chemother Pharmacol 2018; 81:73-80 (NKI) 353. Dean E, Banerji U, Schellens JHM, Krebs MG, Jimenez B, van Brummelen E, Bailey C, Casson E, Cripps D, Cullberg M, Evans S, Foxley A, Lindemann J, Rugman P, Taylor N, Turner G, Yates J, Lawrence P,` A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK`, Cancer Chemother Pharmacol 2018; 81:873-83 (NKI) 354. Decaesteker, B, Denecker, G, van Neste, C, Dolman, EM, van Loocke, W, Gartlgruber, M, Nunes, C, de Vloed, F, Depuydt, P, Verboom, K, Rombaut, D, Loontiens, S, de Wyn, J, Kholosy, WM, Koopmans, B, Essing, AHW, Herrmann, C, Dreidax, D, Durinck, K, Deforce, D, van Nieuwerburgh, F, Henssen, A, Versteeg, R, Boeva, V, Schleiermacher, G, van Nes, J, Mestdagh, P, Vanhauwaert, S, Schulte, JH, Westermann, F, Molenaar, JJ, de Preter, K & Speleman, F 2018, 'TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets', Nature communications, ;9(1): 4866. (AmsterdamUMC) 355. Defraene G, La FM, van Kranen S, Reymen B, Belderbos J, Sonke JJ, de RD,` Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume`, Int J Radiat Oncol Biol Phys 2018; 102:642-50 (NKI) 356. Degeling, K, Franken, MD, May, AM, van Oijen, MGH, Koopman, M, Punt, CJA, IJzerman, MJ & Koffijberg, H 2018, 'Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients', Cancer epidemiology, ;57: 60-67. (AmsterdamUMC) 357. Dei Tos AP, Bonvalot S, Haas R,` The key role of pathology, surgery and radiotherapy in the initial management of soft tissue sarcoma`, Future Oncol 2018; 14:15-23 (NKI) 358. Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P,` Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers`, Med Phys 2018; 45:3449-59 (NKI) 359. Dekker, E & Bronzwaer, MES 2018, 'Effective reporting of key performance indicators is essential for balancing the benefits and drawbacks of colonoscopy', Endoscopy, ;50(9): 837-838. (AmsterdamUMC) 360. Dekker, E & Rex, DK 2018, 'Advances in CRC prevention: screening and surveillance', Gastroenterology, ;154(7): 1970-1984. (AmsterdamUMC) 361. Dekker, H, Bravenboer, N, van Dijk, D, Bloemena, E, Rietveld, DHF, ten Bruggenkate, CM & Schulten, EAJM 2018, 'The irradiated human mandible: A quantitative study on bone vascularity', Oral Oncology, ;87: 126-130. (AmsterdamUMC) 362. Delaney, AR, Dahele, M, Slotman, BJ & Verbakel, WFAR 2018, 'Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans?', Radiotherapy and Oncology, ;127(2): 190-196. (AmsterdamUMC) 363. Delaney, AR, Dong, L, Mascia, A, Zou, W, Zhang, Y, Yin, L, Rosas, S, Hrbacek, J, Lomax, AJ, Slotman, BJ, Dahele, M & Verbakel, WFAR 2018, 'Automated knowledge-based intensity-modulated proton planning: An international multicenter benchmarking study', Cancers, ;10( 11. ): (AmsterdamUMC) 364. Delbart F, Brams M, Gruss F, Noppen S, Peigneur S, Boland S, Chaltin P, Brandao-Neto J, von Delft F, Touw WG, Joosten R, Liekens S, Tytgat J, Ulens C,` An allosteric binding site of the alpha7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine binding protein`, J Biol Chem 2018; 293:2534-45 (NKI) 365. den Bakker, CM & van der Peet, DL 2018, 'Post-treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma', Annals of Surgery, ;268(6): e78-e79. (AmsterdamUMC) 366. den Bakker, CM, Anema, JR, Zaman, AGNM, de Vet, HCW, Sharp, L, Angenete, E, Allaix, ME, Otten, RHJ, Huirne, JAF, Bonjer, HJ, de Boer, AGEM & Schaafsma, FG 2018, 'Prognostic factors for return to work and work disability among colorectal cancer survivors; A systematic review': (AmsterdamUMC) 367. den Braber-Ymker M, Heijker S, Lammens M, Croockewit S, Nagtegaal ID,` Intestinal involvement in amyloidosis is a sequential process`, Neurogastroenterol Motil 2018; 30:e13469 (9 pp) (NKI) 368. Deprez S, de Ruiter MB, Bogaert S, Peeters R, Belderbos J, de RD, Schagen S, Sunaert S, Pullens P, Achten E,` Multi-center reproducibility of structural, diffusion tensor, and resting state functional magnetic resonance imaging measures`, Neuroradiology 2018; 60:617-34 (NKI) 369. Deprez S, Kesler SR, Saykin AJ, Silverman DHS, de Ruiter MB, McDonald BC,` International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients`, J Natl Cancer Inst 2018; 110:223-31 (NKI) 370. Depuydt, P, Boeva, V, Hocking, TD, Cannoodt, R, Ambros, IM, Ambros, PF, Asgharzadeh, S, Attiyeh, EF, Combaret, V, Defferrari, R, Fischer, M, Hero, B, Hogarty, MD, Irwin, MS, Koster, J, Kreissman, S, Ladenstein, R, Lapouble, E, Laureys, G, London, WB, Mazzocco, K, Nakagawara, A, Noguera, R, Ohira, M, Park, JR, Pötschger, U, Theissen, J, Tonini, GP, Valteau-Couanet, D, Varesio, L, Versteeg, R, Speleman, F, Maris, JM, Schleiermacher, G & de Preter, K 2018, 'Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients', Journal of the National Cancer Institute, ;110(10): 1084-1093. (AmsterdamUMC) 371. Depuydt, P, Koster, J, Boeva, V, Hocking, TD, Speleman, F, Schleiermacher, G & de Preter, K 2018, 'Meta-mining of copy number profiles of high-risk neuroblastoma tumors', Scientific data, ;5( 180240. ): (AmsterdamUMC) 372. Depypere, LP, Moons, J, Mariette, C, D'Journo, XB, Thomas, PA, Hölscher, AH, Bollschweiler, E, van Berge-Henegouwen, MI, van Lanschot, JJB, Lerut, TEMR & Nafteux, PR 2018, 'Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study', Annals of surgery, ;286(6): 1000–1007. (AmsterdamUMC) 373. Derissen EJB, Huitema ADR, Rosing H, Schellens JHM, Beijnen JH,` Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides`, Br J Clin Pharmacol 2018; 84:1279-89 (NKI) 374. Derks J, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJ, Smit EF, Damhuis R, van den Broek EC, Chabrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC,` Molecular subtypes of pulmonary large cell neuroendocrine carcinoma predict chemotherapy treatment outcome`, Clin Cancer Res 2018; 24:33-42 (NKI) 375. Derks, J, Wesseling, P, Carbo, EWS, Hillebrand, A, van Dellen, E, de Witt Hamer, PC, Klein, M, Schenk, GJ, Geurts, JJG, Reijneveld, JC & Douw, L 2018, 'Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma', Journal of Neuro- Oncology, ;140(2): 403-412. (AmsterdamUMC) 376. Derks, M, van der Velden, J, de Kroon, CD, Nijman, HW, van Lonkhuijzen, LRCW, van der Zee, AGJ, Zwinderman, AH & Kenter, GG 2018, 'Surgical Treatment of Early-Stage Cervical Cancer: A Multi- Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period', International journal of gynecological cancer, ;28(4): 757-763. (AmsterdamUMC) 377. Derks-Smeets IAP, Schrijver LH, Die-Smulders CEM, Tjan-Heijnen VCG, van Golde RJT, Smits LJ, Caanen B, van Asperen CJ, Ausems M, Collee M, van Engelen K, Kets CM, van der Kolk L, Oosterwijk JC, van Os TAM, Rookus MA, van Leeuwen FE, Gomez Garcia EB,` Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers`, Br J Cancer 2018; 119:357-63 (NKI) 378. deSouza, NM, Liu, Y, Chiti, A, Oprea-Lager, D, Gebhart, GR, van Beers, BE, Herrmann, K & Lecouvet, FE 2018, 'Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group', European Journal of Cancer, ;91: 153-163. (AmsterdamUMC) 379. Deurvorst, SE, Hoekstra, OS, Castelijns, JA, Witte, BI, Leemans, CR & de Bree, R 2018, 'Clinical value of FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma', Clinical Otolaryngology, ;43(3): 875-881. (AmsterdamUMC) 380. Dev H, Chiang TW, Lescale C, de Krijger I, Martin AG, Pilger D, Coates J, Sczaniecka-Clift M, Wei W, Ostermaier M, Herzog M, Lam J, Shea A, Demir M, Wu Q, Yang F, Fu B, Lai Z, Balmus G, Belotserkovskaya R, Serra V, O'Connor MJ, Bruna A, Beli P, Pellegrini L, Caldas C, Deriano L, Jacobs JJL, Galanty Y, Jackson SP,` Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells`, Nat Cell Biol 2018; 20:954-65 (NKI) 381. Dewa, CS, Trojanowski, L, Tamminga, SJ, Ringash, J, McQuestion, M & Hoch, JS 2018, 'Work-related experiences of head and neck cancer survivors: an exploratory and descriptive qualitative study', Disability and rehabilitation, ;40(11): 1252-1258. (AmsterdamUMC) 382. Dewilde, K, Moerman, P, Leunen, K, Amant, F, Neven, P & Vergote, I 2018, 'Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors', Gynecologic and obstetric investigation, ;83(1): 65-69. (AmsterdamUMC) 383. Dickhoff, C, Rodriguez Schaap, PM, Otten, RHJ, Heymans, MW, Heineman, DJ & Dahele, M 2018, 'Salvage surgery for local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review', Therapeutic Advances in Medical Oncology, (AmsterdamUMC) 384. Dieleman, EMT, Uitterhoeve, ALJ, van Hoek, MW, van Os, RM, Wiersma, J, Koolen, MGJ, Kolff, MW, Koning, CCE, Adam, JA, Verberne, HJ, Annema, JT & Rasch, CRN 2018, 'Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer', International journal of radiation oncology, biology, physics, ;102(3): 543-551. (AmsterdamUMC) 385. Dierks, J, Gaspersz, MP, Belkouz, A, van Vugt, JLA, Coelen, RJS, de Groot, JWB, ten Tije, AJ, Meijer, WG, Pruijt, JFM, van Voorthuizen, T, van Spronsen, DJ, Rentinck, M, ten Oever, D, Smit, JM, Otten, HM, van Gulik, TM, Wilmink, JW, Groot Koerkamp, B & Klümpen, H 2018, 'Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin', Acta oncologica (Stockholm, Sweden), ;57(6): 807-812. (AmsterdamUMC) 386. Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, van Rooij N, van Leerdam ME, Depla A, Smit EF, Hartemink KJ, de Groot R, Wolkers MC, Sachs N, Snaebjornsson P, Monkhorst K, Haanen J, Clevers H, Schumacher TN, Voest EE,` Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids`, Cell 2018; 174:1586-98 (AmsterdamUMC/NKI) 387. Dimopoulos, M, Weisel, K, van de Donk, NWCJ, Ramasamy, K, Gamberi, B, Streetly, M, Offidani, M, Bridoux, F, de la Rubia, J, Mateos, M-V, Ardizzoia, A, Kueenburg, E, Collins, S, di Micco, A, Rosettani, B, Li, Y, Bacon, P & Sonneveld, P 2018, 'Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and renal impairment: Results from a phase ii trial', Journal of Clinical Oncology, ;36(20): 2035-2043. (AmsterdamUMC) 388. Dinmohamed, AG, Posthuma, EFM, Visser, O, Kater, AP, Raymakers, RAP & Doorduijn, JK 2018, 'Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in the Netherlands', Blood, ;131: 1380-1383. (AmsterdamUMC) 389. Dirven, L, Armstrong, TS, Blakeley, JO, Brown, PD, Grant, R, Jalali, R, Leeper, H, Mendoza, T, Nayak, L, Reijneveld, JC, Rhun, EL, Walbert, T, Weller, M, Wen, PY & Taphoorn, MJB 2018, 'Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative', The Lancet Oncology, ;19(3): e173-e180. (AmsterdamUMC) 390. Dohmen AJC, Sanders J, Canisius S, Jordanova ES, Aalbersberg EA, van den Brekel MWM, Neefjes J, Zuur CL,` Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model`, Oncotarget 2018; 9:25034-47 (AmsterdamUMC/NKI) 391. Donken, R, King, AJ, Bogaards, JA, Woestenberg, PJ, Meijer, CJLM & de Melker, HE 2018, 'High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years after Vaccination in Young Dutch Women', Journal of Infectious Diseases, ;217(10): 1579-1589. (AmsterdamUMC) 392. Donken, R, Tami, A, Knol, MJ, Lubbers, K, van der Sande, MAB, Nijman, HW, Daemen, T, Weijmar Schultz, WCM & de Melker, HE 2018, 'Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: An observational cohort study', BMC Public Health, ;18(1): 837. (AmsterdamUMC) 393. Dorel M, Klinger B, Gross T, Sieber A, Prahallad A, Bosdriesz E, Wessels L, Bluthgen N,` Modelling Signalling Networks from Perturbation Data`, Bioinformatics 2018; 34:4079-86 (NKI) 394. Douma, JAJ, Verheul, HMW & Buffart, LM 2018, 'Are patient-reported outcomes of physical function a valid substitute for objective measurements?', Current oncology (Toronto, Ont.), ;25(5): e475-e479. (AmsterdamUMC) 395. Douma, JAJ, Verheul, HMW & Buffart, LM 2018, 'Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer', BMC Cancer, ;18(1): 1052. (AmsterdamUMC) 396. Douma, LN, Uiters, E & Timmermans, DRM 2018, 'Why are the public so positive about colorectal cancer screening?', BMC Public Health, ;18(1): 1212. (AmsterdamUMC) 397. Drent, E, Poels, R, Mulders, MJ, van de Donk, NWCJ, Themeli, M, Lokhorst, HM & Mutis, T 2018, 'Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design', PLoS ONE, ;13(5): e0197349. (AmsterdamUMC) 398. Driessen CML, Groenewoud JMM, de Boer JP, Gelderblom H, van der Graaf WTA, Prins JB, Kaanders JHAM, van Herpen CML,` Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial`, Support Care Cancer 2018; 26:1233-42 (NKI) 399. Drost FH, Rannikko A, Valdagni R, Pickles T, Kakehi Y, Remmers S, van der Poel HG, Bangma CH, Roobol MJ,` Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study`, Transl Androl Urol 2018; 7:98-105 (NKI) 400. Druy, AE, Shorikov, EV, Tsaur, GA, Popov, AM, Zaychikov, AN, Tuponogov, SN, Saveliev, LI, Tytgat, GAM & Fechina, LG 2018, 'Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR', Pediatric blood & cancer, ;65(11): e27354. (AmsterdamUMC) 401. D'Souza, N, de Neree tot Babberich, MPM, Lord, A, Shaw, A, Abulafi, M, Tekkis, P, Wiggers, T & Brown, G 2018, 'The rectosigmoid problem', Surgical oncology, ;27(3): 521-525. (AmsterdamUMC) 402. Duarte AA, Gogola E, Sachs N, Barazas M, Annunziato S, Ruiter Rd, Velds A, Blatter S, Houthuijzen JM, van de Ven M, Clevers H, Borst P, Jonkers J, Rottenberg S,` BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance`, Nat Methods 2018; 15:134-40 (NKI) 403. Dufresne, J, Bowden, P, Thavarajah, T, Florentinus-Mefailoski, A, Chen, ZZ, Tucholska, M, Norzin, T, Ho, MT, Phan, M, Mohamed, N, Ravandi, A, Stanton, E, Slutsky, AS, Dos Santos, CC, Romaschin, A, Marshall, JC, Addison, C, Malone, S, Heyland, D, Scheltens, P, Killestein, J, Teunissen, CE, Diamandis, EP, Michael Siu, KW & Marshall, JG 2018, 'The plasma peptides of ovarian cancer', Clinical Proteomics, ;15(1): 41. (AmsterdamUMC) 404. Duijm, M, Tekatli, H, Oomen-de Hoop, E, Verbakel, W, Schillemans, W, Slotman, BJ, Senan, S & Nuyttens, JJ 2018, 'Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling', Radiotherapy and Oncology, ;127(2): 233-238. (AmsterdamUMC) 405. Duijts, SFA 2018, 'Management of work through the seasons of cancer survivorship', Current Opinion in Supportive and Palliative Care, ;12(1): 80-85. (AmsterdamUMC) 406. Duley, JA, Ni, M, Shannon, C, Norris, RL, Sheffield, L, Cowley, D, Harris, M, van Kuilenburg, ABP, Helsby, N, George, R & Charles, BG 2018, 'Preliminary evidence for enhanced thymine absorption: A putative new phenotype associated with fluoropyrimidine toxicity in cancer patients', Therapeutic drug monitoring, ;40(4): 495-502. (AmsterdamUMC) 407. Dumonceau, J-M, Tringali, A, Papanikolaou, IS, Blero, D, Mangiavillano, B, Schmidt, A, Vanbiervliet, G, Costamagna, G, Devière, J, García-Cano, J, Gyökeres, T, Hassan, C, Prat, F, Siersema, PD & van Hooft, JE 2018, 'Endoscopic biliary stenting: Indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017', Endoscopy, ;50(9): 910-930. (AmsterdamUMC) 408. Dutch ColoRectal Audit Group 2018, 'Achievements in colorectal cancer care during 8 years of auditing in The Netherlands', European journal of surgical oncology, ;44(9): 1361-1370. (AmsterdamUMC) 409. Dutch Pancreatic Cancer Group 2018, 'A web-based overview, systematic review and meta-analysis of pancreatic anastomosis techniques following pancreatoduodenectomy', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(9): 777-785. (AmsterdamUMC) 410. Dutch Pancreatic Cancer Group 2018, 'Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis', Acta oncologica (Stockholm, Sweden), ;57(12): 1655-1622. (AmsterdamUMC) 411. Dutch Pancreatic Cancer Group 2018, 'Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(8): 759-767. (AmsterdamUMC) 412. Dutch Snapshot Research Group 2018, 'What to do with the rectal stump during sphincter preserving rectal cancer resection with end colostomy: A collaborative snapshot study', Colorectal disease, ;20(8): 696-703. (AmsterdamUMC) 413. Dutch WIN-O Consortium 2018, 'Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma', Cancer Immunology, Immunotherapy. (AmsterdamUMC) 414. Eeltink, CM, Witte, BI, Stringer, J, Liptrott, S, Babic, A, Greenfield, DM, Salooja, N, Incrocci, L, Visser, O, Verdonck-de Leeuw, IM, Duarte, RF & Zweegman, S 2018, 'Health-care professionals’ perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation', Bone Marrow Transplantation, ;53(3): 235-245. (AmsterdamUMC) 415. Efficace, F, Cottone, F, Abel, G, Niscola, P, Gaidano, G, Bonnetain, F, Anota, A, Caocci, G, Cronin, A, Fianchi, L, Breccia, M, Stauder, R, Platzbecker, U, Palumbo, GA, Luppi, M, Invernizzi, R, Bergamaschi, M, Borin, L, Di Tucci, AA, Zhang, H, Sprangers, M, Vignetti, M & Mandelli, F 2018, 'Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes', Cancer, ;124(6): 1251-1259. (AmsterdamUMC) 416. Eggen, CAM, Durgaram, VVL, van Doorn, R, Mooi, WJ, Pardo, LM, Pasmans, SGMA & Hollestein, LM 2018, 'Incidence and relative survival of melanoma in children and adolescents in the Netherlands, 1989–2013', Journal of the European Academy of Dermatology and Venereology, ;32(6): 956-961. (AmsterdamUMC) 417. Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C,` Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma`, N Engl J Med 2018; 378:1789-801 (AmsterdamUMC/NKI) 418. Eifler K, Cuijpers SAG, Willemstein E, Raaijmakers JA, El Atmioui D, Ovaa H, Medema RH, Vertegaal ACO,` SUMO targets the APC/C to regulate transition from metaphase to anaphase`, Nat Commun 2018; 9:1119 (15 pp) (NKI) 419. Eijgelaar RS, Bruynzeel AME, Lagerwaard FJ, Muller DMJ, Teunissen FR, Barkhof F, van Herk M, Witt Hamer PC, Witte MG,` Earliest radiological progression in glioblastoma by multidisciplinary consensus review`, J Neurooncol 2018; 139:591-8 (AmsterdamUMC/NKI) 420. Eijzenga W, de Geus E, Aalfs CM, Menko FH, Sijmons RH, De Haes HCJM, Smets EMA,` How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial`, Patient Educ Couns 2018; 101:1611-9 (AmsterdamUMC/NKI) 421. El Amrani M, Szanto C, Hack CE, Huitema A, Nierkens S, van Maarseveen E,` Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry`, Anal Bioanal Chem 2018; 410:5849-58 (NKI) 422. Eleveld, TF, Schild, L, Koster, J, Zwijnenburg, DA, Alles, LK, Ebus, ME, Volckmann, R, Tijtgat, GA, van Sluis, P, Versteeg, R & Molenaar, JJ 2018, 'RaS–MAPK pathway-driven tumor progression is associated with loss of CIC and other genomic aberrations in neuroblastoma', Cancer research, ;78(21): 6297- 6307. (AmsterdamUMC) 423. Elshof LE, Schmidt MK, Rutgers EJT, van Leeuwen FE, Wesseling J, Schaapveld M,` Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ`, Ann Surg 2018; 267:952-8 (NKI) 424. Eluri, S, Klaver, E, Duits, LC, Jackson, SA, Bergman, JJ & Shaheen, NJ 2018, 'Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma', Diseases of the esophagus, ;31( 11. ): (AmsterdamUMC) 425. EMBRACE Collaborative Group & Koedooder, K 2018, 'Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy', Radiotherapy and oncology, ;129(3): 567-574. (AmsterdamUMC) 426. Engelhardt, EG, Révész, D, Tamminga, HJ, Punt, CJA, Koopman, M, Onwuteaka-Philipsen, BD, Steyerberg, EW, Jansma, IP, de Vet, HCW & Coupé, VMH 2018, 'Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review', Clinical colorectal cancer, ;17(1): e1-e12. (AmsterdamUMC) 427. Engelhardt, EG, Révész, DR, Tamminga, HJ, Punt, CJA, Koopman, M, Onwuteaka-Philipsen, BD, Steyerberg, EW, de Vet, HCW & Coupé, VMH 2018, 'Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer', BMC medical informatics and decision making, ;18(1): 132. (AmsterdamUMC) 428. EORTC-Pharmacology and Molecular Mechanism Group 2018, 'The role of pharmacology in anticancer drug development', ADMET & DMPK, ;6(1): 4-14. (AmsterdamUMC) 429. Eppenga R, Kuhlmann K, Ruers T, Nijkamp J,` Accuracy assessment of wireless transponder tracking in the operating room environment`, Int J Comput Assist Radiol Surg 2018; 138:1937-48 (NKI) 430. Eshuis, WJ, van Berge Henegouwen, MI, Draaisma, WA & Gisbertz, SS 2018, 'Compliance to D2 lymphadenectomy in laparoscopic gastrectomy', Updates in surgery, ;70(2): 197-205. (AmsterdamUMC) 431. Eskes M, Balm AJM, van Alphen MJA, Smeele LE, Stavness I, van der Heijden F,` Simulation of facial expressions using person-specific sEMG signals controlling a biomechanical face model`, Int J Comput Assist Radiol Surg 2018; 13:47-59 (NKI) 432. EUMDS Steering Committee 2018, 'Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes', Haematologica, ;103(1): 67-79. (AmsterdamUMC) 433. EU-RHAB consortium 2018, 'The extraordinary challenge of treating patients with congenital rhabdoid tumors—a collaborative European effort', Pediatric Blood and Cancer, ;65(6): e26999. (AmsterdamUMC) 434. European paediatric Soft tissue sarcoma Study Group 2018, 'Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial', lancet oncology, ;19(8): 1061-1071. (AmsterdamUMC) 435. European Study Group on Cystic Tumours of the Pancreas and the International Association of Pancreatology 2018, 'Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case-vignette study', Surgery, ;164(1): 17-23. (AmsterdamUMC) 436. European Study Group on Cystic Tumours of the Pancreas, Study group members AMC, , Scholten, L, Besselink, MGH, Engelbrecht, M, Fockens, P & Bossuyt, PMM 2018, 'European evidence-based guidelines on pancreatic cystic neoplasms', Gut, ;67(5): 789-804. (AmsterdamUMC) 437. European Thoracic Oncology Platform Lungscape Consortium 2018, 'Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project', Journal of Thoracic Oncology, ;13(3): e33-e34. (AmsterdamUMC) 438. EURO-SKI investigators 2018, 'Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial', The Lancet Oncology, ;19(6): 747-757. (AmsterdamUMC) 439. EuroSurg Collaborative, (Collaborators 2089),` Body mass index and complications following major gastrointestinal surgery: a prospective, international cohort study and meta-analysis`, Colorectal Dis 2018; 20:O215-O225 (NKI) 440. ExPo-r-Net Working Group 2018, 'The ‘Survivorship Passport’ for childhood cancer survivors', European journal of cancer (Oxford, England, ;102: 69-81. (AmsterdamUMC) 441. Fanti, S, Minozzi, S, Antoch, G, Banks, I, Briganti, A, Carrio, I, Chiti, A, Clarke, N, Eiber, M, de Bono, J, Fizazi, K, Gillessen, S, Gledhill, S, Haberkorn, U, Herrmann, K, Hicks, RJ, Lecouvet, F, Montironi, R, Ost, P, O'Sullivan, JM, Padhani, AR, Schalken, JA, Scher, HI, Tombal, B, van Moorselaar, RJA, van Poppel, H, Vargas, HA, Walz, J, Weber, WA, Wester, H-JR & Oyen, WJG 2018, 'Consensus on molecular imaging and theranostics in prostate cancer', The Lancet Oncology, ;19(12): e696-e708. (AmsterdamUMC) 442. Farag S, Geus-Oei LF, van der Graaf WT, van Coevorden F, Grunhagen DJ, Reyners AKL, Boonstra PA, Desar IME, Gelderblom HJ, Steeghs N,` Early response evaluation by 18F-FDG-PET influences management in gastrointestinal stromal tumor (GIST) patients treated with imatinib with neo- adjuvant intent`, J Nucl Med 2018; 59:194-6 (NKI) 443. Farag S, van der Kolk LE, van Boven HH, van Akkooi ACJ, Beets GL, Wilmink JW, Steeghs N,` Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview`, Fam Cancer 2018; 17:247-53 (AmsterdamUMC/NKI) 444. Fassunke J, Muller F, Keul M, Michels S, Dammert MA, Schmitt A, Plenker D, Lategahn J, Heydt C, Bragelmann J, Tumbrink HL, Alber Y, Klein S, Heimsoeth A, Dahmen I, Fischer RN, Scheffler M, Ihle MA, Priesner V, Scheel AH, Wagener S, Kron A, Frank K, Garbert K, Persigehl T, Pusken M, Haneder S, Schaaf B, Rodermann E, Engel-Riedel W, Felip E, Smit EF, Merkelbach-Bruse S, Reinhardt HC, Kast SM, Wolf J, Rauh D, Buttner R, Sos ML,` Overcoming EGFR(G724S)-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors`, Nat Commun 2018; 9:4655 (13 pp) (NKI) 445. Fazio N, Buzzoni R, Delle Fave G, Tesselaar ME, Wolin E, Van Cutsem E, Tomassetti P, Strosberg J, Voi M, Pacaud LB, Ridolfi A, Herbst F, Tomasek J, Singh S, Pavel M, Kulke MH, Valle JW, Yao JC,` Everolimus in advanced, progressive, well-differentiated, nonfunctional neuroendocrine tumors: RADIANT-4 lung subgroup analysis`, Cancer Sci 2018; 109:174-81 (NKI) 446. Feenstra HE, Vermeulen IE, Murre JM, Schagen SB,` Online Self-Administered Cognitive Testing Using the Amsterdam Cognition Scan: Establishing Psychometric Properties and Normative Data`, J Med Internet Res 2018; 20:e192 (16 pp) (NKI) 447. Feenstra HEM, Murre JMJ, Vermeulen IE, Kieffer JM, Schagen SB,` Reliability and validity of a self- administered tool for online neuropsychological testing: The Amsterdam Cognition Scan`, J Clin Exp Neuropsychol 2018; 40:253-73 (NKI) 448. Felip, E, Barlesi, F, Besse, B, Chu, Q, Gandhi, L, Kim, S-W, Carcereny, E, Sequist, LV, Brunsvig, P, Chouaid, C, Smit, EF, Groen, HJM, Kim, D-W, Park, K, Avsar, E, Szpakowski, S, Akimov, M & Garon, EB 2018, 'Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer', Journal of Thoracic Oncology, ;13(4): 576-584. (AmsterdamUMC) 449. Feringa FM, Raaijmakers JA, Hadders MA, Vaarting C, Macurek L, Heitink L, Krenning L, Medema RH,` Persistent repair intermediates induce senescence`, Nat Commun 2018; 9:3923 (10 pp) (NKI) 450. Feroldi, F, Verlaan, M, Knaus, H, Davidoiu, V, Vugts, DJ, van Dongen, GAMS, Molthoff, CFM & de Boer, JF 2018, 'High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model', Biomedical Optics Express, ;9(12): 6186-6204. (AmsterdamUMC) 451. Fidler, MM, Reulen, RC, Winter, DL, Allodji, RS, Bagnasco, F, Bárdi, E, Bautz, A, Bright, CJ, Byrne, J, Feijen, EAM, Garwicz, S, Grabow, D, Gudmundsdottir, T, Guha, J, Haddy, N, Jankovic, M, Kaatsch, P, Kaiser, M, Kuonen, R, Linge, H, Maule, M, Merletti, F, Øfstaas, H, Ronckers, CM, Skinner, R, Teepen, J, Terenziani, M, Vu-Bezin, G, Wesenberg, F, Wiebe, T, Jakab, Z, Haupt, R, Lähteenmäki, P, Zaletel, LZ, Kuehni, CE, Winther, JF, de Vathaire, F, Kremer, LC, Hjorth, L & Hawkins, MM 2018, 'Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe', Journal of the National Cancer Institute, ;110(2): djx165. (AmsterdamUMC) 452. Figueiredo N, Panteleimonitis S, Popeskou S, Cunha JF, Qureshi T, Beets GL, Heald RJ, Parvaiz A,` Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes`, Eur J Surg Oncol 2018; 44:484-9 (NKI) 453. Filosso PL, Kidd M, Roffinella M, Lewczuk A, Chung KM, Kolasinska-Cwikla A, Cwikla J, Lowczak A, Doboszynska A, Malczewska A, Catalano M, Zunino V, Boita M, Arvat E, Cristofori R, Guerrera F, Oliaro A, Tesselaar M, Buikhuisen W, Kos-Kudla B, Papotti M, Bodei L, Drozdov I, Modlin I,` The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression`, Eur J Cardiothorac Surg 2018; 53:631-9 (NKI) 454. Fiore, D, Ramesh, P, Proto, MC, Piscopo, C, Franceschelli, S, Anzelmo, S, Medema, JP, Bifulco, M & Gazzerro, P 2018, 'Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids', Frontiers in pharmacology, ;8: 949. (AmsterdamUMC) 455. Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD), Sjoquist, KM, Renfro, LA, Simes, RJ, Tebbutt, NC, Clarke, S, Seymour, MT, Adams, R, Maughan, TS, Saltz, L, Goldberg, RM, Schmoll, H-J, van Cutsem, E, Douillard, J-Y, Hoff, PM, Hecht, JR, Tournigand, C, Punt, CJA, Koopman, M, Hurwitz, H, Heinemann, V & Zalcberg, JR 2018, 'Personalizing survival predictions in advanced colorectal cancer: The ARCAD nomogram project', Journal of the National Cancer Institute, ;110(6): 638-648. (AmsterdamUMC) 456. Fonnes T, Trovik J, Edqvist PD, Fasmer KE, Marcickiewicz J, Tingulstad S, Staff AC, Bjorge L, Amant F, Haldorsen IS, Werner HM, Akslen LA, Tangen IL, Krakstad C,` Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicenter study`, BJOG 2018; 125:1695-703 (NKI) 457. Foty RG, Gibbs EM, Lips EH, Menon M, Hafler JP,` Thinking Critically: How to Teach Translational Medicine`, Front Public Health 2018; 6:284 (NKI) 458. Frampton, AE, Prado, MM, López-Jiménez, E, Fajardo-Puerta, AB, Jawad, ZAR, Lawton, P, Giovannetti, E, Habib, NA, Castellano, L, Stebbing, J, Krell, J & Jiao, LR 2018, 'Glypican-1 is enriched in circulating- exosomes in pancreatic cancer and correlates with tumor burden', Oncotarget, ;9(27): 19006-19013. (AmsterdamUMC) 459. Francica P, Rottenberg S,` Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response`, Genome Med 2018; 10:101 (NKI) 460. Franke V, van der Hiel B, van de Wiel BA, Klop WMC, Ter Meulen S, van Akkooi ACJ,` Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma`, Eur J Cancer 2018; 90:149-52 [Letter] (NKI) 461. Franken MG, Leeneman B, Jochems A, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, de Groot JWB, van der Hoeven KJM, Hospers GAP, Kapiteijn E, Koornstra R, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van Zeijl M, Haanen JBAG, Uyl-de Groot CA,` Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands`, Anticancer Drugs 2018; 29:579-88 (AmsterdamUMC/NKI) 462. Franken, NAP, Stalpers, LJA & Crezee, J 2018, 'Professor Gerrit Willem (Eddie) Barendsen, August 14, 1927 – June 20, 2018', International journal of radiation oncology, biology, physics, ;102(3): 483-484. (AmsterdamUMC) 463. Fransen van de Putte EE, de Wall LL, van Werkhoven E, Heldeweg EA, Bex A, van der Poel HG, van Rhijn BWG, Horenblas S, Hendricksen K,` Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function`, Urol Int 2018; 100:18-24 (NKI) 464. Fransen van de Putte EE, Otto W, Hartmann A, Bertz S, Mayr R, Brundl J, Breyer J, Manach Q, Comperat EM, Boormans JL, Bosschieter J, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Roupret M, Burger M, van der Kwast TH, van Rhijn BWG,` Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer`, Urol Oncol 2018; 36:361 (AmsterdamUMC/NKI) 465. Fransen van de Putte EEF, Bosschieter J, van der Kwast TH, Bertz S, Denzinger S, Manach Q, Comperat EM, Boormans JL, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Roupret M, Otto W, Burger M, Hartmann A, van Rhijn BWG,` The World Health Organization 1973 classification system for grade is an Important prognosticator in T1 non-muscle- invasive bladder cancer`, BJU Int 2018; 122:978-85 (NKI) 466. Franssen, LE, Nijhof, IS, Couto, S, Levin, MD, Bos, GMJ, Broijl, A, Klein, SK, Ren, Y, Wang, M, Koene, HR, Bloem, AC, Beeker, A, Faber, LM, van der Spek, E, Raymakers, R, Leguit, RJ, Sonneveld, P, Zweegman, S, Lokhorst, H, Mutis, T, Thakurta, A, Qian, X & van de Donk, NWCJ 2018, 'Cereblon loss and up- regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients', Haematologica, ;103(8): e368-e371. (AmsterdamUMC) 467. Frerichs, KA, Nagy, NA, Lindenbergh, PL, Bosman, P, Marin Soto, J, Broekmans, M, Groen, RWJ, Themeli, M, Nieuwenhuis, L, Stege, C, Nijhof, IS, Mutis, T, Zweegman, S, Lokhorst, HM & van de Donk, NWCJ 2018, 'CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience', Expert Review of Clinical Immunology, ;14(3): 197-206. (AmsterdamUMC) 468. Freyschlag, CF, Krieg, SM, Kerschbaumer, J, Pinggera, D, Forster, M-T, Cordier, D, Rossi, M, Miceli, G, Roux, A, Reyes, A, Sarubbo, S, Smits, A, Sierpowska, J, Robe, PA, Rutten, G-J, Santarius, T, Matys, T, Zanello, M, Almairac, F, Mondot, L, Jakola, AS, Zetterling, M, Rofes, A, von Campe, G, Guillevin, R, Bagatto, D, Lubrano, V, Rapp, M, Goodden, J, de Witt Hamer, PC, Pallud, J, Bello, L, Thomé, C, Duffau, H & Mandonnet, E 2018, 'Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging', Journal of Neuro-Oncology, ;139(3): 699-711. (AmsterdamUMC) 469. Gade, DR, Makkapati, A, Yarlagadda, RB, Peters, GJ, Sastry, BS & Rajendra Prasad, VVS 2018, 'Elucidation of chemosensitization effect of acridones in cancer cell lines: Combined pharmacophore modeling, 3D QSAR, and molecular dynamics studies', Computational Biology and Chemistry, ;74: 63- 75. (AmsterdamUMC) 470. Galluzzi, L, Vitale, I, Aaronson, SA, Abrams, JM, Adam, D, Agostinis, P, Alnemri, ES, Altucci, L, Amelio, I, Andrews, DW, Annicchiarico-Petruzzelli, M, Antonov, AV, Arama, E, Baehrecke, EH, Barlev, NA, Bazan, NG, Bernassola, F, Bertrand, MJM, Bianchi, K, Blagosklonny, MV, Blomgren, K, Borner, C, Boya, P, Brenner, C, Campanella, M, Candi, E, Carmona-Gutierrez, D, Cecconi, F, Chan, FK-M, Chandel, NS, Cheng, EH, Chipuk, JE, Cidlowski, JA, Ciechanover, A, Cohen, GM, Conrad, M, Cubillos-Ruiz, JR, Czabotar, PE, D'Angiolella, V, Dawson, TM, Dawson, VL, de Laurenzi, V, de Maria, R, Debatin, K-M, DeBerardinis, RJ, Deshmukh, M, Di Daniele, N, Di Virgilio, F, Dixit, VM, Dixon, SJ, Duckett, CS, Dynlacht, BD, El-Deiry, WS, Elrod, JW, Fimia, GM, Fulda, S, García-Sáez, AJ, Garg, AD, Garrido, C, Gavathiotis, E, Golstein, P, Gottlieb, E, Green, DR, Greene, LA, Gronemeyer, H, Gross, A, Hajnoczky, G, Hardwick, JM, Harris, IS, Hengartner, MO, Hetz, C, Ichijo, H, Jäättelä, M, Joseph, B, Jost, PJ, Juin, PP, Kaiser, WJ, Karin, M, Kaufmann, T, Kepp, O, Kimchi, A, Kitsis, RN, Klionsky, DJ, Knight, RA, Kumar, S, Lee, SW, Lemasters, JJ, Levine, B, Linkermann, A, Lipton, SA, Lockshin, RA, López-Otín, C, Lowe, SW, Luedde, T, Lugli, E, MacFarlane, M, Madeo, F, Malewicz, M, Malorni, W, Manic, G, Marine, J-C, Martin, SJ, Martinou, J-C, Medema, JP, Mehlen, P, Meier, P, Melino, S, Miao, EA, Molkentin, JD, Moll, UM, Muñoz-Pinedo, C, Nagata, S, Nuñez, G, Oberst, A, Oren, M, Overholtzer, M, Pagano, M, Panaretakis, T, Pasparakis, M, Penninger, JM, Pereira, DM, Pervaiz, S, Peter, ME, Piacentini, M, Pinton, P, Prehn, JHM, Puthalakath, H, Rabinovich, GA, Rehm, M, Rizzuto, R, Rodrigues, CMP, Rubinsztein, DC, Rudel, T, Ryan, KM, Sayan, E, Scorrano, L, Shao, F, Shi, Y, Silke, J, Simon, H-U, Sistigu, A, Stockwell, BR, Strasser, A, Szabadkai, G, Tait, SWG, Tang, D, Tavernarakis, N, Thorburn, A, Tsujimoto, Y, Turk, B, Vanden Berghe, T, Vandenabeele, P, Vander Heiden, MG, Villunger, A, Virgin, HW, Vousden, KH, Vucic, D, Wagner, EF, Walczak, H, Wallach, D, Wang, Y, Wells, JA, Wood, W, Yuan, J, Zakeri, Z, Zhivotovsky, B, Zitvogel, L, Melino, G & Kroemer, G 2018, 'Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018', Cell death and differentiation, ;25: 486-541. (AmsterdamUMC) 471. Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G,` How can we expand active surveillance criteria in patients with low- and intermediate- risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator`, BJU Int 2018; 122:823-30 (NKI) 472. Gao F, Wesolowska M, Agami R, Rooijers K, Loayza-Puch F, Lawless C, Lightowlers N, Chrzanowska- Lightowlers MA,` Using mitoribosomal profiling to investigate human mitochondrial translation`, Wellcome Open Res 2018; 2:116-(15 pp) (NKI) 473. Gao, Y, Weenink, B, van den Bent, MJ, Erdem-Eraslan, L, Kros, JM, Sillevis Smitt, PAE, Hoang-Xuan, K, Brandes, AA, Vos, M, Dhermain, F, Enting, R, Ryan, GF, Chinot, O, Ben Hassel, M, van Linde, ME, Mason, WP, Gijtenbeek, JMM, Balana, C, von Deimling, A, Gorlia, T, Stupp, R, Hegi, ME, Baumert, BG & French, PJ 2018, 'Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial', European Journal of Cancer, ;94: 168-178. (AmsterdamUMC) 474. Gaspersz, MP, Buettner, S, Roos, E, van Vugt, JLA, Coelen, RJS, Vugts, J, Wiggers, JK, Allen, PJ, Besselink, MG, Busch, ORC, Belt, EJ, D’Angelica, MI, DeMatteo, RP, de Jonge, J, Kingham, TP, Polak, WG, Willemssen, FEJA, van Gulik, TM, Jarnagin, WR, Ijzermans, JNM & Groot Koerkamp, B 2018, 'A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma', Journal of surgical oncology, ;118(3): 469-476. (AmsterdamUMC) 475. Gavish-Izakson M, Velpula BB, Elkon R, Prados-Carvajal R, Barnabas GD, Ugalde AP, Agami R, Geiger T, Huertas P, Ziv Y, Shiloh Y,` Nuclear poly(A)-binding protein 1 is an ATM target and essential for DNA double-strand break repair`, Nucleic Acids Res 2018; 46:730-47 (NKI) 476. Gavriatopoulou, M, Musto, P, Caers, J, Merlini, G, Kastritis, E, van de Donk, N, Gay, F, Hegenbart, U, Hajek, R, Zweegman, S, Bruno, B, Straka, C, Dimopoulos, MA, Einsele, H, Boccadoro, M, Sonneveld, P, Engelhardt, M & Terpos, E 2018, 'European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias', Leukemia, ;32(9): 1883-1898. (AmsterdamUMC) 477. Gay, F, Engelhardt, M, Terpos, E, Wäsch, R, Giaccone, L, Auner, HW, Caers, J, Gramatzki, M, van de Donk, N, Oliva, S, Zamagni, E, Garderet, L, Straka, C, Hajek, R, Ludwig, H, Einsele, H, Dimopoulos, M, Boccadoro, M, Kröger, N, Cavo, M, Goldschmidt, H, Bruno, B & Sonneveld, P 2018, 'From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives', Haematologica, ;103(2): 197-211. (AmsterdamUMC) 478. Gayet, M, Mannaerts, CK, Nieboer, D, Beerlage, HP, Wijkstra, H, Mulders, PFA & Roobol, MJ 2018, 'Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort', European urology focus, ;4(2): 228-234. (AmsterdamUMC) 479. Gee MH, Han A, Lofgren SM, Beausang JF, Mendoza JL, Birnbaum ME, Bethune MT, Fischer S, Yang X, Gomez-Eerland R, Bingham DB, Sibener LV, Fernandes RA, Velasco A, Baltimore D, Schumacher TN, Khatri P, Quake SR, Davis MM, Garcia KC,` Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes`, Cell 2018; 172:549-63 (NKI) 480. Geelen, IGP, Sandin, F, Thielen, N, Janssen, JJWM, Hoogendoorn, M, Visser, O, Cornelissen, JJ, Hoglund, M & Westerweel, PE 2018, 'Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients', Leukemia, ;32(10): 2299-2303. (AmsterdamUMC) 481. Geelen, IGP, Thielen, N, Janssen, JJWM, Hoogendoorn, M, Roosma, TJA, Valk, PJM, Visser, O, Cornelissen, JJ & Westerweel, PE 2018, 'Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe', European Journal of Haematology, ;100(4): 367-371. (AmsterdamUMC) 482. Geenen JJJ, Linn SC, Beijnen JH, Schellens JHM,` PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer`, Clin Pharmacokinet 2018; 57:427-37 (NKI) 483. Geeven G, Teunissen H, de LW, de WE,` peakC: a flexible, non-parametric peak calling package for 4C and Capture-C data`, Nucleic Acids Res 2018; 46:e91 (NKI) 484. Gehring K, Kloek CJ, Aaronson NK, Janssen KW, Jones LW, Sitskoorn MM, Stuiver MM,` Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: a pilot randomized controlled trial`, Clin Rehabil 2018; 32:352-66 (NKI) 485. Genç, CG, Falconi, M, Partelli, S, Muffatti, F, van Eeden, S, Doglioni, C, Klümpen, HJ, van Eijck, CHJ & Nieveen van Dijkum, EJM 2018, 'Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67', Annals of surgical oncology, ;25(8): 2467-2474. (AmsterdamUMC) 486. Genç, CG, Jilesen, AP, Partelli, S, Falconi, M, Muffatti, F, van Kemenade, FJ, van Eeden, S, Verheij, J, van Dieren, S, van Eijck, CHJ & Nieveen van Dijkum, EJM 2018, 'A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors', Annals of surgery, ;267(6): 1148–1154. (AmsterdamUMC) 487. Genç, CG, Jilesen, APJ, Nieveen van Dijkum, EJM, Klümpen, H-J, van Eijck, CHJ, Drozdov, I, Malczewska, A, Kidd, M & Modlin, I 2018, 'Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumors', Journal of surgical oncology, ;118(1): 37-48. (AmsterdamUMC) 488. Genç, CG, Klümpen, H-J, Denecke, T, Wiedenmann, B & Pavel, M 2018, 'Successful treatment of high- grade pancreatic neuroendocrine neoplasms with everolimus', Acta oncologica (Stockholm, Sweden), ;57(5): 686-688. (AmsterdamUMC) 489. Genc, CG, Klümpen, HJ, van Oijen, MGH, van Eijck, CHJ & Nieveen van Dijkum, EJM 2018, 'A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands', World journal of surgery, ;42(2): 490-497. (AmsterdamUMC) 490. Gerhards NM, Blomen VA, Mutlu M, Nieuwenhuis J, Howald D, Guyader C, Jonkers J, Brummelkamp TR, Rottenberg S,` Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents`, Mol Oncol 2018; 12:953-71 (NKI) 491. Geukes Foppen MH, Boogerd W, Blank CU, van Thienen JV, Haanen JB, Brandsma D,` Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma`, Melanoma Res 2018; 28:126-33 (NKI) 492. Geukes Foppen MH, Rozeman EA, van Wilpe S, Postma C, Snaebjornsson P, van Thienen JV, van Leerdam ME, van den Heuvel M, Blank CU, van Dieren J, Haanen JBAG,` Immune checkpoint inhibition- related colitis: symptoms, endoscopic features, histology and response to management`, ESMO Open 2018; 3:e000278-(8 pp) (NKI) 493. Ghezraoui H, Oliveira C, Becker JR, Bilham K, Moralli D, Anzilotti C, Fischer R, Deobagkar-Lele M, Sanchiz-Calvo M, Fueyo-Marcos E, Bonham S, Kessler BM, Rottenberg S, Cornall RJ, Green CM, Chapman JR,` 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ`, Nature 2018; 560:122-7 (NKI) 494. Ghorbanoghli, Z, Bastiaansen, BA, Langers, AM, Nagengast, FM, Poley, J-W, Hardwick, JC, Koornstra, JJ, Sanduleanu, S, de Vos tot Nederveen Cappel, WH, Witteman, BJ, Morreau, H, Dekker, E & Vasen, HF 2018, 'Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis', Journal of medical genetics, ;55(1): 11-14. (AmsterdamUMC) 495. Gielchinsky, I, Chang, J, Cusick, T, Delprado, W, Nguyen, Q, Yuen, C, Savdie, R, Böhm, M, Haynes, A-M, Scheltema, MJ & Stricker, PD 2018, 'Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook', BJU international, ;122: 35-41. (AmsterdamUMC) 496. Gielchinsky, I, Scheltema, MJ, Cusick, T, Chang, J, Shnier, R, Moses, D, Delprado, W, Nguyen, Q, Yuen, C, Haynes, A-M & Stricker, PD 2018, 'Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50', Research and Reports in Urology, ;10: 145- 150. (AmsterdamUMC) 497. Giesinger JM, Aaronson NK, Arraras JI, Efficace F, Groenvold M, Kieffer JM, Loth FLC, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B,` A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important`, Psychooncology 2018; 27:548-55 (NKI) 498. Gillissen, MA, Kedde, M, Jong, GD, Moiset, G, Yasuda, E, Levie, SE, Bakker, AQ, Claassen, YB, Wagner, K, Böhne, M, Hensbergen, PJ, Speijer, D, van Helden, PM, Beaumont, T, Spits, H & Hazenberg, MD 2018, 'AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses', Blood, ;131(1): 131-143. (AmsterdamUMC) 499. Gisbertz, SS, Hagens, ERC, Ruurda, JP, Schneider, PM, Tan, LJ, Domrachev, SA, Hoeppner, J & van Berge Henegouwen, MI 2018, 'The evolution of surgical approach for esophageal cancer', Annals of the New York Academy of Sciences, ;1434(1): 149-155. (AmsterdamUMC) 500. Goedegebuure, RSA, de Klerk, LK, Bass, AJ, Derks, S & Thijssen, VLJL 2018, 'Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy;(): (AmsterdamUMC) 501. Goense L, Heethuis SE, van Rossum PSN, Voncken FEM, Lagendijk JJW, Lam MGEH, Terhaard CH, van Hillegersberg R, Ruurda JP, Mook S, van Lier ALHM, Lin SH, Meijer GJ,` Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer`, Nucl Med Commun 2018; 39:60-7 (NKI) 502. Goey, KKH, Mahmoud, R, Sørbye, H, Glimelius, B, Köhne, C-H, Sargent, DJ, Punt, CJA, van Oijen, MGH & Koopman, M 2018, 'Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review', European journal of cancer (Oxford, England, ;96: 115-124. (AmsterdamUMC) 503. Goey, KKH, Sørbye, H, Glimelius, B, Adams, RA, André, T, Arnold, D, Berlin, JD, Bodoky, G, de Gramont, A, Díaz-Rubio, E, Eng, C, Falcone, A, Grothey, A, Heinemann, V, Hochster, HS, Kaplan, RS, Kopetz, S, Labianca, R, Lieu, CH, Meropol, NJ, Price, TJ, Schilsky, RL, Schmoll, H-J, Shacham-Shmueli, E, Shi, Q, Sobrero, AF, Souglakos, J, van Cutsem, E, Zalcberg, J, van Oijen, MGH, Punt, CJA & Koopman, M 2018, 'Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group', European journal of cancer (Oxford, England, ;100: 35-45. (AmsterdamUMC) 504. Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, De Bruijn R, James DI, Guerrero Llobet S, Vis DJ, Annunziato S, van den Broek B, Barazas M, Kersbergen A, van de Ven M, Tarsounas M, Ogilvie DJ, van Vugt M, Wessels LFA, Bartkova J, Gromova I, Andujar-Sanchez M, Bartek J, Lopes M, van Attikum H, Borst P, Jonkers J, Rottenberg S,` Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality`, Cancer Cell 2018; 33:1078-93 (NKI) 505. Goldschmidt, H, Lokhorst, HM, Mai, EK, van der Holt, B, Blau, IW, Zweegman, S, Weisel, KC, Vellenga, E, Pfreundschuh, M, Kersten, MJ, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, MS, Broijl, A, Lindemann, HW, Bos, GMJ, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, RM, Bertsch, U, Hielscher, T, Jarari, L, Salwender, HJ & Sonneveld, P 2018, 'Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial', Leukemia, ;32(2): 383-390. (AmsterdamUMC) 506. Gollub MJ, Arya S, Beets-Tan RG, dePrisco G, Gonen M, Jhaveri K, Kassam Z, Kaur H, Kim D, Knezevic A, Korngold E, Lall C, Lalwani N, Blair Macdonald D, Moreno C, Nougaret S, Pickhardt P, Sheedy S, Harisinghani M,` Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017`, Abdom Radiol (NY) 2018; 43:2893-902 (NKI) 507. Gomez Tamayo JC, Olivella M, Rios S, Hoogstraat M, Gonzalez A, Mayol E, Deupi X, Campillo M, Cordomi A,` GPCR-SAS: A web application for statistical analyses on G protein-coupled receptors sequences`, PLoS One 2018; 13:e0199843 (NKI) 508. Gooskens SL, Graf N, Furtwangler R, Spreafico F, Bergeron C, Ramirez-Villar GL, Godzinski J, Rube C, Janssens GO, Vujanic GM, Leuschner I, Coulomb-L'Hermine A, Smets AM, de Camargo B, Stoneham S, Van Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM,` Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol`, Nat Rev Urol 2018; 15:309-19 (AmsterdamUMC/NKI) 509. Gooszen, JAH, Goense, L, Gisbertz, SS, Ruurda, JP, van Hillegersberg, R & van Berge Henegouwen, MI 2018, 'Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer', British journal of surgery, ;105(5): 552-560. (AmsterdamUMC) 510. Gooszen, JAH, Slaman, AE, van Dieren, S, Gisbertz, SS & van Berge Henegouwen, MI 2018, 'Incidence and Treatment of Symptomatic Diaphragmatic Hernia After Esophagectomy for Cancer', Annals of thoracic surgery, ;106(1): 199-206. (AmsterdamUMC) 511. Gouw ZAR, Paul de Boer J, Navran A, van den Brekel MWM, Sonke JJ, Al Mamgani A,` Baseline peripheral blood leukocytosis: Biological marker predicts outcome in oropharyngeal cancer, regardless of HPV-status`, Oral Oncol 2018; 78:200-6 (NKI) 512. Greidanus, MA, de Boer, AGEM, de Rijk, AE, Tiedtke, CM, Dierckx de Casterlé, B, Frings-Dresen, MHW & Tamminga, SJ 2018, 'Perceived employer-related barriers and facilitators for work participation of cancer survivors: a systematic review of employers' and survivors' perspectives', Psycho-oncology, ;27(3): 725-733. (AmsterdamUMC) 513. Greven, FE, Claassen, L, Woudenberg, F, Duijm, F & Timmermans, D 2018, 'Where there’s smoke, there’s fire: focal points for risk communication', International Journal of Environmental Health Research, ;28(3): 240-252. (AmsterdamUMC) 514. Grewal, S, Korthouwer, R, Bögels, M, Braster, R, Heemskerk, N, Budding, AE, Pouw, SM, van Horssen, J, Ankersmit, M, Meijerink, J, van den Tol, P, Oosterling, S, Bonjer, J, Gül, N & van Egmond, M 2018, 'Spillage of bacterial products during colon surgery increases the risk of liver metastases development in a rat colon carcinoma model', OncoImmunology, ;7(9): e1461302. (AmsterdamUMC) 515. Gridelli C, Baas P, Barlesi F, Ciardiello F, Crino L, Felip E, Gadgeel S, Papadimitrakopoulou V, Paz-Ares L, Planchard D, Perol M, Hanna N, Sgambato A, Casaluce F, de Marinis F,` Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology`, Clin Lung Cancer 2018; 19:301-14 (NKI) 516. Grivas N, Hinnen K, de Jong J, Heemsbergen W, Moonen L, Witteveen T, van der Poel H, Heijmink S,` Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology`, Eur J Radiol 2018; 98:107-12 (NKI) 517. Grivas N, van der Roest R, Schouten D, Cavicchioli F, Tillier C, Bex A, Schoots I, Artibani W, Heijmink S, van der Poel H,` Quantitative assessment of fascia preservation improves the prediction of membranous urethral length and inner levator distance on continence outcome after robot-assisted radical prostatectomy`, Neurourol Urodyn 2018; 37:417-25 (NKI) 518. Grivas N, Wit E, Kuusk T, KleinJan G, Donswijk M, van Leeuwen F, van der Poel H,` The impact of adding sentinel node biopsy to extended pelvic lymph node dissection on the biochemical recurrence of prostate cancer patients treated with robot-assisted radical prostatectomy`, J Nucl Med 2018; 59:204-9 (NKI) 519. Grob JJ, Schadendorf D, Lorigan P, Ascierto P, Larkin J, Nathan P, Robert C, Hauschild A, Weber J, Daud A, Hamid O, Dummer R, Hansson J, Hoeller C, Schachter J, van Akkooi ACJ, Garbe C,` Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III`, Eur J Cancer 2018; 91:168-70 [Letter] (NKI) 520. Gröbner, SN, Worst, BC, Weischenfeldt, J, Buchhalter, I, Kleinheinz, K, Rudneva, VA, Johann, PD, Balasubramanian, GP, Segura-Wang, M, Brabetz, S, Bender, S, Hutter, B, Sturm, D, Pfaff, E, Hübschmann, D, Zipprich, G, Heinold, M, Eils, J, Lawerenz, C, Erkek, S, Lambo, S, Waszak, S, Blattmann, C, Borkhardt, A, Kuhlen, M, Eggert, A, Fulda, S, Gessler, M, Wegert, J, Kappler, R, Baumhoer, D, Burdach, S, Kirschner-Schwabe, R, Kontny, U, Kulozik, AE, Lohmann, D, Hettmer, S, Eckert, C, Bielack, S, Nathrath, M, Niemeyer, C, Richter, GH, Schulte, J, Siebert, R, Westermann, F, Molenaar, JJ, Vassal, G, Koster, J, Zwijnenburg, DA, Kool, M & AUTHOR GROUP 2018, 'The landscape of genomic alterations across childhood cancers', Nature, ;555: 321-327. (AmsterdamUMC) 521. Groen WG, van Harten WH, Vallance JK,` Systematic review and meta-analysis of distance-based physical activity interventions for cancer survivors (2013-2018): We still haven't found what we're looking for`, Cancer Treat Rev 2018; 69:188-203 (NKI) 522. Groenland SL, Katz D, Huitema ADR, Steeghs N,` Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels`, BMC Cancer 2018; 18:1200 (3 pp) (NKI) 523. Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de WR, Witjes JA, Groenewegen G, de BP, Meijer OWM, Hulshof MCCM, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, van den Bergh ACM, Kerst JM, van den Belt-Dusebout AW, Lubberts S, Jozwiak K, Horenblas S, van Leeuwen FE, Schaapveld M,` Risk of diabetes after para-aortic radiation for testicular cancer`, Br J Cancer 2018; 119:901-7 (AmsterdamUMC/NKI) 524. Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klumpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jozwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M,` Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era`, J Clin Oncol 2018; 36:2504-13 (AmsterdamUMC/NKI) 525. Groß, AS, Schulz, C, Kolb, J, Koster, J, Wehner, S, Czaplinski, S, Khilan, A, Rohrer, H, Harter, PN, Klingebiel, T, Langer, JD, Geerts, D & Schulte, D 2018, 'Tumorigenic and anti-proliferative properties of the TALE-transcription factors MEIS2D and MEIS2A in neuroblastoma', Cancer research, ;78(8): 1935- 1947. (AmsterdamUMC) 526. Grunwald V, Bex A,` The role of nephrectomy in metastatic renal cell carcinoma`, Nat Rev Nephrol 2018; 14:601-2 [News & Views] (NKI) 527. Grunwald V, Eberhardt B, Bex A, Florcken A, Gauler T, Derlin T, Panzica M, Durr HR, Grotz KA, Giles RH, von Falck C, Graser A, Muacevic A, Staehler M,` An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma`, Nat Rev Urol 2018; 15:511-21 (NKI) 528. Guckenberger M, Sweeney RA, Hawkins M, Belderbos J, Andratschke N, Ahmed M, Madani I, Mantel F, Steigerwald S, Flentje M,` Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study`, Cancer 2018; 124:2001-9 (NKI) 529. Gurney-Champion, OJ, Klaassen, R, Froeling, M, Barbieri, S, Stoker, J, Engelbrecht, MRW, Wilmink, JW, Besselink, MG, Bel, A, van Laarhoven, HWM & Nederveen, AJ 2018, 'Comparison of six fit algorithms for the intravoxel incoherent motion model of diffusionweighted magnetic resonance imaging data of pancreatic cancer patients', PLoS ONE, ;13(4): e0194590. (AmsterdamUMC) 530. Haahr P, Borgermann N, Guo X, Typas D, Achuthankutty D, Hoffmann S, Shearer R, Sixma TK, Mailand N,` ZUFSP Deubiquitylates K63-Linked Polyubiquitin Chains to Promote Genome Stability`, Mol Cell 2018; 70:165-74 (NKI) 531. Haanen JB, Cerundolo V,` NKG2A, a New Kid on the Immune Checkpoint Block`, Cell 2018; 175:1720-2 (NKI) 532. Haanen JBAG,` Questions asked in the everyday practice: immune checkpoint inhibitors`, ESMO Open 2018; 3:e000395 (NKI) 533. Haas R,` Managing Extremity Soft Tissue Sarcoma Patients: Surgery Alone or in Combination with Radiotherapy? An Editorial on the Paper by Fiore et al`, Ann Surg Oncol 2018; 25:1461-2 [Editorial] (NKI) 534. Haas RL, Baldini EH, Chung PW, van Coevorden F, DeLaney TF,` Radiation therapy in retroperitoneal sarcoma management`, J Surg Oncol 2018; 117:93-8 (NKI) 535. Haas RL, Gronchi A, van de Sande MAJ, Baldini EH, Gelderblom H, Messiou C, Wardelmann E, Le Cesne A,` Perioperative Management of Extremity Soft Tissue Sarcomas`, J Clin Oncol 2018; 36:118-24 (NKI) 536. Haas RL, Szkandera J,` ASO Author Reflections: Benefit of Adjuvant Radiotherapy for Clinical Outcome in Patients with Soft Tissue Sarcoma`, Ann Surg Oncol 2018; 25(Suppl 3):924-5 (NKI) 537. Haas RL, Walraven I, Lecointe-Artzner E, Scholten AN, van Houdt WJ, Griffin AM, Ferguson PC, Miah AB, Zaidi S, DeLaney TF, Chen YL, Spalek M, Krol SDG, Moeri-Schimmel RG, van de Sande MAJ, Sangalli C, Stacchiotti S ,` Radiation Therapy as Sole Management for Solitary Fibrous Tumors (SFT): A Retrospective Study From the Global SFT Initiative in Collaboration With the Sarcoma Patients EuroNet`, Int J Radiat Oncol Biol Phys 2018; 101:1226-33 (NKI) 538. Haas RL,` Preoperative radiotherapy in soft tissue sarcoma: from general guidelines to personalized medicine`, Chin Clin Oncol 2018; 7:41 (10 pp) (NKI) 539. Habets, EJJ, Taphoorn, MJB, Klein, M, Vissers, T & Dirven, L 2018, 'The level of reporting of neurocognitive outcomes in randomised controlled trials of brain tumour patients: A systematic review', European Journal of Cancer, ;100: 104-125. (AmsterdamUMC) 540. Habib, LA, Francis, JH, Fabius, AWM, Gobin, PY, Dunkel, IJ & Abramson, DH 2018, 'Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: The first 10 years', British Journal of Ophthalmology, ;102(2): 272-275. (AmsterdamUMC) 541. Hage JJ, Lange M, Zijlmans HJ, van Beurden M,` Repeated Use of Gluteal Fold Flaps for Post-Oncologic Vulvoperineal Reconstruction`, Ann Plast Surg 2018; 80:648-52 (NKI) 542. Hagens, ERC, Anderegg, MCJ, van Berge Henegouwen, MI & Gisbertz, SS 2018, 'International Survey on the Management of Anastomotic Leakage After Esophageal Resection', Annals of thoracic surgery, ;106(6): 1702-1708. (AmsterdamUMC) 543. Haghiralsadat, F, Amoabediny, G, Naderinezhad, S, Forouzanfar, T, Helder, MN & Zandieh-Doulabi, B 2018, 'Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy', Artificial Cells, Nanomedicine and Biotechnology, ;46: 684-692. (AmsterdamUMC) 544. Haghiralsadat, F, Amoabediny, G, Naderinezhad, S, Zandieh-Doulabi, B, Forouzanfar, T & Helder, MN 2018, 'Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted pegylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance', International Journal of Nanomedicine, ;13: 3853-3866. (AmsterdamUMC) 545. Halim VA, Garcia-Santisteban I, Warmerdam DO, van den Broek B, Heck AJR, Mohammed S, Medema RH,` Doxorubicin-induced DNA damage causes extensive ubiquitination of ribosomal proteins associated with a decrease in protein translation`, Mol Cell Proteomics 2018; 17:2297-308 (NKI) 546. Halldorsson MO, Hauptmann M, Snaebjornsson P, Haraldsdottir KH, Aspelund T, Gudmundsson EF, Gudnason V, Jonasson JG, Haraldsdottir S,` The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomy`, Scand J Gastroenterol 2018; 53:972-5 (NKI) 547. Hamming-Vrieze O, Navran A, Al Mamgani A, Vogel WV,` Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review`, Q J Nucl Med Mol Imaging 2018; 62:349-68 (NKI) 548. Han R, Li L, Ugalde AP, Tal A, Manber Z, Barbera EP, Chiara VD, Elkon R, Agami R,` Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence`, Genome Biol 2018; 19:118 (13 pp) (NKI) 549. Han SN, Amant F, Cardonick EH, Loibl S, Peccatori FA, Gheysens O, Sangalli CA, Nekljudova V, Steffensen KD, Mhallem Gziri M, Schroder CP, Lok CAR, Verest A, Neven P, Smeets A, Pruneri G, Cremonesi M, Gentilini O,` Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy`, Breast Cancer Res Treat 2018; 168:551-7 (AmsterdamUMC/NKI) 550. Han SN, Amant F, Michielsen K, De Keyzer F, Fieuws S, Van Calsteren K, Dresen RC, Gziri MM, Vandecaveye V,` Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study`, Eur Radiol 2018; 28:1862-74 (AmsterdamUMC/NKI) 551. Hansen IS, Krabbendam L, Bernink JH, Loayza-Puch F, Hoepel W, van Burgsteden JA, Kuijper EC, Buskens CJ, Bemelman WA, Zaat SAJ, Agami R, Vidarsson G, van den Brink GR, de Jong EC, Wildenberg ME, Baeten DLP, Everts B, den Dunnen J,` FcalphaRI co-stimulation converts human intestinal CD103(+) dendritic cells into pro-inflammatory cells through glycolytic reprogramming`, Nat Commun 2018; 9:863 (13 pp) (NKI) 552. Hansen MJ, Feringa FM, Kobauri P, Szymanski W, Medema RH, Feringa BL,` Photoactivation of MDM2 Inhibitors: Controlling Protein-Protein Interaction with Light`, J Am Chem Soc 2018; 140:13136-41 (NKI) 553. Hardon, SF, Horeman, T, Bonjer, HJ & Meijerink, WJHJ 2018, 'Force-based learning curve tracking in fundamental laparoscopic skills training', Surgical Endoscopy, ;32(8): 3609-3621. (AmsterdamUMC) 554. Harmsen MG, Piek JMJ, Bulten J, Casey MJ, Rebbeck TR, Mourits MJ, Greene MH, Slangen BFM, van Beurden M, Massuger LFAG, Hoogerbrugge N, de Hullu JA,` Peritoneal carcinomatosis after risk- reducing surgery in BRCA1/2 mutation carriers`, Cancer 2018; 124:952-9 (NKI) 555. Harmsen T, Klaasen S, van de Vrugt H, Te Riele H,` DNA mismatch repair and oligonucleotide end- protection promote base-pair substitution distal from a CRISPR/Cas9-induced DNA break`, Nucleic Acids Res 2018; 46:2945-55 (AmsterdamUMC/NKI) 556. Harrison P, Raison N, Abe T, Watkinson W, Dar F, Challacombe B, van der Poel H, Khan MS, Dasgupa P, Ahmed K,` The Validation of a Novel Robot-Assisted Radical Prostatectomy Virtual Reality Module`, J Surg Educ 2018; 75:758-66 (NKI) 557. Haslett, K, de Ruysscher, D, Dziadziuszko, R, Guckenberger, M, Pechoux, CL, Nestle, U, Slotman, B & Faivre-Finn, C 2018, 'Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice', Cancer Treatment and Research Communications, ;17: 18-22. (AmsterdamUMC) 558. Hayashi A, Giakoumakis NN, Heidebrecht T, Ishii T, Panagopoulos A, Caillat C, Takahara M, Hibbert RG, Suenaga N, Stadnik-Spiewak M, Takahashi T, Shiomi Y, Taraviras S, von CE, Lygerou Z, Perrakis A, Nishitani H,` Direct binding of Cdt2 to PCNA is important for targeting the CRL4(Cdt2) E3 ligase activity to Cdt1`, Life Sci Alliance 2018; 1:e201800238 (NKI) 559. Hazelaar, C, Dahele, M, Mostafavi, H, van der Weide, L, Slotman, B & Verbakel, W 2018, 'Markerless positional verification using template matching and triangulation of kV images acquired during irradiation for lung tumors treated in breath-hold', Physics in Medicine and Biology, ;63(11): 115005. (AmsterdamUMC) 560. Hazelaar, C, van der Weide, L, Mostafavi, H, Slotman, BJ, Verbakel, WFAR & Dahele, M 2018, 'Feasibility of markerless 3D position monitoring of the central airways using kilovoltage projection images: Managing the risks of central lung stereotactic radiotherapy', Radiotherapy and Oncology, ;129(2): 234-241. (AmsterdamUMC) 561. Hazelaar, C, Verbakel, WFAR, Mostafavi, H, van der Weide, L, Slotman, BJ & Dahele, M 2018, 'First Experience With Markerless Online 3D Spine Position Monitoring During SBRT Delivery Using a Conventional LINAC', International Journal of Radiation Oncology Biology Physics, ;101(5): 1253-1258. (AmsterdamUMC) 562. Hazenberg, HMJL, de Boer, NKH, Mulder, CJJ, Mom, SH, van Bodegraven, AA & Tack, GJ 2018, 'Neoplasia and precursor lesions of the female genital tract in ibd: Epidemiology, role of immunosuppressants, and clinical implications', Inflammatory Bowel Diseases, ;24(3): 510-531. (AmsterdamUMC) 563. Hazenberg, MD 2018, 'Stool can soften GVHD', Blood, ;132(23): 2429-2430. (AmsterdamUMC) 564. HEBON 2018, 'Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers', British Journal of Cancer, ;119(3): 357-363. (AmsterdamUMC) 565. Hectors, S, Jacobs, I, Lok, J, Peters, J, Bussink, J, Hoeben, FJM, Keizer, H, Janssen, HM, Nicolay, K, Schabel, M & Strijkers, G 2018, 'Improved evaluation of antivascular cancer therapy using constrained tracer-kinetic modeling for multi-agent dynamic contrast-enhanced MRI', Cancer research, ;78(6): 1561-1570. (AmsterdamUMC) 566. Heemsbergen WD, Wortel RC, Incrocci L, Smeenk RJ, Witte MG, Pos FJ, Krol S,` In Reply to Gungor et al`, Int J Radiat Oncol Biol Phys 2018; 100:1291-2 [Letter] (NKI) 567. Heemskerk, N & van Egmond, M 2018, 'Monoclonal antibody-mediated killing of tumour cells by neutrophils', European Journal of Clinical Investigations, (AmsterdamUMC) 568. Heeren, AM, van Dijk, I, Berry, DRAI, Khelil, M, Ferns, D, Kole, J, Musters, RJP, Thijssen, VL, Mom, CH, Kenter, GG, Bleeker, MCG, de Gruijl, TD & Jordanova, ES 2018, 'Indoleamine 2,3-dioxygenase expression pattern in the tumor microenvironment predicts clinical outcome in early stage cervical cancer', Frontiers in immunology, ;9: 1598. (AmsterdamUMC) 569. Heethuis SE, Goense L, van Rossum PSN, Borggreve AS, Mook S, Voncken FEM, Bartels-Rutten A, Aleman BMP, van Hillegersberg R, Ruurda JP, Meijer GJ, Lagendijk JJW, van Lier ALHM,` DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer`, Acta Oncol 2018; 57:1201-8 (NKI) 570. Heineman DJ, Beck N, Wouters MW, van Brakel TJ, Daniels JM, Schreurs WH, Dickhoff C,` The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA)`, Eur J Surg Oncol 2018; 44:830-934 (AmsterdamUMC/NKI) 571. Heinemann, M, Ranft, A, Langer, T, Jürgens, H, Kreyer, J, Vieth, V, Schäfers, M, Weckesser, M, Simon, T, Hassenpflug, W, Corbacioglu, S, Bielack, S, Mayer-Steinacker, R, Kühne, T, van den Berg, H, Gelderblom, H, Bauer, S, Stegger, L & Dirksen, U 2018, 'Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?', Pediatric blood & cancer, ;65(7): e27011. (AmsterdamUMC) 572. Heinrich D, Bektic J, Bergman AM, Caffo O, Cathomas R, Chi KN, Daugaard G, Keizman D, Kindblom J, Kramer G, Olmos D, Omlin A, Sridhar SS, Tucci M, van Oort I, Nilsson S,` The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer`, Clin Genitourin Cancer 2018; 16:e223- e231 (NKI) 573. Heins, M, Hofstede, J, Rijken, M, Korevaar, J, Donker, G & Francke, A 2018, 'Palliative care for patients with cancer: Do patients receive the care they consider important? A survey study', BMC Palliative Care, ;17(1): 61. (AmsterdamUMC) 574. Hellingman D, Wan OY, de Wit-van der Veen BJ, van der Ploeg I, Elkhuizen PHM, Rutgers EJT, Stokkel MPM,` Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancer`, Nucl Med Commun 2018;in press (NKI) 575. Hellmann MD, Ciuleanu TE, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, Minenza E, Linardou H, Burgers S, Salman P, Borghaei H, Ramalingam SS, Brahmer J, Reck M, O'Byrne KJ, Geese WJ, Green G, Chang H, Szustakowski J, Bhagavatheeswaran P, Healey D, Fu Y, Nathan F, Paz-Ares L,` Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden`, N Engl J Med 2018; 378:2093- 104 (NKI) 576. Helmers R, Straat NF, Navran A, Nai Chung Tong TAP, Teguh DN, van Hulst RA, de Lange J, Milstein DMJ,` Patient-Side Appraisal of Late Radiation-Induced Oral Microvascular Changes`, Int J Radiat Oncol Biol Phys 2018; 102:1299-307 (AmsterdamUMC/NKI) 577. Hendriks, EJ, Habets, EJJ, Taphoorn, MJB, Douw, L, Zwinderman, AH, Vandertop, WP, Barkhof, F, Klein, M & de Witt Hamer, PC 2018, 'Linking late cognitive outcome with glioma surgery location using resection cavity maps', Human brain mapping, ;39(5): 2064-2074. (AmsterdamUMC) 578. Hendriks, EJ, Idema, S, Hervey-Jumper, SL, Bernat, A-L, Zwinderman, AH, Barkhof, F, Vandertop, WP, Mandonnet, E, Duffau, H, Berger, MS & De Witt Hamer, PC 2018, 'Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map', Neurosurgery. (AmsterdamUMC) 579. Henricks LM, Jacobs BAW, Meulendijks D, Pluim D, van den Broek D, de Vries N, Rosing H, Beijnen JH, Huitema ADR, Guchelaar HJ, Cats A, Schellens JHM,` Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteers`, Br J Clin Pharmacol 2018; 84:2761-9 (NKI) 580. Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Frederix GWJ, Kienhuis E, Creemers GJ, Baars A, Dezentje VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Ten Tije AJ, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, Rosing H, Beijnen JH, van Werkhoven E, van Kuilenburg ABP, van Schaik RHN, Mathijssen RHJ, Swen JJ, Gelderblom H, Cats A, Guchelaar HJ, Schellens JHM,` A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy`, Eur J Cancer 2018; 107:60-7 (NKI) 581. Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Frederix GWJ, Kienhuis E, Creemers GJ, Baars A, Dezentje VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Ten Tije AJ, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, Rosing H, Beijnen JH, van Werkhoven E, van Kuilenburg ABP, van Schaik RHN, Mathijssen RHJ, Swen JJ, Gelderblom H, Cats A, Guchelaar HJ, Schellens JHM,` DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis`, Lancet Oncol 2018; 19:1459-67 (AmsterdamUMC/NKI) 582. Henricks LM, Siemerink EJ, Rosing H, Meijer J, Goorden SM, Polstra AM, Zoetekouw L, Cats A, Schellens JH, van Kuilenburg AB,` Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency`, Int J Cancer 2018; 142:424-30 (AmsterdamUMC/NKI) 583. Henselmans, I, Smets, EMA, de Haes, JCJM, Dijkgraaf, MGW, de Vos, FY & van Laarhoven, HWM 2018, 'A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHOICE): study protocol', BMC cancer, ;18(1): 55. (AmsterdamUMC) 584. Herbrink M, de Vries N, Rosing H, Huitema ADR, Nuijen B, Schellens JHM, Beijnen JH,` Development and validation of a liquid chromatography-tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs`, Biomed Chromatogr 2018; 32:e4147-(9 pp) (NKI) 585. Herbrink M, Groenland SL, Huitema ADR, Schellens JHM, Beijnen JH, Steeghs N, Nuijen B,` Solubility and bioavailability improvement of pazopanib hydrochloride`, Int J Pharm 2018; 544:181-90 (NKI) 586. Herbrink M, Thijssen B, Hillebrand MJX, Rosing H, Schellens JHM, Nuijen B, Beijnen JH,` Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma`, J Pharm Biomed Anal 2018; 148:259-64 (NKI) 587. Herbrink M, Vromans H, Schellens J, Beijnen J, Nuijen B,` Thermal stability study of crystalline and novel spray-dried amorphous nilotinib hydrochloride`, J Pharm Biomed Anal 2018; 148:182-8 (NKI) 588. Hermans TJN, Voskuilen CS, van der Heijden MS, Schmitz-Drager BJ, Kassouf W, Seiler R, Kamat AM, Grivas P, Kiltie AE, Black PC, van Rhijn BWG,` Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future`, Urol Oncol 2018; 36:413-22 (NKI) 589. Hetzel, J, Maldonado, F, Ravaglia, C, Wells, AU, Colby, TV, Tomassetti, S, Ryu, JH, Fruchter, O, Piciucchi, S, Dubini, A, Cavazza, A, Chilosi, M, Sverzellati, N, Valeyre, D, Leduc, D, Walsh, SLF, Gasparini, S, Hetzel, M, Hagmeyer, L, Haentschel, M, Eberhardt, R, Darwiche, K, Yarmus, LB, Torrego, A, Krishna, G, Shah, PL, Annema, JT, Herth, FJF & Poletti, V 2018, 'Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure', Respiration;( ): (AmsterdamUMC) 590. Heukers, R, Fan, TS, de Wit, RH, van Senten, JR, de Groof, TWM, Bebelman, MP, Lagerweij, T, Vieira, J, de Munnik, SM, Smits-de Vries, L, van Offenbeek, J, Rahbar, A, van Hoorick, D, Söderberg-Naucler, C, Würdinger, T, Leurs, R, Siderius, M, Vischer, HF & Smit, MJ 2018, 'The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth', Oncogene, ;37(30): 4110-4121. (AmsterdamUMC) 591. Heuveling, DA, Karagozoglu, KH, Van Lingen, A, Hoekstra, OS, Van Dongen, GAMS & De Bree, R 2018, 'Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe', EJNMMI Research, ;8( 15. ): (AmsterdamUMC) 592. Hidding, JT, Beurskens, CHG, van der Wees, PJ, Bos, WCAM, Nijhuis-van der Sanden, MWG & van Laarhoven, HWM 2018, 'Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer', Supportive care in cancer, ;26(5): 1383-1392. (AmsterdamUMC) 593. Hira, VVV, Aderetti, DA & van Noorden, CJF 2018, 'Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar', journal of histochemistry and cytochemistry, ;66(5): 349-358. (AmsterdamUMC) 594. Hira, VVV, Wormer, JR, Kakar, H, Breznik, B, van der Swaan, B, Hulsbos, R, Tigchelaar, W, Tonar, Z, Khurshed, M, Molenaar, RJ & van Noorden, CJF 2018, 'Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins', journal of histochemistry and cytochemistry, ;66(3): 155-173. (AmsterdamUMC) 595. Hirsch, FR, Kerr, KM, Bunn, PA, Kim, ES, Obasaju, C, Pérol, M, Bonomi, P, Bradley, JD, Gandara, D, Jett, JR, Langer, CJ, Natale, RB, Novello, S, Paz-Ares, L, Ramalingam, SS, Reck, M, Reynolds, CH, Smit, EF, Socinski, MA, Spigel, DR, Stinchcombe, TE, Vansteenkiste, JF, Wakelee, H & Thatcher, N 2018, 'Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies', Clinical Lung Cancer, ;19(4): 331-339. (AmsterdamUMC) 596. Hoebe, E, Wille, C, Hagemeier, S, Kenney, S, Greijer, A & Middeldorp, J 2018, 'Epstein–barr virus gene BARF1 expression is regulated by the epithelial differentiation factor ∆np63α in undifferentiated nasopharyngeal carcinoma', Cancers, ;10(3): 76. (AmsterdamUMC) 597. Hoeijmakers F, Beck N, Wouters MWJM, Prins HA, Steup WH,` National quality registries: how to improve the quality of data? J Thorac Dis 2018; 10:S3490-S3499 `, (NKI) 598. Hoffman, LM, van Zanten, SEMV, Colditz, N, Baugh, J, Chaney, B, Hoffmann, M, Lane, A, Fuller, C, Miles, L, Hawkins, C, Bartels, U, Bouffet, E, Goldman, S, Leary, S, Foreman, NK, Packer, R, Warren, KE, Broniscer, A, Kieran, MW, Minturn, J, Comito, M, Broxson, E, Shih, C-S, Khatua, S, Chintagumpala, M, Carret, AS, Escorza, NY, Hassall, T, Ziegler, DS, Gottardo, N, Dholaria, H, Doughman, R, Benesch, M, Drissi, R, Nazarian, J, Jabado, N, Boddaert, N, Varlet, P, Giraud, GR, Castel, D, Puget, S, Jones, C, Hulleman, E, Modena, P, Giagnacovo, M, Antonelli, M, Pietsch, T, Gielen, GH, Jones, DTW, Sturm, D, Pfister, SM, Gerber, NU, Grotzer, MA, Pfaff, E, von Bueren, AO, Hargrave, D, Solanki, GA, Cvrlje, FJ, Kaspers, GJL, Vandertop, WP, Grill, J, Bailey, S, Biassoni, V, Massimino, M, Calmon, R, Sanchez, E, Bison, B, Warmuth-Metz, M, Leach, J, Jones, B, van Vuurden, DG, Kramm, CM & Fouladi, M 2018, 'Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries', Journal of clinical oncology, ;36(19): 1963-1972. (AmsterdamUMC) 599. Hofstadter-Thalmann E, Dafni U, Allen T, Arnold D, Banerjee S, Curigliano GMD, Garralda E, Garassino MC, Haanen J, Robert C, Sessa C, Tsourti Z, Zygoura P, Peters S,` Report on the status of women occupying leadership roles in oncology`, ESMO Open 2018; 3:e000423 (NKI) 600. Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, Van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC,` Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group`, Pediatr Blood Cancer 2018; 65:e26849 (6 pp) (NKI) 601. Holdenrieder S, Molina R, Qiu L, Zhi X, Rutz S, Engel C, Kasper-Sauer P, Dayyani F, Korse CM,` Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer`, Tumour Biol 2018; 40:1-13 (NKI) 602. Honeywell, RJ, Hitzerd, SM, Kathmann, GAM & Peters, GJ 2018, 'Subcellular localization of several structurally different tyrosine kinase inhibitors', ADMET & DMPK, ;6(3): 258-266. (AmsterdamUMC) 603. Hooi, DJ, Lissenberg-Witte, BI, de Koning, MNC, Pinedo, HM, Kenter, GG, Meijer, CJ & Quint, WG 2018, 'High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine', Sexually transmitted infections, ;94(4): 263-267. (AmsterdamUMC) 604. Hooi, DJ, Lissenberg-Witte, BI, Kenter, G, de Koning, MNC, Bravio, IG, Ardts, K, Kleinmoedig, S, Benita, E, Pinedo, HM, Berkhof, J, Quint, WGV & Meijer, CJLM 2018, 'Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao', PLoS ONE, ;13(7): e0199624. (AmsterdamUMC) 605. Hooi, DJ, Quint, WGV, Lissenberg-Witte, BI, Kenter, G, Pinedo, HM, de Koning, MNC & Meijer, CJLM 2018, 'Human papillomavirus (HPV) types prevalence in cervical samples of female sex-workers on Curaçao', Preventive Medicine Reports, ;11: 120-124. (AmsterdamUMC) 606. Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, Bolla MK, Brenner H, Chang-Claude J, Cora R, Couch FJ, Cuk K, Devilee P, Easton DF, Eccles DM, Eilber U, Hartikainen JM, Heikkila P, Holleczek B, Hooning MJ, Jones M, Keeman R, Mannermaa A, Martens JWM, Muranen TA, Nevanlinna H, Olson JE, Orr N, Perez JIA, Pharoah PDP, Ruddy KJ, Saum KU, Schoemaker MJ, Seynaeve C, Sironen R, Smit VTHB, Swerdlow AJ, Tengstrom M, Thomas AS, Timmermans AM, Tollenaar RAEM, Troester MA, van Asperen CJ, van Deurzen CHM, van Leeuwen FE, van 't Veer LJ, Garcia-Closas M, Figueroa JD,` E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium`, Sci Rep 2018; 8:6574 (11 pp) (NKI) 607. Horrevorts, SK, Duinkerken, S, Bloem, K, Secades, P, Kalay, H, Musters, RJ, van Vliet, SJ, García-Vallejo, JJ & van Kooyk, Y 2018, 'Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN- Targeted Antigens for Presentation on MHC Class I', Frontiers in Immunology, ;9: 1231. (AmsterdamUMC) 608. Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Petrakova K, Blackwell KL, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Mondal S, Su F, Miller M, Elmeliegy M, Germa C, O'Shaughnessy J,` Updated results from MONALEESA-2, a phase III trial of first- line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer`, Ann Oncol 2018; 29:1541-7 (NKI) 609. Houg, DS & Bijlsma, MF 2018, 'The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma', Molecular cancer, ;17(1): 95. (AmsterdamUMC) 610. Houthuijzen JM, Jonkers J,` Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment`, Cancer Metastasis Rev 2018; 37:577-97 (NKI) 611. HOVON CLL study group. 2018, 'Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL', Blood advances, ;2(24): 3566- 3571. (AmsterdamUMC) 612. HPB-RISC Study Group 2018, 'Surgeons’ assessment versus risk models for predicting complications of hepato-pancreato-biliary surgery (HPB-RISC): a multicenter prospective cohort study', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(9): 809-814. (AmsterdamUMC) 613. Huang Q, Yan J, Agami R,` Long non-coding RNAs in metastasis`, Cancer Metastasis Rev 2018; 37:75-81 (NKI) 614. Huang, L, Jansen, L, Balavarca, Y, Babaei, M, van der Geest, L, Lemmens, V, van Eycken, L, de Schutter, H, Johannesen, TB, Primic-Žakelj, M, Zadnik, V, Besselink, MG, Schrotz-King, P & Brenner, H 2018, 'Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: A large, international population-based study', BMC medicine, ;16(1): 125. (AmsterdamUMC) 615. Huang, L, Jansen, L, Balavarca, Y, Molina-Montes, E, Babaei, M, van der Geest, L, Lemmens, V, van Eycken, L, de Schutter, H, Johannesen, TB, Fristrup, CW, Mortensen, MB, Primic-Žakelj, M, Zadnik, V, Becker, N, Hackert, T, Mägi, M, Cassetti, T, Sassatelli, R, Grützmann, R, Merkel, S, Gonçalves, AF, Bento, MJ, Hegyi, P, Lakatos, G, Szentesi, A, Moreau, M, van de Velde, T, Broeks, A, Sant, M, Minicozzi, P, Mazzaferro, V, Real, FX, Carrato, A, Molero, X, Besselink, MG, Malats, N, Büchler, MW, Schrotz-King, P & Brenner, H 2018, 'Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations', Gut, ;68(1): 130-139. (AmsterdamUMC) 616. Huang, L, Jansen, L, Balavarca, Y, van der Geest, L, Lemmens, V, van Eycken, L, de Schutter, H, Johannesen, TB, Primic-Žakelj, M, Zadnik, V, Mägi, M, Pulte, D, Schrotz-King, P & Brenner, H 2018, 'Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003– 2014: a large international population-based study', International journal of cancer. Journal international du cancer, ;143(12): 3227-3239. (AmsterdamUMC) 617. Huels, DJ & Medema, JP 2018, 'Think About the Environment: Cellular Reprogramming by the Extracellular Matrix', Cell stem cell, ;22(1): 7-9. (AmsterdamUMC) 618. Huijbers, EJM, van Beijnum, JR, Lê, CT, Langman, S, Nowak-Sliwinska, P, Mayo, KH & Griffioen, AW 2018, 'An improved conjugate vaccine technology (AmsterdamUMC) 619. Huijskens, SC, van Dijk, IWEM, Visser, J, Balgobind, BV, Rasch, CRN, Alderliesten, T & Bel, A 2018, 'Predictive value of pediatric respiratory-induced diaphragm motion quantified using pre-treatment 4DCT and CBCTs', Radiation oncology (London, England), ;13(1): 198. (AmsterdamUMC) 620. Huijskens, SC, van Dijk, IWEM, Visser, J, Balgobind, BV, te Lindert, D, Rasch, CRN, Alderliesten, T & Bel, A 2018, 'Abdominal organ position variation in children during image-guided radiotherapy', Radiation oncology (London, England), ;13(1): 173. (AmsterdamUMC) 621. Huijts DD, van Groningen JT, Guicherit OR, Dekker JWT, Bodegom-Vos L, Bastiaannet E, Govaert JA, Wouters MW, de Mheen PJM,` Weekend Effect in Emergency Colon and Rectal Cancer Surgery: A Prospective Study Using Data From the Dutch ColoRectal Audit`, J Natl Compr Canc Netw 2018; 16:735-41 (NKI) 622. Huis In 't Veld EA, Grunhagen DJ, Deroose JP, Nijsten TEC, Wouters MWJM, Verhoef C, van Houdt WJ, Hayes AJ,` Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy`, Br J Cancer 2018; 119:429-34 (NKI) 623. Huiskens, J, Olthof, PB, van der Stok, EP, Bais, T, van Lienden, KP, Moelker, A, Krumeich, J, Roumen, RM, Grünhagen, DJ, Punt, CJA, van Amerongen, M, de Wilt, JHW, Verhoef, C & van Gulik, TM 2018, 'Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison', European journal of surgical oncology, ;44(1): 108-114. (AmsterdamUMC) 624. Huisman, M, Sera, T, Vugts, D, Boellaard, R & on behalf of EARL 2018, 'Feasibility of PET/CT system performance harmonisation for quantitative multicentre 89Zr studies', EJNMMI PHYSICS, ;5(1): 26. (AmsterdamUMC) 625. Huizing DMV, de Wit-van der Veen BJ, Verheij M, Stokkel MPM,` Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review`, EJNMMI Res 2018; 8:89 (11 pp) (NKI) 626. Hulsbosch, S, Koskas, M, Tomassetti, C, de Sutter, P, Wildiers, H, Neven, P, D'Hooghe, T & Amant, F 2018, 'A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients', Gynecologic and obstetric investigation, ;83(2): 156–163. (AmsterdamUMC) 627. Hummel SB, van Lankveld JJ, Oldenburg HSA, Hahn DEE, Kieffer JM, Gerritsma MA, Kuenen MA, Bijker N, Borgstein PJ, Heuff G, Cardozo AML, Plaisier PW, Rijna H, van der Meij S, van Dulken EJ, Vrouenraets BC, Broomans E, Aaronson NK,` Internet-based Cognitive Behavioral Therapy Realizes Long-term Improvement in the Sexual Functioning and Body Image of Breast Cancer Survivors`, J Sex Marital Ther 2018; 43:574-7 (AmsterdamUMC/NKI) 628. Hummel, SB, van Lankveld, JJDM, Oldenburg, HSA, Hahn, DEE, Kieffer, JM, Gerritsma, MA, Kuenen, MA, Bijker, N, Borgstein, PJ, Heuff, G, Lopes Cardozo, AMF, Plaisier, PW, Rijna, H, van der Meij, S, van Dulken, EJ, Vrouenraets, BC, Broomans, E & Aaronson, NK 2018, 'Internet-based Cognitive Behavioral Therapy Realizes Long-term Improvement in the Sexual Functioning and Body Image of Breast Cancer Survivors', Journal of sex & marital therapy, ;44(5): 485-496. (AmsterdamUMC) 629. Hupkens BJP, Maas M, Martens MH, van der Sande ME, Lambregts DMJ, Breukink SO, Melenhorst J, Houwers JB, Hoff C, Sosef MN, Leijtens JWA, Berbee M, Beets-Tan RGH, Beets GL,` Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response? `,Ann Surg Oncol 2018; 25:197-203 (NKI) 630. Hupkens BJP, Maas M,` ASO Author Reflections: Decision Timing for Organ Preservation in Rectal Cancer After Chemoradiation`, Ann Surg Oncol 2018; 25(Suppl 3):854-5 [Auth reflect] (NKI) 631. Hupkens, BJP, Breukink, SO, Olde Reuver of Briel, C, Tanis, PJ, de Noo, ME, van Duijvendijk, P, van Westreenen, HL, Dekker, JWT, Chen, TYT & Juul, T 2018, 'Dutch validation of the low anterior resection syndrome score', Colorectal disease, ;20(10): 881-887. (AmsterdamUMC) 632. Huseinovic A, van Dijk M, Vermeulen NPE, van Leeuwen F, Kooter JM, Vos JC,` Drug toxicity profiling of a Saccharomyces cerevisiae deubiquitinase deletion panel shows that acetaminophen mimics tyrosine`, Toxicol In Vitro 2018; 47:259-68 (NKI) 633. Hussein, AA, Forouzanfar, T, Bloemena, E, de Visscher, J, Brakenhoff, RH, Leemans, CR & Helder, MN 2018, 'A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma', British Journal of Cancer, ;119(6): 724-736. (AmsterdamUMC) 634. Ijff, M, van Oorschot, B, Oei, AL, Krawczyk, PM, Rodermond, HM, Stalpers, LJA, Kok, HP, Crezee, J & Franken, NAP 2018, 'Enhancement of radiation effectiveness in cervical cancer cells by combining ionizing radiation with hyperthermia and molecular targeting agents', International journal of molecular sciences, ;19(8): 2420. (AmsterdamUMC) 635. IJsbrandy C, Ottevanger PB, Tsekou Diogeni M, Gerritsen WR, van Harten WH, Hermens RPMG,` Review: Effectiveness of implementation strategies to increase physical activity uptake during and after cancer treatment`, Crit Rev Oncol Hematol 2018; 122:157-63 (NKI) 636. Ijselstein, M, Brouwer, T, Abdulrahman, Z, Reidy, E, Ramalheiro, A, Heeren, AM, Vahrmeijer, A, Jordanova, ES & de Miranda, N 2018, 'Cancer immunophenotyping by 7 colour multispectral imaging without tyramide signal amplification', The Journal of Pathology: Clinical Research. (AmsterdamUMC) 637. Ikink GJ, Boer M, Bakker ERM, Vendel-Zwaagstra A, Klijn C, Ten Hoeve J, Jonkers J, Wessels LF, Hilkens J,` Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance`, Oncogene 2018; 37:1594-609 (NKI) 638. In collaboration with the NGS-ProToCol Consortium:, Komor, MA, Bosch, LJW, Bounova, G, Bolijn, AS, Delis-van Diemen, PM, Rausch, C, Hoogstrate, Y, Stubbs, AP, de Jong, M, Jenster, G, van Grieken, NCT, Carvalho, B, Wessels, LFA, Jimenez, CR, Fijneman, RJA & Meijer, GA 2018, 'Consensus molecular subtype classification of colorectal adenomas', Journal of Pathology, ;246(3): 266-276. (AmsterdamUMC) 639. Innocenti M,` New insights into the formation and the function of lamellipodia and ruffles in mesenchymal cell migration`, Cell Adh Migr 2018; 12:401-16 (NKI) 640. International Society of Pediatric Oncology Sarcoma Committee, the Children's Oncology Group, the Italian Cooperative Soft Tissue Sarcoma Group, and the European pediatric Soft tissue sarcoma Study Group 2018, 'Localized vaginal/uterine rhabdomyosarcoma—results of a pooled analysis from four international cooperative groups', Pediatric blood & cancer, ;65(9): e27096. (AmsterdamUMC) 641. Iqbal, R, Kramer, GM, Frings, V, Smit, EF, Hoekstra, OS, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, 'Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor', EJNMMI Research, ;8( 22. ): (AmsterdamUMC) 642. Isidori, F, Malvi, D, Fittipaldi, S, Forcato, C, Bozzarelli, I, Sala, C, Raulli, G, D'Errico, A, Fiorentino, M, Seri, M, Krishnadath, KK, Bonora, E, Mattioli, S, Lugaresi, ML, D'Errico, A, Castellani, G, Fiocca, R, Mastracci, L, Räsänen, J & Söderström, H 2018, 'Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: Results from a case report', BMC cancer, ;18(1): 889. (AmsterdamUMC) 643. Israels, T, Paintsil, V, Nyirenda, D, Kouya, F, Mbah Afungchwi, G, Hesseling, P, Tump, C, Kaspers, G, Burns, L, Singh Arora, R, Chagaluka, G, Nana, P, Renner, L & Molyneux, E 2018, 'Improved outcome at end of treatment in the collaborative Wilms tumour Africa project', Pediatric Blood and Cancer, ;65(5): e26945. (AmsterdamUMC) 644. Italian Oncological Group of Clinical Research (GOIRC), Tibaldi, C, Camerini, A, Tiseo, M, Mazzoni, F, Barbieri, F, Vittimberga, I, Brighenti, M, Boni, L, Baldini, E, Gilli, A, Honeywell, R, Chartoire, M, Peters, GJ & Giovannetti, E 2018, 'Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study', British Journal of Cancer, ;119(11): 1326-1331. (AmsterdamUMC) 645. Jacobs BAW, Pluim D, van der LP, Tzani A, Beijnen JH, Schellens JHM,` Development and validation of a quantitative method for thymidine phosphorylase activity in peripheral blood mononuclear cells`, Nucleosides Nucleotides Nucleic Acids 2018;1-19 (NKI) 646. Jacobs BAW, Snoeren N, Samim M, Rosing H, de Vries N, Deenen MJ, Beijnen JH, Schellens JHM, Koopman M, van Hillegersberg R,` The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases`, Eur J Clin Pharmacol 2018; 74:737-44 (NKI) 647. Jacobs, M, Henselmans, I, Arts, DL, ten Koppel, M, Gisbertz, SS, Lagarde, SM, van Berge Henegouwen, MI, Sprangers, MAG, de Haes, HCJM & Smets, EMA 2018, 'Development and feasibility of a web-based question prompt sheet to support information provision of health-related quality of life topics after oesophageal cancer surgery', European journal of cancer care, ;27(1): e12593. (AmsterdamUMC) 648. Jacobsen A, Bosch LJW, Martens-de Kemp SR, Carvalho B, Sillars-Hardebol AH, Dobson RJ, de Rinaldis E, Meijer GA, Abeln S, Heringa J, Fijneman RJA, Feenstra KA,` Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer`, Sci Rep 2018; 8:7522 (NKI) 649. Jagt-van Kampen, CT, Colenbrander, DA, Bosman, DK, Grootenhuis, MA, Kars, MC & Schouten-van Meeteren, AY 2018, 'Aspects and Intensity of Pediatric Palliative Case Management Provided by a Hospital-Based Case Management Team: A Comparative Study Between Children With Malignant and Nonmalignant Disease', American journal of hospice & palliative care, ;35(1): 123-131. (AmsterdamUMC) 650. Jain, D, Allen, TC, Aisner, DL, Beasley, MB, Cagle, PT, Capelozzi, VL, Hariri, LP, Lantuejoul, S, Miller, R, Mino-Kenudson, M, Monaco, SE, Moreira, A, Raparia, K, Rekhtman, N, Roden, AC, Roy-Chowdhuri, S, da Cunha Santos, G, Thunnissen, E, Troncone, G & Vivero, M 2018, 'Rapid on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspirations for the diagnosis of lung cancer a perspective from members of the Pulmonary Pathology Society', Archives of pathology & laboratory medicine, ;142(2): 253-262. (AmsterdamUMC) 651. Jangra RK, Herbert AS, Li R, Jae LT, Kleinfelter LM, Slough MM, Barker SL, Guardado-Calvo P, Roman- Sosa G, Dieterle ME, Kuehne AI, Muena NA, Wirchnianski AS, Nyakatura EK, Fels JM, Ng M, Mittler E, Pan J, Bharrhan S, Wec AZ, Lai JR, Sidhu SS, Tischler ND, Rey FA, Moffat J, Brummelkamp TR, Wang Z, Dye JM, Chandran K,` Protocadherin-1 is essential for cell entry by New World hantaviruses`, Nature 2018; 563:559-63 (NKI) 652. Janse, A, Worm-Smeitink, M, Bleijenberg, G, Donders, R & Knoop, H 2018, 'Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial', British journal of psychiatry, ;212(2): 112-118. (AmsterdamUMC) 653. Jansen, BHE, Oudshoorn, FHK, Tijans, AM, Yska, MJ, Lont, AP, Collette, ERP, Nieuwenhuijzen, JA & Vis, AN 2018, 'Local staging with multiparametric MRI in daily clinical practice: diagnostic accuracy and evaluation of a radiologic learning curve', World Journal of Urology, ;36(9): 1409-1415. (AmsterdamUMC) 654. Jansen, F, Coupé, VMH, Eerenstein, SEJ, Leemans, CR & Verdonck-de Leeuw, IM 2018, 'Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?', Supportive Care in Cancer, ;26(4): 1221-1231. (AmsterdamUMC) 655. Jansen, F, Eerenstein, SEJ, Lissenberg-Witte, BI, Uden-Kraan, CFV, Leemans, CR & Leeuw, IMV 2018, 'Unmet supportive care needs in patients treated with total laryngectomy and its associated factors', Head and Neck, ;40(12): 2633-2641. (AmsterdamUMC) 656. Jansen, F, Verdonck-de Leeuw, IM, Cuijpers, P, Leemans, CR, Waterboer, T, Pawlita, M, Penfold, C, Thomas, SJ, Waylen, A & Ness, AR 2018, 'Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study', Psycho-Oncology, ;27(9): 2245-2256. (AmsterdamUMC) 657. Jansen, I, Lucas, M, Savci-Heijink, CD, Meijer, SL, Marquering, HA, de Bruin, DM & Zondervan, PJ 2018, 'Histopathology: ditch the slides, because digital and 3D are on show', World journal of urology, ;36(4): 549-555. (AmsterdamUMC) 658. Jansen, M & Bergman, J 2018, 'Risk-stratified clinical management of superficially invasive esophageal squamous cell carcinoma after endoscopic resection: Finding the sweet spot', Endoscopy, ;50(7): 655- 656. (AmsterdamUMC) 659. Jansen, RW, de Jong, MC, Kooi, IE, Sirin, S, Göricke, S, Brisse, HJ, Maeder, P, Galluzzi, P, van der Valk, P, Cloos, J, Eekhout, I, Castelijns, JA, Moll, AC, Dorsman, JC & de Graaf, P 2018, 'MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles', Radiology, ;288(2): 506-515. (AmsterdamUMC) 660. Jansen, RW, van Amstel, P, Martens, RM, Kooi, IE, Wesseling, P, de Langen, AJ, van Oordt, CWMVDH, Jansen, BHE, Moll, AC, Dorsman, JC, Castelijns, JA, de Graaf, P & de Jong, MC 2018, 'Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis', Oncotarget, ;9(28): 20134-20155. (AmsterdamUMC) 661. Jansen, SM, de Bruin, DM, van Berge Henegouwen, MI, Strackee, SD, Veelo, DP, van Leeuwen, TG & Gisbertz, SS 2018, 'Optical techniques for perfusion monitoring of the gastric tube after esophagectomy: A review of technologies and thresholds', Diseases of the esophagus, ;31( 6. ): (AmsterdamUMC) 662. Janssen LME, Averink TV, Blomen VA, Brummelkamp TR, Medema RH, Raaijmakers JA,` Loss of Kif18A Results in Spindle Assembly Checkpoint Activation at Microtubule-Attached Kinetochores`, Curr Biol 2018; 28:2685-96 (NKI) 663. Janssen N, Eppenga R, Peeters MV, van Duijnhoven F, Oldenburg H, van der Hage J, Rutgers E, Sonke JJ, Kuhlmann K, Ruers T, Nijkamp J,` Real-time wireless tumor tracking during breast conserving surgery`, Int J Comput Assist Radiol Surg 2018; 13:531-9 (NKI) 664. Janssen NNY, van la Parra RFD, Loo CE, Groen EJ, van den Berg MJ, Oldenburg HSA, Nijkamp J, Vrancken Peeters MTFD,` Breast conserving surgery for extensive DCIS using multiple radioactive seeds`, Eur J Surg Oncol 2018; 44:67-73 (NKI) 665. Jastrzebski K, Thijssen B, Kluin RJ, de Lint K, Majewski IJ, Beijersbergen RL, Wessels LFA,` Integrative modeling identifies key determinants of inhibitor sensitivity in breast cancer cell lines`, Cancer Res 2018; 78:4396-410 (NKI) 666. Jauw, YWS, Heijtel, DF, Zijlstra, JM, Hoekstra, OS, de Vet, HCW, Vugts, DJ, Verheul, HM, Boellaard, R, Zweegman, S, van Dongen, GAMS, der Houven van Oordt, CWM, Lammertsma, AA & Huisman, MC 2018, 'Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images', Molecular Imaging and Biology, ;20(6): 1025-1034. (AmsterdamUMC) 667. Jauw, YWS, Huisman, MC, Nayak, TK, Vugts, DJ, Christen, R, Naegelen, VM, Ruettinger, D, Heil, F, Lammertsma, AA, Verheul, HMW, Hoekstra, OS, van Dongen, GAMS & van Oordt, CWMDH 2018, 'Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody', EJNMMI Research, ;8( 6. ): (AmsterdamUMC) 668. Jeene PM, de Vries KC, van Nes JGH, Kwakman JJM, Wester G, Rozema T, Braam PM, Zindler JD, Koper P, Nuyttens JJ, Vos-Westerman HA, Schmeets I, Niel CGHJ, Hutschemaekers S, van der Linden YM, Verhoeff JJC, Stalpers LJA,` Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014`, Acta Oncol 2018; 57:637-43 (AmsterdamUMC/NKI) 669. Jeene, PM, van Laarhoven, HWM & Hulshof, MCCM 2018, 'The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer', Best practice & research. Clinical gastroenterology, ; 36-37: 53-59. (AmsterdamUMC) 670. Jelvehgaran P, de Bruin DM, Salguero FJ, Borst GR, Song JY, van Leeuwen TG, de Boer JF, Alderliesten T, van Herk M,` Feasibility of using optical coherence tomography to detect acute radiation-induced esophageal damage in small animal models`, J Biomed Opt 2018; 23:1-12 (AmsterdamUMC/NKI) 671. Jelvehgaran, P, Alderliesten, T, Georgiou, G, Meijer, SL, Bloemen, PR, Kodach, LL, van Laarhoven, HWM, van Berge Henegouwen, MI, Hulshof, MCCM, Rasch, CRN, van Leeuwen, TG, de Boer, JF, de Bruin, M & van Herk, M 2018, 'Feasibility of using optical coherence tomography to detect radiation- induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: An ex vivo study', Biomedical optics express, ;9(9): 4196-4216. (AmsterdamUMC) 672. Jimenez, CR, Zhang, H, Kinsinger, CR & Nice, EC 2018, 'The cancer proteomic landscape and the HUPO Cancer Proteome Project', Clinical Proteomics, ;15(1): 4. (AmsterdamUMC) 673. Jin, P, Crama, KF, Visser, J, van Wieringen, N, Bel, A, Hulshof, MCCM & Alderliesten, T 2018, 'Density override in treatment planning to mitigate the dosimetric effect induced by gastrointestinal gas in esophageal cancer radiation therapy', Acta oncologica (Stockholm, Sweden), ;57(12): 1646-1654. (AmsterdamUMC) 674. Jin, P, van Wieringen, N, Hulshof, MCCM, Bel, A & Alderliesten, T 2018, 'Tailoring four-dimensional cone-beam CT acquisition settings for fiducial marker-based image guidance in radiation therapy', Journal of medical imaging (Bellingham, Wash.), ;5(2): 021207. (AmsterdamUMC) 675. Jochems A, Leeneman B, Franken MG, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, Groenewegen G, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Koornstra RH, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, Uyl-de Groot CA, van der Hoeven KJM,` Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands`, Anticancer Drugs 2018; 29:572-8 (AmsterdamUMC/NKI) 676. Johnson, C, Price, G, Khalifa, J, Faivre-Finn, C, Dekker, A, Moore, C & van Herk, M 2018, 'A method to combine target volume data from 3D and 4D planned thoracic radiotherapy patient cohorts for machine learning applications', Radiotherapy and oncology, ;126(2): 355-361. (AmsterdamUMC) 677. Joint Head and Neck Radiotherapy-MRI Development Cooperative,`, Collaborators (32), van der Heide UA Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers`, Sci Data 2018; 5:180008 (NKI) 678. Jongen-Lavrencic, M, Grob, T, Hanekamp, D, Kavelaars, FG, Al Hinai, A, Zeilemaker, A, Erpelinck- Verschueren, CAJ, Gradowska, PL, Meijer, R, Cloos, J, Biemond, BJ, Graux, C, van Marwijk Kooy, M, Manz, MG, Pabst, T, Passweg, JR, Havelange, V, Ossenkoppele, GJ, Sanders, MA, Schuurhuis, GJ, Lowenberg, B & Valk, PJM 2018, 'Molecular minimal residual disease in acute myeloid leukemia', New England journal of medicine, ;378(13): 1189-1199. (AmsterdamUMC) 679. Joosse SA, Souche FR, Babayan A, Gasch C, Kerkhoven RM, Ramos J, Fabre JM, Riethdorf S, Konig A, Wikman H, Alix-Panabieres C, Pantel K ,` Chromosomal Aberrations Associated with Sequential Steps of the Metastatic Cascade in Colorectal Cancer Patients`, Clin Chem 2018; 64:1505-12 (NKI) 680. Juenemann K, Jansen AHP, van Riel L, Merkx R, Mulder MPC, An H, Statsyuk A, Kirstein J, Ovaa H, Reits EA,` Dynamic recruitment of ubiquitin to mutant huntingtin inclusion bodies`, Sci Rep 2018; 8:1405 (NKI) 681. Juric D, Rodon J, Tabernero J, Janku F, Burris HA, Schellens JHM, Middleton MR, Berlin J, Schuler M, Gil-Martin M, Rugo HS, Seggewiss-Bernhardt R, Huang A, Bootle D, Demanse D, Blumenstein L, Coughlin C, Quadt C, Baselga J,` Phosphatidylinositol 3-Kinase alpha-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study`, J Clin Oncol 2018; 36:1291-9 (NKI) 682. Kaaij LJT, van der Weide RH, Ketting RF, de Wit E,` Systemic Loss and Gain of Chromatin Architecture throughout Zebrafish Development`, Cell Rep 2018; 24:1-10 (NKI) 683. Kaalep, A, Sera, T, Oyen, W, Krause, BJ, Chiti, A, Liu, Y & Boellaard, R 2018, 'EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems', European Journal of Nuclear Medicine and Molecular Imaging, ;45(3): 412-422. (AmsterdamUMC) 684. Kaalep, A, Sera, T, Rijnsdorp, S, Yaqub, M, Talsma, A, Lodge, MA & Boellaard, R 2018, 'Feasibility of state of the art PET/CT systems performance harmonisation', European Journal of Nuclear Medicine and Molecular Imaging, ;45(8): 1344-1361. (AmsterdamUMC) 685. Kadouch, DJ, van Haersma de With, A, Elshot, YS, Peppelman, M, Bekkenk, MW, Wolkerstorfer, A, Eekhout, I, Prinsen, CAC & de Rie, MA 2018, 'Inter-rater and intra-rater agreement of confocal microscopy imaging in diagnosing and subtyping basal cell carcinoma', Journal of the European Academy of Dermatology and Venereology, ;32(8): 1278-1283. (AmsterdamUMC) 686. Kaijser M, van Ramshorst G, van Wagensveld B, Pierie JP,` Current Techniques of Teaching and Learning in Bariatric Surgical Procedures: A Systematic Review`, J Surg Educ 2018; 75:730-8 (NKI) 687. Kalin, B, Pijnappel, EN, van Gelder, M, Visser, O, van de Loosdrecht, AA, Ossenkoppele, GJ, Cornelissen, JJ, Dinmohamed, AG & Jongen-Lavrencic, M 2018, 'Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The Netherlands', Cancer Epidemiology, ;57: 90-96. (AmsterdamUMC) 688. Kallenberg, FGJ, Aalfs, CM, The, FO, Wientjes, CA, Depla, AC, Mundt, MW, Bossuyt, PMM & Dekker, E 2018, 'Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer', Familial cancer, ;17(3): 371-380. (AmsterdamUMC) 689. Kallenberg, FGJ, Latchford, A, Lips, NC, Aalfs, CM, Bastiaansen, BAJ, Clark, SK & Dekker, E 2018, 'Duodenal Adenomas in Patients With Multiple Colorectal Adenomas Without Germline APC or MUTYH Mutations', Diseases of the colon and rectum, ;61(1): 58-66. (AmsterdamUMC) 690. Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AM, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MF, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM,` Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: an individual patient data meta-analysis of 22 RCTs`, Psychooncology 2018; 27:1150-61 (AmsterdamUMC/NKI) 691. Kammeijer, GSM, Nouta, J, de la Rosette, JJMCH, de Reijke, TM & Wuhrer, M 2018, 'An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen', Analytical chemistry, ;90(7): 4414-4421. (AmsterdamUMC) 692. Kampen, KR, Scherpen, FJG, Mahmud, H, ter Elst, A, Mulder, AB, Guryev, V, Verhagen, HJMP, de Keersmaecker, K, Smit, L, Kornblau, SM & de Bont, ESJM 2018, 'VEGFC antibody therapy drives differentiation of AML', Cancer Research, ;78(20): 5940-5948. (AmsterdamUMC) 693. Kampshoff, CS, van Dongen, JM, van Mechelen, W, Schep, G, Vreugdenhil, A, Twisk, JWR, Bosmans, JE, Brug, J, Chinapaw, MJM & Buffart, LM 2018, 'Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors', Journal of Cancer Survivorship, ;12(3): 417-429. (AmsterdamUMC) 694. Kappelle WFW, van Leerdam ME, Schwartz MP, Bulbul M, Buikhuisen WA, Brink MA, Sie-Go DMDS, Pullens HJM, Nikolakopoulos S, van Diest PJ, Leenders M, Moons LMG, Bogte A, Siersema PD, Vleggaar FP,` Rapid on-site evaluation during endoscopic ultrasound-guided fine-needle aspiration of lymph nodes does not increase diagnostic yield: A randomized, multicenter trial`, Am J Gastroenterol 2018; 113:677-85 (NKI) 695. Karremann, M, Gielen, GH, Hoffmann, M, Wiese, M, Colditz, N, Warmuth-Metz, M, Bison, B, Claviez, A, van Vuurden, DG, von Bueren, AO, Gessi, M, Kühnle, I, Hans, VH, Benesch, M, Sturm, D, Kortmann, R- D, Waha, A, Pietsch, T & Kramm, CM 2018, 'Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location', Neuro-Oncology, ;20(1): 123-131. (AmsterdamUMC) 696. Karthaus EG, Vahl A, Kuhrij LS, Elsman BHP, Geelkerken RH, Wouters MWJM, Hamming JF, de Borst GJ,` The Dutch Audit of Carotid Interventions: Transparency in Quality of Carotid Endarterectomy in Symptomatic Patients in the Netherlands`, Eur J Vasc Endovasc Surg 2018; 56:476-85 (NKI) 697. Kas SM, de Ruiter J, Schut E, Bombardelli L, Wientjens E, Drenth AP, Korte-Grimmerink R, Mahakena S, Phillips C, Smith PD, Klarenbeek S, van de Wetering K, Berns A, Wessels LFA, Jonkers J, Schipper K,` Transcriptomics and transposon mutagenesis identify multiple mechanisms of resistance to the FGFR inhibitor AZD4547`, Cancer Res 2018; 78:5668-79 (NKI) 698. Kaspers GJL, Niewerth D, Wilhelm BAJ, Scholte-van Houtem P, Lopez-Yurda M, Berkhof J, Cloos J, de Haas V, Mathot RA, Attarbaschi A, Baruchel A, de Bont ES, Fagioli F, Rossig C, Klingebiel T, De Moerloose B, Nelken B, Palumbo G, Reinhardt D, Rohrlich PS, Simon P, von Stackelberg A, Zwaan MM,` An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia`, Br J Haematol 2018; 181:523-7 (AmsterdamUMC/NKI) 699. Kastritis, E, Leblond, V, Dimopoulos, MA, Kimby, E, Staber, P, Kersten, MJ, Tedeschi, A & Buske, C 2018, 'Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up', Annals of oncology, ;29: iv41-iv50. (AmsterdamUMC) 700. Kater, AP, Tonino, SH, Spiering, M, Chamuleau, MED, Liu, R, Adewoye, AH, Gao, J, Dreiling, L, Xin, Y, Doorduijn, JK & Kersten, MJ 2018, 'Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies', Blood cancer journal, ;8(2): 16. (AmsterdamUMC) 701. Keikes, L, van Oijen, MGH, Lemmens, VEPP, Koopman, M & Punt, CJA 2018, 'Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group', Clinical colorectal cancer, ;17(1): 58-64. (AmsterdamUMC) 702. Keizer, MP, Aarts, C, Kamp, AM, Caron, HN, van de Wetering, MD, Wouters, D & Kuijpers, TW 2018, 'Asparaginase inhibits the lectin pathway of complement activation', Molecular immunology, ;93: 189- 192. (AmsterdamUMC) 703. Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S,` Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project`, Ann Oncol 2018; 29:200-8 (AmsterdamUMC/NKI) 704. Kershaw L, van Zadelhoff L, Heemsbergen W, Pos F, van Herk M,` Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins`, Int J Radiat Oncol Biol Phys 2018; 100:68-77 (AmsterdamUMC/NKI) 705. Kersting, S, Neppelenbroek, SIM, Visser, HPJ, van Gelder, M, Levin, M-D, Mous, R, Posthuma, W, van der Straaten, HM & Kater, AP 2018, 'Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands', Clinical lymphoma, myeloma & leukemia, ;18(1): 52-57. (AmsterdamUMC) 706. Khurshed, M, Aarnoudse, N, Hulsbos, R, Hira, VVV, van Laarhoven, HWM, Wilmink, JW, Molenaar, RJ & van Noorden, CJF 2018, 'IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity', FASEB journal, ;32(11): 6344-6352. (AmsterdamUMC) 707. Kilsdonk MJ, Siesling S, van Dijk BAC, Wouters MW, van Harten WH,` What drives centralisation in cancer care? PLoS One 2018; 13:e0195673 `, (NKI) 708. King MT, Viney R, Simon Pickard A, Rowen D, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, McTaggart-Cowen H, Mercieca-Bebber R, Peacock S, Street DJ, Young TA, Norman R,` Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30`, Pharmacoeconomics 2018; 36:225-38 (NKI) 709. Kip AE, Castro MDM, Gomez MA, Cossio A, Schellens JHM, Beijnen JH, Saravia NG, Dorlo TPC,` Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships`, J Antimicrob Chemother 2018; 73:2104-11 (NKI) 710. Kip AE, Schellens JHM, Beijnen JH, Dorlo TPC,` Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs`, Clin Pharmacokinet 2018; 57:151-76 (NKI) 711. Kip AE, Wasunna M, Alves F, Schellens JHM, Beijnen JH, Musa AM, Khalil EAG, Dorlo TPC,` Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis`, Front Cell Infect Microbiol 2018; 8:181 (8 pp) (NKI) 712. Klaassen Z, Kamat AM, Kassouf W, Gontero P, Villavicencio H, Bellmunt J, van Rhijn BWG, Hartmann A, Catto JWF, Kulkarni GS,` Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations`, Eur Urol 2018; 74:597-608 (NKI) 713. Klaassen, R, Gurney-Champion, OJ, Engelbrecht, MRW, Stoker, J, Wilmink, JW, Besselink, MG, Bel, A, van Tienhoven, G, van Laarhoven, HWM & Nederveen, AJ 2018, 'Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients', International journal of radiation oncology, biology, physics, ;102(4): 1052-1062. (AmsterdamUMC) 714. Klaassen, R, Gurney-Champion, OJ, Wilmink, JW, Besselink, MG, Engelbrecht, MRW, Stoker, J, Nederveen, AJ & van Laarhoven, HWM 2018, 'Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma', Magnetic resonance imaging, ;50: 1-9. (AmsterdamUMC) 715. Klaassen, R, Larue, RTHM, Mearadji, B, van der Woude, SO, Stoker, J, Lambin, P & van Laarhoven, HWM 2018, 'Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients', PLoS ONE, ;13(11): e0207362. (AmsterdamUMC) 716. Klaver, CEL, van Huijgevoort, NCM, de Buck van Overstraeten, A, Wolthuis, AM, Tanis, PJ, van der Bilt, JDW, Sagaert, X & D'Hoore, A 2018, 'Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases', Annals of surgical oncology, ;25(1): 212-220. (AmsterdamUMC) 717. Klaver, CEL, Wasmann, KATGM, Verstegen, M, van der Bilt, JDW, Nagtegaal, ID, van Ramshorst, B, Tanis, PJ, Wolthuis, AM, van Santvoort, HC, de Wilt, JHW & D'Hoore, A 2018, 'Postoperative abdominal infections after resection of T4 colon cancer increase the risk of intra-abdominal recurrence', European journal of surgical oncology, ;44(12): 1880-1888. (AmsterdamUMC) 718. Klaver, E, van der Wel, MJ, Meijer, SL, Bergman, JJGHM & Pouw, RE 2018, 'Chapter 2: Role of pathologic confirmation for Barrett′s esophagus and dysplasia', Techniques in Gastrointestinal Endoscopy, ;20(2): 62-69. (AmsterdamUMC) 719. Klawer EME, van Houdt PJ, Pos FJ, Heijmink SWTP, van Osch MJP, van der Heide UA,` Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer`, NMR Biomed 2018; 31:e3946 (8 pp) (NKI) 720. Kleijn G, Lissenberg-Witte BI, Bohlmeijer ET, Steunenberg B, Knipscheer-Kuijpers K, Willemsen V, Becker A, Smit EF, Eeltink CM, Bruynzeel AME, van der Vorst M, De Bree R, Leemans CR, van den Brekel MWM, Cuijpers P, Verdonck-de Leeuw IM,` The efficacy of Life Review Therapy combined with Memory Specificity Training (LRT-MST) targeting cancer patients in palliative care: A randomized controlled trial`, PLoS One 2018; 13:e0197277 (AmsterdamUMC/NKI) 721. Klein Nulent TJW, Valstar MH, de Keizer B, Willems SM, Smit LA, Al Mamgani A, Smeele LE, van Es RJJ, De Bree R, Vogel WV,` Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT`, Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125:478-87 (AmsterdamUMC/NKI) 722. Klein, A, Qi, Z, Bahin, FF, Awadie, H, Nayyar, D, Ma, M, Voermans, RP, Williams, SJ, Lee, E & Bourke, MJ 2018, 'Outcomes after endoscopic resection of large laterally spreading lesions of the papilla and conventional ampullary adenomas are equivalent', Endoscopy, ;50(10): 972-983. (AmsterdamUMC) 723. Klein, AP, Wolpin, BM, Risch, HA, Stolzenberg-Solomon, RZ, Mocci, E, Zhang, M, Canzian, F, Childs, EJ, Hoskins, JW, Jermusyk, A, Zhong, J, Chen, F, Albanes, D, Andreotti, G, Arslan, AA, Babic, A, Bamlet, WR, Beane-Freeman, L, Berndt, SI, Blackford, A, Borges, M, Borgida, A, Bracci, PM, Brais, L, Brennan, P, Brenner, H, Bueno-de-Mesquita, B, Buring, J, Campa, D, Capurso, G, Cavestro, GM, Chaffee, KG, Chung, CC, Cleary, S, Cotterchio, M, Dijk, F, Duell, EJ, Foretova, L, Fuchs, C, Funel, N, Gallinger, S, M Gaziano, JM, Gazouli, M, Giles, GG, Giovannucci, E, Goggins, M, Goodman, GE, Goodman, PJ, Hackert, T, Haiman, C, Hartge, P, Hasan, M, Hegyi, P, Helzlsouer, KJ, Herman, J, Holcatova, I, Holly, EA, Hoover, R, Hung, RJ, Jacobs, EJ, Jamroziak, K, Janout, V, Kaaks, R, Khaw, K-T, Klein, EA, Kogevinas, M, Kooperberg, C, Kulke, MH, Kupcinskas, J, Kurtz, RJ, Laheru, D, Landi, S, Lawlor, RT, Lee, I-M, Lemarchand, L, Lu, L, Malats, N, Mambrini, A, Mannisto, S, Milne, RL, Mohelníková-Duchoňová, B, Neale, RE, Neoptolemos, JP, Oberg, AL, Olson, SH, Orlow, I, Pasquali, C, Patel, AV, Peters, U, Pezzilli, R, Porta, M, Real, FX, Rothman, N, Scelo, G, Sesso, HD, Severi, G, Shu, X-O, Silverman, D, Smith, JP, Soucek, P, Sund, M, Talar-Wojnarowska, R, Tavano, F, Thornquist, MD, Tobias, GS, van den Eeden, SK, Vashist, Y, Visvanathan, K, Vodicka, P, Wactawski-Wende, J, Wang, Z, Wentzensen, N, White, E, Yu, H, Yu, K, Zeleniuch-Jacquotte, A, Zheng, W, Kraft, P, Li, D, Chanock, S, Obazee, O, Petersen, GM & Amundadottir, LT 2018, 'Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer', Nature communications, ;9(1): 556. (AmsterdamUMC) 724. Klein, K, de Haas, V & Kaspers, GJL 2018, 'Clinical challenges in de novo pediatric acute myeloid leukemia', Expert Review of Anticancer Therapy, ;18(3): 277-293. (AmsterdamUMC) 725. Klein, K, Hasle, H, Abrahamsson, J, de Moerloose, B & Kaspers, GJL 2018, 'Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin–Frankfürt–Münster (I-BFM) study group', British Journal of Haematology, ;183(1): 87-95. (AmsterdamUMC) 726. KleinJan GH, van Werkhoven E, van den Berg NS, Karakullukcu MB, Zijlmans HJMA, van der Hage JA, van de Wiel BA, Buckle T, Klop WMC, Horenblas S, Valdes Olmos RA, van der Poel HG, van Leeuwen FWB,` The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes`, Eur J Nucl Med Mol Imaging 2018; 45:1915-25 (NKI) 727. Klompmaker, S & Besselink, MG 2018, 'ASO Author Reflections: Distal Pancreatectomy with Celiac Axis Resection for Locally Advanced Pancreatic Cancer—Patient Selection and Surgical Experience are Key', Annals of surgical oncology, ;25(3): 828-829. (AmsterdamUMC) 728. Klompmaker, S, Boggi, U, Hackert, T, Salvia, R, Weiss, M, Yamaue, H, Zeh, HJ & Besselink, MG 2018, 'Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer. How I do It', Journal of gastrointestinal surgery, ;22(10): 1804-1810. (AmsterdamUMC) 729. Kloth JSL, Verboom MC, Swen JJ, van der Straaten T, Sleijfer S, Reyners AKL, Steeghs N, Gelderblom H, Guchelaar HJ, Mathijssen RHJ,` Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib`, Pharmacogenomics J 2018; 18:49-55 (NKI) 730. Kluin RJC, Kemper K, Kuilman T, de Ruiter JR, Iyer V, Forment JV, Cornelissen-Steijger P, de R, I, Ter Brugge P, , Song JY, Klarenbeek S, McDermott U, Jonkers J, Velds A, Adams DJ, Peeper DS, Krijgsman O,``, BMC Bioinformatics 2018; 19:366 {15 pp) (NKI) 731. Kobe, C, Goergen, H, Baues, C, Kuhnert, G, Voltin, C-A, Zijlstra, J, Hoekstra, O, Mettler, J, Drzezga, A, Engert, A, Borchmann, P & Dietlein, M 2018, 'Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma', Blood, ;132(21): 2273-2279. (AmsterdamUMC) 732. Koch, C, Schwing, AM, Herrmann, E, Borner, M, Diaz-Rubio, E, Dotan, E, Feliu, J, Okita, N, Souglakos, J, Arkenau, HT, Porschen, R, Koopman, M, Punt, CJA, de Gramont, A, Tournigand, C, Zeuzem, S & Trojan, J 2018, 'Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: An individual patient data based meta-analysis', Oncotarget, ;9(12): 10272-10283. (AmsterdamUMC) 733. Koedam, TWA, Veltcamp Helbach, M, van de Ven, PM, Kruyt, PM, van Heek, NT, Bonjer, HJ, Tuynman, JB & Sietses, C 2018, 'Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve', Techniques in Coloproctology, ;22(4): 279-287. (AmsterdamUMC) 734. Koenis DS, Medzikovic L, van Loenen PB, van Weeghel M, Huveneers S, Vos M, Evers-van Gogh IJ, Van den Bossche J, Speijer D, Kim Y, Wessels L, Zelcer N, Zwart W, Kalkhoven E, de Vries CJ,` Nuclear Receptor Nur77 Limits the Macrophage Inflammatory Response through Transcriptional Reprogramming of Mitochondrial Metabolism`, Cell Rep 2018; 24:2127-40 (NKI) 735. Koens, L, van de Ven, PM, Hijmering, NJ, Kersten, MJ, Diepstra, A, Chamuleau, M & de Jong, D 2018, 'Interobserver variation in CD30 immunohistochemistry interpretation;(): (AmsterdamUMC) 736. Köhle, N, Drossaert, CHC, Van Uden-Kraan, CF, Schreurs, KMG, Hagedoorn, M, Verdonck-de Leeuw, IM & Bohlmeijer, ET 2018, 'Intent to use a web-based psychological intervention for partners of cancer patients: Associated factors and preferences', Journal of Psychosocial Oncology, ;36(2): 203-221. (AmsterdamUMC) 737. Koitsalu, M, Eklund, M, Adolfsson, J, Sprangers, MAG, Grönberg, H & Brandberg, Y 2018, 'Predictors of participation in risk-based prostate cancer screening', PLoS ONE, ;13(7): e0200409. (AmsterdamUMC) 738. Kok, HP, Korshuize-van Straten, L, Bakker, A, de Kroon–Oldenhof, R, Westerveld, GH, Versteijne, E, Stalpers, LJA & Crezee, J 2018, 'Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia', International journal of hyperthermia, ;34(7): 1082-1091. (AmsterdamUMC) 739. Kok, HP, Navarro, F, Strigari, L, Cavagnaro, M & Crezee, J 2018, 'Locoregional hyperthermia of deep- seated tumours applied with capacitive and radiative systems: a simulation study', International journal of hyperthermia, ;34(6): 714-730. (AmsterdamUMC) 740. Kok, HP, Schooneveldt, G, Bakker, A, de Kroon-Oldenhof, R, Korshuize-van Straten, L, de Jong, CE, Steggerda-Carvalho, E, Geijsen, ED, Stalpers, LJA & Crezee, J 2018, 'Predictive value of simulated SAR and temperature for changes in measured temperature after phase-amplitude steering during locoregional hyperthermia treatments', International journal of hyperthermia, ;35(1): 330-339. (AmsterdamUMC) 741. Koldenhof JJ, Lankheet NAG, Steeghs N, Teunissen SCCM, Witteveen PO,` Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study`, Support Care Cancer 2018; 26:2641-50 (NKI) 742. Kolluri KK, Alifrangis C, Kumar N, Ishii Y, Price S, Michaut M, Williams S, Barthorpe S, Lightfoot H, Busacca S, Sharkey A, Yuan Z, Sage EK, Vallath S, Le Quesne J, Tice DA, Alrifai D, von Karstedt S, Montinaro A, Guppy N, Waller DA, Nakas A, Good R, Holmes A, Walczak H, Fennell DA, Garnett M, Iorio F, Wessels L, McDermott U, Janes SM,` Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells`, Elife 2018;e30224 (23 pp) [Comment] (NKI) 743. Komen MMC, van den Hurk CJG, Nortier JWR, van der Ploeg T, Smorenburg CH, van der Hoeven JJM,` Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia`, Eur J Oncol Nurs 2018; 33:49-55 (NKI) 744. Komor MA, Bosch LJ, Bounova G, Bolijn AS, Delis-Van Diemen PM, Rausch C, Hoogstrate Y, Stubbs AP, de Jong M, Jenster G, van Grieken NC, Carvalho B, Wessels LFA, Jimenez CR, Fijneman RJ, Meijer GA,` Consensus molecular subtype classification of colorectal adenomas`, J Pathol 2018; 246:266-76 (NKI) 745. Konert T, van de Kamer JB, Sonke JJ, Vogel WV,` The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer`, J Thorac Dis 2018; 10:S2508-S2521 (NKI) 746. Kooij L, Groen WG, van Harten WH,` Barriers and Facilitators Affecting Patient Portal Implementation from an Organizational Perspective: Qualitative Study`, J Med Internet Res 2018; 20:e183 (NKI) 747. Koopman, T, Verburg, N, Schuit, RC, Pouwels, PJW, Wesseling, P, Windhorst, AD, Hoekstra, OS, de Witt Hamer, PC, Lammertsma, AA, Boellaard, R & Yaqub, M 2018, 'Quantification of O-(2-[18F]fluoroethyl)- L-tyrosine kinetics in glioma', EJNMMI Research, ;8( 72. ): (AmsterdamUMC) 748. Korthout T, Poramba-Liyanage DW, van Kruijsbergen I, Verzijlbergen KF, van Gemert FPA, van Welsem T, van Leeuwen F,` Decoding the chromatin proteome of a single genomic locus by DNA sequencing`, PLoS Biol 2018; 16:e2005542 (NKI) 749. Kostine M, Briaire-de Bruijn IH, Cleven AHG, Vervat C, Corver WE, Schilham MW, Van Beelen E, van Boven H, Haas RL, Italiano A, Cleton-Jansen AM, Bovee JVMG,` Increased infiltration of M2- macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies`, Oncoimmunology 2018; 7:e1386828-(10 pp) (NKI) 750. Kovtun, Y, Noordhuis, P, Whiteman, KR, Watkins, K, Jones, GE, Harvey, L, Lai, KC, Portwood, S, Adams, S, Sloss, CM, Schuurhuis, GJ, Ossenkoppele, G, Wang, ES & Pinkas, J 2018, 'IMGN779, a Novel CD33- targeting antibody–drug conjugate with DNA-alkylating activity, exhibits potent antitumor activity in models of AML', Molecular Cancer Therapeutics, ;17(6): 1271-1279. (AmsterdamUMC) 751. Kozlovski I, Agami R,` Queuing up the ribosome: nutrition and the microbiome control protein synthesis`, EMBO J 2018; 37:e100405 [News & Views] (NKI) 752. Kramer, GM, Hoekstra, OS & Boellaard, R 2018, 'Reply: Should we assess repeatability of PET quantitative uptake measurements of each 18F-labelled tracer?', European Journal of Nuclear Medicine and Molecular Imaging, ;45(7): 1274-1275. (AmsterdamUMC) 753. Kramer, GM, Liu, Y, de Langen, AJ, Jansma, EP, Trigonis, I, Asselin, MC, Jackson, A, Kenny, L, Aboagye, EO, Hoekstra, OS, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, 'Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis', European Journal of Nuclear Medicine and Molecular Imaging, ;45(6): 951-961. (AmsterdamUMC) 754. Krayenbuehl, J, Zamburlini, M, Ghandour, S, Pachoud, M, Lang-Tanadini, S, Tol, J, Guckenberger, M & Verbakel, WFAR 2018, 'Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer', Radiation Oncology, ;13(1): 170. (AmsterdamUMC) 755. Kremer, MEB, Althof, JF, Derikx, JPM, van Baren, R, Heij, HA, Wijnen, MHWA, Wijnen, RMH, van der Zee, DC & van Heurn, LWE 2018, 'The incidence of associated abnormalities in patients with sacrococcygeal teratoma', Journal of Pediatric Surgery, ;53(10): 1918-1922. (AmsterdamUMC) 756. Kremer, WW, van Zummeren, M, Heideman, DAM, Lissenberg-Witte, BI, Snijders, PJF, Steenbergen, RDM, Dreyer, G & Meijer, CJLM 2018, 'HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV', International Journal of Molecular Sciences, ;19( 11. ): (AmsterdamUMC) 757. Krikken, E, Khlebnikov, V, Zaiss, M, Jibodh, RA, van Diest, PJ, Luijten, PR, Klomp, DWJ, van Laarhoven, HWM & Wijnen, JP 2018, 'Amide chemical exchange saturation transfer at 7T: A possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients', Breast cancer research, ;20(1): 51. (AmsterdamUMC) 758. Kruger DT, Beelen KJ, Opdam M, Sanders J, van der Noort, V, Boven E, Linn SC,` Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences`, Br J Cancer 2018; 119:832-9 AmsterdamUMC/(NKI) 759. Kruis, RWJ, Schouten-van Meeteren, AYN, Finken, MJJ, Oostdijk, W, van Trotsenburg, ASP, Boot, AM, Claahsen-van der Grinten, HL, van Lindert, EJ, Han, KS, Hoving, EW, Michiels, EMC & van Santen, HM 2018, 'Management and consequences of postoperative fluctuations in plasma sodium concentration after pediatric brain tumor surgery in the sellar region: a national cohort analysis', Pituitary, ;21(4): 384-392. (AmsterdamUMC) 760. Kruizinga, R, Jafari, N, Scherer-Rath, M, Schilderman, H, Bires, J, Puchalski, C & van Laarhoven, H 2018, 'Relating to the experience of contingency in patients with advanced cancer;(): (AmsterdamUMC) 761. Krul IM, Opstal-van Winden AWJ, Janus CPM, Daniels LA, Appelman Y, Maas AHEM, de Vries S, Jozwiak K, Aleman BMP, van Leeuwen FE,` Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma`, J Am Coll Cardiol 2018; 72:3374-5 [Letter] (NKI) 762. Krul IM, Opstal-van Winden AWJ, Zijlstra JM, Appelman Y, Schagen SB, Meijboom LJ, Serne E, Lambalk CB, Lips P, van Dulmen-den Broeder E, Hauptmann M, Daniels LA, Aleman BMP, van Leeuwen FE,` Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA)`, BMJ Open 2018; 8:e018120 (AmsterdamUMC/NKI) 763. Kudchadkar RR, Michielin O, van Akkooi ACJ,` Practice-Changing Developments in Stage III Melanoma: Surgery, Adjuvant Targeted Therapy, and Immunotherapy`, Am Soc Clin Oncol Educ Book 2018;759-62 (NKI) 764. Kuipers AJ, Middelbeek J, Vrenken K, Perez-Gonzalez C, Poelmans G, Klarenbeek J, Jalink K, Trepat X, van Leeuwen FN,` TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4`, Biochim Biophys Acta - Mol Basis Dis 2018; 1864:2409-19 (NKI) 765. Künzli, HT, Belghazi, K, Pouw, RE, Meijer, SL, Seldenrijk, CA, Weusten, BLAM & Bergman, JJGHM 2018, 'Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma', United European gastroenterology journal, ;6(5): 669-677. (AmsterdamUMC) 766. Kurilova I, Beets-Tan RGH, Ulaner GA, Boas FE, Petre EN, Yarmohammadi H, Ziv E, Deipolyi AR, Brody LA, Gonen M, Sofocleous CT,` (90)Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material`, Cardiovasc Intervent Radiol 2018; 41:1419-27 (NKI) 767. Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, Erinjeri J, Petre EN, Gonen M, Bains M, Kemeny NE, Solomon SB, Sofocleous CT,` Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases`, Cardiovasc Intervent Radiol 2018; 41:1530-44 (NKI) 768. Kurk, SA, Peeters, PHM, Dorresteijn, B, de Jong, PA, Jourdan, M, Kuijf, HJ, Punt, CJA, Koopman, M & May, AM 2018, 'Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients', JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, ;9(5): 909- 919. (AmsterdamUMC) 769. Kuusk T, De Bruijn R, Brouwer OR, de Jong J, Donswijk M, Hendricksen K, Horenblas S, Jozwiak K, Prevoo W, Valdes Olmos RA, van der Poel HG, van Rhijn BW, Wit EM, Bex A,` Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma`, Scand J Urol 2018; 52:411-8 (AmsterdamUMC/NKI) 770. Kuusk T, Donswijk ML, Valdes Olmos RA, De Bruijn RE, Brouwer OR, Hendricksen K, Horenblas S, Jozwiak K, Prevoo W, van der Poel HG, van Rhijn BWG, Wit EM, Bex A,` An analysis of SPECT/CT non- visualization of sentinel lymph nodes in renal tumors`, EJNMMI Res 2018; 8:105 (NKI) 771. Kvistborg P, Yewdell JW,` Enhancing responses to cancer immunotherapy`, Science 2018; 359:516-7 [Comment] (NKI) 772. Kwakman JJM, Vink G, Vestjens JH, Beerepoot LV, de Groot JW, Jansen RL, Opdam FL, Boot H, Creemers GJ, van Rooijen JM, Los M, Vulink AJE, Schut H, van Meerten E, Baars A, Hamberg P, Kapiteijn E, Sommeijer DW, Punt CJA, Koopman M,` Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands`, Int J Clin Oncol 2018; 23:482-9 (AmsterdamUMC/NKI) 773. La Fontaine M, Vogel W, van Diessen J, Van Elmpt W, Reymen B, Persson G, Westman G, De Ruysscher D, Belderbos J, Sonke JJ,` A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC`, Radiother Oncol 2018; 127:259-66 (NKI) 774. La Fortezza M, Grigolon G, Cosolo A, Pinduyrin A, Breimann L, Blum H, van Steensel B, Classen AK,` DamID profiling of dynamic Polycomb-binding sites in Drosophila imaginal disc development and tumorigenesis`, Epigenetics Chromatin 2018; 11:27 (NKI) 775. Labeur, TA, ten Cate, DWG, Bart Takkenberg, R, Azahaf, H, van Oijen, MGH, van Delden, OM, de Man, RA, van Vugt, JLA, IJzermans, JNM, Eskens, FALM & Klümpen, H-J 2018, 'Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma', Acta oncologica (Stockholm, Sweden), ;57(11): 1467-1474. (AmsterdamUMC) 776. Labots M, Van der Mijn JC, Dekker H, Ruijter R, Pham TV, van der Vliet HJ, van der Hoeven JJM, Meijer GA, Verheul HMW,` Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study`, Oncologist 2018; 23:1135-e118 (NKI) 777. Lacroix R, Rozeman EA, Kreutz M, Renner K, Blank CU,` Targeting tumor-associated acidity in cancer immunotherapy`, Cancer Immunol Immunother 2018; 67:1331-48 (NKI) 778. Lagarde, SM, Anderegg, MCJ, Gisbertz, SS, Meijer, SL, Hulshof, MCCM, Bergman, JJGHM, van Laarhoven, HWM & Henegouwen, MIVB 2018, 'Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery', Journal of thoracic disease, ;10(3): 1511-1521. (AmsterdamUMC) 779. Lagerwaard, F, Bohoudi, O, Tetar, S, Admiraal, MA, Rosario, TS & Bruynzeel, A 2018, 'Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery', Cureus, ;10(4): e2434. (AmsterdamUMC) 780. Lagerweij, T, Pérez-Lanzón, M & Baglio, SR 2018, 'A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells', Journal of Visualized Experiments, no. 135. (AmsterdamUMC) 781. Laguna, MP 2018, 'Re: A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma', Journal of urology, ;200(5): 941-942. (AmsterdamUMC) 782. Laguna, MP 2018, 'Re: Patients' Preferences for Adjuvant Sorafenib after Resection of Renal Cell Carcinoma in the SORCE Trial: What Makes it Worthwhile?', Journal of urology, ;200(3): 494-496. (AmsterdamUMC) 783. Laguna, MP 2018, 'Re: Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-Based Analysis', Journal of urology, ;200(3): 495-496. (AmsterdamUMC) 784. Lam SW, van der Noort V, van der Straaten T, Honkoop AH, Peters GJ, Guchelaarc HJ, Boven E,` Single- nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer`, Pharmacol Res 2018; 128:122-9 (AmsterdamUMC/NKI) 785. Lambregts DMJ, Yassien AB, Lahaye MJ, Betgen A, Maas M, Beets GL, van der Heide UA, van Triest B, Beets-Tan RGH,` Monitoring early changes in rectal tumor morphology and volume during 5weeks of preoperative chemoradiotherapy - An evaluation with sequential MRIs`, Radiother Oncol 2018; 126:431-6 (NKI) 786. Lancee, M, Tikkinen, KAO, de Reijke, TM, Kataja, VV, Aben, KKH & Vernooij, RWM 2018, 'Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer', BJU international, ;122(4): 535-548. (AmsterdamUMC) 787. Landier, W, Skinner, R, Wallace, WH, Hjorth, L, Mulder, RL, Wong, FL, Yasui, Y, Bhakta, N, Constine, LS, Bhatia, S, Kremer, LC & Hudson, MM 2018, 'Surveillance for late effects in childhood cancer survivors', Journal of clinical oncology, ;36(21): 2216-2222. (AmsterdamUMC) 788. Langendijk, JA, Boersma, LJ, Rasch, CRN, van Vulpen, M, Reitsma, JB, van der Schaaf, A & Schuit, E 2018, 'Clinical Trial Strategies to Compare Protons With Photons', Seminars in radiation oncology, ;28(2): 79-87. (AmsterdamUMC) 789. Langhout GC, Bydlon TM, van der Voort M, Muller M, Kortsmit J, Lucassen G, Balthasar AJR, van Geffen GJ, Steinfeldt T, Sterenborg HJCM, Hendriks BHW, Ruers TJM,` Nerve detection using optical spectroscopy, an evaluation in four different models: In human and swine, in-vivo, and post mortem`, Lasers Surg Med 2018; 50:253-61 (NKI) 790. Langhout GC, Kuhlmann KFD, Schreuder P, Bydlon T, Smeele LE, van den Brekel MWM, Sterenborg HJCM, Hendriks BHW, Ruers TJM,` In vivo nerve identification in head and neck surgery using diffuse reflectance spectroscopy`, Laryngoscope Investig Otolaryngol 2018; 3:349-55 (NKI) 791. Langhout GC, Kuhlmann KFD, Wouters MWJM, van der Hage JA, van Coevorden F, Muller M, Bydlon TM, Sterenborg HJCM, Hendriks BHW, Ruers TJM,` Nerve detection during surgery: optical spectroscopy for peripheral nerve localization`, Lasers Med Sci 2018; 33:619-25 (NKI) 792. Lansaat L, De Kleijn B, Hilgers F, Van der Laan B, van den Brekel M,` Comparative Study Between Peristomal Patches in Patients with Definitive Tracheostomy`, Int Arch Otorhinolaryngol 2018; 22:130- 5 (NKI) 793. Lansaat L, van der Noort V, Bernard SE, Eerenstein SEJ, Plaat BEC, Langeveld TAPM, Lacko M, Hilgers FJM, De Bree R, Takes RP, van den Brekel MWM,` Predictive factors for pharyngocutaneous fistulization after total laryngectomy: a Dutch Head and Neck Society audit`, Eur Arch Otorhinolaryngol 2018; 275:783-94 (NKI) 794. Lansdorp-Vogelaar I, Goede SL, Bosch LJW, Melotte V, Carvalho B, van Engeland M, Meijer GA, de Koning HJ, van Ballegooijen M,` Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Non-Invasive Colorectal Cancer Screening`, Clin Gastroenterol Hepatol 2018; 16:504-12 (NKI) 795. Lansu J, Klop WM, Heemsbergen W, Navran A, Al Mamgani A, Langendijk JA, Kaanders JH, Terhaard C, Karakullukcu B, Hamming-Vrieze O,` Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy`, Head Neck 2018; 40:86-93 (NKI) 796. Larkin J, Brown MP, Arance AM, Hauschild A, Queirolo P, Vecchio MD, Ascierto PA, Krajsova I, Schachter J, Neyns B, Garbe C, Sileni VC, Mandala M, Gogas H, Espinosa E, Hospers G, Lorigan P, Nyakas M, Guminski A, Liszkay G, Rutkowski P, Miller W, Jr , Donica M, Makrutzki M, Blank C,``, Eur J Cancer 2018; 107:175-85 (NKI) 797. Larocca, A, Dold, SM, Zweegman, S, Terpos, E, Wäsch, R, D’Agostino, M, Scheubeck, S, Goldschmidt, H, Gay, F, Cavo, M, Ludwig, H, Straka, C, Bringhen, S, Auner, HW, Caers, J, Gramatzki, M, Offidani, M, Dimopoulos, MA, Einsele, H, Boccadoro, M, Sonneveld, P & Engelhardt, M 2018, 'Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)', Leukemia, ;32(8): 1697-1712. (AmsterdamUMC) 798. Larue, RTHM, Klaassen, R, Jochems, A, Leijenaar, RTH, Hulshof, MCCM, van Berge Henegouwen, MI, Schreurs, WMJ, Sosef, MN, van Elmpt, W, van Laarhoven, HWM & Lambin, P 2018, 'Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer', Acta oncologica (Stockholm, Sweden), ;57(11): 1475-1481. (AmsterdamUMC) 799. Lazzari, C, Gregorc, V, Cangi, MG, Giovannetti, E, Bulotta, A & Santarpia, M 2018, 'Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer', Journal of Thoracic Disease, ;10: S4023-S4027. (AmsterdamUMC) 800. le, CT, Leenders, WPJ, Molenaar, RJ & van Noorden, CJF 2018, 'Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature', Nutrition and cancer, ;70(3): 317-333. (AmsterdamUMC) 801. Leahy, R, Boellaard, R & Zaidi, H 2018, 'Whole-body parametric PET imaging will replace conventional image-derived PET metrics in clinical oncology', Medical Physics, ;45(12): 5355-5358. (AmsterdamUMC) 802. Lecouvet, FE, Oprea-Lager, DE, Liu, Y, Ost, P, Bidaut, L, Collette, L, Deroose, CM, Goffin, K, Herrmann, K, Hoekstra, OS, Kramer, G, Lievens, Y, Lopci, E, Pasquier, D, Petersen, LJ, Talbot, J-N, Zacho, H, Tombal, B & deSouza, NM 2018, 'Use of modern imaging methods to facilitate trials of metastasis- directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group', Lancet Oncology, ;19(10): e534-e545. (AmsterdamUMC) 803. Lee, C-C, Trifiletti, DM, Sahgal, A, DeSalles, A, Fariselli, L, Hayashi, M, Levivier, M, Ma, L, Álvarez, RM, Paddick, I, Regis, J, Ryu, S, Slotman, B & Sheehan, J 2018, 'Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline: A Systematic Review', Neurosurgery, ;83(6): 1128-1142. (AmsterdamUMC) 804. Lee, W, Nanou, A, Rikkert, L, Coumans, FAW, Otto, C, Terstappen, LWMM & Offerhaus, HL 2018, 'Label-Free Prostate Cancer Detection by Characterization of Extracellular Vesicles Using Raman Spectroscopy', Analytical chemistry, ;90(19): 11290-11296. (AmsterdamUMC) 805. Leeman, A, Ebisch, RMF, Kasius, A, Bosgraaf, RP, Jenkins, D, van de Sandt, MM, de Strooper, LMA, Heideman, DAM, Snijders, PJF, Massuger, LFAG, Bekkers, RLM, Meijer, CJLM, van Kemenade, FJ, Quint, WGV & Melchers, WJG 2018, 'Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124- 2 methylation', Gynecologic Oncology, ;151(2): 311-318. (AmsterdamUMC) 806. Leemans, CR, Snijders, PJF & Brakenhoff, RH 2018, 'The molecular landscape of head and neck cancer', Nature Reviews Cancer, ;18(5): 269-282. (AmsterdamUMC) 807. Leensen, MCJ, Groeneveld, IF, Rejda, T, Groenenboom, P, van Berkel, S, Brandon, T, de Boer, AGEM & Frings-Dresen, MHW 2018, 'Feasibility of a multidisciplinary intervention to help cancer patients return to work', European journal of cancer care, ;27(2): e12690. (AmsterdamUMC) 808. Leermakers, L, Döking, S, Thewes, B, Braamse, AMJ, Gielissen, MFM, de Wilt, JHW, Collette, EH, Dekker, J & Prins, JB 2018, 'Study protocol of the CORRECT multicenter trial: The efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors', BMC cancer, ;18(1): 748. (AmsterdamUMC) 809. Leijenaar, RTH, Bogowicz, M, Jochems, A, Hoebers, FJP, Wesseling, FWR, Huang, SH, Chan, B, Waldron, JN, O'Sullivan, B, Rietveld, D, Leemans, CR, Brakenhoff, RH, Riesterer, O, Tanadini-Lang, S, Guckenberger, M, Ikenberg, K & Lambin, P 2018, 'Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study', British Journal of Radiology, ;91( 1086. ): (AmsterdamUMC) 810. Leijtens, JWA, Koedam, TWA, Borstlap, WAA, Maas, M, Doornebosch, PG, Karsten, TM, Derksen, EJ, Stassen, LPS, Rosman, C, de Graaf, EJR, Bremers, AJA, Heemskerk, J, Beets, GL, Tuynman, JB & Rademakers, KLJ 2018, 'Transanal Endoscopic Microsurgery with or without Completion Total Mesorectal Excision for T2 and T3 Rectal Carcinoma', Digestive Surgery, ;36(1): 76-82. (AmsterdamUMC) 811. Leite de Oliveira R, Bernards R,` Anti-cancer therapy: senescence is the new black`, EMBO J 2018; 37:e99386 [News & Views] (NKI) 812. Leite de Oliveira R, Wang L, Bernards R,` With great power comes great vulnerability`, Mol Cell Oncol 2018; 5:e1509488 (3 pp) (NKI) 813. Lenos, KJ, Miedema, DM, Lodestijn, SC, Nijman, LE, van den Bosch, T, Romero Ros, X, Lourenço, FC, Lecca, MC, van der Heijden, M, van Neerven, SM, van Oort, A, Leveille, N, Adam, RS, de Sousa e Melo, F, Otten, J, Veerman, P, Hypolite, G, Koens, L, Lyons, SK, Stassi, G, Winton, DJ, Medema, JP, Morrissey, E, Bijlsma, MF & Vermeulen, L 2018, 'Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer', Nature cell biology, ;20(10): 1193-1202. (AmsterdamUMC) 814. Letovanec I, Finn S, Zygoura P, Smyth P, Soltermann A, Bubendorf L, Speel EJ, Marchetti A, Nonaka D, Monkhorst K, Hager H, Martorell M, Sejda A, Cheney R, Hernandez-Losa J, Verbeken E, Weder W, Savic S, Di Lorito A, Navarro A, Felip E, Warth A, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dienemann H, Dziadziuszko R, Vansteenkiste J, O'Brien C, Geiger T, Sherlock J, Schageman J, Dafni U, Kammler R, Kerr K, Thunnissen E, Stahel R, Peters S,` Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: Results from the ETOP Lungscape Project`, J Thorac Oncol 2018; 13:413-25 (NKI) 815. Leusink FK, Koudounarakis E, Frank MH, Koole R, van Diest PJ, Willems SM,` Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma`, BMC Cancer 2018; 18:385 (NKI) 816. Lew, J-B, St John, DJB, Macrae, FA, Emery, JD, Ee, HC, Jenkins, MA, He, E, Grogan, P, Caruana, M, Greuter, MJ, Coupe, VMH & Canfell, K 2018, 'Benefits, harms and cost-effectiveness of potential age- extensions to the National Bowel Cancer Screening Program in Australia', Cancer Epidemiology Biomarkers and Prevention, ;27(12): 1450-1461. (AmsterdamUMC) 817. Lew, J-B, St John, DJB, Macrae, FA, Emery, JD, Ee, HC, Jenkins, MA, He, E, Grogan, P, Caruana, M, Sarfati, D, Greuter, MJE, Coupé, VMH & Canfell, K 2018, 'Evaluation of the benefits, harms and cost- effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia', International Journal of Cancer, ;143(2): 269-282. (AmsterdamUMC) 818. Li J, Svilar D, McClellan S, Kim JH, Ahn EE, Vens C, Wilson DM, III, Sobol RW,` DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacity`, Oncotarget 2018; 9:31719-43 (NKI) 819. Li L, van Breugel PC, Loayza-Puch F, Pineiro Ugalde A, Korkmaz G, Messika-Gold N, Han R, Lopes R, Barbera EP, Teunissen H, de Wit E, Soares RJ, Nielsen BS, Holmstrom K, Martinez-Herrera DJ, Huarte M, Louloupi A, Drost J, Elkon R, Agami R,` LncRNA-OIS1 regulates DPP4 activation to modulate senescence induced by RAS`, Nucleic Acids Res 2018; 46:4213-27 (NKI) 820. Li W, Sparidans RW, Wang Y, Lebre MC, Beijnen JH, Schinkel AH,` P-glycoprotein and Breast Cancer Resistance Protein restrict brigatinib brain accumulation and toxicity, and, alongside CYP3A, limit its oral availability`, Pharmacol Res 2018; 137:47-55 (AmsterdamUMC/NKI) 821. Li, RE, van Vliet, SJ & van Kooyk, Y 2018, 'Using the glycan toolbox for pathogenic interventions and glycan immunotherapy', Current opinion in biotechnology, ;51: 24-31. (AmsterdamUMC) 822. Li, Y, Gong, D, Zhang, L, Li, H, Zhang, S, Zhang, J, Li, K, Zheng, QW, Zhao, G, Zhang, Y, Chen, Y, Guo, Y, Xiang, R, Lin, P & Wei, Y 2018, 'Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription', Cell death & disease, ;9(12): 1162. (AmsterdamUMC) 823. Liegl G, Petersen MA, Groenvold M, Aaronson NK, Costantini A, Fayers PM, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M, Nolte S,` Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core`, Eur J Cancer 2018; 107:133-41 (NKI) 824. Liem, EIML, Freund, JE, Baard, J, de Bruin, DM, Laguna Pes, MP, Savci-Heijink, CD, van Leeuwen, TG, de Reijke, TM & de La Rosette, JJMCH 2018, 'Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies', JMIR research protocols, ;7(2): e34. (AmsterdamUMC) 825. Liem, EIML, McCormack, M, Chan, ESY, Matsui, Y, Geavlete, P, Choi, YD, de Reijke, TM, Farahat, Y, Inman, BA, de la Rosette, JJMCH & Naito, S 2018, 'Monopolar vs. bipolar transurethral resection for non–muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial', Urologic oncology, ;36(7): 338.e1-338.e11. (AmsterdamUMC) 826. Lijftogt N, Karthaus EG, Vahl A, van Zwet EW, van der Willik EM, Tollenaar RAEM, Hamming JF, Wouters MWJM,` Failure to Rescue - a Closer Look at Mortality Rates Has No Added Value for Hospital Comparisons but Is Useful for Team Quality Assessment in Abdominal Aortic Aneurysm Surgery in The Netherlands`, Eur J Vasc Endovasc Surg 2018; 56:652-61 (NKI) 827. Lin, W, Yip, YL, Jia, L, Deng, W, Zheng, H, Dai, W, Ko, JMY, Lo, KW, Chung, GTY, Yip, KY, Lee, S-D, Kwan, JS-H, Zhang, J, Liu, T, Chan, JY-W, Kwong, DL-W, Lee, VH-F, Nicholls, JM, Busson, P, Liu, X, Chiang, AKS, Hui, KF, Kwok, H, Cheung, ST, Cheung, YC, Chan, CK, Li, B, Cheung, AL-M, Hau, PM, Zhou, Y, Tsang, CM, Middeldorp, J, Chen, H, Lung, ML & Tsao, SW 2018, 'Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma', Nature Communications, ;9(1): 4663. (AmsterdamUMC) 828. Lind, A, Siersema, PD, Kusters, JG, Konijn, T, Mebius, RE & Koenderman, L 2018, 'The microenvironment in Barrett's esophagus tissue is characterized by high FOXP3 and RALDH2 levels', Frontiers in Immunology, ;9: 1375. (AmsterdamUMC) 829. Lindeman, NI, Cagle, PT, Aisner, DL, Arcila, ME, Beasley, MB, Bernicker, EH, Colasacco, C, Dacic, S, Hirsch, FR, Kerr, K, Kwiatkowski, DJ, Ladanyi, M, Nowak, JA, Sholl, L, Temple-Smolkin, R, Solomon, B, Souter, LH, Thunnissen, E, Tsao, MS, Ventura, CB, Wynes, MW & Yatabe, Y 2018, 'Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology', The Journal of molecular diagnostics, ;20(2): 129-159. (AmsterdamUMC) 830. Lindeman, NI, Cagle, PT, Aisner, DL, Arcila, ME, Beasley, MB, Bernicker, EH, Colasacco, C, Dacic, S, Hirsch, FR, Kerr, K, Kwiatkowski, DJ, Ladanyi, M, Nowak, JA, Sholl, L, Temple-Smolkin, R, Solomon, B, Souter, LH, Thunnissen, E, Tsao, MS, Ventura, CB, Wynes, MW & Yatabe, Y 2018, 'Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology', Journal of Thoracic Oncology, ;13(3): e33-e34. (AmsterdamUMC) 831. Lindeman, NI, Cagle, PT, Aisner, DL, Arcila, ME, Beasley, MB, Bernicker, EH, Colasacco, C, Dacic, S, Hirsch, FR, Kerr, K, Kwiatkowski, DJ, Ladanyi, M, Nowak, JA, Sholl, L, Temple-Smolkin, R, Solomon, B, Souter, LH, Thunnissen, E, Tsao, MS, Ventura, CB, Wynes, MW & Yatabe, Y 2018, 'Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors guideline from the college of American pathologists, the international association for the study of lung cancer, and the association for molecular pathology', Archives of pathology & laboratory medicine, ;142(3): 321-346. (AmsterdamUMC) 832. Lindenberg MA, Retel VP, van den Berg JH, Geukes Foppen MH, Haanen JB, van Harten WH,` Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product`, J Immunother 2018; 41:413-25 (NKI) 833. Linder S, van der Poel HG, Bergman AM, Zwart W, Prekovic S,` Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond`, Endocr Relat Cancer 2018; 26:R31-R52 (NKI) 834. Linnekamp, JF, van Hooff, SR, Prasetyanti, PR, Kandimalla, R, Buikhuisen, JY, Fessler, E, Ramesh, P, Lee, KAST, Bochove, GGW, de Jong, JH, Cameron, K, van Leersum, R, Rodermond, HM, Franitza, M, Nürnberg, P, Mangiapane, LR, Wang, X, Clevers, H, Vermeulen, L, Stassi, G & Medema, JP 2018, 'Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models', Cell death and differentiation, ;25: 616-633. (AmsterdamUMC) 835. Liu, X, Swen, JJ, Diekstra, MHM, Boven, E, Castellano, D, Gelderblom, H, Mathijssen, RHJ, Vermeulen, SH, Oosterwijk, E, Junker, K, Roessler, M, Alexiusdottir, K, Sverrisdottir, A, Radu, MT, Ambert, V, Eisen, T, Warren, A, Rodríguez-Antona, C, García-Donas, J, Bohringer, S, Koudijs, KKM, Kiemeney, LALM, Rini, BI & Guchelaar, H-J 2018, 'A genetic polymorphism in ctla-4 is associated with overall survival in sunitinib-treated patients with clear cell metastatic renal cell carcinoma', Clinical Cancer Research, ;24(10): 2350-2356. (AmsterdamUMC) 836. Lodewijk, L, Willems, SM, Dreijerink, KMA, de Keizer, B, van Diest, PJ, Schepers, A, Morreau, H, Bonenkamp, HJ, van Engen–van Grunsven, IACH, Kruijff, S, van Hemel, BM, Links, TP, Nieveen van Dijkum, E, van Eeden, S, Valk, GD, Borel Rinkes, IHM & Vriens, MR 2018, 'The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer', Human pathology, ;81: 245-254. (AmsterdamUMC) 837. Loeffen, EAH, van Dalen, EC, Mulder, RL, van de Wetering, MD, Kremer, LCM & Tissing, WJE 2018, 'The duration of anthracycline infusion should be at least one hour in children with cancer: A clinical practice guideline', Pediatric blood & cancer, ;65(2): e26867. (AmsterdamUMC) 838. Løhmann, DJA, Asdahl, PH, Abrahamsson, J, Ha, S-Y, Jónsson, ÓG, Kaspers, GJL, Koskenvuo, M, Lausen, B, de Moerloose, B, Palle, J, Zeller, B & Hasle, H 2018, 'Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia', Pediatric Blood and Cancer, ;65(9): e27231. (AmsterdamUMC) 839. Lohy Das J, Rulisa S, de Vries PJ, Mens PF, Kaligirwa N, Agaba S, Tarning J, Karlsson MO, Dorlo TPC,` Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated Plasmodium falciparum malaria`, Antimicrob Agents Chemother 2018; 62:e00518-18 (14 pp) (NKI) 840. Looijaard, SMLM, Slee-Valentijn, MS, Groeneveldt, LN, Deeg, DJH, Huisman, M & Maier, AB 2018, 'Do older individuals who are diagnosed with cancer have worse physical performance prior to diagnosis compared to matched controls? A longitudinal cohort study', BMC Geriatrics, ;18(1): 166. (AmsterdamUMC) 841. Loonen, JJ, Blijlevens, NMA, Prins, J, Dona, DJS, den Hartogh, J, Senden, T, van Dulmen-den Broeder, E, van der Velden, K & Hermens, RPMG 2018, 'Cancer survivorship care: Person centered care in a multidisciplinary shared care model', International Journal of Integrated Care, ;18(1): 4. (AmsterdamUMC) 842. Loozen, CS, van Santvoort, HC, van Duijvendijk, P, Besselink, MG, Gouma, DJ, Nieuwenhuijzen, GA, Kelder, JC, Donkervoort, SC, van Geloven, AA, Kruyt, PM, Roos, D, Kortram, K, Kornmann, VN, Pronk, A, van der Peet, DL, Crolla, RM, van Ramshorst, B, Bollen, TL & Boerma, D 2018, 'Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): Multicentre randomised clinical trial', BMJ (Clinical research ed.), ;363(): k3965. (AmsterdamUMC) 843. Lopes R, Korkmaz G, Revilla SA, van Vliet R, Nagel R, Custers L, Kim Y, van Breugel PC, Zwart W, Moumbeini B, Manber Z, Elkon R, Agami R,` CUEDC1 is a primary target of ERalpha essential for the growth of breast cancer cells`, Cancer Lett 2018; 436:87-95 (NKI) 844. López-Hernández, A, Vivanco, B, Franchi, A, Bloemena, E, Cabal, VN, Potes, S, Riobello, C, García- Inclán, C, López, F, Llorente, JL & Hermsen, M 2018, 'Genetic profiling of poorly differentiated sinonasal tumours', Scientific Reports, ;8(1): 3998. (AmsterdamUMC) 845. Lorenzon, L, Biondi, A, Carus, T, Dziki, A, Espin, E, Figueiredo, N, Ruiz, MG, Mersich, T, Montroni, I, Tanis, PJ, Benz, SR, Bianchi, PP, Biebl, M, Broeders, I, de Luca, R, Delrio, P, D'Hondt, M, Fürst, A, Grosek, J, Guimaraes Videira, JF, Herbst, F, Jayne, D, Lázár, G, Miskovic, D, Muratore, A, Helmer Sjo, O, Scheinin, T, Tomazic, A, Türler, A, van de Velde, C, Wexner, SD, Wullstein, C, Zegarski, W & D'Ugo, D 2018, 'Achieving high quality standards in laparoscopic colon resection for cancer: A Delphi consensus- based position paper', European journal of surgical oncology, ;44(4): 469-483. (AmsterdamUMC) 846. Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Benitez J, Bjorge L, Brenton J, Butzow R, Caldes T, Caligo MA, Campbell IG, Chang-Claude J, Claes KBM, Couch FJ, Cramer DW, Daly MB, DeFazio A, Dennis J, Diez O, Domchek SM, Dork T, Easton DF, Eccles DM, Fasching PA, Fortner RT, Fountzilas G, Friedman E, Ganz PA, Garber J, Giles GG, Godwin AK, Goldgar DE, Goodman MT, Greene MH, Gronwald J, Hamann U, Heitz F, Hildebrandt MAT, Hogdall CK, Hollestelle A, Hulick PJ, Huntsman DG, Imyanitov EN, Isaacs C, Jakubowska A, James P, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Kwong A, Le ND, Leslie G, Lesueur F, Levine DA, Mattiello A, May T, McGuffog L, McNeish IA, Merritt MA, Modugno F, Montagna M, Neuhausen SL, Nevanlinna H, Cilius Nielsen FC, Nikitina-Zake L, Nussbaum RL, Offit K, Olah E, Olopade OI, Olson SH, Olsson H, Osorio A, Park SK, Parsons MT, Peeters PHM, Pejovic T, Peterlongo P, Phelan CM, Pujana MA, Ramus SJ, Rennert G, Risch H, Rodriguez GC, Rodriguez-Antona C, Romieu I, Rookus MA, Rossing MA, Rzepecka IK, Sandler DP, Schmutzler RK, Setiawan VW, Sharma P, Sieh W, Simard J, Singer CF, Song H, Southey MC, Spurdle AB, Sutphen R, Swerdlow AJ, Teixeira MR, Teo SH, Thomassen M, Tischkowitz M, Toland AE, Trichopoulou A, Tung N, Tworoger SS, van Rensburg EJ, Vanderstichele A, Vega A, Velez Edwards D, Webb PM, Weitzel JN, Wentzensen N, White E, Wolk A, Wu AH, Yannoukakos D, Zorn KK, Gayther SA, Antoniou AC, Berchuck A, Goode EL, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J,` A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk`, Cancer Res 2018; 78:5419-30 (NKI) 847. Lubin JH, Hauptmann M, Blair A,` Indirect adjustment of relative risks of an exposure with multiple categories for an unmeasured confounder`, Ann Epidemiol 2018; 28:801-7 (NKI) 848. Ludwig, H, Delforge, M, Facon, T, Einsele, H, Gay, F, Moreau, P, Avet-Loiseau, H, Boccadoro, M, Hajek, R, Mohty, M, Cavo, M, Dimopoulos, MA, San-Miguel, JF, Terpos, E, Zweegman, S, Garderet, L, Mateos, M-V, Cook, G, Leleu, X, Goldschmidt, H, Jackson, G, Kaiser, M, Weisel, K, van de Donk, NWCJ, Waage, A, Beksac, M, Mellqvist, UH, Engelhardt, M, Caers, J, Driessen, C, Bladé, J & Sonneveld, P 2018, 'Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network', Leukemia, ;32(7): 1542-1560. (AmsterdamUMC) 849. Luimstra JJ, Garstka MA, Roex MCJ, Redeker A, Janssen GMC, van Veelen PA, Arens R, Falkenburg JHF, Neefjes J, Ovaa H,` A flexible MHC class I multimer loading system for large-scale detection of antigen- specific T cells`, J Exp Med 2018; 215:1493-504 (NKI) 850. Luk, SJ, Steen, DMVD, Hagedoorn, RS, Jordanova, ES, Schilham, MW, Bovée, JVMG, Cleven, AHG, Falkenburg, JHF, Szuhai, K & Heemskerk, MHM 2018, 'PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy', OncoImmunology, ;7( 12. ): (AmsterdamUMC) 851. Lunenburg CATC, Henricks LM, Dreussi E, Peters FP, Fiocco M, Meulendijks D, Toffoli G, Guchelaar HJ, Swen JJ, Cecchin E, Schellens JHM, Gelderblom H,` Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers`, Eur J Cancer 2018; 104:210-8 (NKI) 852. Lunenburg CATC, Henricks LM, van Kuilenburg ABP, Mathijssen RHJ, Schellens JHM, Gelderblom H, Guchelaar HJ, Swen JJ,` Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants`, Genes (Basel) 2018; 9:585 (13 pp) (AmsterdamUMC/NKI) 853. Luong, NH, Alderliesten, T, Bel, A, Niatsetski, Y & Bosman, PAN 2018, 'Application and benchmarking of multi-objective evolutionary algorithms on high-dose-rate brachytherapy planning for prostate cancer treatment', Swarm and Evolutionary Computation, ;40: 37-52. (AmsterdamUMC) 854. Lyman GH, Balaban E, Diaz M, Ferris A, Tsao A, Voest E, Zon R, Francisco M, Green S, Sherwood S, Harvey RD, Schilsky RL,` American Society of Clinical Oncology Statement: Biosimilars in Oncology`, J Clin Oncol 2018; 36:1260-5 (NKI) 855. MA)NEC group 2018, 'Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study', European journal of surgical oncology, ;44(12): 1955-1962. (AmsterdamUMC) 856. Macedo JC, Vaz S, Bakker B, Ribeiro R, Bakker PL, Escandell JM, Ferreira MG, Medema R, Foijer F, Logarinho E,` FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence`, Nat Commun 2018; 9:2834 (17 pp) (NKI) 857. Machiels, ML, Jin, P, van Gurp, CH, van Hooft, JE, Alderliesten, T & Hulshof, MCCM 2018, 'Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy', Radiation oncology (London, England), ;13(1): 48. (AmsterdamUMC) 858. Macintyre, G, Goranova, TE, De Silva, D, Ennis, D, Piskorz, AM, Eldridge, M, Sie, D, Lewsley, LA, Hanif, A, Wilson, C, Dowson, S, Glasspool, RM, Lockley, M, Brockbank, E, Montes, A, Walther, A, Sundar, S, Edmondson, R, Hall, GD, Clamp, A, Gourley, C, Hall, M, Fotopoulou, C, Gabra, H, Paul, J, Supernat, A, Millan, D, Hoyle, A, Bryson, G, Nourse, C, Mincarelli, L, Sanchez, LN, Ylstra, B, Jimenez-Linan, M, Moore, L, Hofmann, O, Markowetz, F, McNeish, IA & Brenton, JD 2018, 'Copy number signatures and mutational processes in ovarian carcinoma', Nature Genetics, ;50(9): 1262-1270. (AmsterdamUMC) 859. Mackay, A, Burford, A, Molinari, V, Jones, DTW, Izquierdo, E, Brouwer-Visser, J, Giangaspero, F, Haberler, C, Pietsch, T, Jacques, TS, Figarella-Branger, D, Rodriguez, D, Morgan, PS, Raman, P, Waanders, AJ, Resnick, AC, Massimino, M, Garrè, ML, Smith, H, Capper, D, Pfister, SM, Würdinger, T, Tam, R, Garcia, J, Thakur, MD, Vassal, G, Grill, J, Jaspan, T, Varlet, P & Jones, C 2018, 'Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial', Cancer Cell, ;33(5): 829-842.e5. (AmsterdamUMC) 860. Mackay, TM, Genç, CGN, Takkenberg, RB, Besselink, MG, Somers, I & Nieveen van Dijkum, EJM 2018, 'New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors', Journal of surgical oncology, ;117(7): 1548-1555. (AmsterdamUMC) 861. MacNeill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honore C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Barretta F, Raut CP, Strauss DC,` Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group`, Ann Surg 2018; 267:959-64 (NKI) 862. Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA,` Imaging predictors of treatment outcomes in rectal cancer: An overview`, Crit Rev Oncol Hematol 2018; 129:153-62 (NKI) 863. Maia ARR, Linder S, Song JY, Vaarting C, Boon U, Pritchard CEJ, Velds A, Huijbers IJ, van Tellingen O, Jonkers J, Medema RH,` Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division`, Br J Cancer 2018; 118:1586-95 (NKI) 864. Mainardi S, Mulero-Sanchez A, Prahallad A, Germano G, Bosma A, Krimpenfort P, Lieftink C, Steinberg JD, de Wit N, Goncalves-Ribeiro S, Nadal E, Bardelli A, Villanueva A, Bernards R,` SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo`, Nat Med 2018; 24:961-7 (NKI) 865. Malcikova, J, Tausch, E, Rossi, D, Sutton, LA, Soussi, T, Zenz, T, Kater, AP, Niemann, CU, Gonzalez, D, Davi, F, Gonzalez Diaz, M, Moreno, C, Gaidano, G, Stamatopoulos, K, Rosenquist, R, Stilgenbauer, S, Ghia, P & Pospisilova, S 2018, 'ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation', Leukemia, ;32: 1070-1080. (AmsterdamUMC) 866. Man WH, Perez-Pitarch A, Wilting I, Heerdink ER, van Solinge WW, Egberts ACG, Huitema ADR,` Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence`, Br J Clin Pharmacol 2018; 84:1228-37 (NKI) 867. Mangat PK, Halabi S, Bruinooge SS, Garrett-Mayer E, Alva A, Janeway KA, Stella PJ, Voest E, Yost KJ, Perlmutter J, Pinto N, Kim ES, Schilsky RL,` Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study`, JCO Precis Oncol 2018; 2018: (NKI) 868. Mannaerts, CK, Wildeboer, RR, Postema, AW, Hagemann, J, Budäus, L, Tilki, D, Mischi, M, Wijkstra, H & Salomon, G 2018, 'Multiparametric ultrasound: Evaluation of greyscale, shear wave elastography and contrast-enhanced ultrasound for prostate cancer detection and localization in correlation to radical prostatectomy specimens', BMC urology, ;18(1): 98. (AmsterdamUMC) 869. Marabelle A, Andtbacka R, Harrington K, Melero I, Leidner R, de BT, Robert C, Ascierto PA, Baurain JF, Imperiale M, Rahimian S, Tersago D, Klumper E, Hendriks M, Kumar R, Stern M, Ohrling K, Massacesi C, Tchakov I, Tse A, Douillard JY, Tabernero J, Haanen J, Brody J,` Starting the Fight in the Tumor: Expert Recommendations for the Development of Human Intratumoral Immunotherapy (HIT-IT)`, Ann Oncol 2018; 29:2163-74 (NKI) 870. Maracle, CX, Jeucken, KCM, Helder, B, Gulik, TMV, Steins, A, Laarhoven, HWMV & Tas, SW 2018, 'Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis', Oncotarget, ;9(47): 28445-28455. (AmsterdamUMC) 871. Marconi L, De Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Ljungberg B, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A,` External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma`, World J Urol 2018; 36:1973-80 (NKI) 872. Marees AT, Hammerschlag AR, Bastarache L, de Kluiver H, Vorspan F, van den Brink W, Smit DJ, Denys D, Gamazon ER, Li-Gao R, Breetvelt EJ, de Groot MCH, Galesloot TE, Vermeulen SH, Poppelaars JL, Souverein PC, Keeman R, de Mutsert R, Noordam R, Rosendaal FR, Stringa N, Mook-Kanamori DO, Vaartjes I, Kiemeney LA, den Heijer M, van Schoor NM, Klungel OH, Maitland-Van der Zee AH, Schmidt MK, Polderman TJC, van der Leij AR, Posthuma D, Derks EM,` Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use`, Drug Alcohol Depend 2018; 188:94-101 (NKI) 873. Mari, L, Hoefnagel, SJM, Zito, D, van de Meent, M, van Endert, P, Calpe, S, Sancho Serra, MDC, Heemskerk, MHM, van Laarhoven, HWM, Hulshof, MCCM, Gisbertz, SS, Medema, JP, van Berge Henegouwen, MI, Meijer, SL, Bergman, JJGHM, Milano, F & Krishnadath, KK 2018, 'microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients', Gastroenterology, ;155(3): 784-798. (AmsterdamUMC) 874. Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel Iii EE, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, Ziai J, Senbabaoglu Y, Santoro S, Sheinson D, Hung J, Giltnane JM, Pierce AA, Mesh K, Lianoglou S, Riegler J, Carano RAD, Eriksson P, Hoglund M, Somarriba L, Halligan DL, van der Heijden MS, Loriot Y, Rosenberg JE, Fong L, Mellman I, Chen DS, Green M, Derleth C, Fine GD, Hegde PS, Bourgon R, Powles T,` TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells`, Nature 2018; 554:544-8 (NKI) 875. Marsidi N, Beijnen JH, van Zuuren EJ,` Palladium-induced granulomas analysed with inductively coupled plasma mass spectrometry`, Contact Dermatitis 2018; 79:41-2 (NKI) 876. Mat Lazim N, Abdullah K, Karakullukcu B, Tan IB,` Feasibility of Salvage Selective Neck Dissection after Primary Irradiation of Pharyngeal and Laryngeal Carcinoma`, ORL J Otorhinolaryngol Relat Spec 2018; 80:10-8 (NKI) 877. Mathus-Vliegen, EMH, van der Vliet, K, Wignand-van der Storm, IJ & Stadwijk, JS 2018, 'Split-dose bowel cleansing with picosulphate is safe and better tolerated than 2-l polyethylene glycol solution', European journal of gastroenterology & hepatology, ;30(7): 709-717. (AmsterdamUMC) 878. Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Franke K, Schornagel K, Verkuijlen P, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, van der Werff Ten Bosch, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK,` Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis`, Cell Rep 2018; 23:3946-59 (AmsterdamUMC/NKI) 879. Mayr R, Fritsche HM, Zeman F, Reiffen M, Siebertz L, Niessen C, Pycha A, van Rhijn BWG, Burger M, Gierth M,` Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer`, World J Urol 2018; 36:1201-7 (NKI) 880. Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T,` Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer`, J Cachexia Sarcopenia Muscle 2018; 9:505-13 (NKI) 881. McWilliam, A, Lee, L, Harris, M, Sheikh, H, Pemberton, L, Faivre-Finn, C & van Herk, M 2018, 'Benefit of using motion compensated reconstructions for reducing inter-observer and intra-observer contouring variation for organs at risk in lung cancer patients', Radiotherapy and oncology, ;126(2): 333-338. (AmsterdamUMC) 882. Medema, JP 2018, 'CANCER Escape from senescence boosts tumour growth', Nature, ;553(7686): 37- 38. (AmsterdamUMC) 883. Medendorp, NM, Hillen, MA, Murugesu, L, Aalfs, CM, Stiggelbout, AM & Smets, EMA 2018, 'Uncertainty in consultations about genetic testing for cancer: an explorative observational study', Patient education and counseling, ;101(12): 2083-2089. (AmsterdamUMC) 884. Meel MH, de Gooijer MC, Guillen Navarro M, Waranecki P, Breur M, Buil L, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Montero Carcaboso A, Bugiani M, van Tellingen O, van Vuurden DG, Kaspers GJL, Hulleman E,` MELK inhibition in Diffuse Intrinsic Pontine Glioma`, Clin Cancer Res 2018; 24:5645-57 (NKI) 885. Meel, MH, de Gooijer, MC, Navarro, MG, Waranecki, P, Breur, M, Buil, LCM, Wedekind, LE, Twisk, JWR, Koster, J, Hashizume, R, Raabe, EH, Carcaboso, AM, Bugiani, M, van Tellingen, O, van Vuurden, DG, Kaspers, GJL & Hulleman, E 2018, 'MeLK inhibition in diffuse intrinsic pontine glioma', Clinical cancer research, ;24(22): 5645-5657. (AmsterdamUMC) 886. Meel, MH, Metselaar, DS, Waranecki, P, Kaspers, GJL & Hulleman, E 2018, 'An efficient method for the transduction of primary pediatric glioma neurospheres', MethodsX, ;5: 173-183. (AmsterdamUMC) 887. Meel, MH, Schaper, SA, Kaspers, GJL & Hulleman, E 2018, 'Signaling pathways and mesenchymal transition in pediatric high-grade glioma', Cellular and Molecular Life Sciences, ;75(5): 871-887. (AmsterdamUMC) 888. Meershoek P, KleinJan GH, van Oosterom MN, Wit EM, van Willigen DM, Bauwens KP, van Gennep EJ, Mottrie AM, van der Poel HG, van Leeuwen F,` Multispectral fluorescence imaging as a tool to separate healthy and disease related lymphatic anatomies during robot-assisted laparoscopic procedures`, J Nucl Med 2018; 59:1757-60 (NKI) 889. Mege, D, Depypere, L, Piessen, G, Slaman, AE, Wijnhoven, BPL, Hölscher, A, Nilsson, M, van Berge Henegouwen, MI, van Lanschot, JJB, Schroeder, W, Thomas, PA, Nafteux, P & D'Journo, XB 2018, 'Surgical management of esophageal sarcoma: A multicenter European experience', Diseases of the esophagus, ;31(3): dox146. (AmsterdamUMC) 890. Meghani K, Fuchs W, Detappe A, Drane P, Gogola E, Rottenberg S, Jonkers J, Matulonis U, Swisher EM, Konstantinopoulos PA, Chowdhury D,` Multifaceted Impact of MicroRNA 493-5p on Genome- Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas`, Cell Rep 2018; 23:100-11 (NKI) 891. Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B,` Sentinel lymph node imaging in urologic oncology`, Transl Androl Urol 2018; 7:887-902 (NKI) 892. Meijer TG, Verkaik NS, Sieuwerts AM, van Riet J, Naipal KAT, van Deurzen CHM, den Bakker M, Sleddens HFBM, Dubbink HJ, den Toom TD, Dinjens WNM, Lips EH, Nederlof PM, Smid M, van de Werken HJG, Kanaar R, Martens JWM, Jager A, van Gent DC,` Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects`, Clin Cancer Res 2018; 24:6277-87 (NKI) 893. Meijer, BJ, Wielenga, MCB, Hoyer, PB, Amos-Landgraf, JM, Hakvoort, TBM, Muncan, V, Heijmans, J & van den Brink, GR 2018, 'Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status', Oncotarget, ;9(55): 30561-30567. (AmsterdamUMC) 894. Meijer, LL, Alberga, AJ, de Bakker, JK, van der Vliet, HJ, le Large, TYS, van Grieken, NCT, de Vries, R, Daams, F, Zonderhuis, BM & Kazemier, G 2018, 'Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis', Annals of surgical oncology, ;25(9): 2681- 2692. (AmsterdamUMC) 895. Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J,` Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis`, Cardiovasc Intervent Radiol 2018; 41:1189-204 (AmsterdamUMC/NKI) 896. Melan, K, Amant, F, Veronique-Baudin, J, Joachim, C & Janky, E 2018, 'Fertility preservation healthcare circuit and networks in cancer patients worldwide: What are the issues?', BMC cancer, ;18(1): 192. (AmsterdamUMC) 897. Melchers, RC, Willemze, R, Bekkenk, MW, de Haas, ERM, Horvath, B, van Rossum, MM, Sanders, CJG, Veraart, JCJM, Vermeer, MH & Quint, KD 2018, 'Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group', British journal of dermatology, ;179(3): 724-731. (AmsterdamUMC) 898. Melissant HC, Neijenhuijs KI, Jansen F, Aaronson NK, Groenvold M, Holzner B, Terwee CB, Uden-Kraan CF, Cuijpers P, Verdonck-de Leeuw IM,` A systematic review of the measurement properties of the Body Image Scale (BIS) in cancer patients`, Support Care Cancer 2018; 26:1715-26 (AmsterdamUMC/NKI) 899. Melissant, HC, Jansen, F, Schutte, LER, Lissenberg-Witte, BI, Buter, J, Leemans, CR, Sprangers, MA, Vergeer, MR, Laan, ETM & Verdonck-de Leeuw, IM 2018, 'The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapy', Oral oncology, ;83: 120- 126. (AmsterdamUMC) 900. Melissant, HC, Verdonck-de Leeuw, IM, Lissenberg-Witte, BI, Konings, IR, Cuijpers, P & Van Uden- Kraan, CF 2018, '‘Oncokompas’, a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors', Acta Oncologica, ;57(7): 924-934. (AmsterdamUMC) 901. Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors and Pathology Committees 2018, 'Eighth edition staging of thoracic malignancies: Implications for the reporting pathologist', Archives of pathology & laboratory medicine, ;142(5): 645-661. (AmsterdamUMC) 902. Menard C, Paulson E, Nyholm T, McLaughlin P, Liney G, Dirix P, van der Heide UA,` Role of Prostate MR Imaging in Radiation Oncology`, Radiol Clin North Am 2018; 56:319-25 (NKI) 903. Ménard, M, Costechareyre, C, Ichim, G, Blachier, J, Neves, D, Jarrosson-Wuilleme, L, Depping, R, Koster, J, Saintigny, P, Mehlen, P & Tauszig-Delamasure, S 2018, 'Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth', PLoS biology, ;16(5): e2002912. (AmsterdamUMC) 904. Menezes GL, Winter-Warnars GA, Koekenbier EL, Groen EJ, Verkooijen HM, Pijnappel RM,` Simplifying Breast Imaging Reporting and Data System classification of mammograms with pure suspicious calcifications`, J Med Screen 2018; 25:82-7 (NKI) 905. Menezes GLG, Pijnappel RM, Meeuwis C, Bisschops R, Veltman J, Lavin PT, van de Vijver MJ, Mann RM,` Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging`, Radiology 2018; 288:355-65 (NKI) 906. Menghi F, Barthel FP, Yadav V, Tang M, Ji B, Tang Z, Carter GW, Ruan Y, Scully R, Verhaak RGW, Jonkers J, Liu ET,` The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations`, Cancer Cell 2018; 34:197-210 (NKI) 907. Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HSA, Reneman L, Schagen SB,` Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study`, Brain Imaging Behav 2018; 12:324-34 (AmsterdamUMC/NKI) 908. Mercieca S, Belderbos J, van Loon J, Gilhuijs K, Julyan P, van Herk M,` Comparison of SUVmax and SUVpeak based segmentation to determine primary lung tumour volume on FDG PET-CT correlated with pathology data`, Radiother Oncol 2018; 129:227-33 (AmsterdamUMC/NKI) 909. Mercieca S, Belderbos JSA, De Jaeger K, Schinagl DAX, van der Voort Van Zijp, Pomp J, Theuws J, Khalifa J, van de Vaart P, van Herk M,` Interobserver variability in the delineation of the primary lung cancer and lymph nodes on different four-dimensional computed tomography reconstructions`, Radiother Oncol 2018; 126:325-32 (AmsterdamUMC/NKI) 910. Merckel LG, Verburg E, van der Velden BHM, Loo CE, van den Bosch MAAJ, Gilhuijs KGA,` Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle`, Breast J 2018; 24:501-8 (NKI) 911. Meulepas JM, Hauptmann M, Lubin JH, Shuryak I, Brenner DJ,` Is there Unmeasured Indication Bias in Radiation-Related Cancer Risk Estimates from Studies of Computed Tomography?`, Radiat Res 2018; 189:128-35 (NKI) 912. Micheel CM, Sweeney SM, LeNoue-Newton ML, Andre F, Bedard PL, Guinney J, Meijer GA, Rollins BJ, Sawyers CL, Schultz N, Shaw KRM, Velculescu VE, Levy MA,` American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond-Lessons Learned and Member Institutions' Perspectives`, JCO Clin Cancer Inform 2018;1-14 (NKI) 913. Mijnheer B, Jomehzadeh A, Gonzalez P, Olaciregui-Ruiz I, Rozendaal R, Shokrani P, Spreeuw H, Tielenburg R, Mans A,` Error detection during VMAT delivery using EPID-based 3D transit dosimetry`, Phys Med 2018; 54:137-45 (NKI) 914. Mikropoulos C, Selkirk CGH, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadalo L, Oldenburg R, Cremers R, Verhaegh G, Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MG, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden AT, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra AV, Moynihan C, Rennert G, Suri M, Tricker K, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA,` Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition`, Br J Cancer 2018; 118:266-76 (AmsterdamUMC/NKI) 915. Milano, RV, Bergman, JJ & Pouw, RE 2018, 'Endoscopic treatment of early esophageal adenocarcinoma', Minerva chirurgica, ;73(4): 355-365. (AmsterdamUMC) 916. Milroy LG, Koning B, Scheppingen DSV, Jager NGL, Beijnen JH, Koek J, Brunsveld L,` A multi-gram-scale stereoselective synthesis of Z-endoxifen`, Bioorg Med Chem Lett 2018; 28:1352-6 (NKI) 917. Mir MC, Matin SF, Bex A, Spiess PE, Thompson RH, Grob B, van Poppel H,` The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review`, Minerva Urol Nefrol 2018; 70:109-25 (NKI) 918. Mishra, MV, Louie, AV, Gondi, V & Slotman, B 2018, 'The evolving role of radiotherapy in the management of small cell lung cancer', Journal of Thoracic Disease, ;10: S2545-S2554. (AmsterdamUMC) 919. Miyazaki, Y, Tuechler, H, Sanz, G, Schanz, J, Garcia-Manero, G, Solé, F, Bennett, JM, Bowen, D, Fenaux, P, Dreyfus, F, Kantarjian, H, Kuendgen, A, Malcovati, L, Cazzola, M, Cermak, J, Fonatsch, C, le Beau, MM, Slovak, ML, Santini, V, Lübbert, M, Maciejewski, J, Machherndl-Spandl, S, Magalhaes, SMM, Pfeilstöcker, M, Sekeres, MA, Sperr, WR, Stauder, R, Tauro, S, Valent, P, Vallespi, T, van de Loosdrecht, AA, Germing, U, Haase, D & Greenberg, PL 2018, 'Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS', Leukemia Research, ;73: 51-57. (AmsterdamUMC) 920. Moghadasi S, Grundeken V, Janssen LAM, Dijkstra NH, Rodriguez-Girondo M, Zelst-Stams WAG, Oosterwijk JC, Ausems MGEM, Oldenburg RA, Adank MA, Blom EW, Ruijs M, van Os TAM, van Deurzen CHM, Martens JWM, Schroder CP, Wijnen JT, Vreeswijk MPG, van Asperen CJ,` Performance of BRCA1/2 mutation prediction models in male breast cancer patients`, Clin Genet 2018; 93:52-9 (AmsterdamUMC/NKI) 921. Moghadasi, S, Meeks, HD, Vreeswijk, MPG, Janssen, LAM, Borg, Å, Ehrencrona, H, Paulsson-Karlsson, Y, Wappenschmidt, B, Engel, C, Gehrig, A, Arnold, N, Van Overeem Hansen, T, Thomassen, M, Jensen, UB, Kruse, TA, Ejlertsen, B, Gerdes, AM, Pedersen, IS, Caputo, SM, Couch, F, Hallberg, EJ, van den Ouweland, AMW, Collée, MJ, Teugels, E, Adank, MA, van der Luijt, RB, Mensenkamp, AR, Oosterwijk, JC, Blok, MJ, Janin, N, Claes, KBM, Tucker, K, Viassolo, V, Toland, AE, Eccles, DE, Devilee, P, Van Asperen, CJ, Spurdle, AB, Goldgar, DE & García, EG 2018, 'The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium', Journal of Medical Genetics, ;55(1): 15-20. (AmsterdamUMC) 922. Moiola CP, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, Fonnes T, Vidal A, Villanueva A, Matias-Guiu X, Krakstad C, Amant F, Gil-Moreno A, Colas E,` Patient-Derived Xenograft Models for Endometrial Cancer Research`, Int J Mol Sci 2018; 19:2431 (17 pp) (AmsterdamUMC/NKI) 923. Molenaar, RJ, Khurshed, M, Hira, VVV & van Noorden, CJF 2018, 'Metabolic mapping: Quantitative enzyme cytochemistry and histochemistry to determine the activity of dehydrogenases in cells and tissues', Journal of visualized experiments, ;2018(135): e56843. (AmsterdamUMC) 924. Molenaar, RJ, Maciejewski, JP, Wilmink, JW & van Noorden, CJF 2018, 'Wild-type and mutated IDH1/2 enzymes and therapy responses', Oncogene, ;37: 1949-1960. (AmsterdamUMC) 925. Molenaar, RJ, Pleyer, C, Radivoyevitch, T, Sidana, S, Godley, A, Advani, AS, Gerds, AT, Carraway, HE, Kalaycio, M, Nazha, A, Adelstein, D, Nasr, C, Angelini, D, Maciejewski, JP, Majhail, N, Sekeres, MA & Mukherjee, S 2018, 'Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine', Leukemia, ;32: 952-959. (AmsterdamUMC) 926. Molenaar, RJ, Radivoyevitch, T, Nagata, Y, Khurshed, M, Przychodzen, B, Makishima, H, Xu, M, Bleeker, FE, Wilmink, JW, Carraway, H, Mukherjee, S, Sekeres, MA, van Noorden, CJF & Maciejewski, JP 2018, 'IDH1/2 mutations sensitize acute myeloid leukemia to PARP inhibition and this is reversed by IDH1/2- mutant inhibitors', Clinical cancer research, pp. 1705-1715. (AmsterdamUMC) 927. Molenaar, RJ, van de Venne, T, Weterman, MJ, Mathot, RA, Klümpen, H-J, Richel, DJ & Wilmink, JW 2018, 'A phase Ib study of everolimus combined with metformin for patients with advanced cancer', Investigational new drugs, ;36(1): 53-61. (AmsterdamUMC) 928. Monninkhof EM, van Loon JWL, van Vulpen M, Kerkmeijer LGW, Pos FJ, Haustermans K, van den Bergh L, Isebaert S, McColl GM, Jan Smeenk R, Noteboom J, Walraven I, Peeters PHM, van der Heide UA,` Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial`, Radiother Oncol 2018; 127:74-80 (NKI) 929. Montroni I, Ugolini G, Saur NM, Spinelli A, Rostoft S, Millan M, Wolthuis A, Daniels IR, Hompes R, Penna M, Furst A, Papamichael D, Desai AM, Cascinu S, Gerard JP, Myint AS, Lemmens VEPP, Berho M, Lawler M, Liguori Carino N, Potenti F, Nanni O, Altini M, Beets G, Rutten H, Winchester D, Wexner SD, Audisio RA,` Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer`, Eur J Surg Oncol 2018; 44:1685-702 [Review] (NKI) 930. Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, Gonzalez-Martin A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P,` Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer`, N Engl J Med 2018; 379:2495-505 (NKI) 931. Moraes, FY, Mendez, LC, Taunk, NK, Raman, S, Suh, JH, Souhami, L, Slotman, B, Weltman, E, Spratt, DE, Berlin, A & Marta, GN 2018, 'Funding source, conflict of interest and positive conclusions in neuro- oncology clinical trials', Journal of Neuro-Oncology, ;136(3): 585-593. (AmsterdamUMC) 932. Mordang, JJ, Gubern-Mérida, A, Bria, A, Tortorella, F, Mann, RM, Broeders, MJM, den Heeten, GJ & Karssemeijer, N 2018, 'The importance of early detection of calcifications associated with breast cancer in screening', Breast cancer research and treatment, ;167(2): 451-458. (AmsterdamUMC) 933. Moritz R, Muller M, Korse CM, van den Broek D, Baas P, van den Noort V, Ten Hoeve JJ, van den Heuvel MM, van Rossum HH,` Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot`, Clin Chim Acta 2018; 487:6-14 (NKI) 934. Morrow ME, Morgan MT, Clerici M, Growkova K, Yan M, Komander D, Sixma TK, Simicek M, Wolberger C,` Active site alanine mutations convert deubiquitinases into high-affinity ubiquitin-binding proteins`, EMBO Rep 2018; 19:e45680 (9 pp) (NKI) 935. Mottet N, De Santis M, Briers E, Gillessen S, Grummet JP, Lam TB, van der Poel HG, Rouviere O, van den Bergh RC, Cornford P,` Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard`, Eur Urol 2018; 73:316-21 (NKI) 936. Motzer RJ, Tannir NM, McDermott DF, Aren FO, Melichar B, Choueiri TK, Plimack ER, Barthelemy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B,` Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma`, N Engl J Med 2018; 378:1277-90 [Comment] (NKI) 937. Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, Jimenez-Linan M, Garcia-Corbacho J, Patel K, Ostrup O, Murphy S, Eldridge MD, Gale D, Stewart GD, Burge J, Cooper WN, van der Heijden MS, Massie CE, Watts C, Corrie P, Pacey S, Brindle KM, Baird RD, Mau-Sorensen M, Parkinson CA, Smith CG, Brenton JD, Rosenfeld N,` Enhanced detection of circulating tumor DNA by fragment size analysis`, Sci Transl Med 2018; 10:466 (14 pp) (NKI) 938. Mount, CW, Majzner, RG, Sundaresh, S, Arnold, EP, Kadapakkam, M, Haile, S, Labanieh, L, Hulleman, E, Woo, PJ, Rietberg, SP, Vogel, H, Monje, M & Mackall, CL 2018, 'Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas letter', Nature Medicine, ;24(5): 572-579. (AmsterdamUMC) 939. Mourits, DL, Hartong, DT, Lissenberg-Witte, BI, Bosscha, MI, Tan, HS & Moll, AC 2018, 'Cosmetic results of enucleation and/or external beam radiation therapy in 195 retinoblastoma survivors', Acta Ophthalmologica, ;96(6): 631-640. (AmsterdamUMC) 940. Mourits, DL, Mourits, MP, Kloos, RJHM, Tan, HS, Moll, AC & Hartong, DT 2018, 'Case series: effect of dermis-fat implants in different late onset socket problems encountered in retinoblastoma patients', Ophthalmic Genetics, ;39(5): 619-624. (AmsterdamUMC) 941. MRC CHORUS study investigators 2018, 'Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials', The Lancet Oncology, ;19(12): 1680-1687. (AmsterdamUMC) 942. Mufti, GJ, McLornan, DP, van de Loosdrecht, AA, Germing, U & Hasserjian, RP 2018, 'Diagnostic algorithm for lower-risk myelodysplastic syndromes', Leukemia, ;32(8): 1679-1696. (AmsterdamUMC) 943. Mughini-Gras L, Schaapveld M, Kramers J, Mooij S, Neefjes-Borst EA, Pelt WV, Neefjes J,` Increased colon cancer risk after severe Salmonella infection`, PLoS One 2018; 13:e0189721-(19 pp) (AmsterdamUMC/NKI) 944. Mullen JT, van Houdt W,` Soft tissue tumors of the pelvis: Technical and histological considerations`, J Surg Oncol 2018; 117:48-55 (NKI) 945. Muller, BG, van Kollenburg, RAA, Swaan, A, Zwartkruis, ECH, Brandt, MJ, Wilk, LS, Almasian, M, Schreurs, AW, Faber, DJ, Rozendaal, LR, Vis, AN, Nieuwenhuijzen, JA, van Moorselaar, JRJA, de la Rosette, JJMCH, de Bruin, DM & van Leeuwen, TG 2018, 'Needle-based optical coherence tomography for the detection of prostate cancer: A visual and quantitative analysis in 20 patients', Journal of biomedical optics, ;23(8): 086001. (AmsterdamUMC) 946. Muns, JA, Montserrat, V, Houthoff, HJ, Codée-Van Der Schilden, K, Zwaagstra, O, Sijbrandi, NJ, Merkul, E & Van Dongen, GAMS 2018, 'In vivo characterization of platinum (II)-based linker technology for the development of antibody-drug conjugates: Taking advantage of dual labeling with 195mPt and 89Zr', Journal of Nuclear Medicine, ;59(7): 1146-1151. (AmsterdamUMC) 947. Mureau MAM, Breast Reconstruction Guideline Working Group, Collaborators (13), Woerdeman LAE,` Dutch breast reconstruction guideline`, J Plast Reconstr Aesthet Surg 2018; 71:290-304 (NKI) 948. Musoro, ZJ, Hamel, J-F, Ediebah, DE, Cocks, K, King, MT, Groenvold, M, Sprangers, MAG, Brandberg, Y, Velikova, G, Maringwa, J, Flechtner, H-H, Bottomley, A & Coens, C 2018, 'Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol', BMJ open, ;8(1): e019117. (AmsterdamUMC) 949. Nanou, A, Coumans, FAW, Dalum, GV, Zeune, LL, Dolling, D, Onstenk, W, Crespo, M, Fontes, MS, Rescigno, P, Fowler, G, Flohr, P, Brune, C, Sleijfer, S, de Bono, JS & Terstappen, LWMM 2018, 'Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration- resistant prostate cancer patients', Oncotarget, ;9(27): 19283-19293. (AmsterdamUMC) 950. Narayan, RS, Gasol, A, Slangen, PLG, Cornelissen, FMG, Lagerweij, T, Veldman, HYYE, Dik, R, van den Berg, J, Slotman, BJ, Wurdinger, T, Haas-Kogan, DA, Stalpers, LJA, Baumert, BG, Westerman, BA, Theys, J & Sminia, P 2018, 'Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma', Molecular cancer therapeutics, ;17(2): 347-354. (AmsterdamUMC) 951. Naspro, R, Lerner, LB, Rossini, R, Manica, M, Woo, HH, Calopedos, RJ, Cracco, CM, Scoffone, CM, Herrmann, TR, de la Rosette, JJ, Cornu, J-N & DA Pozzo, LF 2018, 'Perioperative antithrombotic therapy in patients undergoing endoscopic urologic surgery: where do we stand with current literature?', Minerva urologica e nefrologica = The Italian journal of urology and nephrology, ;70(2): 126-136. (AmsterdamUMC) 952. Natkunam, Y, Gratzinger, D, Chadburn, A, Goodlad, JR, Chan, JKC, Said, J, Jaffe, ES & de Jong, D 2018, 'Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?', Blood, ;132(18): 1871-1878. (AmsterdamUMC) 953. Nauta, IH, Rietbergen, MM, van Bokhoven, AAJD, Bloemena, E, Lissenberg-Witte, BI, Heideman, DAM, Baatenburg de Jong, RJ, Brakenhoff, RH & Leemans, CR 2018, 'Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing', Annals of Oncology, ;29(5): 1273-1279. (AmsterdamUMC) 954. Necchi A, Lo Vullo S, Mariani L, Moschini M, Hendricksen K, Rink M, Sosnowski R, Dobruch J, Raman JD, Wood CG, Margulis V, Roupret M, Briganti A, Montorsi F, Xylinas E, Shariat SF,` Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration`, BJU Int 2018; 121:252-9 (NKI) 955. Neerincx M, Poel D, Sie DLS, van Grieken NCT, Shankaraiah RC, van der Wolf-de Lijster FSW, van Waesberghe JTM, Burggraaf JD, Eijk PP, Verhoef C, Ylstra B, Meijer GA, van de Wiel MA, Buffart TE, Verheul HMW,` Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer`, PLoS One 2018; 13:e0201809 (20 pp) (AmsterdamUMC/NKI) 956. Neijenhuijs KI, Jansen F, Aaronson NK, Bredart A, Groenvold M, Holzner B, Terwee CB, Cuijpers P, Verdonck-de Leeuw IM,` A systematic review of the measurement properties of the European Organisation for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire, the EORTC IN-PATSAT32`, Support Care Cancer 2018; 26:2551-60 (AmsterdamUMC/NKI) 957. Nell, S, Borel Rinkes, IHM, Verkooijen, HM, Bonsing, BA, van Eijck, CH, van Goor, H, de Kleine, RHJ, Kazemier, G, Nieveen van Dijkum, EJ, Dejong, CHC, Valk, GD & Vriens, MR 2018, 'Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors', Annals of surgery, ;267(2): 352-356. (AmsterdamUMC) 958. Nestle U, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pottgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Slotman B, Ramella S, Faivre-Finn C, McDonald F, Manapov F, Putora PM, LePechoux C, Van Houtte P,` ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer`, Radiother Oncol 2018; 127:1-5 (AmsterdamUMC/NKI) 959. Neves JB, Withington J, Fowler S, Patki P, Barod R, Mumtaz F, O'Brien T, Aitchison M, Bex A, Tran MG,` Contemporary Surgical Management of Renal Oncocytoma: A nation's outcome`, BJU Int 2018; 121:893-9 (NKI) 960. Nicholson, AG, Torkko, K, Viola, P, Duhig, E, Geisinger, K, Borczuk, AC, Hiroshima, K, Tsao, MS, Warth, A, Lantuejoul, S, Russell, PA, Thunnissen, E, Marchevsky, A, Mino-Kenudson, M, Beasley, MB, Botling, J, Dacic, S, Yatabe, Y, Noguchi, M, Travis, WD, Kerr, K, Hirsch, FR, Chirieac, LR, Wistuba, II, Moreira, A, Chung, J-H, Chou, TY, Bubendorf, L, Chen, G, Pelosi, G, Poleri, C, Detterbeck, FC & Franklin, WA 2018, 'Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung', Journal of Thoracic Oncology, ;13(2): 205- 217. (AmsterdamUMC) 961. Niemeijer AN, Leung D, Huisman MC, Bahce I, Hoekstra OS, van Dongen GAMS, Boellaard R, Du S, Hayes W, Smith R, Windhorst AD, Hendrikse NH, Poot A, Vugts DJ, Thunnissen E, Morin P, Lipovsek D, Donnelly DJ, Bonacorsi SJ, Velasquez LM, de Gruijl TD, Smit EF, de Langen AJ,` Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer`, Nat Commun 2018; 9:4664 (5 pp) (AmsterdamUMC/NKI) 962. Nies, M, Dekker, BL, Sulkers, E, Huizinga, GA, Klein Hesselink, MS, Maurice-Stam, H, Grootenhuis, MA, Brouwers, AH, Burgerhof, JGM, van Dam, EWCM, Havekes, B, van den Heuvel-Eibrink, MM, Corssmit, EPM, Kremer, LCM, Netea-Maier, RT, van der Pal, HJH, Peeters, RP, Plukker, JTM, Ronckers, CM, van Santen, HM, van der Horst-Schrivers, ANA, Tissing, WJE, Bocca, G & Links, TP 2018, 'Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study', European journal of endocrinology / European Federation of Endocrine Societies, ;178(3): 215-223. (AmsterdamUMC) 963. Nijhof, IS, van de Donk, NWCJ, Zweegman, S & Lokhorst, HM 2018, 'Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update', Drugs, ;78(1): 19-37. (AmsterdamUMC) 964. Noij, DP, Martens, RM, Koopman, T, Hoekstra, OS, Comans, EFI, Zwezerijnen, B, de Bree, R, de Graaf, P & Castelijns, JA 2018, 'Use of Diffusion-Weighted Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma', Clinical Oncology, ;30(12): 780- 792. (AmsterdamUMC) 965. Noij, DP, Martens, RM, Zwezerijnen, B, Koopman, T, de Bree, R, Hoekstra, OS, de Graaf, P & Castelijns, JA 2018, 'Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis', European Journal of Radiology, ;107: 20-25. (AmsterdamUMC) 966. Nolte S, Liegl G, Petersen MA, Aaronson NK, Costantini A, Fayers PM, Groenvold M, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M,` General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States`, Eur J Cancer 2018; 107:153-63 (NKI) 967. Noordermeer SM, Adam S, Setiaputra D, Barazas M, Pettitt SJ, Ling AK, Olivieri M, Alvarez-Quilon A, Moatti N, Zimmermann M, Annunziato S, Krastev DB, Song F, Brandsma I, Frankum J, Brough R, Sherker A, Landry S, Szilard RK, Munro MM, McEwan A, Goullet de Rugy T, Lin ZY, Hart T, Moffat J, Gingras AC, Martin A, van Attikum H, Jonkers J, Lord CJ, Rottenberg S, Durocher D,` The shieldin complex mediates 53BP1-dependent DNA repair`, Nature 2018; 560:117-21 (NKI) 968. Noordman BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, Coene PPLO, Dekker JWT, Doukas M, van der Gaast A, Heisterkamp J, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JEN, Rosman C, van Sandick JW, van der Sangen MJC, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB,` Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial`, BMC Cancer 2018; 18:142 (NKI) 969. Noordman, BJ, van Klaveren, D, van Berge Henegouwen, MI, Wijnhoven, BPL, Gisbertz, SS, Lagarde, SM, van der Gaast, A, Hulshof, MCCM, Biermann, K, Steyerberg, EW & van Lanschot, JJB 2018, 'Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy', Annals of surgery, ;267(5): 892-897. (AmsterdamUMC) 970. Noordman, BJ, Verdam, MGE, Lagarde, SM, Hulshof, MCCM, van Hagen, P, van Berge Henegouwen, MI, Wijnhoven, BPL, van Laarhoven, HWM, Nieuwenhuijzen, GAP, Hospers, GAP, Bonenkamp, JJ, Cuesta, MA, Blaisse, RJB, Busch, OR, ten Kate, FJW, Creemers, G-JM, Punt, CJA, Plukker, JTM, Verheul, HMW, Spillenaar Bilgen, EJ, van Dekken, H, van der Sangen, MJC, Rozema, T, Biermann, K, Beukema, JC, Piet, AHM, van Rij, CM, Reinders, JG, Tilanus, HW, Steyerberg, EW, van der Gaast, A, Sprangers, MAG & van Lanschot, JJB 2018, 'Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial', Journal of clinical oncology, ;36(3): 268-+. (AmsterdamUMC) 971. Noordman, BJ, Verdam, MGE, Lagarde, SM, Shapiro, J, Hulshof, MCCM, van Berge Henegouwen, MI, Wijnhoven, BPL, Nieuwenhuijzen, GAP, Bonenkamp, JJ, Cuesta, MA, Plukker, JTM, Spillenaar Bilgen, EJ, Steyerberg, EW, van der Gaast, A, Sprangers, MAG & van Lanschot, JJB 2018, 'Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial', Annals of oncology, ;29(2): 445-451. (AmsterdamUMC) 972. Nota, NM, Wiepjes, CM, De Blok, CJM, Gooren, LJG, Peerdeman, SM, Kreukels, BPC & Den Heijer, M 2018, 'The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment', Brain, ;141(7): 2047-2054. (AmsterdamUMC) 973. Nout, R, Kirisits, C, Tanderup, K, Pötter, R, Haie-Méder, C, Pieters, B & Lindegaard, J 2018, 'Renaud Mazeron: A great scientist and teacher who contributed to GEC ESTRO for a decade. Tribute to Dr. Renaud Mazeron (1977–2016)', Cancer radiotherapie, ;22(4): 305-306. (AmsterdamUMC) 974. Nowak-Sliwinska, P & Griffioen, AW 2018, 'Apoptosis on the move', Apoptosis, ;23( 5-6): 251-254. (AmsterdamUMC) 975. Nyen, TV, Moiola, CP, Colas, E, Annibali, D & Amant, F 2018, 'Modeling endometrial cancer: Past, present, and future', International journal of molecular sciences, ;19(8): 2348. (AmsterdamUMC) 976. O’Mara, TA, Glubb, DM, Amant, F, Annibali, D, Ashton, K, Attia, J, Auer, PL, Beckmann, MW, Black, A, Bolla, MK, Brauch, H, Brenner, H, Brinton, L, Buchanan, DD, Burwinkel, B, Chang-Claude, J, Chanock, SJ, Chen, C, Chen, MM, Cheng, THT, Clarke, CL, Clendenning, M, Cook, LS, Couch, FJ, Cox, A, Crous-Bous, M, Czene, K, Day, F, Dennis, J, Depreeuw, J, Doherty, JA, Dörk, T, Dowdy, SC, Dürst, M, Ekici, AB, Fasching, PA, Fridley, BL, Friedenreich, CM, Fritschi, L, Fung, J, García-Closas, M, Gaudet, MM, Giles, GG, Goode, EL, Gorman, M, Haiman, CA, Hall, P, Hankison, SE, Healey, CS, Hein, A, Hillemanns, P, Hodgson, S, Hoivik, EA, Holliday, EG, Hopper, JL, Hunter, DJ, Jones, A, Krakstad, C, Kristensen, VN, Lambrechts, D, Marchand, LL, Liang, X, Lindblom, A, Lissowska, J, Long, J, Lu, L, Magliocco, AM, Martin, L, McEvoy, M, Meindl, A, Michailidou, K, Milne, RL, Mints, M, Montgomery, GW, Nassir, R, Olsson, HK, Orlow, I, Otton, G, Palles, C, Perry, JRB, Peto, J, Pooler, L, Prescott, J, Proietto, T, Rebbeck, TR, Risch, HA, Rogers, PAW, Rübner, M, Runnebaum, I, Sacerdote, C, Sarto, GE, Schumacher, F, Scott, RJ, Setiawan, VW, Shah, M, Sheng, X, Shu, X-O, Southey, MC, Swerdlow, AJ, Tham, E, Trovik, J, Turman, C, Tyrer, JP, Vachon, C, VanDen Berg, D, Vanderstichele, A, Wang, Z, Webb, PM, Wentzensen, N, Werner, HMJ, Winham, SJ, Wolk, A, Xia, L, Xiang, Y-B, Yang, HP, Yu, H, Zheng, W, Pharoah, PDP, Dunning, AM, Kraft, P, de Vivo, I, Tomlinson, I, Easton, DF, Spurdle, AB & Thompson, DJ 2018, 'Identification of nine new susceptibility loci for endometrial cancer', Nature communications, ;9(1): 3166. (AmsterdamUMC) 977. Oei, AL, Ahire, VR, van Leeuwen, CM, ten Cate, R, Stalpers, LJA, Crezee, J, Kok, HP & Franken, NAP 2018, 'Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i', International journal of hyperthermia, ;34(1): 39-48. (AmsterdamUMC) 978. Oerlemans R, Berkers CR, Assaraf YG, Scheffer GL, Peters GJ, Verbrugge SE, Cloos J, Slootstra J, Meloen RH, Shoemaker RH, Dijkmans BAC, Scheper RJ, Ovaa H, Jansen G,` Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide`, Invest New Drugs 2018; 36:797- 809 (NKI) 979. Oja AE, Piet B, van der Zwan D, Blaauwgeers H, Mensink M, de Kivit S, Borst J, Nolte MA, van Lier RAW, Stark R, Hombrink P,` Functional Heterogeneity of CD4(+) Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC`, Front Immunol 2018; 9:2654 (15 pp) (NKI) 980. Olazabal-Herrero, A, Peters, GJ, Giovannetti, E & Rodriguez, JA 2018, 'WDR48 (WD repeat domain 48)', Atlas of Genetics and Cytogenetics in Oncology and Haematology, ;22(2): 44-50. (AmsterdamUMC) 981. Olbara, G, Parigger, J, Njuguna, F, Skiles, J, Sitaresmi, MN, Gordijn, S, van de Ven, P, Kaspers, G & Mostert, S 2018, 'Health-care providers' perspectives on traditional and complementary alternative medicine of childhood cancer in Kenya', Pediatric Blood and Cancer, pp. 65. (AmsterdamUMC) 982. Oldenborg, S, Rasch, CRN, van Os, R, Kusumanto, YH, Oei, BS, Venselaar, JL, Heymans, MW, Zum Vörde Sive Vörding, PJ, Crezee, H & van Tienhoven, G 2018, 'Reirradiation + hyperthermia for recurrent breast cancer en cuirasse Rebestrahlung + Hyperthermie bei Brustkrebs in Form von Cancer en cuirasse', Strahlentherapie und Onkologie, ;194(3): 206-214. (AmsterdamUMC) 983. on behalf of the Dutch Colorectal Audit 2018, 'Evaluation of a completion total mesorectal excision in patients after local excision of rectal cancer: A word of caution', Journal of the National Comprehensive Cancer Network, ;16(7): 822-828. (AmsterdamUMC) 984. On behalf of the Dutch Head and Neck Society 2018, 'Predictive factors for pharyngocutaneous fistulization after total laryngectomy: a Dutch Head and Neck Society audit', European Archives of Oto- Rhino-Laryngology, ;275(3): 783-794. (AmsterdamUMC) 985. on behalf of the EAES committees 2018, 'EAES classification of intraoperative adverse events in laparoscopic surgery', Surgical Endoscopy, ;32(9): 3822-3829. (AmsterdamUMC) 986. on behalf of the EORTC QLG 2018, 'Understanding the quality of life (QOL) issues in survivors of cancer: Towards the development of an EORTC QOL cancer survivorship questionnaire', Health and Quality of Life Outcomes, ;16(1): 114. (AmsterdamUMC) 987. on behalf of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) 2018, 'Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)', Cancer, ;124(15): 3201-3209. (AmsterdamUMC) 988. on behalf of the PanCareSurFup Consortium 2018, 'The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries', European journal of epidemiology, ;33(3): 335-349. (AmsterdamUMC) 989. on behalf of the PLASTIC Study Group 2018, 'Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: A multicenter prospective study (PLASTIC-study)', BMC cancer, ;18(1): 450. (AmsterdamUMC) 990. on behalf of the St.Gallen Colorectal Consensus Expert Group 2018, 'St.Gallen consensus on safe implementation of transanal total mesorectal excision', Surgical Endoscopy, ;32(3): 1091-1103. (AmsterdamUMC) 991. Ooft ML, van Ipenburg JA, Sanders ME, Kranendonk M, Hofland I, De Bree R, Koljenovic S, Willems SM,` Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma`, J Clin Pathol 2018; 71:267-74 (NKI) 992. Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, Smeekes OS, Kersten MJ, Hardi L, Baars JW, Demandt AMP, Stevens WBC, Nijland M, van Imhoff GW, Brouwer R, Uyl-de Groot CA, Kluin PM, de Jong D, Veelken H,` Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens`, Ann Hematol 2018; 97:255-66 (AmsterdamUMC/NKI) 993. Oosterveld-Vlug, M, Donker, G, Atsma, F, Brom, L, de Man, Y, Groenewoud, S & Onwuteaka-Philipsen, B 2018, 'How do treatment aims in the last phase of life relate to hospitalizations and hospital mortality? A mortality follow-back study of Dutch patients with five types of cancer', Supportive Care in Cancer, ;26(3): 777-786. (AmsterdamUMC) 994. O'Shaughnessy J, Petrakova K, Sonke GS, Conte P, Arteaga CL, Cameron DA, Hart LL, Villanueva C, Jakobsen E, Beck JT, Lindquist D, Souami F, Mondal S, Germa C, Hortobagyi GN,` Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+`, Breast Cancer Res Treat 2018; 168:127- 34 (NKI) 995. Otten, JDM, van Schoor, G, Peer, PGM, den Heeten, GJ, Holland, R, Broeders, MJM & Verbeek, ALM 2018, 'Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population', Journal of medical screening, ;25(1): 40-46. (AmsterdamUMC) 996. Ottenhof SR, Djajadiningrat RS, Thygesen HH, Jakobs PJ, Jozwiak K, Heeren AM, de Jong J, Sanders J, Horenblas S, Jordanova ES,` The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma`, Front Immunol 2018; 9:1253 (AmsterdamUMC/NKI) 997. Otto W, van Rhijn BW, Breyer J, Bertz S, Eckstein M, Mayr R, Lausenmeyer EM, Denzinger S, Burger M, Hartmann A,` Infiltrative lamina propria invasion pattern as an independent predictor for cancer- specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer`, Int J Urol 2018; 25:442-9 (NKI) 998. Painter, JN, O'Mara, TA, Morris, AP, Cheng, THT, Gorman, M, Martin, L, Hodson, S, Jones, A, Martin, NG, Gordon, S, Henders, AK, Attia, J, McEvoy, M, Holliday, EG, Scott, RJ, Webb, PM, Fasching, PA, Beckmann, MW, Ekici, AB, Hein, A, Rübner, M, Hall, P, Czene, K, Dörk, T, Dürst, M, Hillemanns, P, Runnebaum, I, Lambrechts, D, Amant, F, Annibali, D, Depreeuw, J, Vanderstichele, A, Goode, EL, Cunningham, JM, Dowdy, SC, Winham, SJ, Trovik, J, Hoivik, E, Werner, HMJ, Krakstad, C, Ashton, K, Otton, G, Proietto, T, Tham, E, Mints, M, Ahmed, S, Healey, CS, Shah, M, Pharoah, PDP, Dunning, AM, Dennis, J, Bolla, MK, Michailidou, K, Wang, Q, Tyrer, JP, Hopper, JL, Peto, J, Swerdlow, AJ, Burwinkel, B, Brenner, H, Meindl, A, Brauch, H, Lindblom, A, Chang-Claude, J, Couch, FJ, Giles, GG, Kristensen, VN, Cox, A, Zondervan, KT, Nyholt, DR, MacGregor, S, Montgomery, GW, Tomlinson, I, Easton, DF, Thompson, DJ & Spurdle, AB 2018, 'Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses', Cancer medicine, ;7(5): 1978-1987. (AmsterdamUMC) 999. Pal SK, Rosenberg JE, Hoffman-Censits JH, Berger R, Quinn DI, Galsky MD, Wolf J, Dittrich C, Keam B, Delord JP, Schellens JHM, Gravis G, Medioni J, Maroto P, Sriuranpong V, Charoentum C, Burris HA, Grunwald V, Petrylak D, Vaishampayan U, Gez E, De Giorgi U, Lee JL, Voortman J, Gupta S, Mortazavi A, Vaughn DJ, Isaacs RE, Parker K, Chen X, Yu K, Porter D, Sharma S, Graus Porta D, Bajorin DF,` Efficacy of BGJ398, a fibroblast growth factor receptor 1-3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations`, Cancer Discov 2018; 8:812-21 (AmsterdamUMC/NKI) 1000. Palacios, MA, Bohoudi, O, Bruynzeel, AME, van Sörnsen-de Koste, JR, Cobussen, P, Slotman, BJ, Lagerwaard, FJ & Senan, S 2018, 'Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases', International journal of radiation oncology, biology, physics, ;102(2): 426-433. (AmsterdamUMC) 1001. Palanivelu, C, Takaori, K, Abu Hilal, M, Kooby, DA, Wakabayashi, G, Agarwal, A, Berti, S, Besselink, M, Chen, KH, Gumbs, AA, Han, H-S, Honda, G, Min Zheng, H, Khatkov, I, KIm, HJ, Li, JT, Duy Long, TC, Machado, MA, Matsushita, A, Menon, K, Nakamura, M, Nagakawa, Y, Pekolj, J, Poves, I, Rahman, S, Rong, L, Sa Cunha, A, Senthilnathan, P, Shrikhande, SV, Srivatsan, GS, Sup Yoon, D, Yoon, Y-S & Khatri , VP 2018, 'International Summit on Laparoscopic Pancreatic Resection (ISLPR) (AmsterdamUMC) 1002. PALGA Group 2018, 'A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands', International Journal of Cancer, ;143(4): 758-766. (AmsterdamUMC) 1003. PALGA-Group 2018, 'Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome', Clinical Cancer Research, ;24(1): 33-42. (AmsterdamUMC) 1004. Palmen, NGM, Lenderink, AF & Godderis, L 2018, 'New and emerging risks of chemical carcinogens: Detection and prevention', Occupational medicine (Oxford, England), ;68(2): 80-82. (AmsterdamUMC) 1005. Palmer AL, De Jong A, Leestemaker Y, Geurink PP, Wijdeven RH, Ovaa H, Dolan BP,` Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation`, J Immunol 2018; 200:928- 36 (NKI) 1006. Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larre S, Di Stasi S, van Rhijn B, Witjes AJ, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Gontero P,` Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought`, World J Urol 2018; 36:1621-7 (NKI) 1007. Pama, MR, Janse, M, Sprangers, MAG, Fleer, J & Ranchor, AV 2018, 'Reducing discrepancies of personal goals in the context of cancer: A longitudinal study on the relation with well-being, psychological characteristics, and goal progress', British journal of health psychology, ;23(1): 128-147. (AmsterdamUMC) 1008. PanCareLIFE Consortium 2018, 'Fertility among female survivors of childhood, adolescent, and young adult cancer: Protocol for two pan-European studies (PanCareLIFE)', Journal of medical Internet research, ;20(9): e10824. (AmsterdamUMC) 1009. PanCareLIFE Consortium 2018, 'Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol', BMC cancer, ;18(1): 930. (AmsterdamUMC) 1010. Pancreas 2000 research group 2018, 'Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(3): 216-221. (AmsterdamUMC) 1011. participants in PanCare 2018, 'Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016)', Journal of cancer survivorship, ;12(5): 647-650. (AmsterdamUMC) 1012. Passiglia, F, Caglevic, C, Giovannetti, E, Pinto, JA, Manca, P, Taverna, S, Listì, A, Gil-Bazo, I, Raez, LE, Russo, A & Rolfo, C 2018, 'Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment', Seminars in Cancer Biology, ;52: 259-268. (AmsterdamUMC) 1013. Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, van der Heide UA, Frank SJ, Nill S, Oelfke U, van Herk M, Li XA, Mittauer K, Ritter M, Choudhury A, Tree AC,` Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment? `,Int J Radiat Oncol Biol Phys 2018; 100:361-73 (AmsterdamUMC/NKI) 1014. Pectasides, E, Stachler, MD, Derks, S, Liu, Y, Maron, S, Islam, M, Alpert, L, Kwak, H, Kindler, H, Polite, B, Sharma, MR, Allen, K, O’Day, E, Lomnicki, S, Maranto, M, Kanteti, R, Fitzpatrick, C, Weber, C, Setia, N, Xiao, S-Y, Hart, J, Nagy, RJ, Kim, K-M, Choi, M-G, Min, B-H, Nason, KS, O’Keefe, L, Watanabe, M, Baba, H, Lanman, R, Agoston, AT, Oh, DJ, Dunford, A, Thorner, AR, Ducar, MD, Wollison, BM, Coleman, HA, Ji, Y, Posner, MC, Roggin, K, Turaga, K, Chang, P, Hogarth, K, Siddiqui, UD, Gelrud, A, Ha, G, Freeman, SS, Rhoades, J, Reed, S, Gydush, G, Rotem, D, Davison, J, Imamura, Y, Adalsteinsson, V, Lee, J, Bass, AJ & Catenacci, DV 2018, 'Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma', Cancer discovery, ;8(1): 37-48. (AmsterdamUMC) 1015. Pekošak, A, Bulc, JŽ, Korat, Š, Schuit, RC, Kooijman, E, Vos, R, Rongen, M, Verlaan, M, Takkenkamp, K, Beaino, W, Poot, AJ & Windhorst, AD 2018, 'Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P1-7', Molecular Pharmaceutics, ;15(11): 4872-4883. (AmsterdamUMC) 1016. Pekošak, A, Filp, U, Poot, AJ & Windhorst, AD 2018, 'From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application', Molecular Imaging and Biology, ;20(4): 510-532. (AmsterdamUMC) 1017. Peltenburg B, Driessen JP, Philippens MEP, Pameijer FA, Castelijns J, Dankbaar JW, Dorgelo B, Lange CAH, Meijer FJA, Palm WM, Roosendaal SD, Steens SCA, Verbist BM, Stegeman I, Janssen LM, De Bree R, Terhaard CHJ,` The interobserver agreement in the detection of recurrent HNSCC using MRI including diffusion weighted MRI`, Eur J Radiol 2018; 105:134-40 (NKI) 1018. Penders, YWH, Onwuteaka-Philipsen, B, Moreels, S, Donker, GA, Miccinesi, G, Alonso, TV, Deliens, L & van den Block, L 2018, 'Differences in primary palliative care between people with organ failure and people with cancer: An international mortality follow-back study using quality indicators', Palliative Medicine, ;32(9): 1498-1508. (AmsterdamUMC) 1019. Perego, P, Hempel, G, Linder, S, Bradshaw, TD, Larsen, AK, Peters, GJ, Phillips, RM & EORTC PAMM Group 2018, 'Cellular pharmacology studies of anticancer agents: recommendations from the EORTC- PAMM group', Cancer Chemotherapy and Pharmacology, ;81(3): 427-441. (AmsterdamUMC) 1020. Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Duran I, Theodore C, Grande E, Shen X, Wang J, Nelson B, Derleth CL, van der Heijden MS,` Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens`, Eur Urol 2018; 73:462-8 (NKI) 1021. Perik TJ, Kaas JJ, Greilich S, Wolthaus JWH, Wittkamper FW,` The characterization of a large multi-axis ionization chamber array in a 15 T MRI linac`, Phys Med Biol 2018; 63:225007 (NKI) 1022. Persoon, S, Chinapaw, MJM, Buffart, LM, Brug, J, Kersten, MJ & Nollet, F 2018, 'Lessons learnt from a process evaluation of an exercise intervention in patients treated with autologous stem cell transplantation', European journal of cancer care, ;27(1): e12779. (AmsterdamUMC) 1023. Peters, GJ 2018, 'Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines', Nucleosides, Nucleotides and Nucleic Acids, ;37(6): 329-339. (AmsterdamUMC) 1024. Peterse, EFP, Niessen, B, Addie, RD, de Jong, Y, Cleven, AHG, Kruisselbrink, AB, van den Akker, BEWM, Molenaar, RJ, Cleton-Jansen, A-M & Bovée, JVMG 2018, 'Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation', British journal of cancer, ;118(8): 1074-1083. (AmsterdamUMC) 1025. Petersen JF, Stuiver MM, Timmermans AJ, Chen A, Zhang H, O'Neill JP, Deady S, Vander Poorten V, Meulemans J, Wennerberg J, Skroder C, Day AT, Koch W, van den Brekel MWM,` Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer`, Laryngoscope 2018; 128:1140-5 (NKI) 1026. Petersen JF, Timmermans AJ, van Dijk BAC, Overbeek LIH, Smit LA, Hilgers FJM, Stuiver MM, van den Brekel MWM,` Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands`, Eur Arch Otorhinolaryngol 2018; 275:181-9 (NKI) 1027. Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T, Costantini A, Dirven L, Fayers P, Gamper EM, Giesinger JM, Habets EJJ, Hammerlid E, Helbostad J, Hjermstad MJ, Holzner B, Johnson C, Kemmler G, King MT, Kaasa S, Loge JH, Reijneveld JC, Singer S, Taphoorn MJB, Thamsborg LH, Tomaszewski KA, Velikova G, Verdonck-de Leeuw IM, Young T, Groenvold M,` The EORTC CAT Core- The computer adaptive version of the EORTC QLQ-C30 questionnaire`, Eur J Cancer 2018; 100:8-16 (NKI) 1028. Petri, GL, Cascioferro, S, Parrino, B, Peters, GJ, Diana, P & Giovannetti, E 2018, 'Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma', Pharmacogenomics, ;19(10): 811-814. (AmsterdamUMC) 1029. Pfaehler, E, De Jong, JR, Dierckx, RAJO, van Velden, FHP & Boellaard, R 2018, 'SMART (SiMulAtion and ReconsTruction) PET: an efficient PET simulation-reconstruction tool', EJNMMI PHYSICS, ;5(1): 16. (AmsterdamUMC) 1030. Pilsworth, JA, Cochrane, DR, Xia, Z, Aubert, G, Färkkilä, AEM, Horlings, HM, Yanagida, S, Yang, W, Lim, JLP, Wang, YK, Bashashati, A, Keul, J, Wong, A, Norris, K, Brucker, SY, Taran, F-A, Krämer, B, Staebler, A, van Meurs, H, Oliva, E, Shah, SP, Kommoss, S, Kommoss, F, Gilks, CB, Baird, DM & Huntsman, DG 2018, 'TERT promoter mutation in adult granulosa cell tumor of the ovary', Modern pathology, ;31(7): 1107- 1115. (AmsterdamUMC) 1031. Pindyurin AV, Ilyin AA, Ivankin AV, Tselebrovsky MV, Nenasheva VV, Mikhaleva EA, Pagie L, van Steensel B, Shevelyov YY,` The large fraction of heterochromatin in Drosophila neurons is bound by both B-type lamin and HP1a`, Epigenetics Chromatin 2018; 11:65 (17 pp) (NKI) 1032. Pioche, M, Denis, A, Allescher, H-D, Andrisani, G, Costamagna, G, Dekker, E, Fockens, P, Gerges, C, Groth, S, Kandler, J, Lienhart, I, Neuhaus, H, Petruzziello, L, Schachschal, G, Tytgat, K, Wallner, J, Weingart, V, Touzet, S, Ponchon, T & Rösch, T 2018, 'Impact of 2 generational improvements of colonoscopes on adenoma miss rates: results of a prospective randomized multicenter tandem study', Gastrointestinal endoscopy, ;88(1): 107-116. (AmsterdamUMC) 1033. Pirpinia K, Bosman PAN, Loo CE, Russell NS, van Herk MB, Alderliesten T,` Simplex-based navigation tool for a posteriori selection of the preferred deformable image registration outcome from a set of trade-off solutions obtained with multiobjective optimization for the case of breast MRI`, J Med Imaging (Bellingham) 2018; 5:045501 (NKI) 1034. Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S,` Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up`, Ann Oncol 2018; 29:iv192-iv237 [Guideline] (NKI) 1035. Plenker D, Bertrand M, de Langen AJ, Riedel R, Lorenz C, Scheel AH, Muller JN, Bragelmann J, Dassler- Plenker J, Kobe C, Persigehl T, Kluge A, Wurdinger T, Schellen P, Hartmann G, Zacherle T, Menon R, Thunnissen E, Buttner R, Griesinger F, Wolf J, Heukamp L, Heuckmann JM, Sos ML,` Structural alterations of MET trigger response to MET kinase inhibition in lung adenocarcinoma patients`, Clin Cancer Res 2018; 24:1337-43 (AmsterdamUMC/NKI) 1036. Pluim D, Ros W, van Bussel MTJ, Brandsma D, Beijnen JH, Schellens JHM,` Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid`, J Pharm Biomed Anal 2018; 164:128-34 (NKI) 1037. Plummer, R, Verheul, HM, de Vos, FYFL, Leunen, K, Molife, LR, Rolfo, C, Grundtvig-Sørensen, P, de Grève, J, Rottey, S, Jerusalem, G, Italiano, A, Spicer, J, Dirix, L, Goessl, C, Birkett, J, Spencer, S, Learoyd, M, Bailey, C & Dean, E 2018, 'Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours', Advances in therapy, ;35(11): 1945-1964. (AmsterdamUMC) 1038. Poddighe, PJ, Veening, MA, Mansur, MB, Loonen, AH, Westers, TM, Merle, PA, Wessels, JW, de Haas, V, Kors, WA, Bhola, SL, Wondergem, MJ, Ford, AM & Kaspers, GJL 2018, 'A novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease', Human Pathology: Case Reports, ;11: 34-38. (AmsterdamUMC) 1039. Poel, D, Buffart, TE, Oosterling-Jansen, J, Verheul, HM & Voortman, J 2018, 'Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer', Experimental & Molecular Medicine, ;50(3): e454. (AmsterdamUMC) 1040. Poelemeijer YQM, Detering R, Wouters MWJM,` Reply to "Is obesity a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery?"`, Eur J Surg Oncol 2018; 44:1998 [Letter] (NKI) 1041. Poelemeijer YQM, Lijftogt N, Detering R, Fiocco M, Tollenaar RAEM, Wouters MWJM,` Obesity as a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery: A population-based study (2009-2016)`, Eur J Surg Oncol 2018; 44:1849-57 (AmsterdamUMC/NKI) 1042. Poelman, MR, Brand, HS, Forouzanfar, T, Daley, EM & Jager, DHJ 2018, 'Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students', Journal of Cancer Education, ;33(6): 1347-1354. (AmsterdamUMC) 1043. Ponds, FA, Moonen, A, Smout, AJPM, Rohof, WOA, Tack, J, van Gool, S, Bisschops, R, Bredenoord, AJ & Boeckxstaens, GE 2018, 'Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic Achalasia', American journal of gastroenterology, ;113(6): 855-862. (AmsterdamUMC) 1044. Poodt IGM, Schipper RJ, Vugts G, Woensdregt K, van der Sangen M, Voogd AC, Nieuwenhuijzen GAP,` The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer`, Eur J Surg Oncol 2018; 44:1714-9 (NKI) 1045. Poodt IGM, Spronk PER, Vugts G, van Dalen T, Vrancken Peeters MTFD, Rots ML, Kuijer A, Nieuwenhuijzen GAP, Schipper RJ,` Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era`, Ann Surg 2018; 268:1084-90 (NKI) 1046. Poort, H, Meade, CD, Knoop, H, Gielissen, MFM, Pinilla-Ibarz, J & Jacobsen, PB 2018, 'Adapting an Evidence-Based Intervention to Address Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia Patients', Cancer nursing, ;41(1): E28-E37. (AmsterdamUMC) 1047. PORTEC Study Group & Stalpers, L 2018, 'Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial', lancet oncology, ;19(3): 295-309. (AmsterdamUMC) 1048. PORTEC Study Group & Westerveld, H 2018, 'Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial', Gynecologic oncology, ;151(1): 69-75. (AmsterdamUMC) 1049. Postema, FAM, Hopman, SMJ, Hennekam, RC & Merks, JHM 2018, 'Consequences of diagnosing a tumor predisposition syndrome in children with cancer: A literature review', Pediatric blood & cancer, ;65(1): e26718. (AmsterdamUMC) 1050. Potter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I, Chopra S, van der Heide U, Rumpold T, Lindegaard JC, Jurgenliemk-Schulz I,` The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies`, Clin Transl Radiat Oncol 2018; 9:48-60 (NKI) 1051. Pouw, RE, Beyna, T, Belghazi, K, Koch, AD, Schoon, EJ, Haidry, R, Weusten, BL, Bisschops, R, Shaheen, NJ, Wallace, MB, Marcon, N, Heise-Ginsburg, R, Gotink, AW, Wang, KK, Leggett, CL, Ortiz-Fernández- Sordo, J, Ragunath, K, DiPietro, M, Pech, O, Neuhaus, H & Bergman, JJ 2018, 'A prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett's esophagus', Gastrointestinal endoscopy, ;88(4): 647-654. (AmsterdamUMC) 1052. Pouw, RE, Künzli, HT, Bisschops, R, Sondermeijer, CM, Koch, AD, Didden, P, Gotink, AW, Schoon, EJ, Curvers, WL, Bergman, JJGHM & Weusten, BLAM 2018, 'Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trial', lancet. Gastroenterology & hepatology, ;3(8): 566-574. (AmsterdamUMC) 1053. Powles T, Albiges L, Staehler M, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernandez-Pello S, Tahbaz R, Volpe A, Ljungberg B, Bex A,` Updated European Association of Urology Guidelines Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer`, Eur Urol 2018; 73:311-5 (NKI) 1054. Powles T, Duran I, van der Heijden MS, Loriot Y, Vogelzang NJ, De Giorgi U, Oudard S, Retz MM, Castellano D, Bamias A, Flechon A, Gravis G, Hussain S, Takano T, Leng N, Kadel EE, III, Banchereau R, Hegde PS, Mariathasan S, Cui N, Shen X, Derleth CL, Green MC, Ravaud A,` Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial`, Lancet 2018; 391:748- 57 (NKI) 1055. Pradere B, Peyronnet B, Delporte G, Manach Q, Khene ZE, Moulin M, Roumiguie M, Rizk J, Brichart N, Beauval JB, Cormier L, Bex A, Roupret M, Bruyere F, Bensalah K,` Intraoperative cyst rupture of partial nephrectomy for cystic renal masses: does it increase the risk of recurrence? `,J Urol 2018; 200:1200-6 (NKI) 1056. Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, Sonke GS, Martinez GA, Frenel JS, Karamouzis M, Strijbos M, Yazici O, Bossi P, Banerjee S, Troiani T, Eniu A, Ciardiello F, Tabernero J, Zielinski CC, Casali PG, Cardoso F, Douillard JY, Jezdic S, McGregor K, Bricalli G, Vyas M, Ilbawi A,` Global cancer control: responding to the growing burden, rising costs and inequalities in access`, ESMO Open 2018; 3:e000285 (NKI) 1057. Prekovic S, van den Broeck T, Linder S, van Royen ME, Houtsmuller AB, Handle F, Joniau S, Zwart W, Claessens F,` Molecular underpinnings of enzalutamide resistance`, Endocr Relat Cancer 2018; 25:R545-R557 (NKI) 1058. Puijk, RS, Ruarus, AH, Scheffer, HJ, Vroomen, LGPH, van Tilborg, AAJM, de Vries, JJJ, Berger, FH, van den Tol, PMP & Meijerink, MR 2018, 'Percutaneous Liver Tumour Ablation: Image Guidance, Endpoint Assessment, and Quality Control', Canadian Association of Radiologists Journal, ;69(1): 51-62. (AmsterdamUMC) 1059. Quispel-Janssen J, van der Noort V, de Vries JF, Zimmerman M, Lalezari F, Thunnissen E, Monkhorst K, Schouten R, Schunselaar L, Disselhorst M, Klomp H, Hartemink K, Burgers S, Buikhuisen W, Baas P,` Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma`, J Thorac Oncol 2018; 13:1569-76 (NKI) 1060. Quispel-Janssen JM, Badhai J, Schunselaar L, Price S, Brammeld JS, Iorio F, Kolluri KK, Garnett MJ, Berns A, Baas P, McDermott U, Neefjes J, Alifrangis C,` Comprehensive pharmacogenomic profiling of malignant pleural mesothelioma identifies a subgroup sensitive to FGFR inhibition`, Clin Cancer Res 2018; 24:84-94 (NKI) 1061. Quispel-Janssen, J, van der Noort, V, de Vries, JF, Zimmerman, M, Lalezari, F, Thunnissen, E, Monkhorst, K, Schouten, R, Schunselaar, L, Disselhorst, M, Klomp, H, Hartemink, K, Burgers, S, Buikhuisen, W & Baas, P 2018, 'Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma', Journal of Thoracic Oncology, ;13(10): 1569-1576. (AmsterdamUMC) 1062. Raaijmakers JA, van Heesbeen RGHP, Blomen VA, Janssen LME, van Diemen F, Brummelkamp TR, Medema RH,` BUB1 Is Essential for the Viability of Human Cells in which the Spindle Assembly Checkpoint Is Compromised`, Cell Rep 2018; 22:1424-38 (NKI) 1063. Raap M, Gronewold M, Christgen H, Glage S, Bentires-Alj M, Koren S, Derksen PW, Boelens M, Jonkers J, Lehmann U, Feuerhake F, Kuehnle E, Gluz O, Kates R, Nitz U, Harbeck N, Kreipe HH, Christgen M,` Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2beta`, Lab Invest 2018; 98:117-29 (NKI) 1064. Radivoyevitch, T, Dean, RM, Shaw, BE, Brazauskas, R, Tecca, HR, Molenaar, RJ, Battiwalla, M, Savani, BN, Flowers, MED, Cooke, KR, Hamilton, BK, Kalaycio, M, Maciejewski, JP, Ahmed, I, Akpek, GR, Bajel, A, Buchbinder, D, Cahn, J-Y, D'Souza, A, Daly, A, DeFilipp, Z, Ganguly, S, Hamadani, M, Hayashi, RJ, Hematti, P, Inamoto, Y, Khera, N, Kindwall-Keller, T, Landau, H, Lazarus, H, Majhail, NS, Marks, DI, Olsson, RF, Seo, S, Steinberg, A, William, BM, Wirk, B, Yared, JA, Aljurf, M, Abidi, MH, Allewelt, H, Beitinjaneh, A, Cook, R, Cornell, RF, Fay, JW, Hale, G, Chakrabarty, JH, Jodele, S, Kasow, KA, Mahindra, A, Malone, AK, Popat, U, Rizzo, JD, Schouten, HC, Warwick, AB, Wood, WA, Sekeres, MA, Litzow, MR, Gale, RP & Hashmi, SK 2018, 'Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma', Leukemia research, ;74: 130-136. (AmsterdamUMC) 1065. Raison N, Ahmed K, Abe T, Brunckhorst O, Novara G, Buffi N, McIlhenny C, van der Poel H, Van Hemelrijck M, Gavazzi A, Dasgupta P,` Cognitive Training for Technical and Non-Technical Skills in Robotic Surgery: A Randomised Controlled Trial`, BJU Int 2018; 122:1075-81 (NKI) 1066. Rajaraman P, Hauptmann M, Bouffler S, Wojcik A,` Human individual radiation sensitivity and prospects for prediction`, Ann ICRP 2018; 47:126-41 (NKI) 1067. Rajbhandari, P, Lopez, G, Capdevila, C, Salvatori, B, Yu, J, Rodriguez-Barrueco, R, Martinez, D, Yarmarkovich, M, Weichert-Leahey, N, Abraham, BJ, Alvarez, MJ, Iyer, A, Harenza, JL, Oldridge, D, de Preter, K, Koster, J, Asgharzadeh, S, Seeger, RC, Wei, JS, Khan, J, Vandesompele, J, Mestdagh, P, Versteeg, R, Look, AT, Young, RA, Iavarone, A, Lasorella, A, Silva, JM, Maris, JM & Califano, A 2018, 'Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma', Cancer discovery, ;8(5): 582-599. (AmsterdamUMC) 1068. Raman A, Kuusk T, Hyde ER, Berger LU, Bex A, Mumtaz F,` Robotic-Assisted Laparoscopic Partial Nephrectomy in a Horseshoe Kidney a Case Report and Review of the Literature`, Urology 2018; 114:e3-e5 (NKI) 1069. Raman S, Ding K, Chow E, Meyer RM, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JSY, Nabid A, Haas R, Wiggenraad R, Babington S, Demas WF, Wilson CF, Wong RKS, Zhu L, Brundage M,` Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases`, Qual Life Res 2018; 27:1089-98 (NKI) 1070. Raman, S, Moraes, FY, Mendez, LC, Taunk, NK, Suh, JH, Souhami, L, Slotman, B, Kongkham, P, Spratt, DE, Berlin, A & Marta, GN 2018, 'The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials', Journal of Neuro-Oncology, ;139(1): 195-203. (AmsterdamUMC) 1071. Ramayanti, O, Brinkkemper, M, Verkuijlen, SAWM, Ritmaleni, L, Go, ML & Middeldorp, JM 2018, 'Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas', Cancers, ;10(4): 89. (AmsterdamUMC) 1072. Raskin J, Surmont V, Cornelissen R, Baas P, van Schil PEY, van Meerbeeck JP,` A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)`, Transl Lung Cancer Res 2018; 7:593-8 (NKI) 1073. Raskob, GE, van Es, N, Verhamme, P, Carrier, M, Di Nisio, M, Garcia, D, Grosso, MA, Kakkar, AK, Kovacs, MJ, Mercuri, MF, Meyer, G, Segers, A, Shi, M, Wang, T-F, Yeo, E, Zhang, G, Zwicker, JI, Weitz, JI, Büller, HR & AUTHOR GROUP 2018, 'Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism', New England journal of medicine, ;378(7): 615-624. (AmsterdamUMC) 1074. Rassam, F, Roos, E, van Lienden, KP, van Hooft, JE, Klümpen, HJ, van Tienhoven, G, Bennink, RJ, Engelbrecht, MR, Schoorlemmer, A, Beuers, UHW, Verheij, J, Besselink, MG, Busch, OR & van Gulik, TM 2018, 'Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience', Langenbeck s archives of surgery / Deutsche Gesellschaft fur Chirurgie, ;403(3): 289-307. (AmsterdamUMC) 1075. Rawicz-Pruszynski K, van Sandick JW, Mielko J, Cisel B, Polkowski WP,` Current challenges in gastric cancer surgery: European perspective`, Surg Oncol 2018; 27:650-6 (NKI) 1076. Read, MD, Krishnadath, KK, Clemons, NJ & Phillips, WA 2018, 'Preclinical models for the study of Barrett's carcinogenesis', Annals of the New York Academy of Sciences, ;1434(1): 139-148. (AmsterdamUMC) 1077. Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero EI, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, Adlard J, Agata S, Aittomaki K, Andrews L, Andrulis IL, Arason A, Arnold N, Arun BK, Asseryanis E, Auerbach L, Azzollini J, Balmana J, Barile M, Barkardottir RB, Barrowdale D, Benitez J, Berger A, Berger R, Blanco AM, Blazer KR, Blok MJ, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campbell I, Caputo S, Chiquette J, Chung WK, Claes KBM, Collee JM, Cook J, Davidson R, de la Hoya M, De Leeneer K, de Pauw A, Delnatte C, Diez O, Ding YC, Ditsch N, Domchek SM, Dorfling CM, Velazquez C, Dworniczak B, Eason J, Easton DF, Eeles R, Ehrencrona H, Ejlertsen B, Engel C, Engert S, Evans DG, Faivre L, Feliubadalo L, Ferrer SF, Foretova L, Fowler J, Frost D, Galvao HCR, Ganz PA, Garber J, Gauthier-Villars M, Gehrig A, Gerdes AM, Gesta P, Giannini G, Giraud S, Glendon G, Godwin AK, Greene MH, Gronwald J, Gutierrez-Barrera A, Hahnen E, Hauke J, Henderson A, Hentschel J, Hogervorst FBL, Honisch E, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Joseph V, Kaczmarek K, Karlan BY, Kast K, Investigators K, Kim SW, Konstantopoulou I, Korach J, Laitman Y, Lasa A, Lasset C, Lazaro C, Lee A, Lee MH, Lester J, Lesueur F, Liljegren A, Lindor NM, Longy M, Loud JT, Lu KH, Lubinski J, Machackova E, Manoukian S, Mari V, Martinez-Bouzas C, Matrai Z, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Mickys U, Miller A, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Neuhausen SL, Nevanlinna H, Ngeow J, Nguyen HP, Niederacher D, Nielsen HR, Nielsen FC, Nussbaum RL, Offit K, Ofverholm A, Ong KR, Osorio A, Papi L, Papp J, Pasini B, Pedersen IS, MSc AP, MSc NP, Peterlongo P, Pohl E, Ba NP, Prajzendanc K, Prieur F, Pujol P, Radice P, Ramus SJ, Rantala J, Rashid MU, Rhiem K, Robson M, Rodriguez GC, Rogers MT, Rudaitis V, Schmidt AY, Schmutzler RK, Senter L, Shah PD, Sharma P, Side LE, Simard J, Singer CF, Skytte AB, Slavin TP, Snape K, Sobol H, Southey M, Steele L, Steinemann D, Sukiennicki G, Sutter C, Szabo CI, Tan YY, Teixeira MR, Terry MB, Teule A, Thomas A, Thull DL, Tischkowitz M, Tognazzo S, Toland AE, Topka S, Trainer AH, Tung N, van Asperen CJ, van der Hout AH, van der Kolk LE, van der Luijt RB, Van Heetvelde M, Varesco L, Varon-Mateeva R, Vega A, Villarreal-Garza C, von Wachenfeldt A, Walker L, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Yoon SY, Zanzottera C, Zidan J, Zorn KK, Selkirk CGH, Hulick PJ, Chenevix-Trench G, Spurdle AB, Antoniou AC, Nathanson KL,` Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations`, Hum Mutat 2018; 39:593-620 (NKI) 1078. Rebbeck, TR, Friebel, TM, Friedman, E, Hamann, U, Huo, D, Kwong, A, Olah, E, Olopade, OI, Solano, AR, teo, S-H, Thomassen, M, Weitzel, JN, Chan, TL, Couch, FJ, Goldgar, DE, Kruse, TA, Palmero, EI, Park, SK, Torres, D, van Rensburg, EJ, McGuffog, L, Parsons, MT, Leslie, G, Aalfs, CM, Abugattas, J, Adlard, J, Agata, S, Aittomäki, K, Andrews, L, Andrulis, IL, Arason, A, Arnold, N, Arun, BK, Asseryanis, E, Auerbach, L, Azzollini, J, Balmaña, J, Barile, M, Barkardottir, RB, Barrowdale, D, Benitez, J, Berger, A, Berger, R, Blanco, AM, Blazer, KR, Blok, MJ, Bonadona, V, Bonanni, B, Bradbury, AR, Brewer, C, Buecher, B, Buys, SS, Caldes, T, Caliebe, A, Caligo, MA, Campbell, I, Caputo, S, Chiquette, J, Chung, WK, Claes, KBM, Collée, JM, Cook, J, Davidson, R, de la Hoya, M, de Leeneer, K, de Pauw, A, Delnatte, C, Diez, O, Ding, YC, Ditsch, N, Domchek, SM, Dorfling, CM, Velazquez, C, Dworniczak, B, Eason, J, Easton, DF, Eeles, R, Ehrencrona, H, Ejlertsen, B, Engel, C, Engert, S, Evans, DG, Faivre, L, Feliubadaló, L, Ferrer, SF, Foretova, L, Fowler, J, Frost, D, Galvão, HCR, Ganz, PA, Garber, J, Gauthier-Villars, M, Gehrig, A, Gerdes, A-M, Gesta, P, Giannini, G, Giraud, S, Glendon, G, Godwin, AK, Greene, MH, Gronwald, J, Gutierrez-Barrera, A, Hahnen, E, Hauke, J, Henderson, A, Hentschel, J, Hogervorst, FBL, Honisch, E, Imyanitov, EN, Isaacs, C, Izatt, L, Izquierdo, A, Jakubowska, A, James, P, Janavicius, R, Jensen, UB, John, EM, Joseph, V, Kaczmarek, K, Karlan, BY, Kast, K, Investigators, KC, Kim, S-W, Konstantopoulou, I, Korach, J, Laitman, Y, Lasa, A, Lasset, C, Lázaro, C, Lee, A, Lee, MH, Lester, J, Lesueur, F, Liljegren, A, Lindor, NM, Longy, M, Loud, JT, Lu, KH, Lubinski, J, Machackova, E, Manoukian, S, Mari, V, Martínez- Bouzas, C, Matrai, Z, Mebirouk, N, Meijers-Heijboer, HEJ, Meindl, A, Mensenkamp, AR, Mickys, U, Miller, A, Montagna, M, Moysich, KB, Mulligan, AM, Musinsky, J, Neuhausen, SL, Nevanlinna, H, Ngeow, J, Nguyen, HP, Niederacher, D, Nielsen, HR, Nielsen, FC, Nussbaum, RL, Offit, K, Öfverholm, A, Ong, K-R, Osorio, A, Papi, L, Papp, J, Pasini, B, Pedersen, IS, MSc, AP, MSc, NP, Peterlongo, P, Pohl, E, Ba, NP, Prajzendanc, K, Prieur, F, Pujol, P, Radice, P, Ramus, SJ, Rantala, J, Rashid, MU, Rhiem, K, Robson, M, Rodriguez, GC, Rogers, MT, Rudaitis, V, Schmidt, AY, Schmutzler, RK, Senter, L, Shah, PD, Sharma, P, Side, LE, Simard, J, Singer, CF, Skytte, A-B, Slavin, TP, Snape, K, Sobol, H, Southey, M, Steele, L, Steinemann, D, Sukiennicki, G, Sutter, C, Szabo, CI, Tan, YY, Teixeira, MR, Terry, MB, Teulé, A, Thomas, A, Thull, DL, Tischkowitz, M, Tognazzo, S, Toland, AE, Topka, S, Trainer, AH, Tung, N, van Asperen, CJ, van der Hout, AH, van der Kolk, LE, van der Luijt, RB, van Heetvelde, M, Varesco, L, Varon- Mateeva, R, Vega, A, Villarreal-Garza, C, von Wachenfeldt, A, Walker, L, Wang-Gohrke, S, Wappenschmidt, B, Weber, BHF, Yannoukakos, D, Yoon, S-Y, Zanzottera, C, Zidan, J, Zorn, KK, Selkirk, CGH, Hulick, PJ, Chenevix-Trench, G, Spurdle, AB, Antoniou, AC & Nathanson, KL 2018, 'Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations', Human mutation, ;39(5): 593-620. (AmsterdamUMC) 1079. Rebers S, Vermeulen E, Brandenburg AP, Aaronson NK, Schmidt MK,` Recall and Retention of Consent Procedure Contents and Decisions: Results of a Randomized Controlled Trial`, Public Health Genomics 2018; 21:27-36 (NKI) 1080. Reedijk M, Lenters V, Slottje P, Pijpe A, Peeters PH, Korevaar JC, Bueno-de-Mesquita B, Verschuren WMM, Verheij RA, Pieterson I, van Leeuwen FE, Rookus MA, Kromhout H, Vermeulen RCH,` Cohort profile: LIFEWORK, a prospective cohort study on occupational and environmental risk factors and health in the Netherlands`, BMJ Open 2018; 8:e018504 (NKI) 1081. Regenboog, M, van Dussen, L, Verheij, J, Weinreb, NJ, Santosa, D, vom Dahl, S, Häussinger, D, Müller, MN, Canbay, A, Rigoldi, M, Piperno, A, Dinur, T, Zimran, A, Mistry, PK, Salah, KY, Belmatoug, N, Kuter, DJ & Hollak, CEM 2018, 'Hepatocellular carcinoma in Gaucher disease: an international case series', Journal of inherited metabolic disease, ;41(5): 819-827. (AmsterdamUMC) 1082. Reinders, MG, van Hout, AF, Cosgun, B, Paulussen, AD, Leter, EM, Steijlen, PM, Mosterd, K, van Geel, M & Gille, JJ 2018, 'New mutations and an updated database for the patched-1 (PTCH1) gene', Molecular Genetics and Genomic Medicine, ;6(3): 409-415. (AmsterdamUMC) 1083. Reis H, Krafft U, Niedworok C, Modos O, Herold T, Behrendt M, Al Ahmadie H, Hadaschik B, Nyirady P, Szarvas T,` Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data`, Dis Markers 2018; 2018:7308168 [Review]-(21 pp) (NKI) 1084. Reis H, van der Vos KE, Niedworok C, Herold T, Modos O, Szendroi A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, Ablat J, Okon K, Tolkach Y, Keresztes D, Nagy N, Bremmer F, Gaisa NT, Chlosta P, Kriegsmann J, Kovalszky I, Timar J, Kristiansen G, Radzun HJ, Knuchel R, Schuler M, Black P, Rubben H, Hadaschik B, Schmid KW, van Rhijn BWG, Nyirady P, Szarvas T,` Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas`, Int J Cancer 2018; 143:1764-73 (NKI) 1085. Ren, Z, van Andel, H, de Lau, W, Hartholt, RB, Maurice, MM, Clevers, H, Kersten, MJ, Spaargaren, M & Pals, ST 2018, 'Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins', Blood, ;131(9): 982-944. (AmsterdamUMC) 1086. Ressa A, Bosdriesz E, de Ligt J, Mainardi S, Maddalo G, Prahallad A, Jager M, de la Fonteijne L, Fitzpatrick M, Groten S, Altelaar AFM, Bernards R, Cuppen E, Wessels L, Heck AJR,` A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells`, Mol Cell Proteomics 2018; 17:1892-908 (NKI) 1087. Retel VP, Steuten LMG, Geukes Foppen MH, Mewes JC, Lindenberg MA, Haanen JBAG, van Harten WH,` Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation`, BMC Cancer 2018; 18:895 (NKI) 1088. Reuling, EMBP, Dickhoff, C, Plaisier, PW, Coupé, VMH, Mazairac, AHA, Lely, RJ, Bonjer, HJ & Daniels, JMA 2018, 'Endobronchial Treatment for Bronchial Carcinoid: Patient Selection and Predictors of Outcome', Respiration, ;95(4): 220-227. (AmsterdamUMC) 1089. Rex, DK & Dekker, E 2018, 'How we resect colorectal polyps < 20 mm in size', Endoscopy, ;50(11): 1112-1115. (AmsterdamUMC) 1090. Reynolds LM, Pokinko M, Torres-Berrio A, Cuesta S, Lambert LC, Cid Pellitero E, Wodzinski M, Manitt C, Krimpenfort P, Kolb B, Flores C ,` DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence`, Biol Psychiatry 2018; 83:181-92 (NKI) 1091. Richardson, PG, Zweegman, S, O’Donnell, EK, Laubach, JP, Raje, N, Voorhees, P, Ferrari, RH, Skacel, T, Kumar, SK & Lonial, S 2018, 'Ixazomib for the treatment of multiple myeloma', Expert Opinion on Pharmacotherapy, ;19(17): 1949-1968. (AmsterdamUMC) 1092. Rietbergen, MM, van Bokhoven, AAJD, Lissenberg-Witte, BI, Heideman, DAM, Leemans, CR, Brakenhoff, RH & Bloemena, E 2018, 'Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions', International Journal of Cancer, ;143(2): 283-288. (AmsterdamUMC) 1093. Rietveld, SCM, Witvliet-van Nierop, JE, Ottens-Oussoren, K, van der Peet, DL & de van der Schueren, MAE 2018, 'The Prediction of Deterioration of Nutritional Status during Chemoradiation Therapy in Patients with Esophageal Cancer', Nutrition and Cancer, ;70(2): 229-235. (AmsterdamUMC) 1094. Rigter LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, Aleman BM, Ten Hoeve J, Geurts-Giele WR, van Ravesteyn TW, Hoeksel J, Meijer GA, Te Riele H, van Leeuwen FE, Dinjens WN, van Leerdam ME,` Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment`, Gut 2018; 67:447-55 (AmsterdamUMC/NKI) 1095. Rijken, JA, Niemeijer, ND, Jonker, MA, Eijkelenkamp, K, Jansen, JC, van Berkel, A, Timmers, HJLM, Kunst, HPM, Bisschop, PHLT, Kerstens, MN, Dreijerink, KMA, van Dooren, MF, van der Horst-Schrivers, ANA, Hes, FJ, Leemans, CR, Corssmit, EPM & Hensen, EF 2018, 'The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers', Clinical Genetics, ;93(1): 60-66. (AmsterdamUMC) 1096. Rijkmans EC, van Triest B, Nout RA, Kerkhof EM, Buijsen J, Rozema T, Franssen JH, Velema LA, Laman MS, Cats A, Marijnen CAM,` Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study`, Radiother Oncol 2018; 126:417-23 (NKI) 1097. Rikkert, LG, van der Pol, E, van Leeuwen, TG, Nieuwland, R & Coumans, FAW 2018, 'Centrifugation affects the purity of liquid biopsy-based tumor biomarkers', Cytometry. Part A, ;93(12): 1207-1212. (AmsterdamUMC) 1098. Ringborg U, Celis J, Eggermont A, Berns A,` European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence`, Eur J Cancer 2018; 93:138-9 [Editorial] (NKI) 1099. Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, Bernards R, Di Nicolantonio F, Giordano S, Tamagnone L,` Neuropilin-1 upregulation elicits adaptive resistance to oncogene- targeted therapies`, J Clin Invest 2018; 128:3976-90 (NKI) 1100. Robinson-McCarthy LR, McCarthy KR, Raaben M, Piccinotti S, Nieuwenhuis J, Stubbs SH, Bakkers MJG, Whelan SPJ,` Reconstruction of the cell entry pathway of an extinct virus`, PLoS Pathog 2018; 14:e1007123 ( (NKI) 1101. Rodon J, Perez-Fidalgo A, Krop IE, Burris H, Guerrero-Zotano A, Britten CD, Becerra C, Schellens J, Richards DA, Schuler M, Abu-Khalaf M, Johnson FM, Ranson M, Edenfield J, Silva AP, Hackl W, Quadt C, Demanse D, Duval V, Baselga J,` Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer`, Cancer Chemother Pharmacol 2018; 82:285-98 (NKI) 1102. RodrÍguez, E, Schetters, STT & van Kooyk, Y 2018, 'The tumour glyco-code as a novel immune checkpoint for immunotherapy', Nature Reviews Immunology, ;18(3): 204-211. (AmsterdamUMC) 1103. Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, de Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA,` Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma`, J Clin Oncol 2018; 36:942-50 (AmsterdamUMC/NKI) 1104. Roepman, P, Ten Heuvel, A, Scheidel, KC, Sprong, T, Heideman, DAM, Seldenrijk, KA, Herder, GJM & Kummer, JA 2018, 'Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic Investigation', The Journal of molecular diagnostics, ;20(4): 436-445. (AmsterdamUMC) 1105. Roeten, MSF, Cloos, J & Jansen, G 2018, 'Positioning of proteasome inhibitors in therapy of solid malignancies', Cancer Chemotherapy and Pharmacology, ;81(2): 227-243. (AmsterdamUMC) 1106. Rohaan MW, van den Berg JH, Kvistborg P, Haanen JBAG,` Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option`, J Immunother Cancer 2018; 6:102 (NKI) 1107. Rolfo C, Mack PC, Scagliotti GV, Baas P, Barlesi F, Bivona TG, Herbst RS, Mok TS, Peled N, Pirker R, Raez LE, Reck M, Riess JW, Sequist LV, Shepherd FA, Sholl LM, Tan DS, Wakelee HA, Wistuba II, Wynes MW, Carbone DP, Hirsch FR, Gandara DR,` IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC)`, J Thorac Oncol 2018; 13:1248-68 (NKI) 1108. Rombouts, SJE, Derksen, TC, Nio, CY, van Hillegersberg, R, van Santvoort, HC, Walma, MS, Molenaar, IQ & van Leeuwen, MS 2018, 'Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer', Abdominal radiology (New York), ;43(10): 2702-2711. (AmsterdamUMC) 1109. Ronden, MI, van Sörnsen de Koste, JR, Johnson, C, Slotman, BJ, Spoelstra, FOB, Haasbeek, CJA, Blom, G, Bongers, EM, Warner, A, Ward, A, Palma, D & Senan, S 2018, 'Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early- Stage Non-Small Cell Lung Cancer', International Journal of Radiation Oncology Biology Physics, ;100(1): 115-121. (AmsterdamUMC) 1110. Rood JJM, Dormans PJA, van Haren MJ, Schellens JHM, Beijnen JH, Sparidans RW,` Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry`, J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1090:14-21 (NKI) 1111. Rood, JAJ, Lissenberg-Witte, BI, Eeltink, C, Stam, F, van Zuuren, FJ, Zweegman, S & Verdonck-De Leeuw, IM 2018, 'The need for information among patients with hematological malignancies: Psychometric analyses of the 62-item Hematology Information Needs Questionnaire (HINQ-62)', PLoS ONE, ;13(8): e0201699. (AmsterdamUMC) 1112. Roos, E, Hubers, LM, Coelen, RJS, Doorenspleet, ME, de Vries, N, Verheij, J, Beuers, U & van Gulik, TM 2018, 'IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: A 30-Year Tertiary Care Experience', American journal of gastroenterology, ;113(5): 765-772. (AmsterdamUMC) 1113. Roos, VH, Bastiaansen, BAJ & Dekker, E 2018, 'Gastric adenomas in familial adenomatous polyposis: you only see them when you know what to look for', Gastrointestinal endoscopy, ;88(2): 403-405. (AmsterdamUMC) 1114. Roosendaal J, Rosing H, Lucas L, Oganesian A, Schellens JHM, Beijnen JH,` Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular beta-decitabine nucleotides and genomic DNA incorporated beta-decitabine and 5-methyl-2'-deoxycytidine`, J Pharm Biomed Anal 2018; 164:16-26 (NKI) 1115. Ros, XR & Vermeulen, L 2018, 'Turning Cold Tumors Hot by Blocking TGF-β', Trends in cancer, ;4(5): 335-337. (AmsterdamUMC) 1116. Rosario, T, van der Weide, L, Admiraal, M, Piet, M, Slotman, B & Cuijpers, J 2018, 'Toward planning target volume margin reduction for the prostate using intrafraction motion correction with online kV imaging and automatic detection of implanted gold seeds', Practical Radiation Oncology, ;8(6): 422- 428. (AmsterdamUMC) 1117. Rossi L, Bijman R, Schillemans W, Aluwini S, Cavedon C, Witte M, Incrocci L, Heijmen B,` Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy`, Radiother Oncol 2018; 129:548-53 (NKI) 1118. Rotman, J, Mom, CH, Jordanova, ES, de Gruijl, TD & Kenter, GG 2018, ''DURVIT': A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour- and lymph node microenvironment', BMC cancer, ;18(1): 888. (AmsterdamUMC) 1119. Rottenberg, Y & de Boer, AGEM 2018, 'Higher incidence of screening-related cancers in the employed population', Occupational medicine (Oxford, England), ;68(4): 273-278. (AmsterdamUMC) 1120. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, van Rhijn BWG, Mostafid AH, Palou J, Shariat SF,` European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update`, Eur Urol 2018; 73:111-22 (NKI) 1121. Rozeman EA, Dekker TJA, Haanen JBAG, Blank CU,` Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives`, Am J Clin Dermatol 2018; 19:303-7 (NKI) 1122. Ruarus, A, Vroomen, L, Puijk, R, Scheffer, H & Meijerink, M 2018, 'Locally advanced pancreatic cancer: A review of local ablative therapies', Cancers, ;10(1): 16. (AmsterdamUMC) 1123. Ruarus, AH, Vroomen, LGPH, Puijk, RS, Scheffer, HJ, Faes, TJC & Meijerink, MR 2018, 'Conductivity Rise During Irreversible Electroporation: True Permeabilization or Heat?', CardioVascular and Interventional Radiology, ;41(8): 1257-1266. (AmsterdamUMC) 1124. Ruarus, AH, Vroomen, LGPH, Puijk, RS, Scheffer, HJ, Zonderhuis, BM, Kazemier, G, van den Tol, MP, Berger, FH & Meijerink, MR 2018, 'Irreversible Electroporation in Hepatopancreaticobiliary Tumours', Canadian Association of Radiologists Journal, ;69(1): 38-50. (AmsterdamUMC) 1125. Rubenstein, JH, Waljee, A, Dwamena, B, Bergman, J, Vieth, M & Wani, S 2018, 'Yield of higher-grade neoplasia in Barrett's esophagus with low-grade dysplasia is double in the first year following diagnosis', Clinical gastroenterology and hepatology, ;16(9): 1529-1530. (AmsterdamUMC) 1126. Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, Wang Q, Dennis J, Wilcox AN, Hopper JL, Southey MC, Keeman R, Fasching PA, Beckmann MW, Gago-Dominguez M, Castelao JE, Guenel P, Truong T, Bojesen SE, Flyger H, Brenner H, Arndt V, Brauch H, Bruning T, Mannermaa A, Kosma VM, Lambrechts D, Keupers M, Couch FJ, Vachon C, Giles GG, MacInnis RJ, Figueroa J, Brinton L, Czene K, Brand JS, Gabrielson M, Humphreys K, Cox A, Cross SS, Dunning AM, Orr N, Swerdlow A, Hall P, Pharoah PDP, Schmidt MK, Easton DF, Chatterjee N, Chang-Claude J, Garcia- Closas M,` Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium`, Int J Epidemiol 2018; 47:526-36 (NKI) 1127. Rugo HS, Delord JP, Im SA, Ott PA, Piha-Paul SA, Bedard PL, Sachev J, Le Tourneau C, van Brummelen EMJ, Varga A, Salgado R, Loi S, Saraf S, Pietrangelo D, Karantza V, Tan AR,` Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen ReceptorPositive/Human Epidermal Growth Factor Receptor 2Negative Advanced Breast Cancer`, Clin Cancer Res 2018; 24:2804-11 (NKI) 1128. Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A,` Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort`, J Thorac Oncol 2018; 13:1851-63 (AmsterdamUMC/NKI) 1129. Ruslin, M, Hendra, FN, Vojdani, A, Hardjosantoso, D, Gazali, M, Tajrin, A, Wolff, J & Forouzanfar, T 2018, 'The epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study', Medicina oral patologia oral y cirugia bucal, ;23(1): e54-e58. (AmsterdamUMC) 1130. Rutgers E, Balmana J, Beishon M, Benn K, Evans DG, Mansel R, Pharoah P, Perry S, V, Stoppa-Lyonnet D, Travado L, Wyld L,` European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer`, Eur J Cancer 2018; 106:45-53 (NKI) 1131. Rutkowski, S, Modena, P, Williamson, D, Kerl, K, Nysom, K, Pizer, B, Bartels, U, Puget, S, Doz, F, Michalski, A, von Hoff, K, Chevignard, M, Avula, S, Murray, MJ, Schönberger, S, Czech, T, Schouten-van Meeteren, AYN, Kordes, U, Kramm, CM, van Vuurden, DG, Hulleman, E, Janssens, GO, Solanki, GA, van Veelen, M-LC, Thomale, U, Schuhmann, MU, Jones, C, Giangaspero, F, Figarella-Branger, D, Pietsch, T, Clifford, SC, Pfister, SM & van Gool, SW 2018, 'Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group', lancet oncology, ;19(8): e419-e428. (AmsterdamUMC) 1132. Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, Rabeneck L, Robertson DJ, Schoen RE, Singh H, Tinmouth J, Young GP, Sanduleanu S,` World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer`, Gastroenterology 2018; 155:909-25 (AmsterdamUMC/NKI) 1133. Saadeh, LM, Slaman, AE, Pinto, E, Gisbertz, SS, Cavallin, F, Jezerskyte, E, Alfieri, R, Noteboom, L, Bellissimo, MC, Cagol, M, Pirozzolo, G, Castoro, C, Scarpa, M & van Berge Henegouwen, MI 2018, 'Esophageal cancer patients’ information management: Cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information', Journal of thoracic disease, ;10(8): 5123-5130. (AmsterdamUMC) 1134. Sabrkhany, S, Kuijpers, MJE, Knol, JC, Olde Damink, SWM, Dingemans, A-MC, Verheul, HM, Piersma, SR, Pham, TV, Griffioen, AW, oude Egbrink, MGA & Jimenez, CR 2018, 'Exploration of the platelet proteome in patients with early-stage cancer', Journal of Proteomics, ;177: 65-74. (AmsterdamUMC) 1135. Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H, Korving J, van Boxtel R, Duarte AA, Lelieveld D, van Hoeck A, Ernst RF, Blokzijl F, Nijman IJ, Hoogstraat M, van de Ven M, Egan DA, Zinzalla V, Moll J, Boj SF, Voest EE, Wessels L, van Diest PJ, Rottenberg S, Vries RGJ, Cuppen E, Clevers H,` A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity`, Cell 2018; 172:373-86 (NKI) 1136. Sacristan C, Ahmad MUD, Keller J, Fermie J, Groenewold V, Tromer E, Fish A, Melero R, Carazo JM, Klumperman J, Musacchio A, Perrakis A, Kops GJ,` Dynamic kinetochore size regulation promotes microtubule capture and chromosome biorientation in mitosis`, Nat Cell Biol 2018; 20:800-10 (NKI) 1137. Sahasrabudhe, NM, Lenos, K, van der Horst, JC, Rodríguez, E & van Vliet, SJ 2018, 'Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N- acetylgalactosamine-transferase 3', Biological Chemistry, ;399(7): 649-659. (AmsterdamUMC) 1138. Salazar, R, Garcia-Carbonero, R, Libutti, SK, Hendifar, AE, Custodio, A, Guimbaud, R, Lombard-Bohas, C, Ricci, S, Klümpen, H-J, Capdevila, J, Reed, N, Walenkamp, A, Grande, E, Safina, S, Meyer, T, Kong, O, Salomon, H, Tavorath, R & Yao, JC 2018, 'Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors', oncologist, ;23(7): e90 (AmsterdamUMC) 1139. Salembier, C, Villeirs, G, de Bari, B, Hoskin, P, Pieters, BR, van Vulpen, M, Khoo, V, Henry, A, Bossi, A, de Meerleer, G & Fonteyne, V 2018, 'ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer', Radiotherapy and oncology, ;127(1): 49-61. (AmsterdamUMC) 1140. Salgado-Polo F, Fish A, Matsoukas MT, Heidebrecht T, Keune WJ, Perrakis A,` Lysophosphatidic acid produced by Autotaxin acts as an allosteric modulator of its catalytic efficiency`, J Biol Chem 2018; 293:14312-27 (NKI) 1141. Sanchez-Salas, R, de la Rosette, J, Polascik, TJ, Carneiro, A, Sivaraman, A, Cathelineau, X & Walz, J 2018, 'Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients', European urology, ;74(5): 537-539. (AmsterdamUMC) 1142. Sanchez-Spitman AB, Dezentje VO, Swen JJ, Moes DJAR, Gelderblom H, Guchelaar HJ,` Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy`, Breast Cancer Res Treat 2018; 172:401-11 (NKI) 1143. Sandrucci S, Beets G, Braga M, Dejong K, Demartines N,` Perioperative nutrition and enhanced recovery after surgery in gastrointestinal cancer patients A position paper by the ESSO task force in collaboration with the ERAS society (ERAS coalition)`, Eur J Surg Oncol 2018; 44:509-14 (NKI) 1144. SANO study group, van Berge Henegouwen, MI, Hulshof, MCCM, Krishnadath, KK, Bergman, JJGHM, Gisbertz, SS, van Laarhoven, HWM, Meijer, SL, Haj Mohammad, N & Offerhaus, GJA 2018, 'Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study', lancet oncology, ;19(7): 965-974. (AmsterdamUMC) 1145. Santarpia, M, Funel, N, Ali, A & Giovannetti, E 2018, 'Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients', Expert Opinion on Drug Metabolism and Toxicology, ;14(8): 761- 763. (AmsterdamUMC) 1146. Sargos P, Charleux T, Haas RL, Michot A, Llacer C, Moureau-Zabotto L, Vogin G, Le Pechoux C, Verry C, Ducassou A, Delannes M, Mervoyer A, Wiazzane N, Thariat J, Sunyach MP, Benchalal M, Laredo JD, Kind M, Gillon P, Kantor G,` Pre- and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation oncologists`, Cancer Radiother 2018; 22:131-9 (NKI) 1147. Sasse, S, Goergen, H, Plütschow, A, Böll, B, Eichenauer, DA, Fuchs, M, Behringer, K, Zijlstra, JM, Greil, R, Markova, J, Topp, MS, Meissner, J, Neubauer, A, Baues, C, Engert, A, Borchmann, P & von Tresckow, B 2018, 'Outcome of patients with early-stage infradiaphragmatic hodgkin lymphoma: A comprehensive analysis from the German hodgkin study group', Journal of Clinical Oncology, ;36(25): 2603-2611. (AmsterdamUMC) 1148. Scacchetti A, Brueckner L, Jain D, Schauer T, Zhang X, Schnorrer F, van Steensel B, Straub T, Becker PB,` CHRAC/ACF contribute to the repressive ground state of chromatin`, Life Sci Alliance 2018; 1:e201800024 (NKI) 1149. Schaap DP, Ogura A, Nederend J, Maas M, Cnossen JS, Creemers GJ, van Lijnschoten I, Nieuwenhuijzen GAP, Rutten HJT, Kusters M,` Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer`, Br J Surg 2018; 105:1844-52 (NKI) 1150. Schaapveld M, Wesseling J,` Response: DCIS and Breast Cancer: Challenging the Paradigm (Authors Victoria Sopik and Steven A`, Ann Surg 2018; 268:e18 [Letter] (NKI) 1151. Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S,` Melanoma`, Lancet 2018; 392:971-84 (NKI) 1152. Schalk, SG, Huang, J, Li, J, Demi, L, Wijkstra, H, Huang, P & Mischi, M 2018, '3-D Quantitative Dynamic Contrast Ultrasound for Prostate Cancer Localization', Ultrasound in medicine & biology, ;44(4): 807- 814. (AmsterdamUMC) 1153. Schalkwijk S, Ter Heine R, Colbers AC, Huitema ADR, Denti P, Dooley KE, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Mirochnick M, Burger DM,` A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women`, Clin Pharmacokinet 2018; 57:1421-33 (NKI) 1154. Scheltema, MJ, Chang, JI, Böhm, M, van den Bos, W, Blazevski, A, Gielchinsky, I, Kalsbeek, AMF, van Leeuwen, PJ, Nguyen, TV, de Reijke, TM, Siriwardana, AR, Thompson, JE, de la Rosette, JJ & Stricker, PD 2018, 'Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy', World journal of urology, ;36(9): 1383-1389. (AmsterdamUMC) 1155. Scheltema, MJ, Chang, JI, van den Bos, W, Gielchinsky, I, Nguyen, TV, de Reijke, TM, Siriwardana, AR, Böhm, M, de la Rosette, JJ & Stricker, PD 2018, 'Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments', Diagnostic and interventional radiology (Ankara, Turkey), ;24(5): 268-275. (AmsterdamUMC) 1156. Schepers, SA, Sint Nicolaas, SM, Maurice-Stam, H, Haverman, L, Verhaak, CM & Grootenhuis, MA 2018, 'Parental Distress 6 Months After a Pediatric Cancer Diagnosis in Relation to Family Psychosocial Risk at Diagnosis', Cancer, ;124(2): 381-390. (AmsterdamUMC) 1157. Schetters, STT, Kruijssen, LJW, Crommentuijn, MHW, Kalay, H, Ochando, J, den Haan, JMM, Garcia- Vallejo, JJ & van Kooyk, Y 2018, 'Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity', Frontiers in Immunology, ;9: 990. (AmsterdamUMC) 1158. Schillemans M, Karampini E, van den Eshof B, Gangaev A, Hofman M, van Breevoort D, Meems H, Janssen H, Mulder AA, Jost CR, Escher JC, Adam R, Carter T, Koster AJ, van den Biggelaar M, Voorberg J, Bierings R,` The Weibel-Palade Body Localized SNARE (Soluble NSF Attachment Protein Receptor) Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells`, Arterioscler Thromb Vasc Biol 2018; 38:1549-61 (NKI) 1159. Schneider, BJ, Daly, ME, Kennedy, EB, Antonoff, MB, Broderick, S, Feldman, J, Jolly, S, Meyers, B, Rocco, G, Rusthoven, C, Slotman, BJ, Sterman, DH & Stiles, BM 2018, 'Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline', Journal of Clinical Oncology, ;36(7): 710-719. (AmsterdamUMC) 1160. Schneiders, FL, Huijts, CM, Reijm, M, Bontkes, HJ, Verheul, HMW, de Gruijl, TD & van der Vliet, JJ 2018, 'The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer', Immunobiology, ;223(2): 171-177. (AmsterdamUMC) 1161. Scholten, L, van Huijgevoort, NCM, van Hooft, JE, Besselink, MG & del Chiaro, M 2018, 'Pancreatic cystic neoplasms: Different types, different management, new guidelines', Visceral medicine, ;34(3): 173-177. (AmsterdamUMC) 1162. Schooneveldt, G, Kok, HP, Bakker, A, Geijsen, ED, Hulshof, MCCM, Reijke, TMD & Crezee, J 2018, 'The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients', International journal of hyperthermia, ;35(1): 441-449. (AmsterdamUMC) 1163. Schooneveldt, G, Kok, HP, Bakker, A, Geijsen, ED, Rasch, CRN, de la Rosette, JJMCH, Hulshof, MCCM, Reijke, TMD & Crezee, H 2018, 'Clinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic region', International journal of hyperthermia, ;35(1): 383-397. (AmsterdamUMC) 1164. Schouten RD, Muller M, De Gooijer CJ, Baas P, van den Heuvel M,` Real life experience with nivolumab for the treatment of non-small cell lung carcinoma: Data from the expanded access program and routine clinical care in a tertiary cancer centre-The Netherlands Cancer Institute`, Lung Cancer 2018; 126:210-6 (NKI) 1165. Schouwenburg MG, Busweiler LAD, Beck N, Henneman D, Amodio S, Berge Henegouwen MI, Cats A, van Hillegersberg R, van Sandick JW, Wijnhoven BPL, Wouters MWJ, Nieuwenhuijzen GAP,` Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer Results from the Dutch Upper GI Cancer Audit`, Eur J Surg Oncol 2018; 44:532-8 (AmsterdamUMC/NKI) 1166. Schouwenburg MG, Jochems A, Leeneman B, Franken MG, van den Eertwegh AJM, Haanen JBAG, van Zeijl MCT, Aarts MJ, van Akkooi ACJ, van den Berkmortel FWPJ, Blokx WAM, de Groot JWB, Hospers GAP, Kapiteijn E, Koornstra RH, Kruit WH, Louwman MWJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van der Hoeven JJM,` Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes`, Melanoma Res 2018; 28:326-32 (AmsterdamUMC/NKI) 1167. Schreuder, AM, Booij, KAC, de Reuver, PR, van Delden, OM, van Lienden, KP, Besselink, MG, Busch, OR, Gouma, DJ, Rauws, EAJ & van Gulik, TM 2018, 'Percutaneous-endoscopic rendezvous procedure for the management of bile duct injuries after cholecystectomy: short- and long-term outcomes', Endoscopy, ;50(6): 577-587. (AmsterdamUMC) 1168. Schreuder, AM, van Gulik, TM & Rauws, EAJ 2018, 'Intrabiliary Migrated Clips and Coils as a Nidus for Biliary Stone Formation: A Rare Complication following Laparoscopic Cholecystectomy', Case reports in gastroenterology, ;12(3): 686-691. (AmsterdamUMC) 1169. Schrijver W, Schuurman K, van Rossum A, Droog M, Jeronimo C, Salta S, Henrique R, Wesseling J, Moelans C, Linn SC, van de Heuvel M, van Diest P, Zwart W,` FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome`, Mol Oncol 2018; 12:1884-94 (NKI) 1170. Schroten-Loef, C, Verhoeven, RHA, de Hingh, IHJT, van de Wouw, AJ, van Laarhoven, HWM & Lemmens, VEPP 2018, 'Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012', European journal of cancer (Oxford, England, ;101: 77-86. (AmsterdamUMC) 1171. Schuller, Y, Biegstraaten, M, Hollak, CEM, Klümpen, H-J, Gispen-de Wied, CC & Stoyanova-Beninska, V 2018, 'Oncologic orphan drugs approved in the EU - Do clinical trial data correspond with real-world effectiveness?', Orphanet journal of rare diseases, ;13(1): 214. (AmsterdamUMC) 1172. Schultz, CR, Geerts, D, Mooney, M, El-Khawaja, R, Koster, J & Bachmann, AS 2018, 'Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma', Biochemical journal, ;475(2): 531-545. (AmsterdamUMC) 1173. Schunselaar L, Quispel-Janssen JM, Kim Y, Alifrangis C, Zwart W, Baas P, Neefjes J,` Chemical profiling of primary mesothelioma cultures defines subtypes with different expression profiles and clinical responses`, Clin Cancer Res 2018; 24:1761-70 (NKI) 1174. Schunselaar LM, Monkhorst K, van der Noort V, Wijdeven R, Peters D, Zwart W, Neefjes J, Baas P,` Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates`, J Thorac Oncol 2018; 13:1577-87 (NKI) 1175. Schutte, T, van Eekeren, R, Richir, M, van Staveren, J, van Puijenbroek, E, Tichelaar, J & van Agtmael, M 2018, 'The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study', Naunyn- Schmiedeberg's Archives of Pharmacology, pp. 1-10. (AmsterdamUMC) 1176. Schuurhuis, GJ, Heuser, M, Freeman, S, Béné, M-C, Buccisano, F, Cloos, J, Grimwade, D, Haferlach, T, Hills, RK, Hourigan, CS, Jorgensen, JL, Kern, W, Lacombe, F, Maurillo, L, Preudhomme, C, van der Reijden, BA, Thiede, C, Venditti, A, Vyas, P, Wood, BL, Walter, RB, Döhner, K, Roboz, GJ & Ossenkoppele, GJ 2018, 'Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party', Blood, ;131(12): 1275-1291. (AmsterdamUMC) 1177. Schuurhuis, GJ, Ossenkoppele, GJ, Kelder, A & Cloos, J 2018, 'Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization', Expert Review of Hematology, ;11(12): 921-935. (AmsterdamUMC) 1178. Schuurhuizen, CSEW, Marino, P, Braamse, AMJ, Buffart, LM, Joly, F, Fizazi, K, Habibian, M, Boher, J-M, Soulie, M, Oudard, S, Konings, IRHM, Verheul, HMW, Dekker, J & Gravis, G 2018, 'Impact of patient- And clinician-reported cumulative toxicity on quality of life in patients with metastatic castration-naïve prostate cancer', Journal of the National Comprehensive Cancer Network, ;16(12): 1481-1488. (AmsterdamUMC) 1179. Schuurhuizen, CSEW, Verheul, HMW, Braamse, AMJ, Buffart, LM, Bloemendal, HJ, Dekker, J & Konings, IRHM 2018, 'The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy', Cancer Management and Research, ;10: 3015-3021. (AmsterdamUMC) 1180. Seewald, S, Ang, TL, Pouw, RE, Bannwart, F & Bergman, JJ 2018, 'Management of Early-Stage Adenocarcinoma of the Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection', Digestive diseases and sciences, ;63(8): 2146-2154. (AmsterdamUMC) 1181. Senan, S, Rusthoven, CG, Slotman, BJ & Siva, S 2018, 'Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017', Journal of Thoracic Oncology, ;13(4): 488-496. (AmsterdamUMC) 1182. Seravalli, E, Bosman, M, Lassen-Ramshad, Y, Vestergaard, A, Oldenburger, F, Visser, J, Koutsouveli, E, Paraskevopoulou, C, Horan, G, Ajithkumar, T, Timmermann, B, Fuentes, C-S, Whitfield, G, Marchant, T, Padovani, L, Garnier, E, Gandola, L, Meroni, S, Hoeben, BAW, Kusters, M, Alapetite, C, Losa, S, Goudjil, F, Magelssen, H, Evensen, ME, Saran, F, Smyth, G, Rombi, B, Righetto, R, Kortmann, R-D & Janssens, GO 2018, 'Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)*', Acta oncologica (Stockholm, Sweden), ;57(9): 1240-1249. (AmsterdamUMC) 1183. Serresi M, Siteur B, Hulsman D, Company C, Schmitt MJ, Lieftink C, Morris B, Cesaroni M, Proost N, Beijersbergen RL, van Lohuizen M, Gargiulo G,` Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities`, J Exp Med 2018; 215:3115-35 (NKI) 1184. Serroukh, Y, Gu-Trantien, C, Hooshiar Kashani, B, Defrance, M, Vu Manh, T-P, Azouz, A, Detavernier, A, Hoyois, A, Das, J, Bizet, M, Pollet, E, Tabbuso, T, Calonne, E, van Gisbergen, K, Dalod, M, Fuks, F, Goriely, S & Marchant, A 2018, 'The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes', eLife, ;7: e30496. (AmsterdamUMC) 1185. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL) 2018, 'Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review', The Lancet Oncology, ;19(9): e459-e469. (AmsterdamUMC) 1186. Severson TM, Kim Y, Joosten SEP, Schuurman K, van der GP, Moelans CB, Ter Hoeve ND, Manson QF, Martens JW, van Deurzen CHM, Barbe E, Hedenfalk I, Bult P, Smit VTHB, Linn SC, van Diest PJ, Wessels L, Zwart W,` Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer`, Nat Commun 2018; 9:482 (12 pp) (NKI) 1187. Seymour, JF, Kipps, TJ, Eichhorst, B, Hillmen, P, D'Rozario, J, Assouline, S, Owen, C, Gerecitano, J, Robak, T, de la Serna, J, Jaeger, U, Cartron, G, Montillo, M, Humerickhouse, R, Punnoose, EA, Li, Y, Boyer, M, Humphrey, K, Mobasher, M & Kater, AP 2018, 'Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia', New England journal of medicine, ;378(12): 1107-1120. (AmsterdamUMC) 1188. Shaheen, NJ, Fennerty, MB & Bergman, JJ 2018, 'Less is more: A minimalist approach to endoscopy', Gastroenterology, ;154(7): 1993-2003. (AmsterdamUMC) 1189. Sharfo AWM, Dirkx MLP, Bijman RG, Schillemans W, Breedveld S, Aluwini S, Pos F, Incrocci L, Heijmen BJM,` Late toxicity in the randomized multicenter HYPRO trial for prostate cancer analyzed with automated treatment planning`, Radiother Oncol 2018; 128:349-56 (NKI) 1190. Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W,` Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis`, Int J Epidemiol 2018; 128:349-56 (NKI) 1191. Sierevelt IN, Zwiers R, Schats W, Haverkamp D, Terwee CB, Nolte PA, Kerkhoffs GMMJ,` Measurement properties of the most commonly used Foot- and Ankle-Specific Questionnaires: the FFI, FAOS and FAAM A systematic review`, Knee Surg Sports Traumatol Arthrosc 2018; 26:2059-73 (NKI) 1192. Šifrer, R, Rijken, JA, Leemans, CR, Eerenstein, SEJ, van Weert, S, Hendrickx, JJ, Bloemena, E, Heuveling, DA & Rinkel, RNPM 2018, 'Evaluation of vascular features of vocal cords proposed by the European Laryngological Society', European Archives of Oto-Rhino-Laryngology, ;275(1): 147-151. (AmsterdamUMC) 1193. Sikorska K, Lesaffre E, Groenen PJF, Rivadeneira F, Eilers PHC,` Genome-wide Analysis of Large-scale Longitudinal Outcomes using Penalization -GALLOP algorithm`, Sci Rep 2018; 8:6815 (8 pp) (NKI) 1194. Simonetta M, de Krijger I, Serrat J, Moatti N, Fortunato D, Hoekman L, Bleijerveld OB, Altelaar AFM, Jacobs JJL,` H4K20me2 distinguishes pre-replicative from post-replicative chromatin to appropriately direct DNA repair pathway choice by 53BP1-RIF1-MAD2L2`, Cell Cycle 2018; 17:124-36 (NKI) 1195. Skiles, JL, Chiang, C, Li, CH, Martin, S, Smith, EL, Olbara, G, Jones, DR, Vik, TA, Mostert, S, Abbink, F, Kaspers, GJ, Li, L, Njuguna, F, Sajdyk, TJ & Renbarger, JL 2018, 'CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer', Pediatric Blood and Cancer, ;65( 3. ): (AmsterdamUMC) 1196. Slagter AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, van Grieken NCT, Sikorska K, Cats A, Muller-Timmermans P, Hulshof MCCM, Boot H, Los M, Beerepoot LV, Peters FPJ, Hospers GAP, van Etten B, Hartgrink HH, van Berge Henegouwen MI, Nieuwenhuijzen GAP, van Hillegersberg R, van der Peet DL, Grabsch HI, Verheij M,` CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer`, BMC Cancer 2018; 18:877 (AmsterdamUMC/NKI) 1197. Slamon DJ, Neven P, Chia S, Fasching PA, De Laurentiis M, Im SA, Petrakova K, Bianchi GV, Esteva FJ, Martin M, Nusch A, Sonke GS, Cruz-Merino L, Beck JT, Pivot X, Vidam G, Wang Y, Rodriguez Lorenc K, Miller M, Taran T, Jerusalem G,` Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3`, J Clin Oncol 2018; 36:2465-72 (NKI) 1198. Slot, KM, Peters, JVM, Vandertop, WP, Verbaan, D & Peerdeman, SM 2018, 'Meningioma surgery in younger and older adults: patient profile and surgical outcomes', European geriatric medicine, ;9(1): 95-101. (AmsterdamUMC) 1199. Slot, KM, Verbaan, D, Bosscher, L, Sanchez, E, Vandertop, WP & Peerdeman, SM 2018, 'Agreement between extent of meningioma resection based on the surgical Simpson Grade and based on postoperative MRI-findings', World neurosurgery, ;111: e856-e862. (AmsterdamUMC) 1200. Slotman BJ, Vos P, Slot A, Keus R, Verheij M,` Radiation Oncology in The Netherlands`, Int J Radiat Oncol Biol Phys 2018; 100:5-11 [Editorial] (AmsterdamUMC/NKI) 1201. Sluiter, NR, Rovers, KP, Salhi, Y, Vlek, SL, Coupé, VMH, Verheul, HMW, Kazemier, G, de Hingh, IHJT & Tuynman, JB 2018, 'Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC', Annals of Surgical Oncology, ;25(8): 2347-2356. (AmsterdamUMC) 1202. Smeets, BJJ, Brinkman, DJ, Horsten, ECJ, Langius, JAE, Rutten, HJT, de Jonge, WJ & Luyer, MDP 2018, 'The Effect of Myopenia on the Inflammatory Response Early after Colorectal Surgery', Nutrition and Cancer, ;70(3): 460-466. (AmsterdamUMC) 1203. Smeets, D, Miller, IS, O’Connor, DP, Das, S, Moran, B, Boeckx, B, Gaiser, T, Betge, J, Barat, A, Klinger, R, van Grieken, NCT, Cremolini, C, Prenen, H, Mazzone, M, Depreeuw, J, Bacon, O, Fender, B, Brady, J, Hennessy, BT, McNamara, DA, Kay, E, Verheul, HM, Maarten, N, Gallagher, WM, Murphy, V, Prehn, JHM, Koopman, M, Punt, CJA, Loupakis, F, Ebert, MPA, Ylstra, B, Lambrechts, D & Byrne, AT 2018, 'Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy', Nature communications, ;9(1): 4112. (AmsterdamUMC) 1204. Smets, AM, Deurloo, EE, Slager, TJE, Stoker, J & Bipat, S 2018, 'Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review', Pediatric radiology, ;48(2): 241-252. (AmsterdamUMC) 1205. Smit EF, Garon EB, Reck M, Cappuzzo F, Bidoli P, Cohen RB, Gao L, O'Brien LM, Lee P, Zimmermann A, Ferry DR, Melemed AS, Perol M,` Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer`, Cancer Chemother Pharmacol 2018; 82:77-86 (AmsterdamUMC/NKI) 1206. Smolic M, Sombroek C, Bloemers MCWM, van Triest B, Nowee ME, Mans A,` Needle use and dosimetric evaluation in cervical cancer brachytherapy using the Utrecht applicator`, Radiother Oncol 2018; 126:411-6 (NKI) 1207. Sobral-Leite M, Van de Vijver K, Michaut M, van der Linden R, Hooijer GKJ, Horlings HM, Severson TM, Mulligan AM, Weerasooriya N, Sanders J, Glas AM, Wehkamp D, Mittempergher L, Kersten K, Cimino- Mathews A, Peters D, Hooijberg E, Broeks A, van de Vijver MJ, Bernards R, Andrulis IL, Kok M, de Visser KE, Schmidt MK,` Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival`, Oncoimmunology 2018; 7:e1509820 (NKI) 1208. Soer, E, Brosens, L, van de Vijver, M, Dijk, F, van Velthuysen, M-L, Farina-Sarasqueta, A, Morreau, H, Offerhaus, J, Koens, L & Verheij, J 2018, 'Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens: An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens', Virchows Archiv, ;472(4): 533-543. (AmsterdamUMC) 1209. Solaini, L, de Rooij, T, Marsman, EM, te Riele, WW, Tanis, PJ, van Gulik, TM, Gouma, DJ, Bhayani, NH, Hackert, T, Busch, OR & Besselink, MG 2018, 'Pancreatoduodenectomy with colon resection for pancreatic cancer: a systematic review', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(10): 881-887. (AmsterdamUMC) 1210. Sommariva A, Forsea AM, Agius D, Ascierto PA, Bastiaannet E, Borgognoni L, Demetriou A, Garbe C, Gavric Z, Hocevar M, Innos K, Laronningen S, Louwman M, Robsahm TE, Rutkwoski P, van Akkooi A, Zorzi M, Pasquali S, van de Velde C, Rossi CR,` Quality assurance in melanoma care: The EU-MELACARE study`, Eur J Surg Oncol 2018; 44:1773-8 (NKI) 1211. SONIA study steering committee 2018, 'Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial', BMC Cancer, ;18(1): 1146. (AmsterdamUMC) 1212. Sonke GS, Hart LL, Campone M, Erdkamp F, Janni W, Verma S, Villanueva C, Jakobsen E, Alba E, Wist E, Favret AM, Bachelot T, Hegg R, Wheatley-Price P, Souami F, Sutradhar S, Miller M, Germa C, Burris HA,` Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial`, Breast Cancer Res Treat 2018; 167:659-69 (NKI) 1213. Sonneveld, P, Zweegman, S, Johnsen, HE, Hajek, R, Di Raimondo, F, Palumbo, A, Troia, R, van der Holt, B, Pantani, L, Gay, F, Wester, R, Driessen, C, Wu, KL, Beksac, M, Ludwig, H, Dimopoulos, MA, Mellqvist, U-H, Pezzi, A, Cavo, M & Petrucci, MT 2018, 'Upfront autologous stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the European Myeloma Network (EMN02/HO95 MM trial).', Journal of Clinical Oncology, ;34( 15_suppl): 8000-8000. (AmsterdamUMC) 1214. Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larre S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R,` Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy`, World J Urol 2018; 36:1775-81 (NKI) 1215. Soto M, Garcia-Santisteban I, Krenning L, Medema RH, Raaijmakers JA,` Chromosomes trapped in micronuclei are liable to segregation errors`, J Cell Sci 2018; 131:pii: jcs214742 (8 pp) (NKI) 1216. Spaans, VM, Nyoman Bayu Mahendra, I, Purwoto, G, Trietsch, MD, Osse, M, ter Haar, N, Peters, AAW, Fleuren, GJ & Jordanova, ES 2018, 'The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway', Gynecologic Oncology, ;148(1): 189-196. (AmsterdamUMC) 1217. Spaans, VM, Scheunhage, DA, Barzaghi, B, de Kroon, CD, Fleuren, GJ, Bosse, T & Jordanova, ES 2018, 'Independent validation of the prognostic significance of invasion patterns in endocervical adenocarcinoma: Pattern A predicts excellent survival', Gynecologic Oncology, ;151(2): 196-201. (AmsterdamUMC) 1218. Sparidans RW, Li W, Schinkel AH, Schellens JHM, Beijnen JH,` Bioanalytical liquid chromatography- tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates`, J Pharm Biomed Anal 2018; 161:136-43 (NKI) 1219. Sparidans RW, Wang Y, Schinkel AH, Schellens JHM, Beijnen JH,` Quantitative bioanalytical assay for the tropomyosin receptor kinase inhibitor larotrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry`, J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1102-1103:167-72 (NKI) 1220. Sparreboom CL, van Groningen JT, Lingsma HF, Wouters MWJM, Menon AG, Kleinrensink GJ, Jeekel J, Lange JF,` Different Risk Factors for Early and Late Colorectal Anastomotic Leakage in a Nationwide Audit`, Dis Colon Rectum 2018; 61:1258-66 (NKI) 1221. Sparreboom CL, Wu Z, Lingsma HF, Menon AG, Kleinrensink GJ, Nuyttens JJ, Wouters MW, Lange JF,` Anastomotic Leakage and Interval between Preoperative Short-Course Radiotherapy and Operation for Rectal Cancer`, J Am Coll Surg 2018; 227:223-31 (NKI) 1222. Spatari C, Li W, Schinkel AH, Ragno G, Schellens JHM, Beijnen JH, Sparidans RW,` Bioanalytical assay for the quantification of the ALK inhibitor lorlatinib in mouse plasma using liquid chromatography- tandem mass spectrometry`, J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1083:204-8 (NKI) 1223. Specht L, Aleman B, Eich H, Illidge TM, Kirova Y, Mikhaeel NG, Ricardi U, Yahalom J,` Recommendations for the clinical management of the elderly patient with malignant lymphoma`, Ann Oncol 2018; 29:1060-70 [Letter] (NKI) 1224. Spel L, Nieuwenhuis J, Haarsma R, Stickel E, Bleijerveld OB, Altelaar M, Boelens JJ, Brummelkamp TR, Nierkens S, Boes M,` Nedd4 Binding Protein 1 (N4BP1) and TNFAIP3 Interacting Protein 1 (TNIP1) control MHC-1 display in neuroblastoma`, Cancer Res 2018; 78:6621-31 (NKI) 1225. Spronk PER, de Ligt KM, van Bommel ACM, Siesling S, Smorenburg CH, Vrancken Peeters MTFD,` Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts' experiences in the Netherlands`, Patient Educ Couns 2018; 101:2111-5 (NKI) 1226. Staehler M, Battle D, Bex A, Hammers H, George D,` Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma`, Eur Urol 2018; 74:842-3 (NKI) 1227. Stalpers, LJA & Kaplan, EL 2018, 'Edward L. Kaplan and the Kaplan-Meier Survival Curve', BSHM Bulletin, ;33(2): 109-135. (AmsterdamUMC) 1228. Staring J, Raaben M, Brummelkamp TR,` Viral escape from endosomes and host detection at a glance`, J Cell Sci 2018; 131: (8 pp) (NKI) 1229. Staring J, van den Hengel LG, Raaben M, Blomen VA, Carette JE, Brummelkamp TR,` KREMEN1 Is a Host Entry Receptor for a Major Group of Enteroviruses`, Cell Host Microbe 2018; 23:636-43 (NKI) 1230. Starreveld DEJ, Daniels LA, Valdimarsdottir HB, Redd WH, de Geus JL, ncoli-Israel S, Lutgendorf S, Korse CM, Kieffer JM, van Leeuwen FE, Bleiker EMA,` Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial`, BMC Cancer 2018; 18:880 (NKI) 1231. Starreveld DEJ, Markovitz SE, van Breukelen G, Peters ML,` The course of fear of cancer recurrence: Different patterns by age in breast cancer survivors`, Psychooncology 2018; 27:295-01 (NKI) 1232. Steen, MW, van Duijvenbode, DC, Dijk, F, Busch, OR, Besselink, MG, Gerhards, MF & Festen, S 2018, 'Tumor manipulation during pancreatic resection for pancreatic cancer induces dissemination of tumor cells into the peritoneal cavity: a systematic review', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(4): 289-296. (AmsterdamUMC) 1233. Steenbeek SC, Pham TV, de Ligt J, Zomer A, Knol JC, Piersma SR, Schelfhorst T, Huisjes R, Schiffelers RM, Cuppen E, Jimenez CR, van Rheenen J,` Cancer cells copy migratory behavior and exchange signaling networks via extracellular vesicles`, EMBO J 2018; 37:e98357 (20 pp) (AmsterdamUMC/NKI) 1234. Stelloo S, Nevedomskaya E, Kim Y, Hoekman L, Bleijerveld OB, Mirza T, Wessels LFA, van Weerden WM, Altelaar AFM, Bergman AM, Zwart W,` Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis`, Oncogene 2018; 37:313-22 (NKI) 1235. Stelloo S, Nevedomskaya E, Kim Y, Schuurman K, Valle-Encinas E, Lobo J, Krijgsman O, Peeper DS, Chang SL, Feng FY, Wessels LFA, Henrique R, Jeronimo C, Bergman AM, Zwart W,` Integrative epigenetic taxonomy of primary prostate cancer`, Nat Commun 2018; 9:4900 (NKI) 1236. Stevenson, MG, Been, LB, Hoekstra, HJ, Suurmeijer, AJH, Boellaard, R & Brouwers, AH 2018, 'Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study', EJNMMI Research, ;8( 42. ): (AmsterdamUMC) 1237. Stijns RC, Scheenen TW, de Wilt JH, Futterer JJ, Beets-Tan RG,` The influence of endorectal filling on rectal cancer staging with MRI`, Br J Radiol 2018; 91:20180205 (6 pp) (NKI) 1238. Stikvoort, A, Sarkar, S, Poels, R, Donk, NWCJVD, Zweegman, S, O'Dwyer, ME & Mutis, T 2018, 'CD38 Specific Chimeric Antigen Receptor KHYG-1 Natural Killer Cells: A Potential (AmsterdamUMC) 1239. Stolk, D, van der Vliet, HJ, de Gruijl, TD, van Kooyk, Y & Exley, MA 2018, 'Positive & negative roles of innate effector cells in controlling cancer progression', Frontiers in Immunology, ;9: 1990. (AmsterdamUMC) 1240. Stolt-Bergner P, Benda C, Bergbrede T, Besir H, Celie PHN, Chang C, Drechsel D, Fischer A, Geerlof A, Giabbai B, van den Heuvel J, Huber G, Knecht W, Lehner A, Lemaitre R, Norden K, Pardee G, Racke I, Remans K, Sander A, Scholz J, Stadnik M, Storici P, Weinbruch D, Zaror I, Lua LHL, Suppmann S ,` Baculovirus-driven protein expression in insect cells: A benchmarking study`, J Struct Biol 2018; 203:71-80 (NKI) 1241. Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Kerst JM, Kirschbaum C, Reneman L, Schagen SB,` Brain hyperconnectivity >10 years after cisplatin based chemotherapy for testicular cancer`, Brain Connect 2018; 8:398-406 (NKI) 1242. Straatman J, Cuesta MA, Tuynman JB, Veenhof AAFA, Bemelman WA, van der Peet DL,` C-reactive protein in predicting major postoperative complications are there differences in open and minimally invasive colorectal surgery? Substudy from a randomized clinical trial`, Surg Endosc 2018; 32:2877-85 (AmsterdamUMC/NKI) 1243. Strijker, M, Gerritsen, A, van Hilst, J, Bijlsma, MF, Bonsing, BA, Brosens, LA, Bruno, MJ, van Dam, RM, Dijk, F, van Eijck, CH, Farina Sarasqueta, A, Fockens, P, Gerhards, MF, Groot Koerkamp, B, van der Harst, E, de Hingh, IH, van Hooft, JE, Huysentruyt, CJ, Kazemier, G, Klaase, JM, van Laarhoven, CJ, van Laarhoven, HW, Liem, MS, de Meijer, VE, van Rijssen, LB, van Santvoort, HC, Suker, M, Verhagen, JH, Verheij, J, Verspaget, HW, Wennink, RA, Wilmink, JW, Molenaar, IQ, Boermeester, MA, Busch, OR & Besselink, MG 2018, 'The Dutch Pancreas Biobank within the Parelsnoer Institute: A nationwide Biobank of pancreatic and periampullary diseases', Pancreas, ;47(4): 495-501. (AmsterdamUMC) 1244. Stuij, SM, Labrie, NHM, van Dulmen, S, Kersten, MJ, Christoph, N, Hulsman, RL, Smets, E, Drossaert, S, de Haes, H, Pieterse, A & van Weert, J 2018, 'Developing a digital communication training tool on information-provision in oncology: Uncovering learning needs and training preferences', BMC medical education, ;18(1): 220. (AmsterdamUMC) 1245. Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, Wen PY, Zielinski C, Cabanillas ME, Urbanowitz G, Mookerjee B, Wang D, Rangwala F, Keam B,` Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer`, J Clin Oncol 2018; 36:7-13 (NKI) 1246. Sun C, Mezzadra R, Schumacher TN,` Regulation and Function of the PD-L1 Checkpoint`, Immunity 2018; 48:434-52 (NKI) 1247. Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas NB, Harshman LC, Quinn DI, Larkin J, Pal SK, Powles T, Ryan CW, Sternberg CN, Uzzo R, Choueiri TK, Bex A,` Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis`, Eur Urol 2018; 74:611-20 (NKI) 1248. Sustic T, van Wageningen S, Bosdriesz E, Reid RJD, Dittmar J, Lieftink C, Beijersbergen RL, Wessels LFA, Rothstein R, Bernards R,` A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers`, Genome Med 2018; 10:90 (13 pp) (NKI) 1249. Svensson, F, Westerman, B, Würdinger, T & Bailey, D 2018, 'GBM Drug Bank-a new resource for glioblastoma drug discovery and informatics research', Neuro-Oncology, ;20(12): 1680-1681. (AmsterdamUMC) 1250. Swaan, A, Mannaerts, CK, Scheltema, MJV, Nieuwenhuijzen, JA, Dilara Savci-Heijink, C, de la Rosette, JJMCH, Jeroen A van Moorselaar, R, van Leeuwen, TG, de Reijke, TM & de Bruin, DM 2018, 'Confocal laser endomicroscopy and optical coherence tomography for the diagnosis of prostate cancer: A needle-based, in vivo feasibility study protocol (IDEAL phase 2A)', Journal of medical Internet research, ;20(5): e132. (AmsterdamUMC) 1251. Swarts DRA, Voorham QJM, van Splunter AP, Wilting SM, Sie D, Pronk D, van Beurden M, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM, Bleeker MCG,` Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis`, Cancer Med 2018; 7:4542-53 (AmsterdamUMC/NKI) 1252. Sweegers MG, Altenburg TM, Chinapaw MJ, Kalter J, Verdonck-de Leeuw IM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, Brug J, Buffart LM,` Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials`, Br J Sports Med 2018; 52:505-13 (AmsterdamUMC/NKI) 1253. Szabados B, van Dijk N, Tang YZ, van der Heijden MS, Wimalasingham A, Gomez de LA, Chowdhury S, Hughes S, Rudman S, Linch M, Powles T,` Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer`, Eur Urol 2018; 73:149-52 [Letter] (NKI) 1254. Sztankay M, Aaronson NK, Arraras JI, Basso U, Bumbasirevic U, Efficace F, Giesinger JM, Johnson CD, van Leeuwen M, Oberguggenberger AS, Sosnowski R, Young T, Holzner B,` International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26`, BMC Cancer 2018; 18:1104 (NKI) 1255. Tajik, P, van de Vrie, R, Zafarmand, MH, Coens, C, Buist, MR, Vergote, I, Bossuyt, PMM & Kenter, GG 2018, 'The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy', International journal of gynecological cancer, ;28(3): 453-458. (AmsterdamUMC) 1256. Tamminga, SJ, de Jong, M, Frings-Dresen, MHW & de Boer, AGEM 2018, 'The Quality of Working Life Questionnaire for Cancer Survivors: Sufficient responsiveness for use as a patient-reported outcome measurement', European journal of cancer care, ;27(6): e12910. (AmsterdamUMC) 1257. Tang DH, Yan S, Ottenhof SR, Draeger D, Baumgarten AS, Chipollini J, Protzel C, Zhu Y, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE,` Laser ablation as monotherapy for penile squamous cell carcinoma: A multi-center cohort analysis`, Urol Oncol 2018; 36:147-52 (NKI) 1258. Te Riele W, Van Tinteren H, van Sandick J,` Centralization of Upper Gastrointestinal Cancer Care Should be Dictated by Quality of Care`, Ann Surg Oncol 2018; 25(Suppl 3):984-5 [Letter] (NKI) 1259. Teepen JC, Kok JL, van Leeuwen FE, Tissing WJE, Dolsma WV, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, van den Heuvel-Eibrink MM, Dulmen-den Broeder E, van den Berg MH, van der Heiden-van der Loo M, Hauptmann M, Jongmans MC, Overbeek LI, van de Vijver MJ, Kremer LCM, Ronckers CM, Aleman BMP, van den Berg MH, Bresters D, Caron HN, Daniels LA, Dolsma W, Dulmen-den Broeder E, Grootenhuis MA, Haasbeek CJ, den Hartogh JG, Hauptmann M, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, Hollema N, Janssens GO, Jongmans MC, Jaspers MWM, Kok JL, Kremer LCM, van Leeuwen FE, Loonen J, Maduro JH, Neggers SJCM, Oldenburger F, Overbeek LI, van der Pal HJ, Postma A, Ridder-Sluiter JG, van Rij CM, Ronckers CM, Teepen JC, Tersteeg RJ, Tissing WJE, Versluys AB, van de Vijver MJ, Zsiros J,` Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study`, J Natl Cancer Inst 2018; 110:758-67 (AmsterdamUMC/NKI) 1260. Teepen, JC, Curtis, RE, Dores, GM, Berrington de Gonzalez, A, van den Heuvel-Eibrink, MM, Kremer, LCM, Gilbert, ES, van Leeuwen, FE, Ronckers, CCM & Morton, LM 2018, 'Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000– 2014', Leukemia, ;32(12): 2580-2589. (AmsterdamUMC) 1261. Teixeira N, van der Hout A, Oosterwijk JC, Vos JR, Devilee P, van Engelen K, Meijers-Heijboer H, van der Luijt RB, Kriege M, Mensenkamp AR, Rookus MA, van Roozendaal KE, Mourits MJE, de Bock GH,` The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position? Eur J Hum Genet 2018; 26:848-57 `, (AmsterdamUMC/NKI) 1262. Tekatli, H, Duijm, M, Oomen-de Hoop, E, Verbakel, W, Schillemans, W, Slotman, BJ, Nuyttens, JJ & Senan, S 2018, 'Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors', International journal of radiation oncology, biology, physics, ;100(3): 738-747. (AmsterdamUMC) 1263. Tekatli, H, Spoelstra, FOB, Palacios, M, van Sornsen de Koste, J, Slotman, BJ & Senan, S 2018, 'Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches', Lung Cancer, ;123: 142-148. (AmsterdamUMC) 1264. Tekin, C, Shi, K, Daalhuisen, JB, Brink, MST, Bijlsma, MF & Spek, CA 2018, 'PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer', Oncotarget, ;9(62): 32010-32023. (AmsterdamUMC) 1265. Temko D, Van Gool IC, Rayner E, Glaire M, Makino S, Brown M, Chegwidden L, Palles C, Depreeuw J, Beggs A, Stathopoulou C, Mason J, Baker AM, Williams M, Cerundolo V, Rei M, Taylor JC, Schuh A, Ahmed A, Amant F, Lambrechts D, Smit VT, Bosse T, Graham TA, Church DN, Tomlinson I,` Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response`, J Pathol 2018; 245:283-96 (AmsterdamUMC/NKI) 1266. Ten Broeke SW, Elsayed FA, Pagan L, Olderode-Berends MJW, Garcia EG, Gille HJP, van Hest LP, Letteboer TGW, van der Kolk LE, Mensenkamp AR, van Os TA, Spruijt L, Redeker BJW, Suerink M, Vos YJ, Wagner A, Wijnen JT, Steyerberg EW, Tops CMJ, van Wezel T, Nielsen M,` SNP association study in PMS2-associated Lynch syndrome`, Fam Cancer 2018; 17:507-15 (AmsterdamUMC/NKI) 1267. ten Broeke, SW, van Bavel, TC, Jansen, AML, Gómez-García, E, Hes, FJ, van Hest, LP, Letteboer, TGW, Olderode-Berends, MJW, Ruano, D, Spruijt, L, Suerink, M, Tops, CM, van Eijk, R, Morreau, H, van Wezel, T & Nielsen, M 2018, 'Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2', Gastroenterology, ;155(3): 844-851. (AmsterdamUMC) 1268. Teng, J, Hejazi, S, Hiddingh, L, Carvalho, L, de Gooijer, MC, Wakimoto, H, Barazas, M, Tannous, M, Chi, AS, Noske, DP, Wesseling, P, Wurdinger, T, Batchelor, TT & Tannous, BA 2018, 'Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype', Neuro-Oncology, ;20(5): 642-654. (AmsterdamUMC) 1269. ter Veer, E, Creemers, A, de Waal, L, van Oijen, MGH & van Laarhoven, HWM 2018, 'Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis', International journal of cancer. Journal international du cancer, ;143(2): 438-448. (AmsterdamUMC) 1270. ter Veer, E, Prinsen, H, Sprangers, MAG, Zwinderman, KAH, Bleijenberg, G, van der Pouw Kraan, TCTM, de Vries, IJM, Wierenga, EA & van Laarhoven, HWM 2018, 'Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial', Cancer investigation, ;36(7): 371-377. (AmsterdamUMC) 1271. ter Veer, E, van den Ende, T, Creemers, A, de Waal, L, van Oijen, MGH & van Laarhoven, HWM 2018, 'Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis', Acta oncologica (Stockholm, Sweden), ;57(12): 1599-1604. (AmsterdamUMC) 1272. ter Veer, E, van Kleef, JJ, Schokker, S, van der Woude, SO, Laarman, M, Haj Mohammad, N, Sprangers, MAG, van Oijen, MGH & van Laarhoven, HWM 2018, 'Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis', European journal of cancer (Oxford, England, ;103: 214-226. (AmsterdamUMC) 1273. ter Veer, E, van Kleef, JJ, Sprangers, MAG, Haj Mohammad, N, van Oijen, MGH & van Laarhoven, HWM 2018, 'Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review', Gastric cancer, ;21(2): 183-195. (AmsterdamUMC) 1274. ter Veer, E, van Rijssen, LB, Besselink, MG, Mali, RMA, Berlin, JD, Boeck, S, Bonnetain, F, Chau, I, Conroy, T, van Cutsem, E, Deplanque, G, Friess, H, Glimelius, B, Goldstein, D, Herrmann, R, Labianca, R, van Laethem, J-L, Macarulla, T, van der Meer, JHM, Neoptolemos, JP, Okusaka, T, O'Reilly, EM, Pelzer, U, Philip, PA, van der Poel, MJ, Reni, M, Scheithauer, W, Siveke, JT, Verslype, C, Busch, OR, Wilmink, JW, van Oijen, MGH & van Laarhoven, HWM 2018, 'Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease', lancet oncology, ;19(3): e151-e160. (AmsterdamUMC) 1275. Testi, AM, Pession, A, Diverio, D, Grimwade, D, Gibson, B, Cardoso de Azevedo, A, Moran, L, Leverger, G, Elitzur, S, Hasle, H, van der Werff ten Bosch, J, Smith, O, de Rosa, M, Piciocchi, A, Lo Coco, F, Foà, R, Locatelli, F & Kaspers, GJL 2018, 'Risk-adapted treatment of acute promyelocytic leukemia: Results from the international consortium for childhood APL', Blood, ;132(4): 405-412. (AmsterdamUMC) 1276. Testori AA, Suciu S, van Akkooi ACJ, Suppa M, Eggermont AMM, de Vries E, Joosse A,` Lymph node ratio as a prognostic factor in melanoma: results from European Organization for Research and Treatment of Cancer 18871, 18952, and 18991 studies`, Melanoma Res 2018; 28:222-9 (NKI) 1277. Tetar, S, Bruynzeel, A, Bakker, R, Jeulink, M, Slotman, BJ, Oei, S, Haasbeek, C, De Jong, K, Senan, S & Lagerwaard, F 2018, 'Patient-reported Outcome Measurements on the Tolerance of Magnetic Resonance Imaging-guided Radiation Therapy', Cureus, ;10(2): e2236. (AmsterdamUMC) 1278. Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank C, van de Wiel B, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, Mitchell T, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA,` Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma`, Ann Oncol 2018; 29:1861-8 (NKI) 1279. Teulings HE, Tjin EPM, Willemsen KJ, van der Kleij S, Ter Meulen S, Kemp EH, Krebbers G, van Noesel CJM, Franken CLMC, Drijfhout JW, Melief CJM, Nieuweboer-Krobotova L, Nieweg OE, van der Hage JA, van der Veen JPW, Relyveld GN, Luiten RM,` Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial`, Oncoimmunology 2018; 7:e1419113-(14 pp) (AmsterdamUMC/NKI) 1280. Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM,` Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies`, Lancet Haematol 2018; 5:e563-e598 (NKI) 1281. The 2017 and 2015 European Society of Coloproctology (ESCP) collaborating groups 2018, 'The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit', Colorectal disease, ;20: 69-89. (AmsterdamUMC) 1282. The 2017 European Society of Coloproctology (ESCP) collaborating group 2018, 'An international multicentre prospective audit of elective rectal cancer surgery;(): (AmsterdamUMC) 1283. the Dutch Head and Neck Audit Group 2018, 'Needs and preferences of patients with head and neck cancer in integrated care', Clinical otolaryngology, ;43(2): 553-561. (AmsterdamUMC) 1284. the Dutch Pancreatic Cancer Group 2018, 'Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study', Cancer medicine, ;7(10): 4943-4951. (AmsterdamUMC) 1285. the Dutch Pancreatic Cancer Group, Versteijne, E, Vogel, JA, Besselink, MG, Busch, ORC, Wilmink, JW, Daams, JG, Rasch, CRN & van Tienhoven, G 2018, 'Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer', British journal of surgery, ;105(8): 946-958. (AmsterdamUMC) 1286. the Dutch Upper GI Cancer Audit group 2018, 'A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit', Annals of surgical oncology, ;25(5): 1211-1220. (AmsterdamUMC) 1287. the E-AHPBA DP-CAR study group 2018, 'Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study', Annals of surgical oncology, ;25(3): 988. (AmsterdamUMC) 1288. the E-AHPBA DP-CAR study group 2018, 'Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study', Annals of surgical oncology, ;25(5): 1440-1447. (AmsterdamUMC) 1289. the EORTC Melanoma Group and EORTC Quality of Life Group 2018, 'Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma', European journal of cancer (Oxford, England, ;104: 169-181. (AmsterdamUMC) 1290. the ISTH-SSC-VB Working group 2018, 'Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation', Journal of thrombosis and haemostasis, ;16(6): 1236-1245. (AmsterdamUMC) 1291. The PelvEx Collaborative 2018, 'Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer', British Journal of Surgery, ;105(6): 650-657. (AmsterdamUMC) 1292. the WEO Expert Working Group of Surveillance after colonic neoplasm 2018, 'Colonoscopy quality requisites for selecting surveillance intervals: A World Endoscopy Organization Delphi Recommendation', Digestive endoscopy, ;30(6): 750-759. (AmsterdamUMC) 1293. Thewes, B, Rietjens, JAC, van den Berg, SW, Compen, FLR, Abrahams, H, Poort, H, van de Wal, M, Schellekens, MPJ, Peters, MEWJ, Speckens, AEM, Knoop, H & Prins, JB 2018, 'One way or another: The opportunities and pitfalls of self-referral and consecutive sampling as recruitment strategies for psycho-oncology intervention trials', Psycho-oncology, ;27(8): 2056-2059. (AmsterdamUMC) 1294. Thijssen B, Dijkstra TMH, Heskes T, Wessels LFA,` Bayesian data integration for quantifying the contribution of diverse measurements to parameter estimates`, Bioinformatics 2018; 34:803-11 (NKI) 1295. Thijssen, VLJL, Paulis, YWJ, Nowak-Sliwinska, P, Deumelandt, KL, Hosaka, K, Soetekouw, PMMB, Cimpean, AM, Raica, M, Pauwels, P, van den Oord, JJ, Tjan-Heijnen, VCG, Hendrix, MJ, Heldin, C-H, Cao, Y & Griffioen, AW 2018, 'Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth', Journal of Pathology, ;246(4): 447-458. (AmsterdamUMC) 1296. Thomas J, Ferme C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, Andre M, Lybeert MLM, Stamatoullas A, Beijert M, Helias P, Eghbali H, Gabarre J, van der Maazen RWM, Jaubert J, Bouabdallah K, Boulat O, Roesink JM, Christian B, Ong F, Bordessoule D, Tertian G, Gonzalez H, Vranovsky A, Quittet P, Tirelli U, de Jong D, Audouin J, Aleman BMP, Henry-Amar M,` Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial`, Int J Radiat Oncol Biol Phys 2018; 100:1133-45 AmsterdamUMC/(NKI) 1297. Thommen DS, Koelzer VH, Herzig P, Roller A, Trefny M, Dimeloe S, Kiialainen A, Hanhart J, Schill C, Hess C, Savic Prince S, Wiese M, Lardinois D, Ho PC, Klein C, Karanikas V, Mertz KD, Schumacher TN, Zippelius A,` A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade`, Nat Med 2018; 24:994-1004 (NKI) 1298. Thommen DS, Schumacher TN,` T Cell Dysfunction in Cancer`, Cancer Cell 2018; 33:547-62 (NKI) 1299. Thompson, JE, Egger, S, Böhm, M, Siriwardana, AR, Haynes, A-M, Matthews, J, Scheltema, MJ & Stricker, PD 2018, 'Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve-Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases', European urology, ;73(5): 664-671. (AmsterdamUMC) 1300. Thong, MSY, Mols, F, van de Poll-Franse, LV, Sprangers, MAG, van der Rijt, CCD, Barsevick, AM, Knoop, H & Husson, O 2018, 'Identifying the subtypes of cancer-related fatigue: results from the population- based PROFILES registry', Journal of cancer survivorship, ;12(1): 38-46. (AmsterdamUMC) 1301. Thunnissen, E, Allen, TC, Adam, J, Aisner, DL, Beasley, MB, Borczuk, AC, Cagle, PT, Capelozzi, VL, Cooper, W, Hariri, LP, Kern, I, Lantuejoul, S, Miller, R, Mino-Kenudson, M, Radonic, T, Raparia, K, Rekhtman, N, Roy-Chowdhuri, S, Russell, P, Schneider, F, Sholl, LM, Tsao, MS, Vivero, M & Yatabe, Y 2018, 'Immunohistochemistry of pulmonary biomarkers a perspective from members of the pulmonary pathology society', Archives of pathology & laboratory medicine, ;142(3): 408-419. (AmsterdamUMC) 1302. Timmerman JGJ, Dekker-van Weering MGHM, Wouters MWJM, Stuiver MMM, de Kanter WW, Vollenbroek-Hutten MMRM,` Physical behavior and associations with health outcomes in operable NSCLC patients: A prospective study`, Lung Cancer 2018; 119:91-8 (NKI) 1303. Timmermans M, Schuurman MS, Ho VKY, Massuger LF, Nijman HW, Van Gorp T, Sonke GS, Kruitwagen RFPM, Van der Aa MA,` Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery`, Gynecol Oncol 2018; 148:56-61 (NKI) 1304. Timmermans M, Sonke GS, Van de Vijver KK, Van der Aa MA, Kruitwagen RFPM,` No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands`, Eur J Cancer 2018; 88:31-7 (NKI) 1305. Timmermans M, Sonke GS, van Driel WJ, Lalisang RI, Ottevanger PB, de Kroon CD, Van de Vijver KK, Van der Aa MA, Kruitwagen RF,` Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands`, Eur J Obstet Gynecol Reprod Biol 2018; 223:98-102 (NKI) 1306. Timmermans M, Van der Aa MA, Lalisang RI, Witteveen PO, Van de Vijver KK, Kruitwagen RF, Sonke GS,` Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer`, Gynecol Oncol 2018; 150:446-50 (NKI) 1307. Tjon-Kon-Fat, L-A, Lundholm, M, Schröder, M, Wurdinger, T, Thellenberg-Karlsson, C, Widmark, A, Wikström, P & Nilsson, RJA 2018, 'Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients', Prostate, ;78(1): 48-53. (AmsterdamUMC) 1308. Tjon-Kon-Fat, L-A, Sol, N, Wurdinger, T & Nilsson, RJA 2018, 'Platelet RNA in Cancer Diagnostics', Seminars in Thrombosis and Hemostasis, ;44(2): 135-141. (AmsterdamUMC) 1309. Toes-Zoutendijk E, Kooyker AI, Elferink MA, Spaander MCW, Dekker E, Koning HJ, Lemmens VE, van Leerdam ME, Lansdorp-Vogelaar I,` Stage distribution of screen-detected colorectal cancers in the Netherlands`, Gut 2018; 67:1745-6 [Letter] (AmsterdamUMC/NKI) 1310. Toffalorio, F, Santarpia, M, Radice, D, Jaramillo, CA, Spitaleri, G, Manzotti, M, Catania, C, Jordheim, LP, Pelosi, G, Peters, GJ, Tibaldi, C, Funel, N, Spaggiari, L, de Braud, F, de Pas, T & Giovannetti, E 2018, '5'- nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer', Oncotarget, ;9(23): 16437-16450. (AmsterdamUMC) 1311. Toland AE, Forman A, Couch FJ, Culver JO, Eccles DM, Foulkes WD, Hogervorst FBL, Houdayer C, Levy- Lahad E, Monteiro AN, Neuhausen SL, Plon SE, Sharan SK, Spurdle AB, Szabo C, Brody LC,` Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices`, NPJ Genom Med 2018; 3:7 (NKI) 1312. Torres-Xirau I, Olaciregui-Ruiz I, Baldvinsson G, Mijnheer BJ, van der Heide UA, Mans A,` Characterization of the a-Si EPID in the unity MR-linac for dosimetric applications`, Phys Med Biol 2018; 63:025006-(9 pp) (NKI) 1313. Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, van den Broeck T, van der Poel H, Walz J, de Meerleer G, Bossi A, Haustermans K, van Poppel H, Spahn M, Joniau S,` The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis`, Eur Urol Focus 2018; 4:369-75 (NKI) 1314. Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG),` Management of metastatic retroperitoneal sarcoma: a consensus approach from the Transatlantic Retroperitoneal Sarcoma Working Group (TARPSWG)`, Ann Oncol 2018; 29:857-71 (NKI) 1315. Treffers, LW, van Houdt, M, Bruggeman, CW, Heineke, MH, Zhao, XW, van der Heijden, J, Nagelkerke, SQ, Verkuijlen, PJJH, Geissler, J, Lissenberg-Thunnissen, S, Valerius, T, Peipp, M, Franke, K, van Bruggen, R, Kuijpers, TW, van Egmond, M, Vidarsson, G, Matlung, HL & van den Berg, TK 2018, 'FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils', Frontiers in immunology, ;9: 3124. (AmsterdamUMC) 1316. Treffers, LW, Zhao, XW, van der Heijden, J, Nagelkerke, SQ, van Rees, DJ, Gonzalez, P, Geissler, J, Verkuijlen, P, van Houdt, M, de Boer, M, Kuijpers, TW, van den Berg, TK & Matlung, HL 2018, 'Genetic variation of human neutrophil Fc gamma receptors and SIRP alpha in antibody-dependent cellular cytotoxicity towards cancer cells', European journal of immunology, ;48(2): 344-354. (AmsterdamUMC) 1317. TREND study group 2018, 'The occurrence and characteristics of endoscopically unexpected malignant degeneration in large rectal adenomas', Gastrointestinal endoscopy, ;87(3): 862-871.e1. (AmsterdamUMC) 1318. Trinh, A, Lädrach, C, Dawson, HE, ten Hoorn, S, Kuppen, PJK, Reimers, MS, Koopman, M, Punt, CJA, Lugli, A, Vermeulen, L & Zlobec, I 2018, 'Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data', British journal of cancer, ;119(10): 1244-1251. (AmsterdamUMC) 1319. Trumpi, K, Frenkel, N, Peters, T, Korthagen, NM, Jongen, JMJ, Raats, D, van Grevenstein, H, Backes, Y, Moons, LM, Lacle, MM, Koster, J, Zwijnenburg, D, Rinkes, IHMB & Kranenburg, O 2018, 'Macrophages induce (AmsterdamUMC) 1320. Tsao, MS, Kerr, KM, Kockx, M, Beasley, M-B, Borczuk, AC, Botling, J, Bubendorf, L, Chirieac, L, Chen, G, Chou, T-Y, Chung, J-H, Dacic, S, Lantuejoul, S, Mino-Kenudson, M, Moreira, AL, Nicholson, AG, Noguchi, M, Pelosi, G, Poleri, C, Russell, PA, Sauter, J, Thunnissen, E, Wistuba, I, Yu, H, Wynes, MW, Pintilie, M, Yatabe, Y & Hirsch, FR 2018, 'PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project', Journal of Thoracic Oncology, ;13(9): 1302-1311. (AmsterdamUMC) 1321. Tseng WW, Tsao-Wei DD, Callegaro D, Grignani G, D'Ambrosio L, Bonvalot S, Ethun CG, Cardona K, Mullen JT, Canter RJ, Mullinax JE, Gonzalez RJ, van Coevorden F, Albertsmeier M, Dhanireddy KK, Renne SL, Gronchi A,``, Eur J Surg Oncol 2018; 44:810-5 (NKI) 1322. Tubb VM, Schrikkema DS, Croft NP, Purcell AW, Linnemann C, Freriks MR, Chen F, Long HM, Lee SP, Bendle GM,` Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies`, J Immunother Cancer 2018; 6:70 (NKI) 1323. Tudini E, Moghadasi S, Parsons MT, van der Kolk L, van den Ouweland AMW, Niederacher D, Feliubadalo L, Wappenschmidt B, Spurdle AB, Lazaro C,` Substantial evidence for the clinical significance of missense variant BRCA1 c5309G>T p(Gly1770Val)`, Breast Cancer Res Treat 2018; 172:497-503 (NKI) 1324. Tullemans, BME, Nagy, M, Sabrkhany, S, Griffioen, AW, Oude Egbrink, MGA, Aarts, M, Heemskerk, JWM & Kuijpers, MJE 2018, 'Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients', Frontiers in cardiovascular medicine, ;5: 142. (AmsterdamUMC) 1325. Turcan, S, Makarov, V, Taranda, J, Wang, Y, Fabius, AWM, Wu, W, Zheng, Y, El-Amine, N, Haddock, S, Nanjangud, G, LeKaye, HC, Brennan, C, Cross, J, Huse, JT, Kelleher, NL, Osten, P, Thompson, CB & Chan, TA 2018, 'Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence', Nature Genetics, ;50(1): 62-72. (AmsterdamUMC) 1326. Turco S, Lavini C, Heijmink S, Barentsz J, Wijkstra H, Mischi M,` Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study`, AJR Am J Roentgenol 2018; 211:W242- W251 (AmsterdamUMC/NKI) 1327. Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, Hodgson DC, Yasui Y, Oeffinger KC, Henderson TO,` Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review`, J Clin Oncol 2018; 36:2145-52 (AmsterdamUMC/NKI) 1328. Tuyaerts, S & Amant, F 2018, 'Endometrial stromal sarcomas: A revision of their potential as targets for immunotherapy', Vaccines, ;6(3): 56. (AmsterdamUMC) 1329. Twisk, DE, van der Sande, MAB, van Eeden, A, Heideman, DAM, van der Klis, FRM, de Vries, HJC & Schim van der Loeff, MF 2018, 'Detection of Incident Anal High-Risk HPV-DNA in MSM: Incidence or Reactivation?', Journal of Infectious Diseases, ;218(7): 1018-1026. (AmsterdamUMC) 1330. Ubink I, van Eden WJ, Snaebjornsson P, Kok NFM, van Kuik J, van Grevenstein WMU, Lacle MM, Sanders J, Fijneman RJA, Elias SG, Borel Rinkes IHM, Aalbers AGJ, Kranenburg O,` Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases`, Br J Surg 2018; 105:e204-e211 (NKI) 1331. Uckelmann M, Densham RM, Baas R, Winterwerp HHK, Fish A, Sixma TK, Morris JR,` USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A`, Nat Commun 2018; 9:229 (16 pp) (NKI) 1332. Umulisa, MC, Franceschi, S, Baussano, I, Tenet, V, Uwimbabazi, M, Rugwizangoga, B, Heideman, DAM, Uyterlinde, AM, Darragh, TM, Snijders, PJF, Sayinzoga, F & Clifford, GM 2018, 'Evaluation of human- papillomavirus testing and visual inspection for cervical cancer screening in Rwanda', BMC Women's Health, ;18(1): 59. (AmsterdamUMC) 1333. Uyl-de Groot, CA, van Rooijen, EM, Punt, CJA & Pescott, CP 2018, 'Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands', Health economics, ;8(1): 13. (AmsterdamUMC) 1334. Vaarwerk, B, van der Lee, JH, Breunis, WB, Orbach, D, Chisholm, JC, Cozic, N, Jenney, M, van Rijn, RR, McHugh, K, Gallego, S, Glosli, H, Devalck, C, Gaze, MN, Kelsey, A, Bergeron, C, Stevens, MCG, Oberlin, O, Minard-Colin, V & Merks, JHM 2018, 'Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study', Cancer, ;124(5): 1016-1024. (AmsterdamUMC) 1335. Valkenet, K, Trappenburg, JCA, Ruurda, JP, Guinan, EM, Reynolds, JV, Nafteux, P, Fontaine, M, Rodrigo, HE, van der Peet, DL, Hania, SW, Sosef, MN, Willms, J, Rosman, C, Pieters, H, Scheepers, JJG, Faber, T, Kouwenhoven, EA, Tinselboer, M, Räsänen, J, Ryynänen, H, Gosselink, R, van Hillegersberg, R & Backx, FJG 2018, 'Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer', British Journal of Surgery, ;105(5): 502-511. (AmsterdamUMC) 1336. van Andel L, Rosing H, Lubomirov R, Aviles P, Fudio S, Tibben MM, Nan-Offeringa L, Schellens JHM, Beijnen JH,` Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of lurbinectedin in human plasma and urine`, J Pharm Biomed Anal 2018; 158:160-5 (NKI) 1337. van Andel L, Rosing H, Schellens JHM, Beijnen JH,` Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment`, Mar Drugs 2018; 16:248 (30 pp) (NKI) 1338. van Andel L, Rosing H, Tibben MM, Lucas L, Lubomirov R, Aviles P, Francesch A, Fudio S, Gebretensae A, Hillebrand MJX, Schellens JHM, Beijnen JH,` Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of (14)C-plitidepsin`, Cancer Chemother Pharmacol 2018; 82:441-5 (NKI) 1339. van Andel L, Rosing H, Zhang Z, Hughes L, Kansra V, Sanghvi M, Tibben MM, Gebretensae A, Schellens JHM, Beijnen JH,` Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients`, Cancer Chemother Pharmacol 2018; 81:39-46 (NKI) 1340. van As, JW, van den Berg, H & van Dalen, EC 2018, 'Different infusion durations for preventing platinum-induced hearing loss in children with cancer', Cochrane database of systematic reviews (Online), ;2018(7): CD010885. (AmsterdamUMC) 1341. van Asten SD, Raaben M, Nota B, Spaapen RM,` Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication`, J Virol 2018; 92:e00260-18 (NKI) 1342. van Baal JOAM, van Noorden CJF, Nieuwland R, Van de Vijver KK, Sturk A, van Driel WJ, Kenter GG, Lok CAR,` Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review`, J Histochem Cytochem 2018; 66:67-83 (AmsterdamUMC/NKI) 1343. van Baar, GJC, Forouzanfar, T, Liberton, NPTJ, Winters, HAH & Leusink, FKJ 2018, 'Accuracy of computer-assisted surgery in mandibular reconstruction: A systematic review', Oral Oncology, ;84: 52- 60. (AmsterdamUMC) 1344. van Balen, P, van der Zouwen, B, Kruisselbrink, AB, Eefting, M, Szuhai, K, Jordanova, ES, Falkenburg, JHF & Jedema, I 2018, 'Tissue damage caused by myeloablative, but not non-myeloablative, conditioning before allogeneic stem cell transplantation results in dermal macrophage recruitment without active T-cell interaction', Frontiers in Immunology, ;9: 331. (AmsterdamUMC) 1345. van Bastelaar J, Granzier R, van Roozendaal LM, Beets G, Dirksen CD, Vissers Y,` A multi-center, double blind randomized controlled trial evaluating flap fixation after mastectomy using sutures or tissue glue versus conventional closure: protocol for the Seroma reduction After Mastectomy (SAM) trial`, BMC Cancer 2018; 18:830 (8 pp) (NKI) 1346. van Bastelaar J, van Roozendaal L, Granzier R, Beets G, Vissers Y,` A systematic review of flap fixation techniques in reducing seroma formation and its sequelae after mastectomy`, Breast Cancer Res Treat 2018; 167:409-18 (NKI) 1347. van Berlo-van de Laar IRF, Brummelhuis WJ, Imholz ALT, Schellens JH, Huitema ADR, Jansman FGA,` Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations`, J Clin Pharm Ther 2018; 43:574-7 (NKI) 1348. van Beusekom B, Heidebrecht T, Adamopoulos A, Fish A, Pardon E, Steyaert J, Joosten RP, Perrakis A,` Characterization and structure determination of a llama-derived nanobody targeting the J-base binding protein 1`, Acta Crystallogr F Struct Biol Commun 2018; 74:690-5 (NKI) 1349. van Beusekom B, Joosten K, Hekkelman ML, Joosten RP, Perrakis A,` Homology-based loop modeling yields more complete crystallographic protein structures`, IUCrJ 2018; 5:585-94 (NKI) 1350. van Beusekom B, Touw WG, Tatineni M, Somani S, Rajagopal G, Luo J, Gilliland GL, Perrakis A, Joosten RP,` Homology-based hydrogen bond information improves crystallographic structures in the PDB`, Protein Sci 2018; 27:798-808 (NKI) 1351. van Bommel ACM, Schreuder K, Veenstra RK, de Ligt KM, Vrancken Peeters MTFD, Maduro JH, Siesling S, Mureau MAM,` Discrepancies Between Surgical Oncologists and Plastic Surgeons in Patient Information Provision and Personal Opinions Towards Immediate Breast Reconstruction`, Ann Plast Surg 2018; 81:383-8 (NKI) 1352. van Broekhoven DLM, Verschoor AJ, van Dalen T, Grunhagen DJ, den Bakker MA, Gelderblom H, Bovee JVMG, Haas RLM, Bonenkamp HJ, van Coevorden F, Ten Oever D, van der Graaf WTA, Flucke UE, Pras E, Reyners AKL, Westermann AM, Oldenburger F, Verhoef C, Steeghs N,` Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands`, Sarcoma 2018; 2018:5982575 (NKI) 1353. van Brummelen EMJ, Huisman MC, de Wit-van der Veen LJ, Nayak TK, Stokkel MPM, Mulder ER, Hoekstra OS, Vugts DJ, van Dongen GAMS, Verheul HM, Evers S, Tessier JJL, Saro J, Schellens JHM, Menke-van der Houven van Oordt CW,` (89)Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding`, Oncotarget 2018; 9:24737-49 (AmsterdamUMC/NKI) 1354. van Bussel MTJ, Pluim D, Bol M, Beijnen JH, Schellens JHM, Brandsma D,` EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid`, J Neurooncol 2018; 137:1-10 (NKI) 1355. van de Donk, NWCJ & Usmani, SZ 2018, 'CD38 antibodies in multiple myeloma: Mechanisms of action and modes of resistance', Frontiers in Immunology, ;9: 2134. (AmsterdamUMC) 1356. van de Donk, NWCJ 2018, 'Immunomodulatory effects of CD38-targeting antibodies', Immunology Letters, ;199: 16-22. (AmsterdamUMC) 1357. van de Donk, NWCJ, Richardson, PG & Malavasi, F 2018, 'CD38 antibodies in multiple myeloma: Back to the future', Blood, ;131(1): 13-29. (AmsterdamUMC) 1358. van de Donk, NWCJ, van der Holt, B, Minnema, MC, Vellenga, E, Croockewit, S, Kersten, MJ, von dem Borne, PA, Ypma, P, Schaafsma, R, de Weerdt, O, Klein, SK, Delforge, M, Levin, M-D, Bos, GM, Jie, K-SG, Sinnige, H, Coenen, JLLM, de Waal, EG, Zweegman, S, Sonneveld, P & Lokhorst, HM 2018, 'Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial', Lancet. Haematology, ;5(10): e479-e492. (AmsterdamUMC) 1359. van de Kamp M, Meijer R, Pos F, Kerst M, van Werkhoven E, van Rhijn B, Horenblas S, Bex A,` Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome`, Urol Oncol 2018; 36:307 (NKI) 1360. van de Lindt T, Sonke JJ, Nowee M, Jansen E, van Pelt V, van der Heide U, Fast M,` A Self-Sorting Coronal 4D-MRI Method for Daily Image Guidance of Liver Lesions on an MR-LINAC`, Int J Radiat Oncol Biol Phys 2018; 102:875-84 (NKI) 1361. van de Lindt TN, Fast MF, van der Heide UA, Sonke JJ,` Retrospective self-sorted 4D-MRI for the liver`, Radiother Oncol 2018; 127:474-80 (NKI) 1362. van de Loosdrecht, AA, van Wetering, S, Santegoets, SJAM, Singh, SK, Eeltink, CM, den Hartog, Y, Koppes, M, Kaspers, J, Ossenkoppele, GJ, Kruisbeek, AM & de Gruijl, TD 2018, 'A novel allogeneic off- the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia', Cancer Immunology and Immunotherapy, ;67(10): 1505-1518. (AmsterdamUMC) 1363. van de Putte, EEF, Bosschieter, J, van der Kwast, TH, Bertz, S, Denzinger, S, Manach, Q, Compérat, EM, Boormans, JL, Jewett, MAS, Stoehr, R, van Leenders, GJLH, Nieuwenhuijzen, JA, Zlotta, AR, Hendricksen, K, Rouprêt, M, Otto, W, Burger, M, Hartmann, A & van Rhijn, BWG 2018, 'The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non- muscle-invasive bladder cancer', BJU International, ;122(6): 978-985. (AmsterdamUMC) 1364. van de Ven M, Liu X, van der Burg E, Klarenbeek S, Alexi X, Zwart W, Dijcks F, Bouwman P, Jonkers J,` BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling`, J Pathol 2018; 246:41-53 (NKI) 1365. van de Wiel HJ, Stuiver MM, May AM, van Grinsven S, Aaronson NK, Retel VP, Oldenburg HSA, van der Poel HG, Horenblas S, van Harten WH, Groen WG,` (Cost-)effectiveness of an internet-based physical activity support program (with and without physiotherapy counselling) on physical activity levels of breast and prostate cancer survivors: design of the PABLO trial`, BMC Cancer 2018; 18:1073 (NKI) 1366. van den Bent, MJ, Klein, M, Smits, M, Reijneveld, JC, French, PJ, Clement, P, de Vos, FYF, Wick, A, Mulholland, PJ, Taphoorn, MJB, Lewis, J, Weller, M, Chinot, OL, Kros, JM, de Heer, I, Verschuere, T, Coens, C, Golfinopoulos, V, Gorlia, T & Idbaih, A 2018, 'Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial', The Lancet Oncology, ;19(9): 1170-1179. (AmsterdamUMC) 1367. van den Berg J, Manjon G, Kielbassa K, Feringa F, Freire R, Medema R,` A limited number of double- strand DNA breaks is sufficient to delay cell cycle progression`, Nucleic Acids Res 2018; 46:10132-44 (NKI) 1368. van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, Calaminus G, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, Kremer LC, Kruseova J, Kuehni CE, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Morsellino V, Spix C, Kaatsch P, van Dulmen-den BE,` Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)`, JMIR Res Protoc 2018; 7:e10824 (NKI) 1369. van den Berg, MH, Overbeek, A, Lambalk, CB, Kaspers, GJL, Bresters, D, van den Heuvel-Eibrink, MM, Kremer, LC, Loonen, JJ, van der Pal, HJ, Ronckers, CM, Tissing, WJE, Versluys, AB, van der Heiden-van der Loo, M, Heijboer, AC, Hauptmann, M, Twisk, JWR, Laven, JSE, Beerendonk, CCM, van Leeuwen, FE & van Dulmen-den Broeder, E 2018, 'Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve', Human reproduction (Oxford, England), ;33(8): 1474- 1488. (AmsterdamUMC) 1370. van den Bergh RCN, van der Poel HG, Murphy DG,` Editorial Comment`, J Urol 2018; 200:1254-5 [Editorial] (NKI) 1371. van den Boorn, HG, Engelhardt, EG, van Kleef, J, Sprangers, MAG, van Oijen, MGH, Abu-Hanna, A, Zwinderman, AH, Coupé, VMH & van Laarhoven, HWM 2018, 'Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis', PLoS ONE, ;13(2): e0192310. (AmsterdamUMC) 1372. van den Bos, W, Scheltema, MJ, Siriwardana, AR, Kalsbeek, AMF, Thompson, JE, Ting, F, Böhm, M, Haynes, A-M, Shnier, R, Delprado, W & Stricker, PD 2018, 'Focal irreversible electroporation as primary treatment for localized prostate cancer', BJU international, ;121(5): 716-724. (AmsterdamUMC) 1373. van den Bosch S, Vogel WV, Raaijmakers CP, Dijkema T, Terhaard CHJ, Al Mamgani A, Kaanders JHAM,` Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation`, Radiother Oncol 2018; 128:472-8 (NKI) 1374. van den Bossche, WBL, Kleijn, A, Teunissen, CE, Voerman, JSA, Teodosio, C, Noske, DP, van Dongen, JJM, Dirven, CMF & Lamfers, MLM 2018, 'Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment', Neuro- Oncology, ;20(11): 1494-1504. (AmsterdamUMC) 1375. van den Broek E, den Uil SH, Coupe VMH, Delis-Van Diemen PM, Bolijn AS, Bril H, Stockmann HBAC, van Grieken NCT, Meijer GA, Fijneman RJA,` MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer`, Oncotarget 2018; 9:29445-52 (AmsterdamUMC/NKI) 1376. van den Ende RPJ, Rijkmans EC, Kerkhof EM, Nout RA, Ketelaars M, Laman MS, Marijnen CAM, van der Heide UA,` Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer`, Brachytherapy 2018; 17:78-85 (NKI) 1377. van den Ende, T, Smyth, E, Hulshof, MCCM & van Laarhoven, HWM 2018, 'Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer', Best practice & research. Clinical gastroenterology, ; 36-37: 45-52. (AmsterdamUMC) 1378. van den Eynden, J, Umapathy, G, Ashouri, A, Cervantes-Madrid, D, Szydzik, J, Ruuth, K, Koster, J, Larsson, E, Guan, J, Palmer, RH & Hallberg, B 2018, 'Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways', Science signaling, ;11(557): aar5680. (AmsterdamUMC) 1379. van den Heuvel, CNAM, Das, AI, de Bitter, T, Simmer, F, Wurdinger, T, Molina-Vila, MA & Leenders, WPJ 2018, 'Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes', Scientific Reports, ;8(1): 7072. (AmsterdamUMC) 1380. van der Aa, AAMA, Mannaerts, CK, van der Linden, H, Gayet, M, Schrier, BP, Mischi, M, Beerlage, HP & Wijkstra, H 2018, 'Concordance of Gleason grading with three-dimensional ultrasound systematic biopsy and biopsy core pre-embedding', World journal of urology, ;36(6): 863-869. (AmsterdamUMC) 1381. van der Ende-van Loon, MCM, Rosmolen, WD, Houterman, S, Schoon, EJ & Curvers, WL 2018, 'Cancer risk perception in relation to associated symptoms in Barrett's patients: A cross sectional study on quality of life', United European gastroenterology journal, ;6(9): 1316-1322. (AmsterdamUMC) 1382. van der Heide UA, Thorwarth D,` Quantitative Imaging for Radiation Oncology`, Int J Radiat Oncol Biol Phys 2018; 102:683-6 [Editorial] (NKI) 1383. van der Horst, A, Versteijne, E, Besselink, MGH, Daams, JG, Bulle, EB, Bijlsma, MF, Wilmink, JW, van Delden, OM, van Hooft, JE, Franken, NAP, van Laarhoven, HWM, Crezee, J & van Tienhoven, G 2018, 'The clinical benefit of hyperthermia in pancreatic cancer: a systematic review', International journal of hyperthermia, ;34(7): 969-979. (AmsterdamUMC) 1384. van der Kaaij RT, de Rooij MV, van Coevorden F, Voncken FEM, Snaebjornsson P, Boot H, van Sandick JW,` Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery`, Br J Surg 2018; 105:561-9 (NKI) 1385. van der Kaaij RT, van Kessel JP, van Dieren JM, Snaebjornsson P, Balague O, van Coevorden F, van der Kolk LE, Sikorska K, Cats A, van Sandick JW,` Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer`, Br J Surg 2018; 105:e176-e182 (NKI) 1386. van der Leeden M, Huijsmans RJ, Geleijn E, de Rooij M, Konings IR, Buffart LM, Dekker J, Stuiver MM,` Tailoring exercise interventions to comorbidities and treatment-induced adverse effects in patients with early stage breast cancer undergoing chemotherapy: a framework to support clinical decisions`, Disabil Rehabil 2018; 40:486-96 (AmsterdamUMC/NKI) 1387. van der Meer, PB, Habets, EJJ, Wiggenraad, RG, Verbeek-de Kanter, A, Lycklama à Nijeholt, GJ, Zwinkels, H, Klein, M, Dirven, L & Taphoorn, MJB 2018, 'Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy', Journal of Neuro-Oncology, ;139(2): 359-368. (AmsterdamUMC) 1388. van der Meulen, MP, Lansdorp-Vogelaar, I, Goede, SL, Kuipers, EJ, Dekker, E, Stoker, J & van Ballegooijen, M 2018, 'Colorectal Cancer: Cost-effectiveness of Colonoscopy versus CT Colonography Screening with Participation Rates and Costs', Radiology, ;287(3): 901-911. (AmsterdamUMC) 1389. van der Noordaa MEM, van Duijnhoven FH, Loo CE, van Werkhoven E, Van de Vijver KK, Wiersma T, Winter-Warnars HAO, Sonke GS, Vrancken Peeters MTFD,` Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)`, Breast 2018; 40:76-81 (NKI) 1390. van der Noordaa MEM, van Duijnhoven FH, Straver ME, Groen EJ, Stokkel M, Loo CE, Elkhuizen PHM, Russell NS, Vrancken Peeters MTFD,` Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure`, Ann Surg Oncol 2018; 25:1512-20 (NKI) 1391. van der Noordaa MEM, Vrancken Peeters MTFD,` ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients`, Ann Surg Oncol 2018; 25(Suppl 3):677-8 [Auth reflect] (NKI) 1392. van der Paardt, MP & Stoker, J 2018, 'Current Status of Magnetic Resonance Colonography for Screening and Diagnosis of Colorectal Cancer', Radiologic clinics of North America, ;56(5): 737-749. (AmsterdamUMC) 1393. van der Poel H, Grivas N,` Towards an individualized approach for predicting post-prostatectomy urinary incontinence: the role of nerve preservation and urethral stump length`, BJU Int 2018; 122:354-5 [Editorial] (NKI) 1394. van der Poel HG, Grivas N, van Leeuwen F,` Comprehensive Assessment of Indocyanine Green Usage: One Tracer, Multiple Urological Applications`, Eur Urol Focus 2018; 4:665-8 (NKI) 1395. van der Poel HG, van den Bergh RCN, Briers E, Cornford P, Govorov A, Henry AM, Lam TB, Mason MD, Rouviere O, De Santis M, Willemse PM, van Poppel H, Mottet N,` Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018`, Eur Urol 2018; 74:84-91 (NKI) 1396. van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp- Vogelaar I, van Krieken JH, Bisseling TM, Cats A,` Outcomes of Screening Gastroscopy in First-degree Relatives of Patients Fulfilling Hereditary Diffuse Gastric Cancer Criteria`, Gastrointest Endosc 2018; 87:397-404 (NKI) 1397. van der Putten, LJM, Visser, NCM, van de Vijver, K, Santacana, M, Bronsert, P, Bulten, J, Hirschfeld, M, Colas, E, Gil-Moreno, A, Garcia, A, Mancebo, G, Alameda, F, Trovik, J, Kopperud, RK, Huvila, J, Schrauwen, S, Koskas, M, Walker, F, Weinberger, V, Minar, L, Jandakova, E, Snijders, MPLM, van den Berg-van Erp, S, Matias-Guiu, X, Salvesen, HB, Werner, HMJ, Amant, F, Massuger, LFAG & Pijnenborg, JMA 2018, 'Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study', International journal of gynecological cancer, ;28(3): 514-523. (AmsterdamUMC) 1398. van der Sluis, IM, de Groot-Kruseman, H, te Loo, M, Tissing, WJE, van den Bos, C, Kaspers, GJL, Bierings, M, Kollen, WJW, König, T, Pichlmeier, U, Kühnel, H-JR & Pieters, R 2018, 'Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group', Pediatric blood & cancer, ;65(8): e27083. (AmsterdamUMC) 1399. van der Sommen, F, Klomp, SR, Swager, A-F, Zinger, S, Curvers, WL, Bergman, JJGHM, Schoon, EJ & de With, PHN 2018, 'Predictive features for early cancer detection in Barrett's esophagus using Volumetric Laser Endomicroscopy', Computerized medical imaging and graphics, ;67: 9-20. (AmsterdamUMC) 1400. van der Spek, N, Jansen, F, Holtmaat, K, Vos, J, Breitbart, W, van Uden-Kraan, CF, Tollenaar, RAEM, Cuijpers, P, Coupé, VMH & Verdonck-de Leeuw, IM 2018, 'Cost-utility analysis of meaning-centered group psychotherapy for cancer survivors', Psycho-Oncology, ;27(7): 1772-1779. (AmsterdamUMC) 1401. Van Der Steen, N, Mentens, Y, Ramael, M, Leon, LG, Germonpré, P, Ferri, J, Gandara, DR, Giovannetti, E, Peters, GJ, Pauwels, P & Rolfo, C 2018, 'Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC', Clinical Lung Cancer, ;19(1): 35-41. (AmsterdamUMC) 1402. van der Toom, EE, Groot, VP, Glavaris, SA, Gemenetzis, G, Chalfin, HJ, Wood, LD, Wolfgang, CL, de La Rosette, JJMCH, de Reijke, TM & Pienta, KJ 2018, 'Analogous detection of circulating tumor cells using the AccuCyte((R))CyteFinder((R)) system and ISET system in patients with locally advanced and metastatic prostate cancer', Prostate, ;78(4): 300-307. (AmsterdamUMC) 1403. van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH, IWWD Consortium,` Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study`, Lancet 2018; 391:2537-45 (NKI) 1404. van der Veen A, Seesing MFJ, Wijnhoven BPL, de Steur WO, van Berge Henegouwen MI, Rosman C, van Sandick JW, Mook S, Haj Mohammad N, Ruurda JP, Brosens LAA, van Hillegersberg R,` Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study`, Eur J Surg Oncol 2018; 44:1955-62 (NKI) 1405. van der Velden DL, Cirkel GA, Houthuijzen JM, van Werkhoven E, Roodhart JML, Daenen LGM, Kaing S, Gerrits J, Verhoeven-Duif NM, Grootscholten C, Boot H, Sessa C, Bloemendal HJ, De Vos FY, Voest EE,` Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum- induced fatty acids`, Cancer Chemother Pharmacol 2018; 81:911-21 (NKI) 1406. van der Velden DL, Houthuijzen JM, Roodhart JML, van Werkhoven E, Voest EE,` Detection of endogenously circulating Mesenchymal Stem Cells in human cancer patients`, Int J Cancer 2018; 143:2516-24 (NKI) 1407. van der Vlugt, M, Grobbee, EJ, Bossuyt, PM, Bos, ACRK, Kuipers, EJ, Lansdorp-Vogelaar, I, Spaander, MCW & Dekker, E 2018, 'Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program', Clinical gastroenterology and hepatology, ;16(8): 1237-1243.e2. (AmsterdamUMC) 1408. van der Wagen, L, te Boome, L, Schiffler, M, Nijhof, I, Schoordijk, M, van Dorp, S, van Dijk, M, Raymakers, R, Petersen, E, de Witte, M, de Jong, N, Bellido, M, Bär, B, Meijer, E & Kuball, JR 2018, 'Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib', Bone Marrow Transplantation, ;53(10): 1255-1262. (AmsterdamUMC) 1409. van der Weele, P, Meijer, CJLM & King, AJ 2018, 'High whole-genome sequence diversity of human papillomavirus type 18 isolates', Viruses, ;10(2): 68. (AmsterdamUMC) 1410. van der Wel, MJ, Duits, LC, Klaver, E, Pouw, RE, Seldenrijk, CA, Offerhaus, GJA, Visser, M, ten Kate, FJW, Tijssen, JG, Bergman, JJGHM & Meijer, SL 2018, 'Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases', United European gastroenterology journal, ;6(6): 830-837. (AmsterdamUMC) 1411. van der Wel, MJ, Duits, LC, Pouw, RE, Seldenrijk, CA, Offerhaus, GJA, Visser, M, ten Kate, FJ, Biermann, K, Brosens, LAA, Doukas, M, Huysentruyt, C, Karrenbeld, A, Kats-Ugurlu, G, van der Laan, JS, van Lijnschoten, G, Moll, FCP, Ooms, AHAG, van der Valk, H, Tijssen, JG, Bergman, JJ & Meijer, SL 2018, 'Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by TP53 immunohistochemical staining', Histopathology, ;72(6): 1015-1023. (AmsterdamUMC) 1412. van der Werf, A, Arthey, K, Hiesmayr, M, Sulz, I, Schindler, K, Laviano, A, Langius, J & de van der Schueren, M 2018, 'The determinants of reduced dietary intake in hospitalised colorectal cancer patients', Supportive Care in Cancer, ;26(6): 2039-2047. (AmsterdamUMC) 1413. van der Werf, A, de van der Schueren, MAE, Rovithi, M, Labots, M, Hashemi, SMS, Langius, JAE & Verheul, HMW 2018, 'Taste Alterations During Treatment With Protein Kinase Inhibitors: A Pilot Study', Journal of Pain and Symptom Management, ;56(4): e1-e4. (AmsterdamUMC) 1414. van der Werf, A, van Bokhorst, QNE, de van der Schueren, MAE, Verheul, HMW & Langius, JAE 2018, 'Cancer Cachexia: Identification by Clinical Assessment versus International Consensus Criteria in Patients with Metastatic Colorectal Cancer', Nutrition and Cancer. (AmsterdamUMC) 1415. van der Werf, LR, Dikken, JL, van der Willik, EM, van Berge Henegouwen, MI, Nieuwenhuijzen, GAP, Wijnhoven, BPL & AUTHOR GROUP 2018, 'Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study', European journal of cancer (Oxford, England, ;91: 76-85. (AmsterdamUMC) 1416. van der Wielen, N, Straatman, J, Cuesta, MA, Daams, F & van der Peet, DL 2018, 'Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature', Gastric Cancer, ;21(1): 19-30. (AmsterdamUMC) 1417. van der Wildt, B, Wilhelmus, MMM, Beaino, W, Kooijman, EJM, Schuit, RC, Bol, JGJM, Breve, JJP, Pasternack, R, Lammertsma, AA, Windhorst, AD & Drukarch, B 2018, 'In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model', EJNMMI Research, ;8(1): 39. (AmsterdamUMC) 1418. van der Willik KD, Koppelmans V, Hauptmann M, Compter A, Ikram MA, Schagen SB,` Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study`, Breast Cancer Res 2018; 20:135 (NKI) 1419. van der Willik KD, Ruiter R, Wolters FJ, Ikram MK, Stricker BH, Hauptmann M, Compter A, Schagen SB, Ikram MA,` Mild Cognitive Impairment and Dementia Show Contrasting Associations with Risk of Cancer`, Neuroepidemiology 2018; 50:207-15 (NKI) 1420. van der Willik KD, Schagen SB, Ikram MA,` Cancer and dementia: two sides of the same coin? Eur J Clin Invest 2018; 48:e13019 `, (NKI) 1421. van der Zwan JM, Siesling S, van Velthuysen L, Links T, Walenkamp A, Tesselaar M,` Extra-Pulmonary Neuroendocrine Carcinomas: A Population-Based Study in the Netherlands`, Neuroendocrinology 2018; 107:50-9 (NKI) 1422. van Dijk DPJ, Bakers FCH, Sanduleanu S, Vaes RDW, Rensen SS, Dejong CHC, Beets-Tan RGH, Olde Damink SWM,` Myosteatosis predicts survival after surgery for periampullary cancer: a novel method using MRI`, HPB (Oxford) 2018; 20:715-20 (NKI) 1423. van Dijk E, Biesma HD, Cordes M, Smeets D, Neerincx M, Das S, Eijk PP, Murphy V, Barat A, Bacon O, Prehn JHM, Betge J, Gaiser T, Fender B, Meijer GA, McNamara DA, Klinger R, Koopman M, Ebert MPA, Kay EW, Hennessey BT, Verheul HMW, Gallagher WM, O'Connor DP, Punt CJA, Loupakis F, Lambrechts D, Byrne AT, van Grieken NCT, Ylstra B,` Loss of Chromosome 18q11 2-q12 1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab`, J Clin Oncol 2018; 36:2052 (NKI) 1424. van Dijk M, van den Berg MH, Overbeek A, Lambalk CB, van den Heuvel-Eibrink MM, Tissing WJ, Kremer LC, van der Pal HJ, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, van Leeuwen FE, Dulmen- den Broeder E,` Reproductive intentions and use of reproductive health care among female survivors of childhood cancer`, Hum Reprod 2018; 33:1167-74 (NKI) 1425. van Dijk, E, Biesma, HD, Cordes, M, Smeets, D, Neerincx, M, Das, S, Eijk, PP, Murphy, V, Barat, A, Bacon, O, Prehn, JHM, Betge, J, Gaiser, T, Fender, B, Meijer, GA, McNamara, DA, Klinger, R, Koopman, M, Ebert, MPA, Kay, EW, Hennessey, BT, Verheul, HMW, Gallagher, WM, O’Connor, DP, Punt, CJA, Loupakis, F, Lambrechts, D, Byrne, AT, van Grieken, NCT & Ylstra, B 2018, 'Loss of chromosome 18q11.2-q12.1 is predictive for survival in patients with metastatic colorectal cancer treated with bevacizumab', Journal of clinical oncology, ;36(20): 2052-2060. (AmsterdamUMC) 1426. van Dijk, IWEM, Visser, J, Wiersma, J, van Boggelen, JR, Balgobind, BV, Feijen, EAML, Huijskens, SC, Kok, WEM, Kremer, LCM, Rasch, CRN & Bel, A 2018, 'Heart volume reduction during radiotherapy involving the thoracic region in children: An unexplained phenomenon', Radiotherapy and oncology, ;128(2): 214-220. (AmsterdamUMC) 1427. van Dijk, LV, Noordzij, W, Brouwer, CL, Boellaard, R, Burgerhof, JGM, Langendijk, JA, Sijtsema, NM & Steenbakkers, RJHM 2018, '18F-FDG PET image biomarkers improve prediction of late radiation- induced xerostomia', Radiotherapy and Oncology, ;126(1): 89-95. (AmsterdamUMC) 1428. van Dijk, M, van den Berg, MH, Overbeek, A, Lambalk, CB, van den Heuvel-Eibrink, MM, Tissing, WJ, Kremer, LC, van der Pal, HJ, Loonen, JJ, Versluys, B, Bresters, D, Kaspers, GJL, van Leeuwen, FE & van Dulmen-den Broeder, E 2018, 'Reproductive intentions and use of reproductive health care among female survivors of childhood cancer', Human reproduction (Oxford, England), ;33(6): 1167-1174. (AmsterdamUMC) 1429. van Dijk, SM, Heerkens, HD, Tseng, DSJ, Intven, M, Molenaar, IQ & van Santvoort, HC 2018, 'Systematic review on the impact of pancreatoduodenectomy on quality of life in patients with pancreatic cancer', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(3): 216-221. (AmsterdamUMC) 1430. van Dinther, D, Veninga, H, Iborra, S, Borg, EGF, Hoogterp, L, Olesek, K, Beijer, MR, Schetters, STT, Kalay, H, Garcia-Vallejo, JJ, Franken, KL, Cham, LB, Lang, KS, van Kooyk, Y, Sancho, D, Crocker, PR & den Haan, JMM 2018, 'Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming', Cell Reports, ;22(6): 1484-1495. (AmsterdamUMC) 1431. van Dinther, D, Veninga, H, Revet, M, Hoogterp, L, Olesek, K, Grabowska, J, Borg, EGF, Kalay, H, van Kooyk, Y & den Haan, JMM 2018, 'Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma', Frontiers in Immunology, ;9: 1997. (AmsterdamUMC) 1432. van Doeveren T, van Leeuwen PJ, Aben KKH, van der Aa M, Barendrecht M, Boeve ER, Cornel EB, van der Heijden AG, Hendricksen K, Hirdes W, Kooistra A, Kroon B, Leliveld AM, Meijer RP, van Melick H, Merks B, de Reijke TM, de Vries P, Wymenga LFA, Wijsman B, Boormans JL,` Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial`, Contemp Clin Trials Commun 2018; 9:121-9 (AmsterdamUMC/NKI) 1433. van Doeveren TEM, Karakullukcu MB, van Veen RLP, Lopez-Yurda M, Schreuder WH, Tan IB,` Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins`, Laryngoscope 2018; 128:657-63 (NKI) 1434. van Dorp, W, Haupt, R, Anderson, RA, Mulder, RL, van den Heuvel-Eibrink, MM, van Dulmen-den Broeder, E, Su, HI, Winther, JF, Hudson, MM, Levine, JM & Wallace, WH 2018, 'Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: A review', Journal of clinical oncology, ;36(21): 2169-2180. (AmsterdamUMC) 1435. van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, Van Tinteren H, Aaronson NK, Sonke GS,` Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer`, N Engl J Med 2018; 378:230-40 (AmsterdamUMC/NKI) 1436. van Driel WJ, Koole SN, Sonke GS,` Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer`, N Engl J Med 2018; 378:1363-4 [Comment] (NKI) 1437. van Duren-Koopman, MJ, Tol, JP, Dahele, M, Bucko, E, Meijnen, P, Slotman, BJ & Verbakel, WF 2018, 'Personalized automated treatment planning for breast plus locoregional lymph nodes using Hybrid RapidArc', Practical Radiation Oncology, ;8(5): 332-341. (AmsterdamUMC) 1438. van Eden WJ, Elekonawo FMK, Starremans BJ, Kok NFM, Bremers AJA, de Wilt JHW, Aalbers AGJ,` Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy`, Ann Surg Oncol 2018; 25:1992-2001 (NKI) 1439. van Eden WJ, Kok NFM, Woensdregt K, Huitema ADR, Boot H, Aalbers AGJ,` Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC`, Eur J Surg Oncol 2018; 44:220-7 (NKI) 1440. van Egmond, MA, van der Schaaf, M, Vredeveld, T, Vollenbroek-Hutten, MMR, van Berge Henegouwen, MI, Klinkenbijl, JHG & Engelbert, RHH 2018, 'Effectiveness of physiotherapy with telerehabilitation in surgical patients: a systematic review and meta-analysis', Physiotherapy, ;104(3): 277-298. (AmsterdamUMC) 1441. van Eijkelenburg, NKA, Rasche, M, Ghazaly, E, Dworzak, MN, Klingebiel, T, Rossig, C, Leverger, G, Stary, J, de Bont, ESJM, Chitu, DA, Bertrand, Y, Brethon, B, Strahm, B, van der Sluis, IM, Kaspers, GJL, Reinhardt, D & Zwaan, CM 2018, 'Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: A phase IB study', Haematologica, ;103(9): 1484-1492. (AmsterdamUMC) 1442. van Elk, M, van den Dikkenberg, JB, Storm, G, Hennink, WE, Vermonden, T & Heger, M 2018, 'Preclinical evaluation of thermosensitive poly(N-(2-hydroxypropyl) methacrylamide mono/dilactate)- grafted liposomes for cancer thermochemotherapy', International journal of pharmaceutics, ;550( 1- 2): 190-199. (AmsterdamUMC) 1443. van Es, N, Hisada, Y, di Nisio, M, Cesarman, G, Kleinjan, A, Mahé, I, Otten, H-M, Kamphuisen, PW, Berckmans, RJ, Büller, HR, Mackman, N & Nieuwland, R 2018, 'Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study', Thrombosis research, ;166: 54-59. (AmsterdamUMC) 1444. van Gessel, LD, Abrahams, HJG, Prinsen, H, Bleijenberg, G, Heins, M, Twisk, J, van Laarhoven, HWM, Verhagen, SCAHHVM, Gielissen, MFM & Knoop, H 2018, 'Are the effects of cognitive behavior therapy for severe fatigue in cancer survivors sustained up to 14 years after therapy?', Journal of cancer survivorship, ;12(4): 519-527. (AmsterdamUMC) 1445. van Gils T, Nijeboer P, Overbeek LI, Hauptmann M, Castelijn DA, Bouma G, Mulder CJ, van Leeuwen FE, de Jong D,` Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult- onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma`, United European Gastroenterol J 2018; 6:1485-95 (AmsterdamUMC/NKI) 1446. van Griethuysen JJM, Bus EM, Hauptmann M, Lahaye MJ, Maas M, Ter Beek LC, Beets GL, Bakers FCH, Beets-Tan RGH, Lambregts DMJ,` Gas-induced susceptibility artefacts on diffusion-weighted MRI of the rectum at 15T - Effect of applying a micro-enema to improve image quality`, Eur J Radiol 2018; 99:131- 7 (NKI) 1447. van Harten WH, Goedbloed N, Boekhout AH, Heintzbergen S,` Implementing large scale fast track diagnostics in a comprehensive cancer center, pre- and post-measurement data`, BMC Health Serv Res 2018; 18:85 (NKI) 1448. van Harten WH,` Turning teams and pathways into integrated practice units: Appearance characteristics and added value`, Int J Care Coord 2018; 21:113-6 (NKI) 1449. van Heerden, LE, van Wieringen, N, Koedooder, K, Rasch, CRN, Pieters, BR & Bel, A 2018, 'Dose warping uncertainties for the accumulated rectal wall dose in cervical cancer brachytherapy', Brachytherapy, ;17(2): 449-455. (AmsterdamUMC) 1450. van Heerden, LE, Visser, J, Koedooder, K, Rasch, CRN, Pieters, BR & Bel, A 2018, 'Role of deformable image registration for delivered dose accumulation of adaptive external beam radiation therapy and brachytherapy in cervical cancer', Journal of contemporary brachytherapy, ;10(6): 542-550. (AmsterdamUMC) 1451. van Hees, T, van Weert, S, Witte, B & René Leemans, C 2018, 'Tumors of the parapharyngeal space: the VU University Medical Center experience over a 20-year period', European Archives of Oto-Rhino- Laryngology, ;275(4): 967-972. (AmsterdamUMC) 1452. van Helden, EJ, Vacher, YJL, van Wieringen, WN, van Velden, FHP, Verheul, HMW, Hoekstra, OS, Boellaard, R & Menke-van der Houven van Oordt, CW 2018, 'Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment', European Journal of Nuclear Medicine and Molecular Imaging, ;45(13): 2307-2317. (AmsterdamUMC) 1453. van Hilst, J, de Pastena, M, de Rooij, T, Alseidi, A, Busch, OR, van Dieren, S, van Eijck, CH, Giovinazzo, F, Groot Koerkamp, B, Marchegiani, G, Marshall, GR, Abu Hilal, M, Bassi, C & Besselink, MG 2018, 'Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomy', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(11): 1044-1050. (AmsterdamUMC) 1454. van Hoorn, JE, Dahele, M & Daniels, JMA 2018, 'Bronchoscopic Manifestations of Airway Toxicity After Radiotherapy', Clinical Lung Cancer, ;19(6): e875-e878. (AmsterdamUMC) 1455. van Hoppe S, Rood JJM, Buil L, Wagenaar E, Sparidans RW, Beijnen JH, Schinkel AH,` P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability`, Mol Pharm 2018; 15:5124-34 (NKI) 1456. van Houdt PJ, Agarwal HK, van Buuren LD, Heijmink SWTP, Haack S, van der Poel HG, Ghobadi G, Pos FJ, Peeters JM, Choyke PL, van der Heide UA,` Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems`, Magn Reson Med 2018; 79:1586-94 (NKI) 1457. van Iersel, L, Meijneke, RWH, Schouten-van Meeteren, AYN, Reneman, L, de Win, MM, van Trotsenburg, ASP, Bisschop, PH, Finken, MJJ, Vandertop, WP, van Furth, WR & van Santen, HM 2018, 'The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort', Pediatric blood & cancer, ;65(5): e26911. (AmsterdamUMC) 1458. van Kester MS, Luelmo SAC, Vermeer MH, Blank C, van Doorn R,` Remission of psoriasis during treatment with sorafenib`, JAAD Case Rep 2018; 4:1065-7 (NKI) 1459. van Lankveld, JJDM, Fleer, J, Schroevers, MJ, Sanderman, R, den Oudsten, BL & Dekker, J 2018, 'Recruitment problems in psychosocial oncology research', Psycho-Oncology, ;27(9): 2296-2298. (AmsterdamUMC) 1460. van Leeuwaarde RS, Pieterman CRC, Bleiker EMA, Dekkers OM, van der Horst-Schrivers AN, Hermus AR, de Herder WW, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD,` High fear of disease occurrence is associated with low quality of life in patients with Multiple Endocrine Neoplasia type 1 (MEN1): Results from the Dutch MEN1 Study Group`, J Clin Endocrinol Metab 2018; 103:2354-61 (NKI) 1461. van Leeuwen M, Husson O, Alberti P, Arraras JI, Chinot OL, Costantini A, Darlington AS, Dirven L, Eichler M, Hammerlid EB, Holzner B, Johnson CD, Kontogianni M, Kjaer TK, Morag O, Nolte S, Nordin A, Pace A, Pinto M, Polz K, Ramage J, Reijneveld JC, Serpentini S, Tomaszewski KA, Vassiliou V, Verdonck- de Leeuw IM, Vistad I, Young TE, Aaronson NK, van de Poll-Franse LV,` Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire`, Health Qual Life Outcomes 2018; 16:114 (NKI) 1462. van Leeuwen PJ, van der Poel HG Touijer, Robert Jeffery Karnes, Niccolo Passoni, et al,` Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies`, Eur Urol 2018;73:890-6 (NKI) 1463. van Leeuwen, A, Wind, J, van Weert, H, de Wolff, V & van Asselt, K 2018, 'Experiences of general practitioners participating in oncology meetings with specialists to support GP-led survivorship care;(): (AmsterdamUMC) 1464. van Leeuwen, CM, Crezee, J, Oei, AL, Franken, NAP, Stalpers, LJA, Bel, A & Kok, HP 2018, 'The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose', International journal of hyperthermia, ;34(7): 901-909. (AmsterdamUMC) 1465. van Leeuwen, CM, Oei, AL, Crezee, J, Bel, A, Franken, NAP, Stalpers, LJA & Kok, HP 2018, 'The alfa and beta of tumours: A review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies', Radiation oncology (London, England), ;13(1): 96. (AmsterdamUMC) 1466. van Leeuwen, CM, Oei, AL, ten Cate, R, Franken, NAP, Bel, A, Stalpers, LJA, Crezee, J & Kok, HP 2018, 'Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation', International journal of hyperthermia, ;34(1): 30-38. (AmsterdamUMC) 1467. van Leeuwen-Kerkhoff, N, Lundberg, K, Westers, TM, Kordasti, S, Bontkes, HJ, Lindstedt, M, de Gruijl, TD & van de Loosdrecht, AA 2018, 'Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes', Frontiers in Immunology, ;9( 1619. ): (AmsterdamUMC) 1468. van Lidth de Jeude, JF, Spaan, CN, Meijer, BJ, Smit, WL, Soeratram, TTD, Wielenga, MCB, Florien Westendorp, B, Lee, AS, Meisner, S, Vermeulen, JLM, Wildenberg, ME, van den Brink, GR, Muncan, V & Heijmans, J 2018, 'Heterozygosity of chaperone GRP78 reduces intestinal stem cell regeneration potential and protects against adenoma formation', Cancer research, ;78(21): 6098-6106. (AmsterdamUMC) 1469. van Maaren MC, Lagendijk M, Tilanus-Linthorst MMA, de Munck L, Pijnappel RM, Schmidt MK, Wesseling J, Koppert LB, Siesling S,` Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012`, Eur J Cancer 2018; 101:134-42 (NKI) 1470. van Meerbeeck, JP, Jansen, G, Giovannetti, E & Peters, GJ 2018, 'Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks: new wine deserves new sacks', European Respiratory Journal, ;51(5): pii: 1800807. (AmsterdamUMC) 1471. van Muijen, P, Duijts, S, Bonefaas-Groenewoud, K, van der Beek, A & Anema, H 2018, 'Predictors of fatigue and working ability in cancer patients', Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, ;26(4): 175. (AmsterdamUMC) 1472. van Munster, SN, Overwater, A, Haidry, R, Bisschops, R, Bergman, JJGHM & Weusten, BLAM 2018, 'Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett's esophagus: impact on treatment response and postprocedural pain', Gastrointestinal endoscopy, ;88(5): 795-803.e2. (AmsterdamUMC) 1473. van Nieuwenhuizen AJ, Buffart LM, Uden-Kraan CF, van der Velden LA, Lacko M, Brug J, Leemans CR, Verdonck-de Leeuw IM,` Patient-reported physical activity and the association with health-related quality of life in head and neck cancer survivors`, Support Care Cancer 2018; 26:1087-95 (AmsterdamUMC/NKI) 1474. van Nieuwenhuizen, D, Douw, L, Klein, M, Peerdeman, SM, Heimans, JJ, Reijneveld, JC, Stam, CJ & Hillebrand, A 2018, 'Cognitive functioning and functional brain networks in postoperative WHO grade I meningioma patients', Journal of Neuro-Oncology. (AmsterdamUMC) 1475. van Nuland M, Hillebrand MJX, Rosing H, Burgers JA, Schellens JHM, Beijnen JH,` Ultra-sensitive LC- MS/MS method for the quantification of gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma for a microdose clinical trial`, J Pharm Biomed Anal 2018; 151:25-31 (NKI) 1476. van Nuland M, Vreman RA, Ten Ham RMT, de Vries Schultink AHM, Rosing H, Schellens JHM, Beijnen JH, Hovels AM,` Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen`, Breast Cancer Res Treat 2018; 172:143-50 (NKI) 1477. van Ommen-Nijhof A, Konings IR, van Zeijl CJJ, Uyl-de Groot CA, van der Noort V, Jager A, Sonke GS,` Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial`, BMC Cancer 2018; 18:1146 (NKI) 1478. van Oosterom M, den Houting D, van de Velde C, van Leeuwen F,` Navigating surgical fluorescence cameras using near-infrared optical tracking`, J Biomed Opt 2018; 23:1-10 (NKI) 1479. van Oosterom MN, Meershoek P, KleinJan GH, Hendricksen K, Navab N, van de Velde CJH, van der Poel HG, van Leeuwen FWB,` Navigation of fluorescence cameras during soft-tissue surgery - is it possible to use a single navigation setup for various open and laparoscopic urological surgery applications? `,J Urol 2018; 199:1061-8 (NKI) 1480. van Oosterom MN, van der Poel HG, Navab N, van de Velde CJH, van Leeuwen FWB,` Computer- assisted surgery: virtual- and augmented-reality displays for navigation during urological interventions`, Curr Opin Urol 2018; 28:213 (NKI) 1481. van Overveld LFJ, Takes RP, Braspenning JCC, de Jong RJB, de Boer JP, Brouns JJA, Bun RJ, Dik EA, van Dijk BAC, van Es RJJ, Hoebers FJP, Kolenaar B, Kropveld A, Langeveld TPM, Verschuur HP, de Visscher JGAM, van Weert S, Witjes MJH, Smeele LE, Merkx MAW, Hermens RPMG,` Variation in Integrated Head and Neck Cancer Care: Impact of Patient and Hospital Characteristics`, J Natl Compr Canc Netw 2018; 16:1491-8 (NKI) 1482. van Overveld LFJ, Takes RP, Turan AS, Braspenning JCC, Smeele LE, Merkx MAW, Hermens RPMG,` Needs and preferences of patients with head and neck cancer in integrated care`, Clin Otolaryngol 2018; 43:553-61 (NKI) 1483. van Overveld, LFJ, Takes, RP, Braspenning, JCC, Baatenburg de Jong, RJ, de Boer, JP, Brouns, JJA, Bun, RJ, Dik, EA, van Dijk, BAC, van Es, RJJ, Hoebers, FJP, Kolenaar, B, Kropveld, A, Langeveld, TPM, Verschuur, HP, de Visscher, JGAM, van Weert, S, Witjes, MJH, Smeele, LE, Merkx, MAW & Hermens, RPMG 2018, 'Variation in integrated head and neck cancer care: Impact of patient and hospital characteristics', Journal of the national comprehensive cancer network, ;16(12): 1491-1498. (AmsterdamUMC) 1484. van Putten, M, Koëter, M, van Laarhoven, HWM, Lemmens, VEPP, Siersema, PD, Hulshof, MCCM, Verhoeven, RHA & Nieuwenhuijzen, GAP 2018, 'Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer', Annals of surgery, ;267(2): 303-310. (AmsterdamUMC) 1485. van Ramshorst MS, van der Veen A, van Werkhoven ED, Mandjes IA, Kemper I, Dezentje VO, Oving IM, Honkoop AH, Tick LW, van de Wouw AJ, Mandigers CM, van Warmerdam LJ, Wesseling J, Vrancken Peeters MT, Linn SC, Sonke GS,` Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial`, Lancet Oncol 2018; 19:1630-40 (NKI) 1486. van Roessel, S & Tseng, JF 2018, 'The Prognostic Significance of Resection Margins After Pancreaticoduodenectomy', Annals of surgical oncology, ;25(3): 802-803. (AmsterdamUMC) 1487. van Roessel, S, Kasumova, GG, Tabatabaie, O, Ng, SC, van Rijssen, LB, Verheij, J, Najarian, RM, van Gulik, TM, Besselink, MG, Busch, OR & Tseng, JF 2018, 'Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center', Annals of surgical oncology, ;25(6): 1760-1767. (AmsterdamUMC) 1488. van Roessel, S, Kasumova, GG, Verheij, J, Najarian, RM, Maggino, L, de Pastena, M, Malleo, G, Marchegiani, G, Salvia, R, Ng, SC, de Geus, SW, Lof, S, Giovinazzo, F, van Dam, JL, Kent, TS, Busch, OR, van Eijck, CH, Koerkamp, BG, Abu Hilal, M, Bassi, C, Tseng, JF & Besselink, MG 2018, 'International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients with Resected Pancreatic Cancer', JAMA surgery, ;153(12): e183617. (AmsterdamUMC) 1489. van Rooijen E, van de Hoek G, Logister I, Ajzenberg H, Knoers NVAM, van Eeden F, Voest EE, Schulte- Merker S, Giles RH,` The von Hippel-Lindau Gene Is Required to Maintain Renal Proximal Tubule and Glomerulus Integrity in Zebrafish Larvae`, Nephron 2018; 138:310-23 (NKI) 1490. van Rooijen, KL, Shi, Q, Goey, KKH, Meyers, J, Heinemann, V, Diaz-Rubio, E, Aranda, E, Falcone, A, Green, E, de Gramont, A, Sargent, DJ, Punt, CJA & Koopman, M 2018, 'Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first- line randomised trials from the ARCAD database', European journal of cancer (Oxford, England, ;91: 99-106. (AmsterdamUMC) 1491. van Rossum AGJ, Kok M, van Werkhoven E, Opdam M, Mandjes IAM, Leeuwen-Stok AE, Van Tinteren H, Imholz ALT, Portielje JEA, Bos MMEM, van Bochove A, Wesseling J, Rutgers EJ, Linn SC, Oosterkamp HM,` Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin- cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)`, Eur J Cancer 2018; 102:40-8 (NKI) 1492. van Ruiten MS, Rowland BD,` SMC Complexes: Universal DNA Looping Machines with Distinct Regulators`, Trends Genet 2018; 34:477-87 (NKI) 1493. van Schie MA, Dinh CV, van Houdt PJ, Pos FJ, Heijmink SWTJ, Kerkmeijer LGW, Kotte ANTJ, Oyen R, Haustermans K, van der Heide UA,` Contouring of prostate tumors on multiparametric MRI: Evaluation of clinical delineations in a multicenter radiotherapy trial`, Radiother Oncol 2018; 128:321-6 (NKI) 1494. van Seijen M, Mooyaart AL, Mulder L, Hoogstraat M, Drukker CA, Loo CE, Pouw B, Sonke GS, Wesseling J, Lips EH,` Enrichment of high-grade tumors in breast cancer gene expression studies`, Breast Cancer Res Treat 2018; 168:327-35 (NKI) 1495. van Sloun, RJG, Demi, L, Schalk, SG, Caresio, C, Mannaerts, C, Postema, AW, Molinari, F, van der Linden, HC, Huang, P, Wijkstra, H & Mischi, M 2018, 'Contrast-enhanced ultrasound tractography for 3D vascular imaging of the prostate', Scientific reports, ;8(1): 14640. (AmsterdamUMC) 1496. van Sluis KE, van der Molen L, van Son RJJH, Hilgers FJM, Bhairosing PA, van den Brekel MWM,` Objective and subjective voice outcomes after total laryngectomy: a systematic review`, Eur Arch Otorhinolaryngol 2018; 275:11-26 (NKI) 1497. van Solinge, TS, Zeijlemaker, W, Ossenkoppele, GJ, Cloos, J & Schuurhuis, GJ 2018, 'The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia', Cytometry Part B. Clinical Cytometry, ;94(1): 151-158. (AmsterdamUMC) 1498. van Sörnsen de Koste, JR, Palacios, MA, Bruynzeel, AME, Slotman, BJ, Senan, S & Lagerwaard, FJ 2018, 'MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis', International journal of radiation oncology, biology, physics, ;102(4): 858-866. (AmsterdamUMC) 1499. van Stam MA, Pieterse AH, van der Poel HG, Bosch JLHR, Tillier C, Horenblas S, Aaronson NK,` Shared Decision-Making in Prostate Cancer Care: Encouraging every patient to be actively involved in decision-making, or ensuring patients' preferred level of involvement? `,J Urol 2018; 200:582-9 (NKI) 1500. van Stam MA, van der Poel H,` The New Standard: Personalised Information about the Risks and Benefits of Treatment Strategies for Localised Prostate Cancer`, Eur Urol 2018; 74:34-6 [Editorial] (NKI) 1501. van Stam MA, van der Poel HG, van der Voort van Zyp JRN, Tillier CN, Horenblas S, Aaronson NK, Bosch JLHR,` The accuracy of patients' perceptions of the risks associated with localized prostate cancer treatments`, BJU Int 2018; 121:405-14 (NKI) 1502. van Steenhoven JEC, Kuijer A, van Diest PJ, van Gorp JM, Straver M, Elias SG, Wesseling J, Rutgers E, Timmer-Bonte JNH, Nieboer P, Smilde TJ, Imholz A, Blanken CFJM, Siesling S, van Dalen T,` Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study`, Genes (Basel) 2018; 9:E261 (10 pp) (NKI) 1503. van Steensel B,` Scientific honesty and publicly shared lab notebooks: Sharing lab notebooks along with publication would increase transparency and help to improve honesty when reporting results`, EMBO Rep 2018; 19:e46866 [Science & Society] (NKI) 1504. van Treijen MJC, Korse CM, van Leeuwaarde RS, Saveur LJ, Vriens MR, Verbeek WHM, Tesselaar MET, Valk GD,` Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study`, Front Endocrinol (Lausanne) 2018; 9:740 (NKI) 1505. van Veen M, Mans LA, Matas-Rico E, van Pelt J, Perrakis A, Moolenaar WH, Haramis AG,` Glycerophosphodiesterase GDE2/GDPD5 affects pancreas differentiation in zebrafish`, Int J Biochem Cell Biol 2018; 94:71-8 (NKI) 1506. van Veenendaal LM, van Akkooi ACJ, Verhoef C, Grunhagen DJ, Klop WMC, Valk GD, Tesselaar MET,` Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients`, J Surg Oncol 2018; 117:1768-75 (NKI) 1507. van Veggel B, de Langen AJ, Hashemi S, Monkhorst K, Heideman DAM, Thunnissen E, Smit EF,` Brief report: Afatinib and cetuximab in four patients with EGFR exon 20 insertion positive advanced non- small-cell lung cancer`, J Thorac Oncol 2018; 13:1222-6 (AmsterdamUMC/NKI) 1508. van Veggel B, de Langen AJ, Hashemi S, Monkhorst K, Rosenberg EH, Heideman DAM, Radonic T, Smit EF,` Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses`, Lung Cancer 2018; 124:130-4 (AmsterdamUMC/NKI) 1509. van Veldhuisen, E, Vogel, JA, Klompmaker, S, Busch, OR, van Laarhoven, HWM, van Lienden, KP, Wilmink, JW, Marsman, HA & Besselink, MG 2018, 'Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(7): 605-611. (AmsterdamUMC) 1510. van Vugt, JLA, Gaspersz, MP, Coelen, RJS, Vugts, J, Labeur, TA, de Jonge, J, Polak, WG, Busch, ORC, Besselink, MG, Ijzermans, JNM, Nio, CY, van Gulik, TM, Willemssen, FEJA & Groot Koerkamp, B 2018, 'The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma', HPB: The official journal of the International Hepato Pancreato Biliary Association, ;20(1): 83-92. (AmsterdamUMC) 1511. van Waart H, Stuiver MM, van Harten WH, Geleijn E, Maaker-Berkhof M, Schrama J, Geenen MM, Meerum Terwogt JM, van den Heiligenberg SM, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK,` Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer`, Int J Colorectal Dis 2018; 33:29-40 (AmsterdamUMC/NKI) 1512. van Waart H, van Dongen JM, van Harten WH, Stuiver MM, Huijsmans R, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK,` Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy`, Eur J Health Econ 2018; 19:893-904 (NKI) 1513. van Welsem T, Korthout T, Ekkebus R, Morais D, Molenaar TM, van Harten K, Poramba-Liyanage DW, Sun SM, Lenstra TL, Srivas R, Ideker T, Holstege FCP, van Attikum H, El Oualid F, Ovaa H, Stulemeijer IJE, Vlaming H, van Leeuwen F,` Dot1 promotes H2B ubiquitination by a methyltransferase- independent mechanism`, Nucleic Acids Res 2018; 46:11251-61 (NKI) 1514. van Winden LJ, van Tellingen O, van Rossum HH,` Serum Testosterone by Liquid Chromatography Tandem Mass Spectrometry for Routine Clinical Diagnostics`, Methods Mol Biol 2018; 1730:93-102 (NKI) 1515. van Workum, F, Fransen, L, Luyer, MDP & Rosman, C 2018, 'Learning curves in minimally invasive esophagectomy', World Journal of Gastroenterology, ;24(44): 4974-4978. (AmsterdamUMC) 1516. van Zelst JCM, Vreemann S, Witt HJ, Gubern-Merida A, Dorrius MD, Duvivier K, Lardenoije-Broker S, Lobbes MBI, Loo C, Veldhuis W, Veltman J, Drieling D, Karssemeijer N, Mann RM,` Multireader Study on the Diagnostic Accuracy of Ultrafast Breast Magnetic Resonance Imaging for Breast Cancer Screening`, Invest Radiol 2018; 53:579-86 (AmsterdamUMC/NKI) 1517. van Zummeren, M, Leeman, A, Kremer, WW, Bleeker, MCG, Jenkins, D, van de Sandt, M, Heideman, DAM, Steenbergen, R, Snijders, PJF, Quint, WGV, Berkhof, J & Meijer, CJLM 2018, 'Three-tiered score for Ki-67 and p16 improves accuracy and reproducibility of grading CIN lesions', Journal of Clinical Pathology, ;71(11): 981-988. (AmsterdamUMC) 1518. van Zweeden, AA, van Groeningen, CJ, Honeywell, RJ, Giovannetti, E, Ruijter, R, Smorenburg, CH, Giaccone, G, Verheul, HMW, Peters, GJ & van der Vliet, HJ 2018, 'Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer', Cancer Chemotherapy and Pharmacology, ;82(1): 39-48. (AmsterdamUMC) 1519. Vanhove, K, Mesotten, L, Heylen, M, Derwael, R, Louis, E, Adriaensens, P, Thomeer, M & Boellaard, R 2018, 'Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer', Cancer Treatment and Research Communications, ;15: 7-12. (AmsterdamUMC) 1520. Varga, Z, van der Pol, E, Pálmai, M, Garcia-Diez, R, Gollwitzer, C, Krumrey, M, Fraikin, JL, Gasecka, A, Hajji, N, van Leeuwen, TG & Nieuwland, R 2018, 'Hollow organosilica beads as reference particles for optical detection of extracellular vesicles', Journal of thrombosis and haemostasis, ;16(8): 1646-1655. (AmsterdamUMC) 1521. Vargas, HA, Kramer, GM, Scott, AM, Weickhardt, A, Meier, AA, Parada, N, Beattie, BJ, Humm, JL, Staton, KD, Zanzonico, PB, Lyashchenko, SK, Lewis, JS, Yaqub, M, Sosa, RE, van den Eertwegh, AJ, Davis, ID, Ackermann, U, Pathmaraj, K, Schuit, RC, Windhorst, AD, Chua, S, Weber, WA, Larson, SM, Scher, HI, Lammertsma, AA, Hoekstra, OS & Morris, MJ 2018, 'Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study', Journal of Nuclear Medicine, ;59(10): 1516- 1523. (AmsterdamUMC) 1522. Veenstra, VL, Damhofer, H, Waasdorp, C, van Rijssen, LB, van de Vijver, MJ, Dijk, F, Wilmink, HW, Besselink, MG, Busch, OR, Chang, DK, Bailey, PJ, Biankin, AV, Kocher, HM, Medema, JP, Li, JS, Jiang, R, Pierce, DW, van Laarhoven, HWM & Bijlsma, MF 2018, 'ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy', Oncogenesis, ;7(11): 87. (AmsterdamUMC) 1523. Veenstra, VL, Dingjan, I, Waasdorp, C, Damhofer, H, van der Wal, AC, van Laarhoven, HW, Medema, JP & Bijlsma, MF 2018, 'Patched-2 functions to limit Patched-1 deficient skin cancer growth', Cellular oncology, ;41(4): 427-437. (AmsterdamUMC) 1524. Veenstra, VL, Garcia-Garijo, A, van Laarhoven, HW & Bijlsma, MF 2018, 'Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer', Cancers, ;10(2): E34. (AmsterdamUMC) 1525. Veldhuijzen van Zanten, SEM, Sewing, ACP, van Lingen, A, Hoekstra, OS, Wesseling, P, Meel, MH, van Vuurden, DG, Kaspers, GJL, Hulleman, E & Bugiani, M 2018, 'Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma', Journal of Nuclear Medicine, ;59(4): 612-615. (AmsterdamUMC) 1526. Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS, MRC SUPREMO trial UK investigators,` Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial`, Lancet Oncol 2018; 19:1516-29 (NKI) 1527. Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grenman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C,` Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma`, Oncotarget 2018; 9:18198-213 (NKI) 1528. Verhagen, HJMP, van Gils, N, Martiañez, T, van Rhenen, A, Rutten, A, Denkers, F, de Leeuw, DC, Smit, MA, Tsui, M-L, de Vos Klootwijk, LLE, Menezes, RX, Çil, M, Roemer, MGM, Vermue, E, Heukelom, S, Zweegman, S, Janssen, JJWM, Ossenkoppele, GJ, Schuurhuis, GJ & Smit, L 2018, 'IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis', Cell Reports, ;25(11): 3021-3035.e5. (AmsterdamUMC) 1529. Verheecke, M, Cortès Calabuig, A, Finalet Ferreiro, J, Brys, V, van Bree, R, Verbist, G, Everaert, T, Leemans, L, Gziri, MM, Boere, I, Halaska, MJ, Vanhoudt, J, Amant, F & van Calsteren, K 2018, 'Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction', Placenta, ;64: 61-70. (AmsterdamUMC) 1530. Verheijen RB, Atrafi F, Schellens JHM, Beijnen JH, Huitema ADR, Mathijssen RHJ, Steeghs N,` Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial`, Clin Pharmacokinet 2018; 57:637-44 (NKI) 1531. Verheijen RB, Thijssen B, Rosing H, Schellens JHM, Nan L, Venekamp N, Beijnen JH, Steeghs N, Huitema ADR,` Fast and straightforward method for the quantification of pazopanib in human plasma using LC- MS/MS`, Ther Drug Monit 2018; 40:230-6 (NKI) 1532. Verheijen RB, Yaqub MM, Sawicki E, van Tellingen O, Lammertsma AA, Nuijen B, Schellens JHM, Beijnen JH, Huitema ADR, Hendrikse NH, Steeghs N,` Molecular Imaging of ABCB1/ABCG2 Inhibition at the Human Blood Brain Barrier using Elacridar and (11)C-Erlotinib PET`, J Nucl Med 2018; 59:973-9 AmsterdamUMC/(NKI) 1533. Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, van Splunter AP, Peeters CFW, van Trommel NE, Massuger LFAG, Bekkers RLM, Melchers WJ, van Kemenade FJ, Berkhof J, van de Wiel MA, Meijer CJLM, Steenbergen RDM,` Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples`, Clin Cancer Res 2018; 24:3456-64 (AmsterdamUMC/NKI) 1534. Verlaat, W, van Leeuwen, RW, Novianti, PW, Schuuring, E, Meijer, CJLM, van der Zee, AGJ, Snijders, PJF, Heideman, DAM, Steenbergen, RDM & Wisman, GBA 2018, 'Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer', Epigenetics, ;13(7): 769-778. (AmsterdamUMC) 1535. Verly, IRN, van Kuilenburg, ABP, Abeling, NGGM, Goorden, SMI, Fiocco, M, Vaz, FM, van Noesel, MM, Zwaan, CM, Kaspers, GJL, Merks, JHM, Caron, HN & Tytgat, GAM 2018, '3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients', European journal of cancer (Oxford, England, ;90: 102-110. (AmsterdamUMC) 1536. Vermeulen E, Rebers S, Aaronson NK, Brandenburg AP, van Leeuwen FE, Schmidt MK,` Patients' Attitudes Towards the Return of Incidental Findings After Research with Residual Tissue: A Mixed Methods Study`, Genet Test Mol Biomarkers 2018; 22:178-86 (NKI) 1537. Vermeulen RFM, van Beurden M, Gaarenstroom KN, Teunis T, Kieffer JM, Aaronson NK, Kenter GG, Korse CM,` Does anti-Mullerian hormone predict change in menopausal symptoms following risk- reducing salpingo-oophorectomy? A prospective observational study`, Climacteric 2018; 21:574-80 (NKI) 1538. Versluis JM, Brandsma D, van den Berg JG, Tesselaar M,` Leptomeningeal metastases of a well- differentiated neuroendocrine tumour: a rare entity`, BMJ Case Rep 2018; 2018:226557 (NKI) 1539. Versteeg, KS, Blauwhoff-Buskermolen, S, Buffart, LM, de van der Schueren, MAE, Langius, JAE, Verheul, HMW, Maier, AB & Konings, IR 2018, 'Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer', The Oncologist, ;23(5): 580-585. (AmsterdamUMC) 1540. Verver D, Louwman WJ, Koljenovic S, Verhoef C, Grunhagen DJ, van Akkooi ACJ,` Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study`, Eur J Cancer 2018; 92:100-7 (NKI) 1541. Verver D, Madu MF, Oude Ophuis CMC, Faut M, de Wilt JHW, Bonenkamp JJ, Grunhagen DJ, van Akkooi ACJ, Verhoef C, van Leeuwen BL,` Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin`, Br J Surg 2018; 105:96-105 (NKI) 1542. Verver D, Oude Ophuis CMC, Koppert LB, de Monye C, van Deurzen CHM, Koljenovic S, Bruining A, van der Hiel B, Ter Meulen S, van Akkooi ACJ, Verhoef C, Grunhagen DJ,` Gamma probe and ultrasound- guided fine needle aspiration cytology of the sentinel node (GULF) trial`, Eur J Nucl Med Mol Imaging 2018; 45:1926-33 (NKI) 1543. Verver D, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell BWEM, Robert C, Testori A, van Leeuwen BL, van der Veldt AAM, Keilholz U, Eggermont AMM, Verhoef C, Grunhagen DJ,` Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations`, Eur J Cancer 2018; 96:25-33 (NKI) 1544. Verweij FJ, Bebelman MP, Jimenez CR, Garcia-Vallejo JJ, Janssen H, Neefjes J, Knol JC, Goeij-de Haas R, Piersma SR, Baglio SR, Verhage M, Middeldorp JM, Zomer A, van Rheenen J, Coppolino MG, Hurbain I, Raposo G, Smit MJ, Toonen RFG, van Niel G, Pegtel DM,` Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling`, J Cell Biol 2018; 217:1129-42 (AmsterdamUMC/NKI) 1545. Vetsch, J, Wakefield, CE, Robertson, EG, Trahair, TN, Mateos, MK, Grootenhuis, M, Marshall, GM, Cohn, RJ & Fardell, JE 2018, 'Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: a systematic review', Quality of life research, ;27(6): 1431-1443. (AmsterdamUMC) 1546. Viale G, de Snoo FA, Slaets L, Bogaerts J, van 't Veer L, Rutgers EJ, Piccart-Gebhart MJ, Stork-Sloots L, Glas A, Russo L, Dell'Orto P, Tryfonidis K, Litiere S, Cardoso F,` Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial`, Breast Cancer Res Treat 2018; 167:123-31 (NKI) 1547. Vidal-Sicart S, Valdes Olmos R, Nieweg OE, Faccini R, Grootendorst MR, Wester HJ, Navab N, Vojnovic B, van der Poel H, Martinez-Roman S, Klode J, Wawroschek F, van Leeuwen FWB,` From interventionist imaging to intraoperative guidance: New perspectives by combining advanced tools and navigation with radio-guided surgery`, Rev Esp Med Nucl Imagen Mol 2018; 37:28-40 (NKI) 1548. Vink, MA, Bogaards, JA, Meijer, CJ & Berkhof, J 2018, 'Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safelyextended? (vol 137, pg 420, 2015)', International Journal of Cancer, ;142(8): E4-E4. (AmsterdamUMC) 1549. Virgolin, M, van Dijk, IWEM, Wiersma, J, Ronckers, CM, Witteveen, C, Bel, A, Alderliesten, T & Bosman, PAN 2018, 'On the feasibility of automatically selecting similar patients in highly individualized radiotherapy dose reconstruction for historic data of pediatric cancer survivors', Medical physics, ;45(4): 1504-1517. (AmsterdamUMC) 1550. Visser LL, Elshof LE, Schaapveld M, Van de Vijver K, Groen EJ, Almekinders MM, Bierman C, van Leeuwen FE, Rutgers EJT, Schmidt MK, Lips EH, Wesseling J,` Clinicopathological risk factors for an invasive breast cancer recurrence after ductal carcinoma in situ - A nested case-control study`, Clin Cancer Res 2018; 24:3593-601 (NKI) 1551. Visser, A, Prins, JB, Jansen, L, Radema, SA, Schlooz, MS, van Dalen, T & van Laarhoven, HWM 2018, 'Group medical consultations (GMCs) and tablet-based online support group sessions in the follow-up of breast cancer: A multicenter randomized controlled trial', Breast (Edinburgh, Scotland), ;40: 181- 188. (AmsterdamUMC) 1552. Visser, E, van Rossum, PSN, van Veer, H, Al-Naimi, K, Chaudry, MA, Cuesta, MA, Gisbertz, SS, Gutschow, CA, Hölscher, AH, Luyer, MDP, Mariette, C, Moorthy, K, Nieuwenhuijzen, GAP, Nilsson, M, Räsänen, JV, Schneider, PM, Schröder, W, Cheong, E & van Hillegersberg, R 2018, 'A structured training program for minimally invasive esophagectomy for esophageal cancer-a Delphi consensus study in Europe', Diseases of the Esophagus, ;31(3): dox124. (AmsterdamUMC) 1553. Vleugels JLA, Dijkgraaf MGW, Hazewinkel Y, Wanders LK, Fockens P, Dekker E, Becx MCJM, van Berkel AM, Slot WB, Cazemier M, Depla ACTM, Geesing JMJ, Grool TA, Houben GMP, Jansen JM, Kessels K, van Leerdam ME, van Lelyveld N, Mallant-Hent RC, Marsman WA, Schnekenburger E, van Soest EJ, van der Spek BW, Stokkers PCF, Tenthof van Noorden J, van Tuyl SAC, Tytgat KMAJ, Uiterwaal MT, Verdonk RC, Verhagen MAMT, van der Vlugt M, Voorburg A, Wientjes CA,` Effects of Training and Feedback on Accuracy of Predicting Rectosigmoid Neoplastic Lesions and Selection of Surveillance Intervals by Endoscopists Performing Optical Diagnosis of Diminutive Polyps`, Gastroenterology 2018; 154:1682-93 (AmsterdamUMC/NKI) 1554. Vleugels JLA, Sahin H, Hazewinkel Y, Koens L, van den Berg JG, van Leerdam ME, Dekker E,` Endoscopic detection rate of sessile serrated lesions in Lynch syndrome patients is comparable to an age- and gender-matched control population: case-control study with expert pathology review`, Gastrointest Endosc 2018; 87:1289-96 (AmsterdamUMC/NKI) 1555. Vleugels, JLA, Rutter, MD, Ragunath, K, Rees, CJ, Ponsioen, CY, Lahiff, C, Ket, SN, Wanders, LK, Samuel, S, Butt, F, Kuiper, T, Travis, SPL, D'Haens, G, Wang, LM, van Eeden, S, East, JE & Dekker, E 2018, 'Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial', lancet. Gastroenterology & hepatology, ;3(5): 305-316. (AmsterdamUMC) 1556. Vlijm-Kievit, A, Jorna, NGE, Moll, E, Pajkrt, E, Pals, ST, Middeldorp, S, Biemond, BJ, Zeerleder, SS, Tio, MA, Kemper, EM & Hazenberg, MD 2018, 'Acute lymphoblastic leukemia during the third trimester of pregnancy', Leukemia & lymphoma, ;59(5): 1274-1276. (AmsterdamUMC) 1557. Vlot, MC, Bijnsdorp, I, den Heijer, M, de Jonge, R, van Moorselaar, RJA & Heijboer, AC 2018, 'Plasma FGF23 is not elevated in prostate cancer', Clinica Chimica Acta, ;478: 129-131. (AmsterdamUMC) 1558. Voeten SC, Krijnen P, Voeten DM, Hegeman JH, Wouters MWJM, Schipper IB,` Quality indicators for hip fracture care, a systematic review`, Osteoporos Int 2018; 29:1963-85 (NKI) 1559. Volders JH, Negenborn VL, Haloua MH, Krekel NMA, Jozwiak K, Meijer S, van den Tol PM,` Breast- specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study`, J Surg Oncol 2018; 117:1001-8 (AmsterdamUMC/NKI) 1560. Volders, JH, Negenborn, VL, Spronk, PE, Krekel, NMA, Schoonmade, LJ, Meijer, S, Rubio, IT & van Den Tol, MP 2018, 'Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes', Breast Cancer Research and Treatment, ;168(1): 1-11. (AmsterdamUMC) 1561. Von Hoff DD, Rasco DW, Heath EI, Munster PN, Schellens JHM, Isambert N, Le Tourneau C, O'Neil BH, Mathijssen RH, Lopez-Martin JA, Edenfield WJ, Martin M, LoRusso PM, Bray GL, DiMartino J, Nguyen A, Liu K, Laille E, Bendell JC,` Phase I Study of CC-486 Alone and in Combination With Carboplatin or nabpaclitaxel in Patients With Relapsed or Refractory Solid Tumors`, Clin Cancer Res 2018; 24:4072-80 (NKI) 1562. von Landenberg N, Aziz A, von Rundstedt FC, Dobruch J, Kluth LA, Necchi A, Noon A, Rink M, Hendricksen K, Decaestecker KPJ, Seiler R, Poyet C, Fajkovic H, Shariat SF, Xylinas E, Roghmann F, Young Academic Urologists' Working Group on Urothelial Cancer of the European Association of Urology,` Conditional analyses of recurrence and progression in patients with TaG1 non-muscle- invasive bladder cancer`, Urol Oncol 2018; 36:238 (NKI) 1563. Voncken FEM, Aleman BMP, van Dieren JM, Grootscholten C, Lalezari F, van Sandick JW, Steinberg JD, Vegt E,` Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review`, (NKI) 1564. Voncken FEM, van der Kaaij RT, Sikorska K, van Werkhoven E, van Dieren JM, Grootscholten C, Snaebjornsson P, van Sandick JW, Aleman BMP,` Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer`, Am J Clin Oncol 2018; 41:919-26 (NKI) 1565. Vondeling, GT, Menezes, GL, Dvortsin, EP, Jansman, FGA, Konings, IR, Postma, MJ & Rozenbaum, MH 2018, 'Burden of early, advanced and metastatic breast cancer in The Netherlands', BMC Cancer, ;18(1): 262. (AmsterdamUMC) 1566. Voorwerk L, Kat M, Kok M,` Towards predictive biomarkers for immunotherapy response in breast cancer patients`, Breast Cancer Management 2018; 7:BMT05 (12 pp) (NKI) 1567. Voskuilen C, Fransen van de Putte E, Perez-Reggeti J, van Werkhoven E, Mertens L, van Rhijn B, Saad M, Bex A, Cathelineau X, van der Poel H, Horenblas S, Sanchez-Salas R, Meijer R,` Prostate sparing cystectomy for bladder cancer: A two-center study`, Eur J Surg Oncol 2018; 44:1446-52 (NKI) 1568. Voskuilen CS, van de Putte EEF, der Hulst JB, van Werkhoven E, de Blok WM, van Rhijn BWG, Horenblas S, Meijer RP,` Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube`, World J Urol 2018; 36:221-9 (NKI) 1569. Vossen DM, Verhagen CVM, Grenman R, Kluin RJC, Verheij M, van den Brekel MWM, Wessels LFA, Vens C,` Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association`, PLoS One 2018; 13:e0206632 (16 pp) (NKI) 1570. Vossen DM, Verhagen CVM, Verheij M, Wessels LFA, Vens C, van den Brekel MWM,` Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer`, Oral Oncol 2018; 81:35-44 (NKI) 1571. Wakabayashi, G, Iwashita, Y, Hibi, T, Takada, T, Strasberg, SM, Asbun, HJ, Endo, I, Umezawa, A, Asai, K, Suzuki, K, Mori, Y, Okamoto, K, Pitt, HA, Han, H-S, Hwang, T-L, Yoon, Y-S, Yoon, D-S, Choi, I-S, Huang, WS-W, Giménez, ME, Garden, OJ, Gouma, DJ, Belli, G, Dervenis, C, Jagannath, P, Chan, ACW, Lau, WY, Liu, K-H, Su, C-H, Misawa, T, Nakamura, M, Horiguchi, A, Tagaya, N, Fujioka, S, Higuchi, R, Shikata, S, Noguchi, Y, Ukai, T, Yokoe, M, Cherqui, D, Honda, G, Sugioka, A, de Santibañes, E, Supe, AN, Tokumura, H, Kimura, T, Yoshida, M, Mayumi, T, Kitano, S, Inomata, M, Hirata, K, Sumiyama, Y, Inui, K & Yamamoto, M 2018, 'Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos)', Journal of hepato-biliary- pancreatic sciences, ;25(1): 73-86. (AmsterdamUMC) 1572. Waliyanti E, Dewi FST, Supriyati S, Fles R,` Treatment-seeking behaviour of nasopharyngeal cancer patients in Yogyakarta, Indonesia`, Pan Afr Med J 2018; 29:98 (6 pp) (NKI) 1573. Walraven I, Kwint M, Belderbos J,` The Additional Prognostic Value of Tumor Volume Changes during Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer`, J Thorac Oncol 2018; 13:e181-e182 [Letter] (NKI) 1574. Walraven M, Homs MYV, van der Veldt AAM, Dekker H, Koldenhof J, Honeywell R, Barendrecht A, Sebastian SAE, Parr N, Koekman AC, Voest EE, Roest M, Korporaal SJA, Verheul HMW,` Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab`, Angiogenesis 2018; 21:325-34 (AmsterdamUMC/NKI) 1575. Walter, JE, Heuvelmans, MA, Yousaf-Khan, U, Dorrius, MD, Thunnissen, E, Schermann, A, Groen, HJM, van der Aalst, CM, Nackaerts, K, Vliegenthart, R, de Koning, HJ & Oudkerk, M 2018, 'New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial', Journal of Thoracic Oncology, ;13(9): 1410-1414. (AmsterdamUMC) 1576. Wang C, Jin H, Gao D, Lieftink C, Evers B, Jin G, Xue Z, Wang L, Beijersbergen RL, Qin W, Bernards R,` phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer`, J Hepatol 2018; 69:1057-65 (NKI) 1577. Wang C, Jin H, Gao D, Wang L, Evers B, Xue Z, Jin G, Lieftink C, Beijersbergen RL, Qin W, Bernards R,` A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma`, Cell Res 2018; 28:690-2 [Letter] (NKI) 1578. Wang J, Gan C, Retmana IA, Sparidans RW, Li W, Lebre MC, Beijnen JH, Schinkel AH,` P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice`, Int J Pharm 2018; 556:172-80 (NKI) 1579. Wang J, Gan C, Sparidans RW, Wagenaar E, van Hoppe S, Beijnen JH, Schinkel AH,` P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) affect brain accumulation and intestinal disposition of encorafenib in mice`, Pharmacol Res 2018; 129:414-23 (NKI) 1580. Wang L, Bernards R,` Taking advantage of drug resistance, a new approach in the war on cancer`, Front Med 2018; 12:490-5 (NKI) 1581. Wang L, Leite de Oliveira R, Huijberts S, Bosdriesz E, Pencheva N, Brunen D, Bosma A, Song JY, Zevenhoven J, Los-de Vries GT, Horlings H, Nuijen B, Beijnen JH, Schellens JHM, Bernards R,` An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential`, Cell 2018; 173:1413- 25 (NKI) 1582. Wang, M, Rule, S, Zinzani, PL, Goy, A, Casasnovas, O, Smith, SD, Damaj, G, Doorduijn, J, Lamy, T, Morschhauser, F, Panizo, C, Shah, B, Davies, A, Eek, R, Dupuis, J, Jacobsen, E, Kater, AP, Le Gouill, S, Oberic, L, Robak, T, Covey, T, Dua, R, Hamdy, A, Huang, X, Izumi, R, Patel, P, Rothbaum, W, Slatter, JG & Jurczak, W 2018, 'Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial', Lancet, ;391(10121): 659-667. (AmsterdamUMC) 1583. Wang, Z, van Dijk, IWEM, Wiersma, J, Ronckers, CM, Oldenburger, F, Balgobind, BV, Bosman, PAN, Bel, A & Alderliesten, T 2018, 'Are age and gender suitable matching criteria in organ dose reconstruction using surrogate childhood cancer patients’ CT scans?', Medical physics, ;45(6): 2628-2638. (AmsterdamUMC) 1584. Watkinson W, Raison N, Abe T, Harrison P, Khan S, van der Poel H, Dasgupta P, Ahmed K,` Establishing objective benchmarks in robotic virtual reality simulation at the level of a competent surgeon using the RobotiX Mentor simulator`, Postgrad Med J 2018; 94:270-7 (NKI) 1585. Weber, DC, Ares, C, Villa, S, Peerdeman, SM, Renard, L, Baumert, BG, Lucas, A, Veninga, T, Pica, A, Jefferies, S, Ricardi, U, Miralbell, R, Stelmes, J-J, Liu, Y, Collette, L & Collette, S 2018, 'Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non- randomized and observation study (EORTC 22042-26042)', Radiotherapy and Oncology, ;128(2): 260- 265. (AmsterdamUMC) 1586. Weberpals, J, Jansen, L, Silversmit, G, Verbeeck, J, van der Geest, L, Vissers, PAJ, Zadnik, V & Brenner, H 2018, 'Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: Exemplary cohort study among resected pancreatic cancer patients', Clinical epidemiology, ;10: 1109-1125. (AmsterdamUMC) 1587. Wei, D, Heus, P, van de Wetering, FT, van Tienhoven, G, Verleye, L & Scholten, RJPM 2018, 'Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer', Cochrane database of systematic reviews (Online), ;2018(8): CD008831. (AmsterdamUMC) 1588. Weijts, BGMW, Westendorp, B, Hien, BT, Martínez-López, LM, Zijp, M, Thurlings, I, Thomas, RE, Schulte-Merker, S, Bakker, WJ & de Bruin, A 2018, 'Atypical E2Fs inhibit tumor angiogenesis', Oncogene, ;37(2): 271-276. (AmsterdamUMC) 1589. Wellenstein MD, de Visser KE,` Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape`, Immunity 2018; 48:399-416 (NKI) 1590. Welters, MJP, Ma, W, Santegoets, SJAM, Goedemans, R, Ehsan, I, Jordanova, ES, Van Ham, VJ, Van Unen, V, Koning, F, Van Egmond, SI, Charoentong, P, Trajanoski, Z, Van Der Velden, LA & Van Der Burg, SH 2018, 'Intratumoral HPV16-specific T cells constitute a type I–oriented tumor microenvironment to improve survival in HPV16-driven oropharyngeal cancer', Clinical Cancer Research, ;24(3): 634-647. (AmsterdamUMC) 1591. Wentink, MQ, Verheul, HMW, Griffioen, AW, Schafer, KA, McPherson, S, Early, RJ, van der Vliet, HJ & de Gruijl, TD 2018, 'A safety and immunogenicity study of immunization with hVEGF/RFASE in cynomolgus monkeys', Vaccine, ;36(15): 2025-2032. (AmsterdamUMC) 1592. Wentink, MQ, Verheul, HMW, Pal, SK, George, S, Voortman, J, Danchaivijitr, P, Adelaiye, R, Poslinski, D, Groman, A, Hutson, A & Pili, R 2018, 'Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma', Clinical Genitourinary Cancer, ;16(1): e1-e9. (AmsterdamUMC) 1593. Weren RDA, van der Post RS, Vogelaar IP, van Krieken JH, Spruijt L, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Oliveira C, Kamping EJ, Schackert HK, Ranzani GN, Gomez Garcia EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Cats A, Bjornevoll I, Hoogerbrugge N, Ligtenberg MJL,` Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility`, J Med Genet 2018; 55:669-74 (AmsterdamUMC/NKI) 1594. Wesseling, P & Capper, D 2018, 'WHO 2016 Classification of gliomas', Neuropathology and Applied Neurobiology, ;44(2): 139-150. (AmsterdamUMC) 1595. Wesseling, P & Jacques, TS 2018, 'Taxonomy of CNS tumours;(): (AmsterdamUMC) 1596. Westerduin, E, Borstlap, WAA, Musters, GD, Westerterp, M, van Geloven, AAW, Tanis, PJ, Wolthuis, AM, Bemelman, WA & D'Hoore, A 2018, 'Redo coloanal anastomosis for anastomotic leakage after low anterior resection for rectal cancer: an analysis of 59 cases', Colorectal disease, ;20(1): 35-43. (AmsterdamUMC) 1597. Westerduin, E, Klaver, CEL, van Geloven, AAW, Westerterp, M, Bemelman, WA & Tanis, PJ 2018, 'Outcome After Redo Surgery for Complicated Colorectal and Coloanal Anastomosis: A Systematic Review', Diseases of the colon and rectum, ;61(8): 988-998. (AmsterdamUMC) 1598. Westgeest, HM, Uyl-de Groot, CA, van Moorselaar, RJA, de Wit, R, van den Bergh, ACM, Coenen, JLLM, Beerlage, HP, Hendriks, MP, Bos, MMEM, van den Berg, P, van de Wouw, AJ, Spermon, R, Boerma, MO, Geenen, MM, Tick, LW, Polee, MB, Bloemendal, HJ, Cordia, I, Peters, FPJ, de Vos, AI, van den Bosch, J, van den Eertwegh, AJM & Gerritsen, WR 2018, 'Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry', European Urology Focus, ;4(5): 694-701. (AmsterdamUMC) 1599. Westra, WM, Lutzke, LS, Mostafavi, NS, Roes, AL, Calpe, S, Wang, KK & Krishnadath, KK 2018, 'Smokeless Tobacco and Cigar and/or Pipe Are Risk Factors for Barrett Esophagus in Male Patients With Gastroesophageal Reflux Disease', Mayo Clinic proceedings. Mayo Clinic, ;93(9): 1282-1289. (AmsterdamUMC) 1600. Whelan, J, le Deley, M-C, Dirksen, U, Teuff, GL, Brennan, B, Gaspar, N, Hawkins, DS, Amler, S, Bauer, S, Bielack, S, Blay, J-Y, Burdach, S, Castex, M-P, Dilloo, D, Eggert, A, Gelderblom, H, Gentet, J-C, Hartmann, W, Hassenpflug, W-A, Hjorth, L, Jimenez, M, Klingebiel, T, Kontny, U, Kruseova, J, Ladenstein, R, Laurence, V, Lervat, C, Marec-Berard, P, Marreaud, S, Michon, J, Morland, B, Paulussen, M, Ranft, A, Reichardt, P, van den Berg, H, Wheatley, K, Judson, I, Lewis, I, Craft, A, Juergens, H & Oberlin, O 2018, 'High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk ewing sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing- 2008', Journal of clinical oncology, ;36(31): 3110-3119. (AmsterdamUMC) 1601. Wiegand, S, Wichmann, G, Golusinski, W, Leemans, CR, Klussmann, JP & Dietz, A 2018, 'Highlights from the Second International Symposium on HPV infection in head and neck cancer', European Archives of Oto-Rhino-Laryngology, ;275(6): 1365-1373. (AmsterdamUMC) 1602. Wielders CLC, van Nierop P, Vormer TL, Foijer F, Verheij J, Lodder JC, Andersen JB, Mansvelder HD, Te Riele H,` RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation`, PLoS One 2018; 13:e0196979 [26 pp] (NKI) 1603. Wieldraaijer, T, Bruin, P, Duineveld, LAM, Tanis, PJ, Smits, AB, van Weert, HCPM & Wind, J 2018, 'Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma', Digestive surgery, ;35(1): 35-41. (AmsterdamUMC) 1604. Wieldraaijer, T, Duineveld, LAM, Donkervoort, SC, Busschers, WB, van Weert, HCPM & Wind, J 2018, 'Colorectal cancer patients' preferences for type of caregiver during survivorship care', Scandinavian journal of primary health care, ;36(1): 14-19. (AmsterdamUMC) 1605. Wieten, E, de Klerk, CM, van der Steen, A, Ramakers, CR, Kuipers, EJ, Hansen, BE, Lansdorp-Vogelaar, I, Bossuyt, PM, Dekker, E & Spaander, MCW 2018, 'Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program', Gastroenterology, ;155(5): 1392-1399.e5. (AmsterdamUMC) 1606. Wiggers, JK, Groot Koerkamp, B, van Klaveren, D, Coelen, RJ, Nio, CY, Allen, PJ, Besselink, MG, Busch, OR, D'Angelica, MI, DeMatteo, RP, Kingham, TP, van Gulik, TM & Jarnagin, WR 2018, 'Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging', Journal of the American College of Surgeons, ;227(2): 238-246.e2. (AmsterdamUMC) 1607. Wijn DH, Groeneveld GH, Vollaard AM, Muller M, Wallinga J, Gelderblom H, Smit EF,` Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events`, Eur J Cancer 2018; 104:182-7 (AmsterdamUMC/NKI) 1608. Wildeboer, RR, van Sloun, RJG, Postema, AW, Mannaerts, CK, Gayet, M, Beerlage, HP, Wijkstra, H & Mischi, M 2018, 'Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology', Journal of Ultrasound, ;21(3): 197-207. (AmsterdamUMC) 1609. Wildeboer, RR, van Sloun, RJG, Schalk, SG, Mannaerts, CK, van der Linden, JC, Huang, P, Wijkstra, H & Mischi, M 2018, 'Convective-Dispersion Modeling in Three-Dimensional Contrast-Ultrasound Imaging for the Localization of Prostate Cancer', IEEE transactions on medical imaging, ;37(12): 2593 - 2602 . (AmsterdamUMC) 1610. Wildenberg, ME, Duijvestein, M, Westera, L, van Viegen, T, Buskens, CJ, van der Bilt, JDW, Stitt, L, Jairath, V, Feagan, BG & Vande Casteele, N 2018, 'Evaluation of the effect of storage condition on cell extraction and flow cytometric analysis from intestinal biopsies', Journal of immunological methods, ;459: 50-54. (AmsterdamUMC) 1611. Wils, LJ & Bijlsma, MF 2018, 'Epigenetic regulation of the Hedgehog and Wnt pathways in cancer', Critical reviews in oncology/hematology, ;121: 23-44. (AmsterdamUMC) 1612. Wilson, MJ, Dekker, JW, Bruns, E, Borstlap, W, Jeekel, J, Zwaginga, JJ & Schipperus, M 2018, 'Short- term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study', Transfusion, ;58(3): 795-803. (AmsterdamUMC) 1613. Wind A, Goncalves F, Marosi E, da Pieve L, Groza M, Asioli M, Albini M, van Harten W,` Benchmarking Cancer Centers: From Care Pathways to Integrated Practice Units`, J Natl Compr Canc Netw 2018; 16:1075-83 (NKI) 1614. Wind A, van Dijk J, Nefkens I, van Lent W, Nagy P, Janulionis E, Helander T, Rocha-Goncalves F, van Harten W,` Development of a benchmark tool for cancer centers; results from a pilot exercise`, BMC Health Serv Res 2018; 18:764 (NKI) 1615. Wind, J, Nugteren, IC, van Laarhoven, HWM, van Weert, HCPM & Henselmans, I 2018, 'Who should provide care for patients receiving palliative chemotherapy? A qualitative study among Dutch general practitioners and oncologists', Scandinavian journal of primary health care, ;36(4): 437-445. (AmsterdamUMC) 1616. Winters BR, Vakar-Lopez F, Brown L, Montgomery B, Seiler R, Black PC, Boormans JL, Dall Era M, Davincioni E, Douglas J, Gibb EA, van Rhijn BWG, van der Heijden MS, Hsieh AC, Wright JL, Lam HM,` Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy`, Urol Oncol 2018; 36:342 (NKI) 1617. Woestenberg, PJ, King, AJ, van Benthem, BHB, Donken, R, Leussink, S, van der Klis, FRM, de Melker, HE, van der Sande, MAB, Hoebe, CJPA, Bogaards, JA & Medical Microbiological Laboratories, and the Public Health Services 2018, 'Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors', Journal of Infectious Diseases, ;217(2): 213-222. (AmsterdamUMC) 1618. Wojcik A, Bouffler SD, Hauptmann M, Rajaraman P,` Considerations on the use of the terms radiosensitivity and radiosusceptibility`, J Radiol Prot 2018; 38:N25-N29 (NKI) 1619. Wolff, HB, Alberts, L, Kastelijn, EA, Lissenberg-Witte, BI, Twisk, JW, Lagerwaard, FJ, Senan, S, El Sharouni, SY, Schramel, FMNH & Coupé, VMH 2018, 'Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer', Journal of Thoracic Oncology, ;13(5): 689-698. (AmsterdamUMC) 1620. Wollinga, T, Ezendam, NPM, Eggink, FA, Smink, M, van Hamont, D, Pijlman, B, Boss, E, Robbe, EJ, Ngo, H, Boll, D, Mom, CH, van der Aa, MA, Kruitwagen, RFLP, Nijman, HW & Pijnenborg, JMA 2018, 'Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade', Gynecological Surgery, ;15(1): 7. (AmsterdamUMC) 1621. Wolvers, MDJ, Leensen, MCJ, Groeneveld, IF, Frings-Dresen, MHW & de Boer, AGEM 2018, 'Predictors for earlier return to work of cancer patients', Journal of cancer survivorship, ;12(2): 169-177. (AmsterdamUMC) 1622. Woodings SJ, Wolthaus JWH, van Asselen B, de Vries JHW, Kok JGM, Lagendijk JJW, Raaymakers BW,` Performance of a PTW 60019 microDiamond detector in a 15 T MRI-linac`, Phys Med Biol 2018; 63:05NT04 (9 pp) (NKI) 1623. Woolderink JM, de Bock GH, de Hullu JA, Hollema H, Zweemer RP, Slangen BFM, Gaarenstroom KN, van Beurden M, van Doorn HC, Sijmons RH, Vasen HFA, Mourits MJE,` Characteristics of Lynch syndrome associated ovarian cancer`, Gynecol Oncol 2018; 150:324-30 (NKI) 1624. Wortman BG, Creutzberg CL, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LCHW, van der Steen- Banasik EM, Mens JWM, Slot A, Kroese MCS, van Triest B, Nijman HW, Stelloo E, Bosse T, de Boer SM, van Putten WLJ, Smit VTHB, Nout RA,` Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy`, Br J Cancer 2018; 119:1067-74 (NKI) 1625. Woudstra, AJ, Timmermans, DRM, Uiters, E, Dekker, E, Smets, EMA & Fransen, MP 2018, 'Health literacy skills for informed decision making in colorectal cancer screening: Perceptions of screening invitees and experts', Health expectations, ;21(3): 636-646. (AmsterdamUMC) 1626. Wouters MW, Michielin O, Bastiaannet E, Beishon M, Catalano O, Del Marmol V, Delgado-Bolton R, Dendale R, Trill MD, Ferrari A, Forsea AM, Kreckel H, Lovey J, Luyten G, Massi D, Mohr P, Oberst S, Pereira P, Prata JPP, Rutkowski P, Saarto T, Sheth S, Spurrier-Bernard G, Vuoristo MS, Costa A, Naredi P,` ECCO essential requirements for quality cancer care: Melanoma`, Crit Rev Oncol Hematol 2018; 122:164-78 (NKI) 1627. Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al Ejeh F, Rozali E, Wang Q, Dennis J, Li B, Zeng C, Feng H, Gusev A, Barfield RT, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Barrdahl M, Baynes C, Beckmann MW, Benitez J, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brinton L, Broberg P, Brucker SY, Burwinkel B, Caldes T, Canzian F, Carter BD, Castelao JE, Chang-Claude J, Chen X, Cheng TD, Christiansen H, Clarke CL, Collee M, Cornelissen S, Couch FJ, Cox D, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dork T, Dos-Santos-Silva I, Dumont M, Dwek M, Eccles DM, Eilber U, Eliassen AH, Engel C, Eriksson M, Fachal L, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, Garcia-Closas M, Gaudet MM, Ghoussaini M, Giles GG, Goldberg MS, Goldgar DE, Gonzalez-Neira A, Guenel P, Hahnen E, Haiman CA, Hakansson N, Hall P, Hallberg E, Hamann U, Harrington P, Hein A, Hicks B, Hillemanns P, Hollestelle A, Hoover RN, Hopper JL, Huang G, Humphreys K, Hunter DJ, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones ME, Jung A, Kaaks R, Kerin MJ, Khusnutdinova E, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Li J, Lindstrom S, Lissowska J, Lo WY, Loibl S, Lubinski J, Luccarini C, Lux MP, MacInnis RJ, Maishman T, Kostovska IM, Mannermaa A, Manson JE, Margolin S, Mavroudis D, Meijers-Heijboer H, Meindl A, Menon U, Meyer J, Mulligan AM, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Nordestgaard BG, Olopade OI, Olson JE, Olsson H, Peterlongo P, Peto J, Plaseska-Karanfilska D, Prentice R, Presneau N, Pylkas K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Rudolph A, Saloustros E, Sandler DP, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Scott RJ, Scott CG, Seal S, Shah M, Shrubsole MJ, Smeets A, Southey MC, Spinelli JJ, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper W, Taylor JA, Terry MB, Tessier DC, Thomas A, Thone K, Tollenaar RAEM, Torres D, Truong T, Untch M, Vachon C, Van Den Berg D, Vincent D, Waisfisz Q, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett WC, Winqvist R, Wolk A, Xia L, Yang XR, Ziogas A, Ziv E, Dunning AM, Pharoah PDP, Simard J, Milne RL, Edwards SL, Kraft P, Easton DF, Chenevix-Trench G, Zheng W,` A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer`, Nat Genet 2018; 50:968-78 (AmsterdamUMC/NKI) 1628. Xue Z, Vis DJ, Bruna A, Sustic T, van Wageningen S, Batra AS, Rueda OM, Bosdriesz E, Caldas C, Wessels LFA, Bernards R,` MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models`, Cell Res 2018; 28:719-29 (NKI) 1629. Young-Afat DA, Hoornweg MJ, van Huizum MA,` Autologous breast reconstruction in sickle cell trait: A fine line between success & failure`, Breast J 2018; 24:193-5 (NKI) 1630. Yu Y, Schleich K, Yue B, Ji S, Lohneis P, Kemper K, Silvis MS, Qutob N, van Rooijen E, Werner-Klein M, Li L, Dhawan D, Meierjohann S, Reimann M, Elkahloun A, Treitschke S, Dorken B, Speck C, Mallette FA, Zon LI, Holmen SL, Peeper DS, Samuels Y, Schmitt CA, Lee S,` Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma`, Cancer Cell 2018; 33:322-36 (NKI) 1631. Yu, Y, Böing, AN, Hau, CM, Hajji, N, Ruf, W, Sturk, A & Nieuwland, R 2018, 'Tissue Factor Coagulant Activity is Regulated by the Plasma Membrane Microenvironment', Thrombosis and haemostasis, ;118(6): 990-1000. (AmsterdamUMC) 1632. Yu, Y, Gool, E, Berckmans, RJ, Coumans, FAW, Barendrecht, AD, Maas, C, van der Wel, NN, Altevogt, P, Sturk, A & Nieuwland, R 2018, 'Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets', Journal of thrombosis and haemostasis, ;16(6): 1153-1163. (AmsterdamUMC) 1633. Zafar, S, Sorsa, S, Siurala, M, Hemminki, O, Havunen, R, Cervera-Carrascon, V, Santos, JM, Wang, H, Lieber, A, de Gruijl, T, Kanerva, A & Hemminki, A 2018, 'CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy', OncoImmunology, ;7(10): e1490856. (AmsterdamUMC) 1634. Zaimi I, Sparreboom CL, Lingsma HF, Doornebosch PG, Menon AG, Kleinrensink GJ, Jeekel J, Wouters MWJM, Lange JF,` The effect of age on anastomotic leakage in colorectal cancer surgery: A population- based study`, J Surg Oncol 2018; 118:113-20 (NKI) 1635. Zaman, A-CGNM, Tytgat, KMAJ, Van Hezel, S, Klinkenbijl, JHG, de Boer, AGEM & Frings-Dresen, MHW 2018, 'Development of a tailored work-related support intervention for gastrointestinal cancer patients', European journal of cancer care, ;27(2): e12782. (AmsterdamUMC) 1636. Zamboglou C, Eiber M, Fassbender T, Eder M, Kirste S, Bock M, Schilling O, Reichel K, van der Heide UA, Grosu AL,` Multimodal imaging for radiation therapy planning in patients with primary prostate cancer - a review`, Phys Imag Radiat Oncol 2018; 8:8-16 (NKI) 1637. Zargar H, Shah JB, van Rhijn BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W,` Neoadjuvant dose dense MVAC versus GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy`, J Urol 2018; 199:1452-8 (NKI) 1638. Zazuli Z, Vijverberg S, Slob E, Liu G, Carleton B, Veltman J, Baas P, Masereeuw R, Maitland-Van der Zee AH,` Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review`, Front Pharmacol 2018; 9:1111 (17 pp) (NKI) 1639. Zeki, SS, Bergman, JJ & Dunn, JM 2018, 'Endoscopic management of dysplasia and early oesophageal cancer', Best practice & research. Clinical gastroenterology, ; 36-37: 27-36. (AmsterdamUMC) 1640. Zerhouni S, van Coevorden F, Swallow CJ,` (The role and outcomes of palliative surgery for retroperitoneal sarcoma)`, J Surg Oncol 2018; 117:105-10 (NKI) 1641. Zhang P, Yorke E, Mageras G, Rimner A, Sonke JJ, Deasy JO,` Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer`, Int J Radiat Oncol Biol Phys 2018; 102:978-86 (NKI) 1642. Zijlstra, JM & Boellaard, R 2018, 'Baseline PET as prognostic marker for Hodgkin?', Blood, ;131(1): 3-4. (AmsterdamUMC) 1643. Zijlstra, M, van der Geest, LGM, van Laarhoven, HWM, Lemmens, VEPP, van de Poll-Franse, LV & Raijmakers, NJH 2018, 'Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands', Acta oncologica (Stockholm, Sweden), ;57(9): 1185-1191. (AmsterdamUMC) 1644. Zomerman, WW, Plasschaert, SLA, Conroy, S, Scherpen, FJ, Meeuwsen-de Boer, TGJ, Lourens, HJ, Guerrero Llobet, S, Smit, MJ, Slagter-Menkema, L, Seitz, A, Gidding, CEM, Hulleman, E, Wesseling, P, Meijer, L, van Kempen, LC, van den Berg, A, Warmerdam, DO, Kruyt, FAE, Foijer, F, van Vugt, MATM, den Dunnen, WFA, Hoving, EW, Guryev, V, de Bont, ESJM & Bruggeman, SWM 2018, 'Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma', Cell Reports, ;22(12): 3206-3216. (AmsterdamUMC) 1645. Zuidema A, Wang W, Kreft M, Te ML, Hoekman L, Bleijerveld OB, Nahidiazar L, Janssen H, Sonnenberg A,` Mechanisms of integrin alphaVbeta5 clustering in flat clathrin lattices`, J Cell Sci 2018; 131:221317 (16 pp) (NKI) 1646. Zuiverloon TCM, van Kessel KEM, Bivalacqua TJ, Boormans JL, Ecke TH, Grivas PD, Kiltie AE, Liedberg F, Necchi A, van Rhijn BW, Roghmann F, Sanchez-Carbayo M, Schmitz-Drager BJ, Wezel F, Kamat AM,` Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network`, Urol Oncol 2018; 36:423-31 (NKI) 1647. Zummeren, MV, Kremer, WW, Leeman, A, Bleeker, MCG, Jenkins, D, Sandt, MVD, Doorbar, J, Heideman, DAM, Steenbergen, RDM, Snijders, PJF, Kenter, GG, Quint, WGV, Berkhof, J & Meijer, CJLM 2018, 'HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions', Modern pathology, ;31(12): 1842-1850. (AmsterdamUMC) 1648. Zweegman, S & Cucchi, DGJ 2018, 'RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML', Blood. (AmsterdamUMC)